Scolaris Content Display Scolaris Content Display

Ujian diagnostik yang tidak invasif untuk jangkitan Helicobacter pylori

Contraer todo Desplegar todo

Referencias

References to studies included in this review

Adamopoulos 2009a {published data only}

Adamopoulos AB, Stergiou GS, Saklzlis GN, Tiniakos DG, Nasothimiou EG, Sioutis DK, et al. Diagnostic value of rapid urease test and urea breath test for Helicobacter pylori detection in patients with Billroth ii gastrectomy: A prospective controlled trial. Digestive and Liver Disease 2009;41(1):4‐8. CENTRAL

Adamopoulos 2009b {published data only}

Adamopoulos AB, Stergiou GS, Saklzlis GN, Tiniakos DG, Nasothimiou EG, Sioutis DK, et al. Diagnostic value of rapid urease test and urea breath test for Helicobacter pylori detection in patients with Billroth ii gastrectomy: A prospective controlled trial. Digestive and Liver Disease 2009;41(1):4‐8. CENTRAL

Aguilar 2007 {published data only}

Aguilar RC, Saavedra SP, Mendoza PG, Bussalleu RA, Cok GJ, Martinez MF, et al. Study of urease test or breath test (BT) and correlation with gastric biopsy to detect Helicobacter pylori (hp) in dyspeptic patients at "Hospital Nacional Cayetano Heredia hospital" (HNCH)‐‐Lima. Revista de Gastroenterologia del Peru 2007;27(2):172‐6. CENTRAL

Al‐Fadda 2000 {published data only}

Al‐Fadda M, Powe J, Rezeig M, Al Nazer M, Alrajhi AA, Baynton R. Comparison of carbon‐14‐urea breath test and rapid urease test with gastric biopsy for identification of Helicobacter pylori. Annals of Saudi Medicine 2000;20(2):170‐2. CENTRAL

Allardyce 1997 {published data only}

Allardyce RA, Chapman BA, Tie ABM, Burt MJ, Yeo KJ, Keenan JI, et al. 37 KBQ C‐14‐urea breath test and gastric biopsy analyses of H‐pylori infection. Australian and New Zealand Journal of Surgery 1997;67(1):31‐4. CENTRAL

Argentieri 2007 {published data only}

Argentieri M, Sabbi T, Pansani L, Torroni F, Francalanci P, De Angelis P, et al. Helicobacter pylori infection in children: Utility of culture in diagnosis and study of resistance to metronidazole, clarithromycin and amoxicillin. Journal of Pediatric Infectious Diseases 2007;2(3):135‐9. CENTRAL

Arikan 2004 {published data only}

Arikan S, Kocakusak A, Barut G, Sengoz G, Yucel AF, Gokturk K. Helicobacter pylori stool antigen test: Results of a prospective study. Surgery Today 2004;34(4):318‐22. CENTRAL

Atli 2012 {published data only}

Atli T, Sahin S, Arslan BU, Varli M, Yalcin AE, Aras S. Comparison of the C14 urea breath test and histopathology in the diagnosis of Helicobacter pylori in the elderly. Journal of the Pakistan Medical Association 2012;62(10):1061‐5. CENTRAL

Behrens 1999 {published data only}

Behrens R, Lang T, Keller KM, Bindl L, Becker M, Rodeck B, et al. Dual versus triple therapy of Helicobacter pylori infection: Results of a multicentre trial. Archives of Disease in Childhood 1999;81(1):68‐70. CENTRAL
Behrens R, Lang T, Keller KM, Bindl L, Becker M, Rodeck B, et al. Helicobacter pylori infection in children and adolescents. Diagnosis and treatment. [German]. Tagliche Praxis 2001;42(3):473‐83. CENTRAL

Bosso 2000 {published data only}

Bosso S, Balbo L, Lerro P, Kuvidi M, Musso A, Ansaldi N. Antigen detection in stools as a first choice for laboratory diagnosis of Helicobacter pylori disease. Minerva Gastroenterologica e Dietologica 2000;46(1):15‐8. CENTRAL

Ceken 2011 {published data only}

Ceken N, Yurtsever SG, Baran N, Alper E, Buyrac Z, Unsal B. Comparison of Helicobacter pylori antibody detection in stool with other diagnostic tests for infection. Asian Pacific Journal of Cancer Prevention 2011;12(4):1077‐81. CENTRAL

Chen 1991 {published data only}

Chen CF, Lee MH, Ng JL, Lin CY, Yeh HW, Huang TW. A rapid latex test for the serological diagnosis of Helicobacter pylori. Chinese Journal of Gastroenterology 1991;8(4):266‐70. CENTRAL

Chey 1998 {published data only}

Chey WD, Murthy UK, Linscheer W, Barish C, Riff D, Rubin H, et al. The ChemTrak Hp Chek fingerstick whole blood serology test for the detection of Helicobacter pylori infection. American Journal of Gastroenterology 1998;93(1):16‐9. CENTRAL

Czerwionka‐Szaflarska 2007 {published data only}

Czerwionka‐Szaflarska M, Brazowski J, Kupczyk W. Value of urease breath test in Helicobacter pylori infection diagnostics among children and youth. Medycyna Wieku Rozwojowego 2007;11(2 Pt 1):97‐101. CENTRAL

D'Elios 2000 {published data only}

D'Elios MM, Amedei A, Benagiano M, Azzurri A, Del Prete G. Usefulness of 13C‐urea breath test in the diagnosis of gastric Helicobacter pylori infection. International Journal of Immunopathology and Pharmacology 2000;13(1):27‐30. CENTRAL

Debongnie 1991 {published data only}

Debongnie JC, Pauwels S, Raat A, De Meeus Y, Haot J, Mainguet P. Quantification of Helicobacter pylori infection in gastritis and ulcer disease using a simple and rapid carbon‐14‐urea breath test. Journal of Nuclear Medicine 1991;32(6):1192‐8. CENTRAL

Dede 2015 {published data only}

Dede F, Civen H, Dane F, Aliustaoglu M, Turhal S, Turoglu HT, et al. Carbon‐14 urea breath test: Does it work in patients with partial gastric resection?. Annals of Nuclear Medicine 2015;29(9):786‐91. CENTRAL

Delvin 1999 {published data only}

Delvin EE, Brazier JL, Deslandres C, Alvarez F, Russo P, Seidman E. Accuracy of the [13C]‐urea breath test in diagnosing Helicobacter pylori gastritis in pediatric patients. Journal of Pediatric Gastroenterology and Nutrition 1999;28(1):59‐62. CENTRAL

Dinler 1999 {published data only}

Dinler G, Ozen H, Kocak N, Yuce A, Gurakan F. Detection of Helicobacter pylori infection. American Journal of Gastroenterology 1999;94(4):1118. CENTRAL

Duan 1999 {published data only}

Duan L, Duan X, Ye S, Wang J, Jin Z, Wang Z. The diagnostic value of 13C‐urea breath test in Helicobacter pylori colonization density and the severity of gastritis. Zhonghua Nei Ke za Zhi [Chinese Journal of Internal Medicine] 1999;38(12):824‐6. CENTRAL

Eggers 1990 {published data only}

Eggers RH, Kulp A, Tegeler R, Ludtke FE, Lepsien G, Meyer B, et al. A methodological analysis of the c‐13‐urea breath test for detection of Helicobacter‐pylori infections ‐ high‐sensitivity and specificity within 30‐min using 75‐mg of c‐13‐urea. European Journal of Gastroenterology & Hepatology 1990;2(6):437‐44. CENTRAL

Ekesbo 2006 {published data only}

Ekesbo R, Toth E, Fork FT, Held M, Nilsson I, Wadstrom T, et al. Chronic Helicobacter pylori infection in a population in southern Sweden analysed by histopathology, immunoblot and ELISA serology. European Journal of Gastroenterology & Hepatology 2006;18(6):589‐93. CENTRAL

El‐Din 2013 {published data only}

El‐Din HMA, Hashem AGM, Ragab YM, Hussein IL, Mohamed DB, Mohamed EB. Evaluation of noninvasive versus invasive techniques for the diagnosis of Helicobacter pylori infection. Applied Immunohistochemistry & Molecular Morphology 2013;21(4):326‐33. CENTRAL

El‐Mekki 2011 {published data only}

El‐Mekki A, Kumar A, Alknawy B, Al‐Ammari O, Moosa R, Quli S, et al. Comparison of enzyme immunoassays detecting Helicobacter pylori specific IgG in serum and saliva with endoscopic and biopsy findings in patients with dyspepsia. Indian Journal of Medical Microbiology 2011;29(2):136‐40. CENTRAL

El‐Nasr 2003 {published data only}

El‐Nasr MS, Elibiary SA, Bastawi MB, Hassan A, Shahin Y, Hassan L, et al. Evaluation of a new enzyme immunoassay for the detection of Helicobacter pylori in stool specimens. Journal of the Egyptian Society of Parasitology 2003;33(3):905‐15. CENTRAL

Eltumi 1999 {published data only}

Eltumi M, Brueton MJ, Francis N. Diagnosis of Helicobacter pylori gastritis in children using the 13C urea breath test. Journal of Clinical Gastroenterology 1999;28(3):238‐40. CENTRAL

Epple 1997 {published data only}

Epple HJ, Kirstein FW, Bojarski C, Frege J, Fromm M, Riecken EO, et al. 13C‐urea breath test in Helicobacter pylori diagnosis and eradication. Correlation to histology, origin of 'false' results, and influence of food intake. Scandinavian Journal of Gastroenterology 1997;32(4):308‐14. CENTRAL

Fallone 1995 {published data only}

Fallone CA, Mitchell A, Paterson WG. Determination of the test performance of less costly methods of Helicobacter pylori detection. Clinical and Investigative Medicine. Medecine Clinique et Experimentale 1995;18(3):177‐85. CENTRAL

Fallone 1996 {published data only}

Fallone CA, Elizov M, Cleland P, Thompson JA, Wild GE, Lough J, et al. Detection of Helicobacter pylori infection by saliva IgG testing. American Journal of Gastroenterology 1996;91(6):1145‐9. CENTRAL

Fanti 1999 {published data only}

Fanti L, Mezzi G, Cavallero A, Gesu G, Bonato C, Masci E. A new simple immunoassay for detecting Helicobacter pylori infection: Antigen in stool specimens. Digestion 1999;60(5):456‐60. CENTRAL

Faruqui 2007 {published data only}

Faruqui AN, Majid U, Ahmed L, Khalil M, ul Hassan M. Helicobacter pylori stool antigen test (HpSA) for the diagnosis of gastric infection. Journal of the College of Physicians and Surgeons Pakistan 2007;17(6):316‐9. CENTRAL

Ferrara 1998 {published data only}

Ferrara M, Apuzzo M, Bazuro ME, Tammaro GF, Pippa G. Serology screening for Helicobacter pylori in dyspeptic patients. Giornale Italiano di Endoscopia Digestiva 1998;21(1):15‐22. CENTRAL

Formichella 2013 {published data only}

Formichella L, Romberg L, Bolz C, Vieth M, Geppert M, Gottner G, et al. A novel line immunoassay based on recombinant virulence factors enables highly specific and sensitive serologic diagnosis of Helicobacter pylori infection. Clinical & Vaccine Immunology: CVI 2013;20(11):1703‐10. CENTRAL
Gholi MK, Kalali B, Formichella L, Gottner G, Shamsipour F, Zarnani AH, et al. Helicobacter pylori FliD protein is a highly sensitive and specific marker for serologic diagnosis of H. pylori infection. International Journal of Medical Microbiology 2013;303(8):618‐23. CENTRAL

Germana 2001 {published data only}

Germana B, Galliani E, Lecis P, Costan F. Diagnosis of Helicobacter pylori infections using isotope‐selective non dispersive infrared spectrometry with 13C‐urea breath test. Recenti Progressi in Medicina 2001;92(2):113‐6. CENTRAL
Germana B, Galliani EA, Lecis PE, Doglioni C, Costan F. Isotope‐selective non dispersive infrared spectrometry for detection of Helicobacter‐pylori infection with c‐13‐urea breath test. Gut 1999;45(Suppl 3):A130. CENTRAL

Graham 1996a {published data only}

Graham DY, Evans DJ, Peacock J, Baker JT, Schrier WH. Comparison of rapid serological tests (Flexsure Hp and Quickvue) with conventional ELISA for detection of Helicobacter pylori infection. American Journal of Gastroenterology 1996;91(5):942‐8. CENTRAL

Gramley 1999 {published data only}

Gramley WA, Asghar A, Frierson HF, Powell SM. Detection of Helicobacter pylori DNA in fecal samples from infected individuals. Journal of Clinical Microbiology 1999;37(7):2236‐40. CENTRAL

Guo 2011 {published data only}

Guo JX, Han J, Chen L, Xu J, Liu J, Zhao J, et al. Evaluation of the Helicobacter pylori stool antigen test. Zhonghua Shi Yan He Lin Chuang Bing du Xue za Zhi [Chinese Journal of Experimental and Clinical Virology] 2011;25(6):495‐6. CENTRAL

Gurbuz 2005 {published data only}

Gurbuz AK, Ozel AM, Narin Y, Yazgan Y, Baloglu H, Demirturk L. Is the remarkable contradiction between histology and c‐14 urea breath test in the detection of Helicobacter pylori due to false‐negative histology or false‐positive c‐14 urea breath test?. Journal of International Medical Research 2005;33(6):632‐40. CENTRAL

Hafeez 2007 {published data only}

Hafeez A, Bilal R, Haseeb HA, Khan UF, Latif Z, Hassan M. Comparison of diagnostic accuracy of non‐invasive tests for Helicobacter pylori infection in children. Journal of the College of Physicians and Surgeons‐‐Pakistan : JCPSP 2007;17(5):261‐4. CENTRAL

Han 2012 {published data only}

Han H, Lee S, Hwang T. The significance of positive giemsa stain cases in negative UBT (urea breath test) patients. Helicobacter 2012;17:117. CENTRAL

Inelmen 2004 {published data only}

Inelmen EM, Gasparini G, Sergi G, Enzi G. Evaluation of Helicobacter pylori with a stool antigen assay in frail, elderly patients. Scandinavian Journal of Gastroenterology 2005;40(7):794‐9. CENTRAL
Inelmen EM, Maccari T, Enzi G, Gasparini G, Fuson F, Davanzo B, et al. Helicobacter pylori infection diagnosis in hospitalised elderly patients: The stool antigen test (HpSA) in comparison with other methods. Aging‐Clinical & Experimental Research 2004;16(5):349‐55. CENTRAL

Iqbal 2013 {published data only}

Iqbal S, Fatima S, Raheem A, Khan AH. Agreement between serology and histology for detection of Helicobacter pylori infection. Journal of the College of Physicians and Surgeons‐‐Pakistan : JCPSP 2013;23(10):784‐6. CENTRAL

Islam 2005 {published data only}

Islam S, Weilert F, Babington R, Dickson G, Smith AC. Stool antigen testing for the diagnosis and confirmation of eradication of Helicobacter pylori infection: A prospective blinded trial. Internal Medicine Journal 2005;35(9):526‐9. CENTRAL

Ivanova 2010 {published data only}

Ivanova K, Marina M, Vladimirov B, Churchev J, Tersiev I. Comparison of different methods for detection of Helicobacter pylori infection. Problems of Infectious and Parasitic Diseases 2010;38(1):25‐7. CENTRAL

Jekarl 2013 {published data only}

Jekarl DW, An YJ, Lee S, Lee J, Kim Y, Park YJ, et al. Evaluation of a newly developed rapid stool antigen test using an immunochromatographic assay to detect Helicobacter pylori. Japanese Journal of Infectious Diseases 2013;66(1):60‐4. CENTRAL

Jensen 1998 {published data only}

Jensen G, Friedenberg F, Levine G, Zaeri N, Braitman LE, Tran HD, et al. Accuracy and clinical utility of the mini‐dose c‐14‐urea breath test in the evaluation of Helicobacter pylori infection. Nuclear Medicine Communications 1998;19(8):771‐5. CENTRAL

Jordaan 2008 {published data only}

Jordaan M, Laurens JB. Diagnosis of Helicobacter pylori infection with the c‐13‐urea breath test by means of GC‐MS analysis. Journal of Separation Science 2008;31(2):329‐35. CENTRAL

Kalach 1998a {published data only}

Kalach N, Briet F, Raymond J, Benhamou PH, Barbet P, Bergeret M, et al. The 13Carbon urea breath test for the noninvasive detection of Helicobacter pylori in children: Comparison with culture and determination of minimum analysis requirements. Journal of Pediatric Gastroenterology & Nutrition 1998;26(3):291‐6. CENTRAL

Kamel 2011 {published data only}

Kamel HY, Abd‐Al‐Atty MF, El‐Banoby MH, El‐Baz AA, Sakr MA, Ahmed NS, et al. Stool antigen test in diagnosis of Helicobacter pylori in older adults with dyspepsia. Journal of the American Geriatrics Society 2011;59(9):1769‐70. CENTRAL

Kim 2016 {published data only}

Kim DH, Kim HD, Park H, Choi S, Beom JW, Kim WJ, et al. New monoclonal antibody‐based test for Helicobacter pylori urease in gastric tissue. Korean Journal of Internal Medicine 2016;31(1):40‐5. CENTRAL

Korstanje 2006 {published data only}

Korstanje A, Van Eeden S, Offerhaus GJ, Sabbe LJ, Den Hartog G, Biemond I, et al. The 13Carbon urea breath test for the diagnosis of Helicobacter pylori infection in subjects with atrophic gastritis: Evaluation in a primary care setting. Alimentary Pharmacology & Therapeutics 2006;24(4):643‐50. CENTRAL

Kuloglu 2008 {published data only}

Kuloglu Z, Kansu A, Kirsaclioglu CT, Ustundag G, Aysev D, Ensari A, et al. A rapid lateral flow stool antigen immunoassay and (14)C‐urea breath test for the diagnosis and eradication of Helicobacter pylori infection in children. Diagnostic Microbiology & Infectious Disease 2008;62(4):351‐6. CENTRAL

Ladas 2002a {published data only}

Ladas SD, Malamou H, Triantafyllou K, Varzakakos I, Georgopoulos S, Giota G, et al. Performance of two immunosorbent assay kits for the detection of serum immunoglobulin G to Helicobacter pylori in untreated Greek patients. Scandinavian Journal of Gastroenterology 2002;37(5):512‐6. CENTRAL

Lahner 2004 {published data only}

Lahner E, Vaira D, Figura N, Pilozzi E, Pasquali A, Severi C, et al. Role of noninvasive tests (c‐13‐urea breath test and stool antigen test) as additional tools in diagnosis of Helicobacter pylori infection in patients with atrophic body gastritis. Helicobacter 2004;9(5):436‐42. CENTRAL

Lee 1998 {published data only}

Lee HS, Gwee KA, Teng LY, Kang JY, Yeoh KG, Wee A, et al. Validation of [13C]urea breath test for Helicobacter pylori using a simple gas chromatograph‐mass selective detector. European Journal of Gastroenterology & Hepatology 1998;10(7):569‐72. CENTRAL

Logan 1991a {published data only}

Logan RP, Polson RJ, Misiewicz JJ, Rao G, Karim NQ, Newell D, et al. Simplified single sample 13Carbon urea breath test for Helicobacter pylori: Comparison with histology, culture, and ELISA serology. Gut 1991;32(12):1461‐4. CENTRAL

Lombardo 2003 {published data only}

Lombardo L, Masoero G, Della Monica P, Crocella L, Ruggia O, Ravarino N, et al. Multiple sampling 13C‐urea breath test: Improvement of diagnosis in postgastrectomy patients. Minerva Gastroenterologica e Dietologica 2003;49(3):181‐6. CENTRAL

Lottspeich 2007 {published data only}

Lottspeich C, Schwarzer A, Panthel M, Koletzko S, Russmann H. Evaluation of the novel Helicobacter pylori ClariRes real‐time PCR assay for detection and clarithromycin susceptibility testing of h.pylori in stool specimens from symptomatic children. Journal of Clinical Microbiology 2007;45(6):1718‐22. CENTRAL

Luthra 1998 {published data only}

Luthra GK, DiNuzzo AR, Gourley WK, Crowe SE. Comparison of biopsy and serological methods of diagnosis of Helicobacter pylori infection and the potential role of antibiotics. American Journal of Gastroenterology 1998;93(8):1291‐6. CENTRAL

Mana 2001a {published data only}

Mana F, Franken PR, Ham HR, Urbain D. Cut‐off point, timing and pitfalls of the c‐13‐urea breath test as measured by infrared spectrometry. Digestive and Liver Disease 2001;33(1):30‐5. CENTRAL
Mana F, Fried M, Ham HR, Lacor P, Vandenplas Y, Urbain D. Evaluation of a 10 minute c‐13‐urea breath test for the diagnosis of Helicobacter pylori infection, as measured by infrared spectrometry. Gastroenterology 2000;118(4 Part 1):A508. CENTRAL

Mansour‐Ghanaei 2011 {published data only}

Mansour‐Ghanaei F, Sanaei O, Joukar F. Clinical validation of an office‐based C‐14‐UBT (Heliprobe) for H. Pylori diagnosis in Iranian dyspeptic patients. Gastroenterology Research and Practice 2011 Jun 22 [Epub ahead of print]. [DOI: 10.1155/2011/930941]CENTRAL

Mion 1994 {published data only}

Mion F, Delecluse HJ, Rousseau M, Berger F, Brazier JL, Minaire Y. 13C‐urea breath test for the diagnosis of Helicobacter infection. Comparison with histology. Gastroenterologie Clinique et Biologique 1994;18(12):1106‐11. CENTRAL

Misawa 1998 {published data only}

Misawa K, Kumagai T, Shimizu T, Furihata K, Ota H, Akamatsu T, et al. A new histological procedure for re‐evaluation of the serological test for Helicobacter pylori. European Journal of Clinical Microbiology & Infectious Diseases 1998;17(1):14‐9. CENTRAL

Mohammadian 2007 {published data only}

Mohammadian T, Hagh‐Zare M, Aria H, Doosti M, Paknejad M, Siavoshi F, et al. Comparison of serologic ELISA and histopathologic findings in diagnosis of Helicobacter pylori infection in Iran. Helicobacter 2007;12(4):446. CENTRAL

Monteiro 2001a {published data only}

Monteiro L, De Mascarel A, Sarrasqueta AM, Bergey B, Barberis C, Talby P, et al. Diagnosis of Helicobacter pylori infection: Noninvasive methods compared to invasive methods and evaluation of two new tests. American Journal of Gastroenterology 2001;96(2):353‐8. CENTRAL

Morales 1995 {published data only}

Morales EOS, Vorackova FV, Perez JDV, Alonso SS, Angeles AA, Rivera JE, et al. Optimization of the c‐14 urea breath test for the detection of Helicobacter‐pylori in dyspeptic patients. Revista De Investigacion Clinica 1995;47(2):109‐16. CENTRAL

Noguera 1998 {published data only}

Noguera ECA, Hames W, Bertola S, Mothe G. Helicobacter pylori: C‐14 urea breath test in clinical practice in a general hospital. Medicina‐Buenos Aires 1998;58(1):45‐50. CENTRAL

Novis 1991 {published data only}

Novis BH, Gabay G, Leichtmann G, Peri M, Bernheim J, Pomeranz IS. Two point analysis 15‐minute 14c‐urea breath test for diagnosing Helicobacter pylori infection. Digestion 1991;50(1):16‐21. CENTRAL

Ogata 2001 {published data only}

Ogata SK, Kawakami E, Patricio FR, Pedroso MZ, Santos AM. Evaluation of invasive and non‐invasive methods for the diagnosis of Helicobacter pylori infection in symptomatic children and adolescents. Sao Paulo Medical Journal 2001;119(2):67‐71. CENTRAL

Ozturk 2003 {published data only}

Ozturk E, Yesilova Z, Ilgan S, Arslan N, Erdil A, Celasun B, et al. A new, practical, low‐dose 14c‐urea breath test for the diagnosis of Helicobacter pylori infection: Clinical validation and comparison with the standard method. European Journal of Nuclear Medicine & Molecular Imaging 2003;30(11):1457‐62. CENTRAL

Peitz 2001 {published data only}

Peitz U, Baumann M, Tillenburg B, Borsch G, Stolte M, Malfertheiner P, et al. Insufficient validity of a rapid blood test for diagnosis of Helicobacter pylori infection. Medizinische Klinik 2001;96(12):703‐7. CENTRAL

Peura 1996 {published data only}

Peura DA, Pambianco DJ, Dye KR, Lind C, Frierson HF, Hoffman SR, et al. Microdose c‐14‐urea breath test offers diagnosis of Helicobacter pylori in 10 minutes. American Journal of Gastroenterology 1996;91(2):233‐8. CENTRAL

Puspok 1999 {published data only}

Puspok A, Bakos S, Oberhuber G. A new, non‐invasive method for detection of Helicobacter pylori: Validity in the routine clinical setting. European Journal of Gastroenterology & Hepatology 1999;11(10):1139‐42. CENTRAL

Qadeer 2009 {published data only}

Qadeer AS, Kharal SA, Baig MF, Badvi JA, Durrani MA. Detection of Helicobacter pylori antigen in stool. Journal of the Liaquat University of Medical and Health Sciences 2009;8(2):126‐30. CENTRAL

Rafeey 2007 {published data only}

Rafeey M, Nikvash S. Detection of Helicobacter pylori antigen in stool samples for diagnosis of infection in children. Eastern Mediterranean Health Journal 2007;13(5):1067‐72. CENTRAL

Rasool 2007 {published data only}

Rasool S, Abid S, Jafri W. Validity and cost comparison of 14carbon urea breath test for diagnosis of H pylori in dyspeptic patients. World Journal of Gastroenterology 2007;13(6):925‐9. CENTRAL
Rasool S, Abid S, Mumtaz K, Shah HA, Hamid S, Islam M, et al. C‐14‐urea breath test: A reliable and practical test in office‐based diagnosis of Helicobacter pylori infection. Helicobacter 2005;10(5):525. CENTRAL

Rathbone 1986 {published data only}

Rathbone BJ, Wyatt J, Tompkins D, Heatley RV, Losowsky MS. Diagnostic IgG ELISA for gastric campylobacter‐pyloridis infection using serum samples. Gut 1986;27(5):A607. CENTRAL

Safe 1993 {published data only}

Safe AF, Warren B, Corfield A, McNulty CA, Watson B, Mountford RA, et al. Helicobacter‐pylori infection in elderly people ‐ correlation between histology and serology. Age and Ageing 1993;22(3):215‐20. CENTRAL

Salles‐Montaudon 2002 {published data only}

Salles‐Montaudon N, Dertheil S, Broutet N, Gras N, Monteiro L, De Mascarel A, et al. Detecting Helicobacter pylori infection in hospitalized frail older patients: The challenge. Journal of the American Geriatrics Society 2002;50(10):1674‐80. CENTRAL

Schilling 2001 {published data only}

Schilling D, Jakobs R, Peitz U, Sugilla M, Stolte M, Riemann JF, et al. The diagnostic accuracy of (13)C0urea breath test in diagnosis of Helicobacter pylori (hp) infection in patients with partial gastric resection due to peptic ulcer disease. Gastroenterology 1999;116(4 suppl):A304. CENTRAL
Schilling D, Jakobs R, Peitz U, Sulliga M, Stolte M, Riemann JF, et al. Diagnostic accuracy of c‐13‐urea breath test in the diagnosis of Helicobacter pylori infection in patients with partial gastric resection due to peptic ulcer disease ‐ a prospective multicenter study. Digestion 2001;63(1):8‐13. CENTRAL

Scuderi 2000 {published data only}

Scuderi G, Celi D, Romagnolo M, Lupi A, Alecci L, Dramissino I, et al. Helicobacter pylori: Use of a stool antigen detection test and a six‐day triple therapy [2]. Digestive and Liver Disease 2000;32(1):71‐3. CENTRAL

Segamwenge 2014 {published data only}

Segamwenge IL, Kagimu M, Ocama P, Opio K. The utility of the Helicobacter pylori stool antigen test in managing dyspepsia: An experience from a low resource setting. African Health Sciences 2014;14(4):829‐34. CENTRAL

Selcukcan 2011 {published data only}

Selcukcan Aydin F, Demirkiran Urganci N, Uzum Yenici FU. Comparison of methods in diagnosis of gastritis originated from Helicobacter pylori in pediatric age, and use of urea breath test as a noninvasive technique in post‐treatment follow‐up of the patient. Duzce Medical Journal 2011;13(1):6‐14. CENTRAL

Sharbatdaran 2013 {published data only}

Sharbatdaran M, Kashifard M, Shefaee S, Siadati S, Jahed B, Asgari S. Comparison of stool antigen test with gastric biopsy for the detection of Helicobacter pylori infection. Pakistan Journal of Medical Sciences 2013;29(1):68‐71. CENTRAL

Sheu 1998a {published data only}

Sheu BS, Lee SC, Lin PW, Chang YC, Yang SB, Lin XZ. Diagnostic efficacy of carbon 13 urea breath test to detect H. pylori in patients after gastrectomy. Gut 1998;43(Suppl 2):A57. CENTRAL

Sheu 1998b {published data only}

Sheu BS, Lee SC, Lin PW, Chang YC, Yang SB, Lin XZ. Diagnostic efficacy of carbon 13 urea breath test to detect H. pylori in patients after gastrectomy. Gut 1998;43(Suppl 2):A57. CENTRAL

Shin 2009 {published data only}

Shin CM, Kim N, Lee HS, Lee HE, Lee SH, Park YS, et al. Validation of diagnostic tests for Helicobacter pylori with regard to grade of atrophic gastritis and/or intestinal metaplasia. Helicobacter 2009;14(6):512‐9. CENTRAL

Soomro 2012 {published data only}

Soomro RA, Abro AK, Ujjan ID, Ibraheem Z, Farooq M. Comparison of two diagnostic methods for detection of H.pylori i.e., gastric biopsy by H&E & Giemsa and serum anti H.pylori antibodies. Pakistan Journal of Medical and Health Sciences 2012;6(3):552‐4. CENTRAL
Soomro RA, Sheikh TA, Memon AI, Pathan NA, Qazi N. Two easy and early methods for the diagnosis of H.pylori i.e.: serum anti H.pylori antibodies and stool antigen. Journal of the Liaquat University of Medical and Health Sciences 2013;12(2):87‐90. CENTRAL

Surveyor 1989 {published data only}

Surveyor I, Goodwin CS, Mullan BP, Geelhoed E, Warren JR, Murray RN, et al. The c‐14‐urea breath‐test for the detection of gastric campylobacter‐pylori infection. Medical Journal of Australia 1989;151(8):435‐9. CENTRAL

Thobani 1995 {published data only}

Thobani S, Jafri SMW, Ferrell L, Perezperez GI, Hasan SH, Blaser MJ, et al. Detection of Helicobacter‐pylori gastritis in Pakistan ‐ efficacy of an IgG ELISA based on a United‐States population. Gastroenterology 1995;108(4 suppl):A241. CENTRAL

Tiwari 2014 {published data only}

Tiwari BP, Nistala S, Patil SP, Kalgutkar DP, Jaychandran N, Chander H, et al. Evaluation of the c‐14‐urea breath test using indigenously produced c‐14‐urea capsules and a modified technique for trapping exhaled breath: A pilot study. Nuclear Medicine Communications 2014;35(3):325‐30. CENTRAL

Trevisani 2005 {published data only}

Trevisani L, Sartori S, Rossi MR, Ruina M, Matarese V, Gullini S, et al. Evaluation of a new rapid immunoassay for the detection of Helicobacter pylori in faeces: A prospective pilot study. Alimentary Pharmacology & Therapeutics 2005;21(4):485‐9. CENTRAL

Vandenplas 1992 {published data only}

Vandenplas Y, Blecker U, Devreker T, Keppens E, Nijs J, Cadranel S, et al. Contribution of the 13C‐urea breath test to the detection of Helicobacter pylori gastritis in children. Pediatrics 1992;90(4):608‐11. CENTRAL

Villalobos 1992 {published data only}

Villalobos Perez JJ, Sanchez Morales EO, Vargas Vorackova F, Sixtos Alonso S, Angeles Angeles A, Elizondo Rivera J, et al. Usefulness of the 14c‐urea marked test in the detection of Helicobacter pylori in patients with dyspepsia. Revista de Gastroenterologia de Mexico 1992;57(3):167‐71. CENTRAL

Wang 2008 {published data only}

Wang XY, Yang Y, Shi RH, Ho B, Wang HD, Zhang GX. An evaluation of a serologic test with a current infection marker of Helicobacter pylori before and after eradication therapy in Chinese. Helicobacter 2008;13(1):49‐55. CENTRAL

Wardi 2012 {published data only}

Wardi J, Shalev T, Shevah O, Boaz M, Avni Y, Shirin H. A rapid continuous‐real‐time c‐13‐urea breath test for the detection of Helicobacter pylori in patients after partial gastrectomy. Journal of Clinical Gastroenterology 2012;46(4):293‐6. CENTRAL

Weiss 1994 {published data only}

Weiss J, Mecca J, Da Silva E, Gassner D. Comparison of PCR and other diagnostic techniques for detection of Helicobacter pylori infection in dyspeptic patients. Journal of Clinical Microbiology 1994;32(7):1663‐8. CENTRAL

Yan 2003 {published data only}

Yan S, Lin Q, Song Y, Wang S. Detection of Helicobacter pylori stool antigen by non‐invasive enzyme immunoassay. Chinese Medical Sciences Journal 2003;18(4):218‐21. CENTRAL

Yoshimura 2001 {published data only}

Yoshimura N, Tajiri H, Sawada A, Kozaiwa K, Ida S, Fujisawa T, et al. A c‐13‐urea breath test in children with Helicobacter pylori infection: Assessment of eradication therapy and follow‐up after treatment. Journal of Gastroenterology 2001;36(9):606‐11. CENTRAL

Yu 1999 {published data only}

Yu WK, Chow PKH, Tan SY, Ng EH, Goh ASW, Soo KC, et al. Five micro‐curie urea breath test for the diagnosis of Helicobacter pylori infection: Evaluation in a south‐east Asian population. Australian and New Zealand Journal of Surgery 1999;69(1):37‐40. CENTRAL

Yu 2001 {published data only}

Yu FJ, Wu DC, Kuo CH, Lu CY, Su YC, Lee YC, et al. Diagnosis of Helicobacter pylori infection by stool antigen test in southern Taiwan. Kaohsiung Journal of Medical Sciences 2001;17(7):344‐50. CENTRAL

References to studies awaiting assessment

Buhigas‐Garcia 2008 {published data only}

Buhigas‐Garcia I, Herrero‐Alonso MC, Barrio‐Merino A. From laboratory to clinic: 13‐c urea breath test [Test de urea marcada con carbono 13]. Anales de Pediatria Continuada 2008;6(3):155‐8. [appswl.elsevier.es/watermark/ctl_servlet?_f=10&pident_articulo=80000328&pident_usuario=0&pcontactid=&pident_revista=51&ty=30&accion=L&origen=apccontinuada&web=www.apcontinuada.com&lan=es&fichero=v6n3a328pdf001.pdf&anuncioPdf=ERROR_publi_pdf]CENTRAL

Fazeli 2004 {published data only}

Fazeli A, Safaei HG, Tamizifar H, Rashidi N, Medimond. Diagnosis of Helicobacter pylori infection by salivary immunoglobulin g. Immunology 2004: Immunodeficiency, Infectious Diseases, Immunomodulation, and Vaccines. 12th Annual International Congress of Immunology/4th Annual Conference of the Federation‐of‐Clinical‐Immunology‐Societies (FOCIS); 2004 Jul 18‐23; Montreal. 2004:79‐82. CENTRAL

Fuke 2009 {published data only}

Fuke A, Kunita S, Goto K, Sugiyama F, Yagami K. Diagnosis method based on sandwich ELISA using Helicobacter hepaticus‐specific monoclonal antibody. Journal of the American Association for Laboratory Animal Science 2009;48(5):634‐5. CENTRAL

Glupczynski 1991 {published data only}

Glupczynski Y, Bourdeaux L, Vantricht L, Depre M, Balegamire B, Devos D, et al. C‐14‐urea breath test (ubt), an efficacious tool for studying Helicobacter‐pylori (hp) epidemiology in developing‐countries ‐ a study in Zaire. Nuclear Medicine 1991;27:253‐5. CENTRAL

Karczewska 1997 {published data only}

Karczewska E, Kacka K, Bielanski W, Plonka M, Zarzycki D, Konturek SJ, et al. The seroprevalence of IgG antibodies to h‐pylori caga protein in asymptomatic children assessed by helico blot 2.0 and ELISA methods. Gut 1997;41:A70. CENTRAL

Kushch 2014 {published data only}

Kushch I, Korenev N, Kamarchuk L, Pospelov A, Alexandrov Y, Kamarchuk G, et al. New possibilities in diagnosing Helicobacter pylori infection by the non‐urease products of its activity. 8th World Congress of the World Society for Pediatric Infectious Diseases (WSPID); 2013 Nov 20‐23; Cape Town. Bologna: MEDIMOND International, 2014:89‐92. CENTRAL

Lappas 1997 {published data only}

Lappas A, Bogdanos D, Konstantinou G, Bokolas G, Ioannidis K, Boura P, et al. The value of the saliva‐dental plaque urease test in the diagnosis and treatment of Helicobacter pylori infection associated with peptic ulcer disease. Archives of Hellenic Medicine 1997;14(3):330‐4. CENTRAL

Lee 1999a {published data only}

Lee G, Chun HJ, Lee SJ, Kim KH, Jeen YT, Song CW, et al. Significance of c‐13‐urea breath test results: Delta(co2)‐c‐13 as a predictor of Helicobacter pylori density and activity of gastritis in gastric body. Gastrointestinal Endoscopy 1999;49(4):AB191‐AB. CENTRAL

Martin‐de‐Argila 1997 {published data only}

Martin‐de‐Argila C, Boixeda D, Canton R, Valdezate S, Mir N, De Rafael L, et al. Usefulness of the combined igg and iga antibody determinations for serodiagnosis of Helicobacter pylori infection. European Journal of Gastroenterology & Hepatology 1997;9(12):1191‐6. CENTRAL

Mason 1997 {published data only}

Mason CL, Wong WW. The urea breath test for Helicobacter pylori: A direct application of stable isotope mass spectrometry. Abstracts of Papers of the American Chemical Society 1997;213:274‐CHED. CENTRAL

Thong‐Ngam 2011 {published data only}

Thong‐Ngam D, Chayanupatkul M, Vongchampa P, Hanvivatvong O. An evaluation of a new in‐house serum and urine ELISA test for detection of Helicobacter pylori infection in Thai population. Journal of the Medical Association of Thailand 2011;94(8):985‐90. CENTRAL

Tokunaga 2005a {published data only}

Tokunaga K, Tanaka A, Takahashi S. Evaluation of diagnostic method for Helicobacter pylori infection. Nippon Rinsho [Japanese Journal of Clinical Medicine] 2005;63 Suppl 11:403‐8. CENTRAL

Xu 1995 {published data only}

Xu C, Xu H, Cheng S. 14c‐urea breath test in the diagnosis of Helicobacter pylori infection in the stomach. Zhonghua Nei Ke Za Zhi [Chinese Journal of Internal Medicine] 1995;34(4):239‐42. CENTRAL

Abadi 2011

Abadi ATB, Taghvaei T, Wolfram L. Inefficiency of rapid urease test for confirmation of Helicobacter pylori. Saudi Journal of Gastroenterology 2011;17(1):84‐5.

Abdullah 1997a

Abdullah AM, Gad el Rab MO, al Ayed I, Kambal AM, al Sohaibani M, al Mazyad AL. Helicobacter pylori infection in children in Saudi Arabia. Tropical Gastroenterology 1997;18(2):63‐5.

Abdullah 1997b

Abdullah AM, Gad el Rab MO, al Ayed I, al Mazyad AS, al Sanie A. Comparison of Helicobacter pylori antibody levels in children in Riyadh. Tropical Gastroenterology 1997;18(2):65‐6.

Abdulqawi 2012

Abdulqawi K, El‐Mahalaway AM, Abdelhameed A, Abdelwahab AA. Correlation of serum antibody titres with invasive methods for rapid detection of Helicobacter pylori infections in symptomatic children. International Journal of Experimental Pathology 2012;93(4):295‐304.

Abu 2015

Abu Shady MM, Fathy HA, Ali A, Galal EM, Fathy GA, Sibaii H. Comparison of serum IgG antibody test with gastric biopsy for the detection of Helicobacter pylori infection among Egyptian children. Macedonian Journal of Medical Sciences 2015;3(2):303‐6.

Abu‐Sbeih 2014

Abu‐Sbeih RS, Hawari AD, Hassawi DS, Al‐Daghistani HI. Isolation and detection of Helicobacter pylori from patients suffering from peptic ulcer using biochemical tests and molecular techniques. American Journal of Biochemistry and Biotechnology 2014;10(1):58‐68.

Abukhadir 1998

Abukhadir BA, Heneghan MA, Kearns M, Little CL, McCarthy CF. Evaluation of a 20 minute C‐14 urea breath test for the diagnosis of Helicobacter pylori infection. Irish Medical Journal 1998;91(1):23‐5.

Abut 2006

Abut E, Guveli H, Kurdas OO. Diagnostic tests used for the detection of Helicobacter pylori . Sendrom 2006;18(3):53‐9.

Aceti 1989

Aceti A, Pennica A, Leri O, Caferro M, Grilli A, Celestino D, et al. Time‐resolved fluoroimmunoassay for campylobacter pylori antibodies. Lancet 1989;2(8661):505.

Adachi 2002

Adachi K, Kawamura A, Ono M, Masuzaki K, Takashima T, Yuki M, et al. Comparative evaluation of urine‐based and other minimally invasive methods for the diagnosis of Helicobacter pylori infection. Journal of Gastroenterology 2002;37(9):703‐8.

Adamczyk 2013

Adamczyk M, Peczek Ł, Rudnicki C, Nawrot B, Stec‐Michalska K. The clinical significance of GastroPanel in diagnostics of Helicobacter pylori eradication efficiency in patients with dyspepsia with correlation of family history of gastric cancer. Polski Merkuriusz Lekarski 2013;35(207):141‐7.

Adamek 1994

Adamek RJ, Freitag M, Labenz J, Opferkuch W, Ruhl GH, Aygen S, et al. Modified 13C‐urea breath test in the detection of Helicobacter pylori in the gastric mucosa. Deutsche Medizinische Wochenschrift 1994;119(46):1569‐72.

Adamek 1995

Adamek RJ, Wegener M, Labenz J. C‐12 urea breath test in Helicobacter‐pylori infection of the gastric‐mucosa ‐ reply. Deutsche Medizinische Wochenschrift 1995;120(25‐26):941‐2.

Adamsson 2000

Adamsson I, Edlund C, Nord CE. Microbial ecology and treatment of Helicobacter pylori infections: Review. Journal of Chemotherapy 2000;12(1):5‐16.

Adiloglu 2003

Adiloglu AK, Nazli C, Cicioglu‐Aridogan B, Kinay O, Can R, Ergene O. Gastroduodenal Helicobacter pylori infection diagnosed by Helicobacter pylori stool antigen is related to atherosclerosis. Acta Cardiologica 2003;58(4):335‐9.

Adiloglu 2007

Adiloglu AK, Isler M, Goren I, Candir O, Senol A, Onal S, et al. Quantitative correlation of Helicobacter pylori stool antigen (HpSA) test with the severity of H. pylori‐related gastritis. Tohoku Journal of Experimental Medicine 2007;212(2):159‐67.

Agha‐Amiri 1999a

Agha‐Amiri K, Mainz D, Peitz U, Kahl S, Leodolter A, Malfertheiner P. Evaluation of an enzyme immunoassay for detecting Helicobacter pylori antigens in human stool samples. Zeitschrift Fur Gastroenterologie 1999;37(12):1145‐9.

Agha‐Amiri 1999b

Agha‐Amiri K, Leodolter A, Peitz U, Malfertheiner P. How does the Helicobacter pylori antigen concentration in stool correlate with the urease activity in c‐13‐urea breath test?. Gut 1999;45(Suppl 3):A132.

Agha‐Amiri 2001

Agha‐Amiri K, Peitz U, Mainz D, Kahl S, Leodolter A, Malfertheiner P. A novel immunoassay based on monoclonal antibodies for the detection of Helicobacter pylori antigens in human stool. Zeitschrift Fur Gastroenterologie 2001;39(8):555‐60.

Agudo 2009a

Agudo S, Alarcón T, Urruzuno P, Lopez‐Brea M. Evaluation of two monoclonal‐based antigen in stool enzyme immunoassay for diagnosis of H.pylori infection in Spanish children. Helicobacter 2009;14(4):341‐2.

Agudo 2009b

Agudo S, Alarcón T, Urruzuno P, Somodevilla A, Lopez‐Brea M. Evaluation of a monoclonal‐based antigen in stool enzyme immunoassay for diagnosis of Helicobacter pylori infection in Spanish children. Clinical Microbiology and Infection 2009;15:S315.

Aguemon 2004

Aguemon B, Struelens M, Deviere J, Denis O, Golstein P, Nagy N, et al. Evaluation of stool antigen detection for diagnosis of Helicobacter pylori infection in adults. Acta Clinica Belgica 2004;59(5):246‐50.

Aguemon 2005

Aguemon B, Struelens M, Deviere J, Denis O, Golstein P, Salmon I, et al. Primary antibiotic resistance and effectiveness of Helicobacter pylori triple therapy in ulcero‐inflammatory pathologies of the upper digestive tract. Acta Gastroenterologica Belgica 2005;68(3):287‐93.

Aguilar‐Soto 2004

Aguilar‐Soto O, Majalca‐Martńez C, León‐Espinosa F, Avila‐Vargas G, Sánchez‐Medina R, Figueroa SA, et al. Comparative study between rapid urease test, imprint and histopathological study for Helicobacter pylori diagnosis. Revista de Gastroenterologia de Mexico 2004;69(3):136‐42.

Ahmed 2005

Ahmed F, Murthy UK, Chey WD, Toskes PP, Wagner DA. Evaluation of the Ez‐HBT Helicobacter blood test to establish Helicobacter pylori eradication. Alimentary Pharmacology & Therapeutics 2005;22(9):875‐80.

Ahuja 1998

Ahuja V, Bal CS, Sharma MP. Can the c‐14 urea breath test replace follow‐up endoscopic biopsies in patients treated for Helicobacter pylori infection?. Clinical Nuclear Medicine 1998;23(12):815‐9.

Aje 2010

Aje AO, Otegbayo JA, Odaibo GN, Bojuwoye BJ. Comparative study of stool antigen test and serology for Helicobacter pylori among Nigerian dyspeptic patients: a pilot study. Nigerian Journal of Clinical Practice 2010;13(2):120‐4.

Aksoy 2003

Aksoy DY, Aybar M, Ozaslan E, Kav T, Engin D, Ercis S, et al. Evaluation of the Helicobacter pylori stool antigen test (HpSA) for the detection of Helicobacter pylori infection and comparison with other methods. Hepato‐Gastroenterology 2003;50(52):1047‐9.

Aktepe 2011

Aktepe OC, Ciftci IH, Safak B, Uslan I, Dilek FH. Five methods for detection of Helicobacter pylori in the Turkish population. World Journal of Gastroenterology 2011;17(47):5172‐6.

Al‐Assi 1999

Al‐Assi MT, Miki K, Walsh JH, Graham DP, Asaka M, Graham DY. Noninvasive evaluation of Helicobacter pylori therapy: role of fasting or postprandial gastrin, pepsinogen i, pepsinogen ii, or serum IgG antibodies. American Journal of Gastroenterology 1999;94(9):2367‐72.

Al‐Humayed 2008

Al‐Humayed SM, Ahmed MEK, Bello CS, Tayyar MA. Comparison of 4 laboratory methods for detection of Helicobacter pylori. Saudi Medical Journal 2008;29(4):530‐2.

Alam 2013

Alam El‐Din HM, Hashem AGM, Ragab YM, Hussein IL, Mohamed DB, Mohamed ECB. Evaluation of noninvasive versus invasive techniques for the diagnosis of Helicobacter pylori infection. Applied Immunohistochemistry and Molecular Morphology 2013;21(4):326‐33.

Alan 2014

Alan Selcuk N, Toklu T, Karaaslan I. Evaluation of sensitivity of post‐therapeutic i‐131 whole body scan on detecting Helicobacter pylori. European Journal of Nuclear Medicine and Molecular Imaging 2014;41:S594.

Alarcón‐Rivera 2011

Alarcón‐Rivera G, Vázquez‐Jiménez G, De la Cruz‐Patiño E, Abarca M, Leyva E, Delgado F, et al. Comparative analysis between breath test, serological immunoassay and rapid‐urease test for detection of Helicobacter pylori infection in Mexican patients with non‐investigated dyspepsia. Revista de Gastroenterologia de Mexico 2011;76(4):322‐9.

Alavi 1996a

Alavi A, Kroser JA, Faigel DO, Childs M, Furth EE, Alavi A, et al. Can quantitative urea breath test for Helicobacter pylori (hp) replace endoscopic biopsy?. Journal of Nuclear Medicine 1996;37(5 Suppl):246 (abstract 1104).

Alavi 1996b

Alavi A, Faigel DO, Childs M, Furth EE, Goin J, Metz DC. Comparison of 14‐urea breath test for the diagnosis of Helicobacter pylori gastritis with standard techniques. Journal of Nuclear Medicine 1996;37(5 Suppl):114 (abstract 448).

Albrecht 2012

Albrecht P, Kotowska M, Misko E, lazowska‐Przeorek I, Karolewska‐Bochenek K, Banaszkiewicz A, et al. Agreement of monoclonal fecal test (amplified IDEA™ hp star™) with the urease breath test, before and after the eradication treatment of H. pylori in children. Pediatria Wspolczesna 2012;14(2):79‐82.

Alcalde 1994

Alcalde M, Perez Garcia JI, Sanchez P, Lancho A, Carpintero P, Pajares JM. Usefulness of the breath test with urea‐13C in the diagnosis of Helicobacter pylori infection. Medicina Clinica 1994;103(10):371‐3.

Alem 2002

Alem M, Alem N, Cohen H, England T, Hamedi N, Moussazadeh M, et al. Diagnostic value of detection of IgM antibodies to Helicobacter pylori. Experimental & Molecular Pathology 2002;72(1):77‐83.

Alemohammad 1993

Alemohammad MM, Foley TJ, Cohen H. Detection of immunoglobulin g antibodies to Helicobacter pylori in urine by an enzyme immunoassay method. Journal of Clinical Microbiology 1993;31(8):2174‐7.

Ali 1997

Ali A, Vaira D, Stanghellini V, Menegatti M, Salardi S, Landi F, et al. C‐13 urea‐breath test (UBT) with and without a citric acid test meal for Helicobacter pylori (hp) detection in adults and children. Gastroenterology 1997;112(4 suppl):A56.

Ali 1998

Ali A, Vaira D, Stanghellini V, Menegatti M, Landi F, Ricci C, et al. C‐13 vs c‐14 urea breath test (UBT) for Helicobacter pylori (hp) detection. Gut 1998;43(Suppl 2):A55‐A6.

Allerberger 1996

Allerberger F, Oberhuber G, Wrba F, Puspok A, Dejaco C, Dierich MP. Detection of Helicobacter pylori infection using single serum specimens: Comparison of five commercial serological tests. Hepato‐Gastroenterology 1996;43(12):1656‐9.

Alpert 1989

Alpert LC, Graham DY, Evans DJ, Yoshimura HH, Hazell SL, Evans DG, et al. Diagnostic possibilities for campylobacter pylori infection. European Journal of Gastroenterology & Hepatology 1989;1(1):17‐26.

Altindis 2002a

Altindis M, Dilek ON. Usefulness of the Helicobacter pylori stool antigen test for detection Helicobacter pylori infection. Acta Gastro‐Enterologica Belgica 2002;65(2):74‐6.

Altindis 2002b

Altindis M, Dilek ON. Erratum: Usefullness of the Helicobacter pylori stool antigen test for detection Helicobacter pylori infection (Acta Gastro‐Enterologica Belgica 2002;65:2:74‐6). Acta Gastro‐Enterologica Belgica 2002;65(4):246.

Altindis 2003

Altindis M, Dilek ON. Erratum: Usefullness of the Helicobacter pylori stool antigen test for detection Helicobacter pylori infection (Acta Gastro‐Enterologica Beljica 2002;65(2):74‐6). Acta Gastro‐Enterologica Belgica 2003;66(2):195.

Amendola 2002

Amendola R, Doweck J, Katz J, Racca J, Menendez G, Schenone L, et al. A new method for detection and eradication of Helicobacter pylori infection by stool antigens test. Acta Gastroenterologica Latinoamericana 2002;32(2):83‐5.

Anania 2007

Anania C, Labalestra V, Neaga M, Ferrara E, Borrelli O, Cirulli M, et al. Evaluation of a polyclonal Helicobacter pylori stool antigen test (HpSA) for the detection of Helicobacter pylori infection in children. Digestive and Liver Disease 2007;39(10):A62.

Anania 2008

Anania C, Pacifico L, Olivero G, Osborn JF, Bonaiuto E, Chiesa C. Breath tests in pediatrics. Clinica Chimica Acta 2008;397(1‐2):1‐12.

Andersen 1989

Andersen LP. Campylobacter pylori antibodies measured by indirect ELISA using O‐antigen. Gastroduodenal pathology and Campylobacter pylori: European Campylobacter Pylori Study Group ICS847. 1989:201‐3.

Andersen 1998

Andersen LP, Kiilerick S, Pedersen G, Thoreson AC, Jorgensen F, Rath J, et al. An analysis of seven different methods to diagnose Helicobacter pylori infections. Scandinavian Journal of Gastroenterology 1998;33(1):24‐30.

Anderson 1993

Anderson G, Alemohammad MM, Foley TJ, Colletti A, Patel A, Dooley CP. Rapid test for detection of antibodies to Helicobacter pylori. Clinical Infectious Diseases 1993;16(SUPPL. 4):S416‐S7.

Andrews 2003

Andrews J, Marsden B, Brown D, Wong VS, Wood E, Kelsey M. Comparison of three stool antigen tests for Helicobocter pylori detection. Journal of Clinical Pathology 2003;56(10):769‐71.

Ang 2007a

Ang CW, Krogfelt K, Herbrink P, Keijser J, Van Pelt W, Dalby T, et al. Validation of an enzyme‐linked immunosorbent assay for the diagnosis of recent campylobacter infections in guillain‐barre and reactive arthritis patients. Zoonoses and Public Health 2007;54:50.

Ang 2007b

Ang CW, Krogfelt K, Herbrink P, Keijser J, Van Pelt W, Dalby T, et al. Validation of an ELISA for the diagnosis of recent campylobacter infections in guillain‐barre and reactive arthritis patients. Clinical Microbiology & Infection 2007;13(9):915‐22.

Anonymous 1989

Anonymous. 14c‐urea breath test for C pylori . Gut 1989;30(11):1656‐7.

Anonymous 1996

Anonymous. Breath test for Helicobacter pylori. WHO Drug Information 1996;10(4):187.

Anonymous 1997

Anonymous. Technical annex: Tests used to assess Helicobacter pylori infection. Working party of the European Helicobacter pylori study group. Gut 1997;41 Suppl 2:S10‐8.

Anonymous 2000

Anonymous. A stool test for H. pylori. Hospital Practice 2000;35(4):140.

Anonymous 2002a

Anonymous. The stool antigen test for detection of Helicobacter pylori after eradication therapy ‐ commentary. Annals of Internal Medicine 2002;136(4):286‐7.

Anonymous 2002b

Anonymous. H. pylori breath test effective. Pharmaceutical Journal 2002;268(7196):601.

Anonymous 2004

Anonymous. Which test for Helicobacter pylori in primary care?. Drug and Therapeutics Bulletin 2004;42(9):71‐2.

Antico 2010

Antico A, Tozzoli R, Villalta D, Tonutti E, Tampoia M, Bizzaro N. Diagnostic efficacy of a specific serological profile for the diagnosis of chronic autoimmune gastritis. Rivista Italiana della Medicina di Laboratorio 2010;6(3):198‐204.

Antoine 1995

Antoine C, Lozniewski A, De Korwin JD, Conroy MC, Feldmann L, Duprez A, et al. Comparative study of four commercial serological tests for the diagnosis of Helicobacter pylori infection. Gastroenterologie Clinique et Biologique 1995;19(2):182‐8.

Antos 2005

Antos D, Crone J, Konstantopoulos N, Koletzko S. Evaluation of a novel rapid one‐step immunochromatographic assay for detection of monoclonal Helicobacter pylori antigen in stool samples from children. Journal of Clinical Microbiology 2005;43(6):2598‐601.

Anwar 2012

Anwar MM, Youssef AI, Sheta MI, Zaki A, Bernaba NR, el‐Toukhi MA. Evaluation of specific biochemical indicators of Helicobacter pylori‐associated gastric cancer in Egypt. Eastern Mediterranean Health Journal 2012;18(5):501‐7.

Arboleda 2013

Arboleda RN, Schneider BG, Bravo LE, Romero‐Gallo J, Peek RM, Mera RM, et al. Use of the noninvasive entero‐test in the detection of Helicobacter pylori in children in an endemic area in Colombia. Journal of Pediatric Gastroenterology & Nutrition 2013;57(2):192‐6.

Archimandritis 2001

Archimandritis A, Giontzis A, Kourtesas D, Tzivras M, Smilakou S, Davaris P. Diagnosis of Helicobacter pylori infection with a stool assay: Is it useful after eradication treatment?. American Journal of Gastroenterology 2001;96(4):1298‐9.

Arents 2001

Arents NL, Van Zwet AA, Thijs JC, De Jong A, Pool MO, Kleibeuker JH. The accuracy of the Helicobacter pylori stool antigen test in diagnosing H. pylori in treated and untreated patients. European Journal of Gastroenterology & Hepatology 2001;13(4):383‐6.

Arents 2002

Arents NL, Van Zwet AA, Thijs JC, De Jong A, Pool MO, Kleibeuker JH. The accuracy of the Helicobacter pylori stool antigen test in diagnosing H. pylori in treated patients ‐ reply. European Journal of Gastroenterology & Hepatology 2002;14(1):89‐90.

Arinton 2011

Arinton IG. Adjustment of cut‐off values in ELISA for detection of Helicobacter pylori infection. Acta Medica Indonesiana 2011;43(2):88‐91.

Arita 1982

Arita K, Yamauchi E, Mizuno S, Maki S. Serological response to campylobacter jejuni infection: Enzyme‐linked immunosorbent assay (ELISA) for detection of antibodies to campylobacter jejuni. Kansenshogaku Zasshi [The Journal of the Japanese Association for Infectious Diseases] 1982;56(7):566‐73.

Arj 2012

Arj A, Ehteram H, Razavizadeh M. Efficacy of stool ag test for the non‐invasive diagnosis of Helicobacter pylori infection in dyspeptic patients. Journal of Gastroenterology and Hepatology 2012;27:420.

Arora 2003

Arora U, Aggarwal A, Singh K. Comparative evaluation of conventional methods and ELISA based IgG antibodies detection for diagnosis of Helicobacter pylori infection in cases of dyspepsia. Indian Journal of Medical Microbiology 2003;21(1):46‐8.

Artiko 2004

Artiko V, Obradovic V, Petrovic N, Davidovic B, Vlajkovic M, Petrovic M, et al. Breath test (c‐14‐urea) in the detection of Helicobacter pylori infection. European Journal of Nuclear Medicine and Molecular Imaging 2004;31:S216‐S7.

Asaka 1988

Asaka M, Mitani S, Yoshida J, Saito M, Meguro T. Clinical significance of ELISA for campylobacter pylori. Nihon Shokakibyo Gakkai Zasshi [Japanese Journal of Gastro‐enterology] 1988;85(4):950.

Asaki 1996

Asaki S, Yamagami H, Noda A, Tachikawa T, Osumi T, Hirao Y, et al. Phase i clinical trial of 13C‐urea breath test (c‐13ubt). Japanese Journal of Clinical Pharmacology and Therapeutics 1996;27(3):607‐16.

Asante 1998

Asante MA, Mendall MA, Finlayson C, Ballam L, Northfield T. Screening dyspeptic patients for Helicobacter pylori prior to endoscopy: Laboratory or near‐patient testing?. European Journal of Gastroenterology & Hepatology 1998;10(10):843‐6.

Asfeldt 2004

Asfeldt AM, Lochen ML, Straume B, Steigen SE, Florholmen J, Goll R, et al. Accuracy of a monoclonal antibody‐based stool antigen test in the diagnosis of Helicobacter pylori infection. Scandinavian Journal of Gastroenterology 2004;39(11):1073‐7.

Ashraf 1999

Ashraf P, Ul Haq M, Amjad R. Assessment of 13C urea breath test's usefulness in the diagnosis of Helicobacter pylori infection. Journal of the College of Physicians and Surgeons Pakistan 1999;9(2):75‐7.

Atherton 1992

Atherton JC, Hymantaylor P, Hawkey CJ, Spiller RC. Direct comparison of c‐13 and low‐dose c‐14 as isotopic markers in the urea breath test for Helicobacter‐pylori. Gut 1992;33(2):S5‐S.

Atherton 1994

Atherton JC, Spiller RC. The urea breath test for Helicobacter pylori. Gut 1994;35(6):723‐5.

Attallah 2004

Attallah AM, Ismail H, Ibrahim GG, Abdel‐Raouf M, El‐Waseef AM, Abdel‐Wahab M. Use of a novel enzyme immunoassay based on detection of circulating antigen in serum for diagnosis of Helicobacter pylori infection. Clinical & Diagnostic Laboratory Immunology 2004;11(4):775‐9.

Attumi 2011

Attumi TA, Graham DY. Follow‐up testing after treatment of Helicobacter pylori infections: Cautions, caveats, and recommendations. Clinical Gastroenterology and Hepatology 2011;9(5):373‐5.

Aucher 1998

Aucher P, Petit ML, Mannant PR, Pezennec L, Babin P, Fauchere JL. Use of immunoblot assay to define serum antibody patterns associated with Helicobacter pylori infection and with h. Pylori‐related ulcers. Journal of Clinical Microbiology 1998;36(4):931‐6.

Aulia 2009

Aulia D, Manz GO, Simadibrata M. Pepsinogen i concentration in organic dyspepsia patients at Gastroenterology Division, Department of Internal Medicine, Cipto Mangunkusumo Hospital. Acta Medica Indonesiana 2009;41(3):107‐14.

Auroux 1998

Auroux J, Lamarque D, Tankovic J, Benamouzig R, Mahe S, Chaumette MT, et al. Comparison of Helicobacter pylori gastric density by culture, histology and c‐13 urea breath test. Gastroenterologie Clinique et Biologique 1998;22(4):407‐12.

Aziz 2014

Aziz F, Sherwani SK, Akhtar SS, Kazmi SU. Development of an in‐house enzyme‐linked immunosorbent assay based on surface whole cell antigen for diagnosis of Helicobacter pylori infection in patients with gastroduodenal ulcer disease. World Journal of Microbiology & Biotechnology 2014;30(1):305‐15.

Bakka 2002

Bakka AS, El‐Gariani AB, AbouGhrara FM, Salih BA. Frequency of Helicobacter pylori infection in dyspeptic patients in Libya. Saudi Medical Journal 2002;23(10):1261‐5.

Balcilar 2012

Balcilar E, Karsidag T, Tuzun S. Relaibility of Helicobacter antigen in stool for screening. Medical Bulletin of Haseki 2012;50(3):89‐92.

Ballam 1998

Ballam L, Mendall MA, Morris J, Strachan D, Whincup P, Cook D. Western blotting (wb) is useful in the salivary diagnosis of h‐pylori infection. Gastroenterology 1998;114(4 suppl):A64.

Ballam 2000a

Ballam LD, Mendall MA, Asante M, Morris J, Strachan DP, Whincup PH, et al. Western blotting is useful in the salivary diagnosis of Helicobacter pylori infection.[Erratum appears in J Clin Pathol 2000;53(9):725]. Journal of Clinical Pathology 2000;53(4):314‐7.

Ballam 2000b

Ballam LD, Mendall MA, Asante. Erratum: Western blotting is useful in the salivary diagnosis of Helicobacter pylori infection (Journal of clinical pathology 2000;53:314‐7). Journal of Clinical Pathology 2000;53(9):725.

Balon 1997

Balon HR, Roff E, Dworkin HJ. Capsule‐based c‐14 urea breath test for Helicobacter pylori: Early experience and comparison with liquid‐based test. Journal of Nuclear Medicine 1997;38(5 Suppl):Abstract 1092.

Baqai 2003

Baqai R, Qureshi H, Arian G, Mehdi I. Diagnostic efficacy of stool antigen test (HPSA), clo test and serology for the detection of Helicobacter pylori infection. Journal of Ayub Medical College, Abbottabad: JAMC 2003;15(4):34‐6.

Baranskaia 2006

Baranskaia EK, Ivashkin VT, Lapshin AV, Stepanov EV, Zyrianov PV. The diagnostic significance of laser 13C‐urea breath test in various Helicobacter pylori‐associated diseases. Klinicheskaia Meditsina 2006;84(8):47‐50.

Barbosa 2003

Barbosa J, Dinis‐Ribeiro M, Guilherme M, Filipe T, Lomba‐Viana R, Guimaraes MA, et al. Use of Helicobacter pylori‐specific antibodies in the evaluation of intestinal metaplasia and gastric dysplasia. British Journal of Biomedical Science 2003;60(4):175‐9.

Barthel 1990

Barthel JS, Everett ED. Diagnosis of campylobacter pylori infections: The "gold standard" and the alternatives. Reviews of Infectious Diseases 1990;12 Suppl 1:S107‐14.

Baryshnikova 2009

Baryshnikova NV. Actual problems of Helicobacteriosis diagnostics. Eksperimental'naia i Klinicheskaia Gastroenterologiia [Experimental & Clinical Gastroenterology] 2009;2:50‐6.

Baryshnikova 2012

Baryshnikova NV, Uspenskiy YP, Smirnova AS, Dmitrienko MA, Bykov SE. Helicobacter pylori in oral cavity in patients with chronic gastritis. Helicobacter 2012;17:90.

Baryshnikova 2013

Baryshnikova NV, Belousova LN, Smirnova AS, Tsopanova EE, Loeva IA, Orlov OY, et al. Breath ammonium test in diagnostic of Helicobacter pylori infection. Helicobacter 2013;18:124.

Baryshnikova 2014

Baryshnikova NV, Belousova LN, Loeva IA, Kudryavtseva AS, Shehman AV, Yakovleva JS. Comparative analysis of efficacy of noninvasive ammonium "helic‐test" and histological method in diagnostic of Helicobacter pylori infection. Helicobacter 2014;19:122.

Basinska 2005

Basinska T, Wisniewska M, Chmiela M. Principle of a new immunoassay based on electrophoretic mobility of poly(styrene/alpha‐tert‐butoxy‐omega‐vinylbenzyl‐polyglycidol) microspheres: Application for the determination of Helicobacter pylori igg in blood serum. Macromolecular Bioscience 2005;5(1):70‐7.

Bassler 1992

Bassler HMS, Dreher RM, Wolf K. Isolation of h. Pylori proteins and their availability in serological tests. Immunitat und Infektion 1992;20(3):103‐6.

Basso 1999

Basso D, Stefani A, Brigato L, Navaglia F, Greco E, Zambon CF, et al. Serum antibodies anti‐h. Pylori and anti‐caga: A comparison between four different assays. Journal of Clinical Laboratory Analysis 1999;13(4):194‐8.

Bateson 1991

Bateson MC, Ching CK, Loffeld RJLF, Arends JW, Stobberingh E. Screening for Helicobacter pylori in dyspepsia [comment]. Lancet 1991;338(8763):393‐4.

Bateson 2001

Bateson MC. Quadruple therapy for symptomatic spontaneous duodenal ulcer disease. Postgraduate Medical Journal 2001;77(909):447‐50.

Bathe 1996

Bathe OF, Rae AJ, Zetler P, Cleator IGM. Validation of a new saliva test for Helicobacter pylori infection. Canadian Journal of Gastroenterology 1996;10(2):93‐6.

Bauernfeind 1989

Bauernfeind A, Przyklenk B, Horl G, Otto U. Representative campylobacter pylori antigen for IgG‐ELISA and diagnostic significance of antibody titres. Gastroduodenal pathology and Campylobacter pylori. The first meeting of the European Campylobacter Pylori Study Group ICS847; 1989. 1989:185‐8.

Bazaz 2005

Bazaz RD, Khalaj A, Beiki D, Eftekhari M, Hosein MHAS, Khoshayand MR. Microdose 14c urea breath test for the diagnosis of Helicobacter pylori: A survey in Iranian population. Daru 2005;13(1):6‐10.

Bazzoli 1994

Bazzoli F, Zagari RM, Pozzato P, Fossi S, Alampi G, Sottili S, et al. C‐13‐urea breath test to quantify Helicobacter‐pylori colonization of gastric‐mucosa and association with severity of inflammation. Gastroenterology 1994;106(4 suppl):A48.

Bazzoli 1995

Bazzoli F, Zagari RM, Pozzato P, Fossi S, Simoni P, Roda A, et al. The c‐13‐urea breath test to evaluate the effect of antisecretory drugs on Helicobacter‐pylori. Gastroenterology 1995;108(4 suppl):A57.

Bazzoli 1996

Bazzoli F, Cecchini L, Corvaglia L, Antonia MD, Libera MD, DeGiacomo C, et al. The c‐13‐urea breath test for the diagnosis of Helicobacter pylori infection in children. Gastroenterology 1996;110(4 Suppl):A60.

Bazzoli 1997a

Bazzoli F, Zagari RM, Festi D, Palli D, Pozzato P, Sottili S, et al. A population based study of Helicobacter pylori infection .2. Uprevalence by c‐13‐urea breath test and association with family history of peptic ulcer and gastric cancer. Gut 1997;41(Suppl):A106.

Bazzoli 1997b

Bazzoli F, Zagari M, Fossi S, Pozzato P, Ricciardiello L, Mwangemi C, et al. Urea breath tests for the detection of Helicobacter pylori infection. Helicobacter 1997;2 Suppl 1:S34‐7.

Bazzoli 1998

Bazzoli F, Zagari M, Pozzato P, Fossi S, Ricciardiello GL, Nicolini G, et al. Diagnosis of Helicobacter pylori infection: Non‐invasive diagnostic tests. Italian Journal of Gastroenterology & Hepatology 1998;30(suppl 3):S313‐4.

Bazzoli 1999

Bazzoli F, Zagari RM, Pozzato P, Fossi S, Ricciardiello L, De Luca L, et al. Helicobacter pylori: Optimum diagnosis and test of cure. Journal of Chemotherapy 1999;11(6):601‐5.

Bazzoli 2000

Bazzoli F, Cecchini L, Corvaglia L, Dall'Antonia M, De Giacomo C, Fossi S, et al. Validation of the 13C‐urea breath test for the diagnosis of Helicobacter pylori infection in children: A multicenter study. American Journal of Gastroenterology 2000;95(3):646‐50.

Befrits 1993

Befrits R, Granstrom M, Rylander M, Rubio C. Helicobacter pylori in 205 consecutive endoscopy patients. Scandinavian Journal of Infectious Diseases 1993;25(2):185‐91.

Beiki 2005

Beiki D, Khalaj A, Dowlatabadi R, Eftekhari M, Hossein MHAS, Fard A, et al. Validation of 13C‐urea breath test with non dispersive isotope selective infrared spectroscopy for the diagnosis of Helicobacter pylori infection: A survey in Iranian population. Daru 2005;13(2):52‐5.

Bekmen 2008

Bekmen N, Demiray E, Gonen C, Dolek D, Soyturk M, Sagol O, et al. Determination of H. pylori antigenic frequency by western blot technique in adult patients with dyspepsia. Helicobacter 2008;13(5):452.

Bell 1987

Bell GD, Weil J, Harrison G, Morden A, Jones PH, Gant PW, et al. 14c‐urea breath analysis, a non‐invasive test for campylobacter pylori in the stomach. Lancet 1987;1(8546):1367‐8.

Bell 1991

Bell GD, Powell K, Weil J, Harrison G, Brookes S, Prosser S. 13C‐urea breath test for Helicobacter pylori infection. Gut 1991;32(5):551‐2.

Bellon 2004

Bellon M. The urea breath test. ANZ Nuclear Medicine 2004;35(2):104‐7.

Bener 2002

Bener A, Uduman SA, Ameen A, Alwash R, Pasha MA, Usmani MA, et al. Prevalence of Helicobacter pylori infection among low socio‐economic workers. Journal of Communicable Diseases 2002;34(3):179‐84.

Benito 1999

Benito LM, Sara S, Gisbert JP, Vasquez MA, Jimenez I, Pajares JM. C‐13‐urea breath test for the diagnosis of H‐pylori infection: Are basal samples necessary?. Gut 1999;45(Suppl 3):A125‐A6.

Benjamin 2012

Benjamin YC, Feng Z, Ho KY, Christopher K, Lim LG, So JB, et al. Risk stratification for gastric cancer using serum pepsinogen and Helicobacter pylori serology in a Chinese population. Gastroenterology 2012;142(5 (Suppl)):S631.

Bennedsen 1998

Bennedsen M, Lehn N, Morgner A, Bayerdorffer E, Andersen LP. Development of a Helicobacter heilmanii specific ELISA. Gut 1998;43(Suppl 2):A115‐A6.

Bennett 2006

Bennett K, Feely J, Thornton O, Dobson M, O'Morain CA, O'Connor HJ. Impact of Helicobacter pylori on the management of dyspepsia in primary care. Alimentary Pharmacology & Therapeutics 2006;24(4):637‐41.

Berger 2002

Berger A. Helicobacter pylori breath tests. BMJ 2002;324(7348):1263.

Bergey 2003

Bergey B, Marchildon P, Peacock J, Megraud F. What is the role of serology in assessing Helicobacter pylori eradication?. Alimentary Pharmacology & Therapeutics 2003;18(6):635‐9.

Bergmann 1997

Bergmann WL. Diagnosis and therapy ofHelicobacter pylori infections in adults. Deutsche Medizinische Wochenschrift 1997;122(11):348‐9.

Berker 2003

Berker B, Soylemez F, Cengiz SD, Kose SK. Serologic assay of Helicobacter pylori infection ‐ is it useful in hyperemesis gravidarum?. Journal of Reproductive Medicine 2003;48(10):809‐12.

Bermejo 2000a

Bermejo San Jose F, Boixeda de Miguel D, Gisbert JP, Martin de Argila de Prados C, Sanz Sacristan JM, Defarges Pons V, et al. Efficacy of four widely used techniques of the diagnosis of Helicobacter pylori infection in gastric ulcer disease. Revista Clinica Española 2000;200(9):475‐9.

Bermejo 2000b

Bermejo F, Boixeda D, Gisbert JP, Sanz JM, Canton R, Defarges V, et al. Concordance between noninvasive tests in detecting Helicobacter pylori and potential use of serology for monitoring eradication in gastric ulcer. Journal of Clinical Gastroenterology 2000;31(2):137‐41.

Bermejo 2002

Bermejo F, Boixeda D, Gisbert JP, Defarges V, Sanz JM, Redondo C, et al. Rapid urease test utility for Helicobacter pylori infection diagnosis in gastric ulcer disease. Hepato‐Gastroenterology 2002;49(44):572‐5.

Berning 2009

Berning M, Krasz S, Schneider‐Brachert W, Madisch A, Laass MW, Knoth H, et al. Randomized multicenter study of esomeprazole, moxifloxacin and amoxicillin for second‐line or rescue treatment of Helicobacter pylori infection ‐ impact of treatment duration. Gastroenterology 2009;136(5 (suppl)):A150.

Bertschinger 1992

Bertschinger P, Brunner J, Flury R, Lammer F, Jost R, Hacki WH. Comparison of effectiveness of omeprazole/bismuth subcitrate and triple therapy in Helicobacter pylori gastritis. Schweizerische Medizinische Wochenschrift 1992;122(39):1446‐51.

Besherdas 2000

Besherdas K, Oben JA, Beck ER, Vicary FR, Wong VS. What proportion of dyspeptic patients having H. pylori breath test subsequently undergo endoscopy?. Gut 2000;46(Suppl 2):A52.

Bessede 2011

Bessede E, Delcamp A, Sifre E, Buissonniere A, Megraud F. New methods for detection of campylobacters in stool samples in comparison to culture. Journal of Clinical Microbiology 2011;49(3):941‐4.

Best 1992

Best LM, Van Zanten SJOV, Bezanson GS, Haldane DJM, Malatjalian DA. Serological detection of Helicobacter pylori by a flow microsphere immunofluorescence assay. Journal of Clinical Microbiology 1992;30(9):2311‐7.

Best 1994

Best LM, Van Zanten SJOV, Sherman PM, Bezanson GS. Serological detection of Helicobacter pylori antibodies in children and their parents. Journal of Clinical Microbiology 1994;32(5):1193‐6.

Beynon 2013

Beynon R, Leeflang MM, McDonald S, Eisinga A, Mitchell RL, Whiting P, et al. Search strategies to identify diagnostic accuracy studies in MEDLINE and EMBASE. Cochrane Database of Systematic Reviews 2013, Issue 9. [DOI: 10.1002/14651858.MR000022.pub3]

Bhewa 2007

Bhewa Y, Hilmi I, Cheah PL, Navaratnam P, Goh KL. Evaluation of the monoclonal stool antigen test for Helicobacter pylori in an asian population with dyspepsia. Journal of Digestive Diseases 2007;8(4):207‐10.

Bielanski 1996a

Bielanski W, Konturek SJ, Dobrzanska MJ, Pytko‐Polonczyk J, Sito E, Marshall BJ. Microdose 14c‐urea breath test in detection of Helicobacter pylori . Journal of Physiology & Pharmacology 1996;47(1):91‐100.

Bielanski 1996b

Bielanski W, Pytko J, Konturek SJ, Sito E, Marshall J. Usefulness of c‐14‐urea breath test in detection of Helicobacter pylori associated gastric diseases. Gastroenterology 1996;110(4 (suppl)):A65.

Bielanski 1996c

Bielanski W, Konturek SJ. New approach to 13C‐urea breath test: Capsule‐based modification with low‐dose of 13C‐urea in the diagnosis of Helicobacter pylori infection. Journal of Physiology & Pharmacology 1996;47(3):545‐53.

Bielanski 1997a

Bielanski W, Plonka M, Dobrzanska M, Kaminska A, Konturek SJ. Screening of H‐pylori (HP) infection in adult population of Krakow, Poland using modified capsulated urea breath test. Gut 1997;41(Suppl):A37‐A8.

Bielanski 1997b

Bielanski W, Dobrzanska J, Kaminska A, Plonka M, Sito E, Konturek SJ. Validation of new low dose and low cost c‐13‐urea breath test in the diagnosis for Helicobacter pylori . Gastroenterology 1997;112(4 (suppl)):A72.

Bielanski 1998

Bielanski W, Bobrzynski A, Kostarczyk W, Karczewska E, Gedliczka O, Konturek SJ. Usefulness of capsulated low dose c‐13‐urea breath test in diagnosing h‐pylori infection in patients with upper gastrointestinal bleeding. Gut 1998;43(Suppl 2):A54‐A5.

Bielanski 1999

Bielanski W, Dobrzanska M, Jakuszewska B, Kaminska A, Plonka M, Konturek SJ. Ethanol as confounding factor in detection of Helicobacter pylori (HP) by c‐13‐urea breath test. Gastroenterology 1999;116(4 (suppl)):A123.

Bielanski 2000

Bielanski W, Loster BW, Plonka M, Dobrzanska M, Kaminska A, Majewski S, et al. Incidence of H‐pylori (HP) infection in Polish endoscopists and dentists: Results of field survey with capsulated c‐13‐urea breath test (ubt). Gut 2000;47(Suppl 1):A50.

Biemond 1997

Biemond I, Veenendaal RA, Lamers C. Rapid diagnostic test for antibodies to Helicobacter pylori in comparison with the ELISA technique. Gut 1997;41(suppl):A159.

Bilal 2007

Bilal R, Khaar B, Qureshi TZ, Mirza SA, Ahmad T, Latif Z, et al. Accuracy of non‐invasive 13C‐urea breath test compared to invasive tests for Helicobacter pylori detection. Journal of the College of Physicians & Surgeons ‐ Pakistan 2007;17(2):84‐8.

Bilardi 2002

Bilardi C, Biagini R, Dulbecco P, Iiritano E, Gambaro C, Mele MR, et al. Stool antigen assay (HPSA) is less reliable than urea breath test for post‐treatment diagnosis of Helicobacter pylori infection. Alimentary Pharmacology & Therapeutics 2002;16(10):1733‐8.

Billaud 1996

Billaud N, Morali A, Conroy MJ, Floquet J. Helicobacter pylori infection in pediatric patients. A review of twenty‐three cases. Annales De Pediatrie 1996;43(4):281‐7.

Bindayna 2006

Bindayna K, Al Baker W, Botta G. Detection of Helicobacter pylori caga gene in gastric biopsies, clinical isolates and faeces. Indian Journal of Medical Microbiology 2006;24(3):195‐200.

Birkenfeld 2004

Birkenfeld S, Keter D, Dikman R, Shevah O, Shirin H, Niv Y. Prevalence of Helicobacter pylori infection in health‐care personnel of primary care and gastroenterology clinics. Journal of Clinical Gastroenterology 2004;38(1):19‐23.

Bjorneklett 1989

Bjorneklett A, Fausa O, Nedenskovsorensen P, Bukholm G, Aase S. The c‐14 urea breath test in the diagnosis of Campylobacter‐pylori infection. Gastroduodenal Pathology and Camphylobacter pylori 1989;847:65‐8.

Blairon 2009

Blairon L, Souayah H, Moens C, Dediste A, Vandenberg O. Comparison of 6 rapid assays for detection of Helicobacter pylori antigen in stool in children with recurrent abdominal pain ‐ preliminary data. Clinical Microbiology and Infection 2009;15:S315.

Blancas 2004

Blancas Valencia JM. Importance of Helicobacter pylori diagnosis. Revista de Gastroenterologia de Mexico 2004;69(3):186‐7.

Blanco 2008

Blanco S, Forne M, Lacoma A, Prat C, Cuesta MA, Latorre I, et al. Comparison of stool antigen immunoassay methods for detecting Helicobacter pylori infection before and after eradication treatment. Diagnostic Microbiology & Infectious Disease 2008;61(2):150‐5.

Blanco 2009

Blanco S, Forne M, Lacoma A, Prat C, Cuesta MA, Fuenzalida L, et al. Evaluation of a latex agglutination test (pylogen) for the detection of Helicobacter pylori in stool specimens. Diagnostic Microbiology & Infectious Disease 2009;63(4):349‐53.

Blashenkov 2013

Blashenkov NM, Sheshenya ES, Solov'ev SM, Sachenko VD, Gall LN, Zarutskii IV, et al. A specialized isotope mass spectrometer for noninvasive diagnostics of Helicobacter pylori infection in human beings. Technical Physics Letters 2013;39(5):431‐4.

Bleau 1998

Bleau BL, Van Zanten SV, Best L, Hutchison D, Blevins J, Thee D. Determination of eradication of Helicobacter pylori (HP) by the HP stool antigen test (HPSAT). Gut 1998;43(Suppl 2):A50.

Blecker 1992a

Blecker U, Vandenplas Y. Helicobacter pylori seropositivity in symptom‐free children. Lancet 1992;339(8808):1537.

Blecker 1992b

Blecker U, Lanciers S, Peeters S, Vandenplas Y. Helicobacter pylori infections in children. Tijdschrift voor Kindergeneeskunde 1992;60(2):35‐9.

Blecker 1993a

Blecker U, Keymolen K, Levy J, Vandenplas Y. Low prevalence of Helicobacter pylori in the acquired immunodeficiency syndrome. American Journal of Gastroenterology 1993;88(8):1294.

Blecker 1993b

Blecker U, Lanciers S, Hauser B. Validation of a new serologic test for the detection of Helicobacter pylori . Acta Gastroenterologica Belgica 1993;56(5‐6):309‐14.

Blecker 1993c

Blecker U, Lanciers S, Hauser B, Vandenplas Y. Diagnosis of Helicobacter pylori infection in adults and children by using the malakit Helicobacter pylori, a commercially available enzyme‐linked immunosorbent assay. Journal of Clinical Microbiology 1993;31(7):1770‐3.

Blecker 1993d

Blecker U, Lanciers S, Hauser B, Vandenplas Y. Positive and negative titres of a new serologic test for the detection of Helicobacter pylori . European Journal of Gastroenterology & Hepatology 1993;5(8):631‐4.

Blecker 1993e

Blecker U, Vandenplas Y. Helicobacter pylori serology. Journal of Clinical Microbiology 1993;31(1):173.

Blecker 1993f

Blecker U, Vandenplas Y, Taha AS, Russell RI. Serological diagnosis of Helicobacter pylori . Gut 1993;34(10):1467.

Blecker 1993g

Blecker U, Hauser B, Lanciers S, Peeters S, Suys B, Vandenplas Y. The prevalence of Helicobacter pylori‐positive serology in asymptomatic children. Journal of Pediatric Gastroenterology and Nutrition 1993;16(3):252‐6.

Blecker 1994a

Blecker U, Lanciers S, Mehta DI, Vandenplas Y. The sensitivity and specificity of a recent generation serum ELISA test for the detection of Helicobacter‐pylori specific IgG antibodies compared to the c‐13‐urea breath test. Gastroenterology 1994;106(4 (suppl)):A54.

Blecker 1994b

Blecker U, Vandenplas Y. Usefulness of specific IgM in the diagnosis of Helicobacter pylori infection. Pediatrics 1994;93(2):342‐3.

Blecker 1994c

Blecker U, Vandenplas Y, Blecker U, Lanciers S, Mehta DI. Concordance between serology and 13C‐urea breath test in the diagnosis of Helicobacter pylori infection. American Journal of Gastroenterology 1994;89(3):459.

Blecker 1994d

Blecker U, Keymolen K, Lanciers S, Bahwere P, Souayah H, Levy J, et al. The prevalence of Helicobacter pylori positivity in human immunodeficiency virus‐infected children. Journal of Pediatric Gastroenterology & Nutrition 1994;19(4):417‐20.

Blecker 1995a

Blecker U, Lanciers S, Hauser B, Mehta DI, Vandenplas Y. Serology as a valid screening test for Helicobacter pylori infection in asymptomatic subjects. Archives of Pathology & Laboratory Medicine 1995;119(1):30‐2.

Blecker 1995b

Blecker U, Lanciers S, Hauser B, De Pont SM, Vandenplas Y. The contribution of specific immunoglobulin m antibodies to the diagnosis of Helicobacter pylori infection in children. European Journal of Gastroenterology & Hepatology 1995;7(10):979‐83.

Blum 1997

Blum AL, Bayerdorffer E, Borsch G, Classen M, Creutzfeldt W, Hotz J, et al. The Helicobacter revolution .2. Diagnosis and therapy. Leber Magen Darm 1997;27(4):241‐6.

Bode 1998

Bode G, Rothenbacher D, Brenner H, Adler G. Variation in the 13C‐urea breath test value by nationality in Helicobacter pylori‐infected children. Scandinavian Journal of Gastroenterology 1998;33(5):468‐72.

Bode 2000

Bode G, Hoffmeister A, Koenig W, Brenner H, Rothenbacher D. Extent and determinants of differences in Helicobacter pylori serology and c‐13‐urea breath test in an asymptomatic sample of blood donors. Gut 2000;47(Suppl 1):A121.

Bode 2001

Bode G, Hoffmeister A, Koenig W, Brenner H, Rothenbacher D. Characteristics of differences in Helicobacter pylori serology and c‐13‐urea breath‐testing in an asymptomatic sample of blood donors. Scandinavian Journal of Clinical & Laboratory Investigation 2001;61(8):603‐8.

Bode 2002

Bode G, Marchildon P, Peacock J, Brenner H, Rothenbacher D. Diagnosis of Helicobacter pylori infection in children: Comparison of a salivary immunoglobulin g antibody test with the c‐13 urea breath test. Clinical and Diagnostic Laboratory Immunology 2002;9(2):493‐5.

Bodger 1999

Bodger K, Wyatt JI, Heatley RV. Serologic screening before endoscopy: The value of Helicobacter pylori serology, serum recognition of the caga and vaca proteins, and serum pepsinogen i. Scandinavian Journal of Gastroenterology 1999;34(9):856‐63.

Bodhidatta 1993

Bodhidatta L, Hoge CW, Churnratanakul S, Nirdnoy W, Sampathanukul P, Tungtaem C, et al. Diagnosis of Helicobacter pylori infection in a developing country: Comparison of two ELISAs and a seroprevalence study. Journal of Infectious Diseases 1993;168(6):1549‐53.

Bohn 1994

Bohn I, Teufel M, Niessen KH. Helicobacter pylori causing chronical stomach‐ache in childhood. Monatsschrift fur Kinderheilkunde 1994;142(4):269‐71.

Bojko 1997

Bojko JB, Braden B, Lembcke B, Stolte M, Burlage M, Folsch UR, et al. C‐13‐urea breath test correlates with the hp corpus colonization score in Helicobacter pylori ‐ infected patients. Gastroenterology 1997;112(4 (suppl)):A75.

Bolton 1989a

Bolton FJ, Hutchinson DN, Hinchiliffe PM, Holt AV. Distribution in various clinical groups of antibody to C. pylori detected by enzyme‐linked immunosorbent assay, complement fixation and microagglutination tests. Serodiagnosis and Immunotherapy in Infectious Disease 1989;3(1):41‐50.

Bolton 1989b

Bolton FJ, Hutchinson DN. Evaluation of three Campylobacter pylori antigen preparations for screening sera from patients undergoing endoscopy. Journal of Clinical Pathology 1989;42(7):723‐6.

Bolton 1997

Bolton FJ, Wareing DRA, Sails AD. Comparison of a novel microaerobic system with three other gas‐generating systems for the recovery of Campylobacter species from human faecal samples. European Journal of Clinical Microbiology and Infectious Diseases 1997;16(11):839‐42.

Bommelaer 2001

Bommelaer G, Des Varannes SB, Flejou JF, Matysiak T, Poynard T, Richard A, et al. Caga status and virulence of Helicobacter pylori strains. Results of a French multicentric prospective study. Gastroenterologie Clinique et Biologique 2001;25(12):1084‐9.

Bonamico 2004

Bonamico M, Strappini PM, Bonci E, Ferri M, Crisogianni M, Guido M, et al. Evaluation of stool antigen test, PCR on oral samples and serology for the noninvasive detection of Helicobacter pylori infection in children. Helicobacter 2004;9(1):69‐76.

Bongermino 2010

Bongermino MP, Ruggero V, Cristallo V, Bonfrate L, Santantonio M, Mola A, et al. Evaluation of non‐invasive methods for the diagnosis of Helicobacter pylori infection. European Journal of Clinical Investigation 2010;40:67.

Booka 2005

Booka M, Okuda M, Shin K, Miyashiro E, Hayashi H, Yamauchi K, et al. Polymerase chain reaction‐restriction fragment length polymorphism analysis of clarithromycin‐resistant Helicobacter pylori infection in children using stool sample. Helicobacter 2005;10(3):205‐13.

Bordin 2013

Bordin DS, Berezina OI, Kim VA, Orobey YA, Patrushev NB. Diagnosis of H. pylori infection in routine clinical practice in Russia. Helicobacter 2013;18:122.

Bornschein 2011

Bornschein J, Selgrad M, Malfertheiner P. Helicobacter pylori ‐ diagnosis and treatment. MMW‐Fortschritte der Medizin 2011;153(38):58‐61.

Borody 2012

Borody T, Wettstein A, Finlayson S, Torres M, Campbell J, Nowak A. Diagnostic value of fundic red spots in Helicobacter pylori (HP) infection. American Journal of Gastroenterology 2012;107:S59.

Borody 2013

Borody TJ, Wettstein AR, Benstock S, Nowak A, Finlayson SJ, Campbell J. Superior diagnosis of H. pylori infection with 14c‐urea helicaptm capsules versus standard pytest capsules. Gastroenterology 2013;144(5 (suppl 1)):S214‐S5.

Boudjella 2009

Boudjella MEA, Matougui N, Tebaibia A, Oumnia N, Lahcene M, Mouffok F, et al. Evaluation of C‐13‐urea breath test in determining H. pylori status after treatment: About 197 cases. Helicobacter 2009;14(4):343.

Boukthir 2005

Boukthir S, Mazigh S, Fendri C, Kalach N, Barsaoui S. Evaluation of a non‐invasive test for detection of Helicobacter pylori antigen in stool from children. Archives de Pediatrie 2005;12(1):85‐7.

Boyanova 2003

Boyanova L, Koumanova R, Lazarova E, Jelev C. Helicobacter pylori and Helicobacter heilmannii in children. A Bulgarian study. Diagnostic Microbiology & Infectious Disease 2003;46(4):249‐52.

Boyanova 2013

Boyanova L, Ilieva Y, Vladimirov B, Gergova G, Nikolov R, Spasova Z, et al. The rate of Helicobacter pylori in adult patients with the 13C urea breath test. General Medicine 2013;15(4):22‐5.

Braden 1991

Braden B, Lembcke B, Caspary WF. Stable isotopes in diagnosis and research. Deutsche Medizinische Wochenschrift 1991;116(45):1721‐7.

Braden 1992

Braden B, Lembcke B, Caspary WF. Diagnosis of Helicobacter‐pylori . Innere Medizin 1992;19(3):103‐7.

Braden 1993

Braden B, Klutz M, Lembcke B, Caspary WF. C‐13 urea breath test for Helicobacter‐pylori ‐ optimal timing of breath sample collection. Gastroenterology 1993;104(4 (suppl)):A45.

Braden 1994a

Braden B, Haisch M, Duan LP, Lembcke B, Caspary WF, Hering P. Clinically feasible stable isotope technique at a reasonable price: Analysis of 13Co2/12co2‐abundance in breath samples with a new isotope selective‐nondispersive infrared spectrometer. Zeitschrift fur Gastroenterologie 1994;32(12):675‐8.

Braden 1994b

Braden B, Duan LP, Caspary WF, Lembcke B. More convenient 13C‐urea breath test modifications still meet the criteria for valid diagnosis of Helicobacter pylori infection. Zeitschrift fur Gastroenterologie 1994;32(4):198‐202.

Braden 1996

Braden B, Schafer F, Caspary WF, Lembcke B. Nondispersive isotope‐selective infrared spectroscopy: A new analytical method for 13C‐urea breath tests. Scandinavian Journal of Gastroenterology 1996;31(5):442‐5.

Braden 1997

Braden B, Duan LP, Caspary WF, Lembcke B. Endoscopy is not a risk factor for Helicobacter pylori infection ‐ but medical practice is. Gastrointestinal Endoscopy 1997;46(4):305‐10.

Braden 1999

Braden B, Caspary WF, Lembcke B. Nondispersive infrared spectrometry for (co2)‐c‐13/(co2)‐c‐12‐measurements: A clinically feasible analyzer for stable isotope breath tests in gastroenterology. Zeitschrift fur Gastroenterologie 1999;37(6):477‐81.

Braden 2000a

Braden B. New faecal antigen test noninvasively detects Helicobacter pylori infection. Biomedicine and Pharmacotherapy 2000;54(7):416‐7.

Braden 2000b

Braden B, Posselt HG, Ahrens P, Kitz R, Dietrich CF, Caspary WF. New immunoassay in stool provides an accurate noninvasive diagnostic method for Helicobacter pylori screening in children. Pediatrics 2000;106(1 Pt 1):115‐7.

Braden 2000c

Braden B, Teuber G, Dietrich CF, Caspary WF, Lembcke B. Comparison of new faecal antigen test with c‐13‐urea breath test for detecting Helicobacter pylori infection and monitoring eradication treatment: Prospective clinical evaluation. BMJ 2000;320(7228):148.

Braden 2001a

Braden B, Gelbmann C, Dietrich CF, Caspary WF, Scholmerich J, Lock G. Qualitative and quantitative clinical evaluation of the laser‐assisted ratio analyser for detection of Helicobacter pylori infection by c‐13‐urea breath tests. European Journal of Gastroenterology & Hepatology 2001;13(7):807‐10.

Braden 2001b

Braden B, Caspary WF. Detection of Helicobacter pylori infection: When to perform which test?. Annals of Medicine 2001;33(2):91‐7.

Braden 2007

Braden B, Lembcke B, Kuker W, Caspary WF. 13C‐breath tests: Current state of the art and future directions. Digestive & Liver Disease 2007;39(9):795‐805.

Braden 2012

Braden B. Diagnosis of Helicobacter pylori infection. BMJ 2012;344:e828.

Brandi 2006

Brandi G, Biavati B, Calabrese C, Granata M, Nannetti A, Mattarelli P, et al. Urease‐positive bacteria other than Helicobacter pylori in human gastric juice and mucosa. American Journal of Gastroenterology 2006;101(8):1756‐61.

Bravo 1999

Bravo LE, Realpe JL, Campo C, Mera R, Correa P. Effects of acid suppression and bismuth medications on the performance of diagnostic tests for Helicobacter pylori infection. American Journal of Gastroenterology 1999;94(9):2380‐3.

Bravos 2000

Bravos ED, Gilman RH. Accurate diagnosis of Helicobacter pylori other tests. Gastroenterology Clinics of North America 2000;29(4):925‐9.

Brennan 1991

Brennan DP, Kennedy NP, Keeling PWN. Serum IgG response to Campylobacter‐pylori antigens as measured by western blotting. Irish Journal of Medical Science 1991;160(2):64‐5.

Brennan 2015a

Brennan D, Smith SM, Omorogbe JA, Holleran G, Hall B, Hussey M, et al. Detection of Helicobacter pylori and antibiotic resistance using a molecular genetics‐based approach in human faecal samples. Gastroenterology 2015;148(4 (suppl)):S420.

Brennan 2015b

Brennan D, Omorogbe J, Holleran G, Hussey M, O'Morain C, Smith S, et al. A comparison of the prevalence of Helicobacter pylori infection and rates of antibiotic resistance in patients undergoing gastroscopy versus the urea breath test. Helicobacter 2015;20:100‐1.

Breslin 1997

Breslin NP, Omorain CA. Noninvasive diagnosis of Helicobacter pylori infection: A review. Helicobacter 1997;2(3):111‐7.

Breslin 1998

Breslin NP, Lee J, Buckley M, O'Morain C. Screening for Helicobacter pylori in young dyspeptic patients referred for investigation ‐ endoscopy for those who test negative. Alimentary Pharmacology and Therapeutics 1998;12(6):577‐82.

Breslin 2000

Breslin NP, Lee JM, Buckley MJ, Balbirnie E, Rice D, O'Morain CA. Validation of serological tests for Helicobacter pylori infection in an Irish population. Irish Journal of Medical Science 2000;169(3):190‐4.

Bretagne 1998

Bretagne JF, Caekaert A, Barthelemy P, Hepysode. Long‐term follow‐up of Helicobacter pylori (HP) serology after successful eradication: A cohort of 203 patients tested by ELISA and heliSAL (TM) rapid blood tests. Gastroenterology 1998;114(4 (suppl)):A80.

Briedigkeit 1992

Briedigkeit H, Montag T, Spiridonow PS, Sielaff F, Wack R, Held C, et al. Detection of Helicobacter pylori infections by antibody determination. Zeitschrift fur Arztliche Fortbildung (Jena) 1992;86(17):869‐72.

Britto 2002

Britto Gomes AT, Coelho LK, Secaf M, Pimenta Modena JL, De Almeida Troncon LE, De Oliveira RB. Accuracy of the 14C‐urea breath test for the diagnosis of Helicobacter pylori . Sao Paulo Medical Journal 2002;120(3):68‐71.

Brmbolic 1997

Brmbolic B, Zerjav S, Bogdanov M, Dordevic M, Radivojevic M, Stojsic Z, et al. The value of serum IgG and IgA antibodies in the diagnosis of Helicobacter pylori infection in dyspeptic patients. Archives of Gastroenterohepatology 1997;16(1):12‐5.

Brown 1993

Brown KE, Peura DA. Diagnosis of Helicobacter pylori infection. Gastroenterology Clinics of North America 1993;22(1):105‐15.

Bruce 2005

Bruce M, Parkinson A, Gessner B. Does delayed testing of urea breath test samples effect results?. Digestion 2005;71(4):261.

Bruden 2011

Bruden DL, Bruce MG, Miernyk KM, Morris J, Hurlburt D, Hennessy TW, et al. Diagnostic accuracy of tests for Helicobacter pylori in an Alaska native population. World Journal of Gastroenterology 2011;17(42):4682‐8.

Bruning 2002

Bruning A, Reimann FM, Homann N, Hussein ZE, Konecny E, Ludwig D. A novel continuous 13C‐urea breath test for detection of H. pylori infection. Gastrointestinal Endoscopy 2002;55(5):AB190‐AB.

Brunner 1989

Brunner H, Markt B, Mittermayer H, Binder L. C‐14 urea breath test (UBT) for the detection and follow‐up of Campylobacter‐pylori infection. Gastroduodenal Pathology and Camphylobacter pylori 1989;847:69‐71.

Buchan 2013

Buchan BW, Olson WJ, Pezewski M, Marcon MJ, Novicki T, Uphoff TS, et al. Clinical evaluation of a real‐time PCR assay for identification of Salmonella, Shigella, Campylobacter (Campylobacter jejuni and C. coli), and shiga toxin‐producing Escherichia coli isolates in stool specimens. Journal of Clinical Microbiology 2013;51(12):4001‐7.

Buchvald 1993

Buchvald D, Buchvaldova D. Antigens for the ELISA test for serodiagnosis of Helicobacter pylori infection. Ceskoslovenska Epidemiologie, Mikrobiologie, Imunologie 1993;42(1):16‐21.

Buhling 2004

Buhling F, Koch G, Wex T, Heimburg A, Vieth M, Leodolter A, et al. Simultaneous detection and differentiation of anti‐Helicobacter pylori antibodies by flow microparticle immunofluorescence assay. Clinical & Diagnostic Laboratory Immunology 2004;11(1):131‐6.

Bures 2000

Bures J, Palicka V, Kopacova M, Vorisek V, Rejchrt S, Zivny P. Diagnosis of Helicobacter pylori with the 13C‐labeled urea breath test: Study methodology. Casopis Lekaru Ceskych 2000;139(24):776‐8.

Burucoa 2013

Burucoa C, Delchier JC, Courillon‐Mallet A, De Korwin JD, Megraud F, Zerbib F, et al. Comparative evaluation of 29 commercial Helicobacter pylori serological kits. Helicobacter 2013;18(3):169‐79.

Busro 2013

Busro VO, Bakry F, Farida A, Yuwono. Sensitivity and specificity value of saliva Helicobacter pylori examination in chronic gastritis patients. Hepatology International 2013;7:S753‐S4.

Butler 2000

Butler AK, Brennan SA, Neal K, Logan RPH. A multi‐centre study of the prevalence of H‐pylori in urban Nottinghamshire children using the HpSA(r) stool antigen test. Gut 2000;47(Suppl 1):A45‐A6.

Buyukbaba‐Boral 2005

Buyukbaba‐Boral O, Kucuker‐Ang M, Aktas G, Issever H, Ang O. HpSA fecoprevalence in patients suspected to have Helicobacter pylori infection in Istanbul, Turkey. International Journal of Infectious Diseases 2005;9(1):21‐6.

Buzas 2001

Buzas GM, Illyes G, Szekely E, Szeles I. Six regimens for the eradication of Helicobacter pylori (HP) in duodenal ulcer patients: Three consecutive trials (1995‐1999). Journal of Physiology, Paris 2001;95(1‐6):437‐41.

Buzas 2008

Buzas GM, Szeles I. Interpretation of the 13C‐urea breath test in the choice of second‐ and third‐line eradication of Helicobacter pylori infection. Journal of Gastroenterology 2008;43(2):108‐14.

Cacoullis 1991

Cacoullis F, Batten JJ, Logan R, Karim QN, Walker M, Baron JH. Quantifying the extent of Helicobacter‐pylori infection with the C‐13 urea breath test. Gut 1991;32(5):A565.

Cadranel 1998

Cadranel S, Corvaglia L, Bontems P, Deprez C, Glupczynski Y, Van Riet A, et al. Detection of Helicobacter pylori infection in children with a standardized and simplified C‐13‐urea breath test. Journal of Pediatric Gastroenterology and Nutrition 1998;27(3):275‐80.

Cagdas 2012

Cagdas U, Otag F, Tezcan S, Sezgin O, Aslan G, Emekdas G. Detection of Helicobacter pylori and antimicrobial resistance in gastric biopsy specimens. Mikrobiyoloji Bulteni 2012;46(3):398‐409.

Caglar 1999

Caglar M, Belzberg AS, Spruston B, Sexsmith G. Time‐optimized carbon‐14 breath test for Helicobacter pylori contamination of the stomach. Clinical Nuclear Medicine 1999;24(9):674‐7.

Cai 2010

Cai J, Olafsson S. Helicobacter pylori breath test in an open access system has a high rate of potentially false negative results. Negative result should be considered false negative until proven otherwise. Gastroenterology 2010;138(5 (suppl 1)):S336.

Calam 1994

Calam J. Helicobacter‐pylori . European Journal of Clinical Investigation 1994;24(8):501‐10.

Calvet 1999

Calvet X, Feu F, Forne M, Montserrat A, Elizalde JI, Viver JM, et al. The evaluation of a new immunoenzyme analysis for the detection of Helicobacter pylori infection in stool samples. [Spanish]. Gastroenterologia Y Hepatologia 1999;22(6):270‐2.

Calvet 2002a

Calvet X, Salceda F, Sanfeliu I, Montserrat A, Brullet E, Real J, et al. Testing a new in‐office test for determination of faecal Helicobacter pylori antigen. Medicina Clinica 2002;118(4):126‐9.

Calvet 2002b

Calvet X, Sanfeliu I, Musulen E, Mas P, Dalmau B, Gil M, et al. Evaluation of Helicobacter pylori diagnostic methods in patients with liver cirrhosis. Alimentary Pharmacology & Therapeutics 2002;16(7):1283‐9.

Calvet 2002c

Calvet X, Rosello M, Quesada M, Sanfeliu I, Salcerda F, Montserrat A, et al. Diagnosis of Helicobacter pylori infection in dyspectic patients by stool antigen detection. Usefulness of a new monoclonal ELISA test. Gastroenterology 2002;122(4 (suppl)):A205‐A6.

Calvet 2003

Calvet X, Quesada M, Rosello M, Salceda F, Sanfeliu I, Dalmau B, et al. Stool antigen for the diagnosis of Helicobacter pylori infection in cirrhosis: Comparative usefulness of three different methods. Alimentary Pharmacology & Therapeutics 2003;17(5):727‐31.

Calvet 2005

Calvet X, Quesada M, Calvet V, Choat T, Sanfeliu I, Segura F. Usefulness of RAPID HP StAR (TM), a new immunochomatographic, monoclonal antigen‐based fecal test for diagnosing Helicobacter pylori infection in dyspeptic patients. Helicobacter 2005;10(5):524.

Calvet 2009

Calvet X, SaDelgado J, Montserrat A, Lario S, Ramirez‐Lazaro MJ, Quesada M, et al. Accuracy of diagnostic tests for Helicobacter pylori: A reappraisal. Clinical Infectious Diseases 2009;48(10):1385‐91.

Calvet 2010a

Calvet X, Lario S, Ramirez‐Lazaro MJ, Montserrat A, Quesada M, Reeves L, et al. Comparative accuracy of 3 monoclonal stool tests for diagnosis of Helicobacter pylori infection among patients with dyspepsia. Clinical Infectious Diseases 2010;50(3):323‐8.

Calvet 2010b

Calvet X, Lario S, Ramirez‐Lazaro MJ, Montserrat A, Quesada M, Reeves L, et al. Accuracy of monoclonal stool tests for determining cure of Helicobacter pylori infection after treatment. Helicobacter 2010;15(3):201‐5.

Calvet 2015

Calvet X. Diagnosis of Helicobacter pylori infection in the proton pump inhibitor era. Gastroenterology Clinics of North America 2015;44(3):507‐18.

Calvo 2013

Calvo XC, Ramirez‐Lazaro M, Lario S, Sanchez‐Delgado J, Montserrat A, Casalots A, et al. C13‐urea breath test skipping citric acid has low specificity for diagnosing H. pylori infection. Helicobacter 2013;18:119‐20.

Camargos 2003

Camargos Rocha AM, Aguiar Rocha G, Santos A, De Oliveira CA, Magalhaes Queiroz DM. Accuracy of a commercial enzyme‐linked immunosorbent assay for CagA in patients from Brazil with and without gastric carcinoma. Journal of Clinical Microbiology 2003;41(1):447‐8.

Camorlinga‐Ponce 1998

Camorlinga‐Ponce M, Torres J, Perez‐Perez G, Leal‐Herrera Y, Gonzalez‐Ortiz B, Madrazo de la Garza A, et al. Validation of a serologic test for the diagnosis of Helicobacter pylori infection and the immune response to urease and CagA in children. American Journal of Gastroenterology 1998;93(8):1264‐70.

Campuzano‐Maya 2007

Campuzano‐Maya G. An optimized C‐13‐urea breath test for the diagnosis of H. pylori infection. World Journal of Gastroenterology 2007;13(41):5454‐64.

Canard 2003

Canard JM, Ponchon T, Napoleon B, Boyer J, Dalbies P, Escourrou J, et al. Specific roles of endoscopy and respiratory test in the diagnosis and eradication control of Helicobacter pylori . Acta Endoscopica 2003;33(5):810‐2.

Canete 2002

Canete A, Abunaji Y, Alvarez‐Calatayud G, De‐Vicente M, Gonzalez‐Holguera J, Leralta M, et al. 13C‐urea breath test with 50 mg of urea: An accurate method for the diagnosis of H. pylori infection in children. Gastroenterology 2002;122(4 (Suppl)):A207.

Canete 2003

Canete A, Abunaji Y, Alvarez‐Calatayud G, DeVicente M, Gonzalez‐Holguera JA, Leralta M, et al. Breath test using a single 50‐mg dose of C‐13‐urea to detect Helicobacter pylori infection in children. Journal of Pediatric Gastroenterology and Nutrition 2003;36(1):105‐11.

Cao 2012

Cao X, Jiang J, Jia ZF, Jin MS. Serum levels of pepsinogen ii are a useful biomarker of Helicobacter pylori‐infected gastric cancer than pepsinogen i. Journal of Gastroenterology and Hepatology 2012;27:24.

Caporali 2003

Caporali R, Epis O, Negrini R, Scire CA, Solcia E, Montecucco C. Salivary gland lymphocytic infiltrates and Helicobacter pylori serology in anti‐SSA/Ro positive patients in Italy. Clinical and Experimental Rheumatology 2003;21(2):266‐7.

Capurso 2006

Capurso G, Carnuccio A, Lahner E, Panzuto F, Baccini F, Fave GD, et al. Corpus‐predominant gastritis as a risk factor for false‐negative C‐13‐urea breath test results. Alimentary Pharmacology & Therapeutics 2006;24(10):1453‐60.

Cardenas 2006

Cardenas VM, Dominguez DC, Puentes F, Aragaki CC, Goodman KJ, Graham DY, et al. Rapid stool antigen test for diagnosis of H‐pylori infection in asymptomatic children. Gastroenterology 2006;130(4 (suppl)):A570.

Cardenas 2008

Cardenas VM, Dominguez DC, Puentes FA, Aragaki CC, Goodman KJ, Graham DY, et al. Evaluation of a novel stool native catalase antigen test for Helicobacter pylori infection in asymptomatic North American children. Journal of Pediatric Gastroenterology & Nutrition 2008;46(4):399‐402.

Cardinali 2003

Cardinali LDC, Rocha GA, Rocha AMC, De Moura SB, Soares TD, Esteves AMB, et al. Evaluation of C‐13 urea breath test and Helicobacter pylori stool antigen test for diagnosis of H‐pylori infection in children from a developing country. Journal of Clinical Microbiology 2003;41(7):3334‐5.

Carrasco 1998

Carrasco MAV, Alonso IJ, Canto JLG, Baruque LL, Molini PS, Gisbert JP, et al. Is fasting required to perform C‐13‐urea breath test in the diagnosis of H‐pylori infection?. Gut 1998;43(Suppl 2):A54.

Casellas 1999

Casellas F, Lopez J, Borruel N, Saperas E, Vergara M, De Torres I, et al. The impact of delaying gastric emptying by either meal substrate or drug on the C‐13 ‐urea breath test. American Journal of Gastroenterology 1999;94(2):369‐73.

Caselli 1999

Caselli M, Zaffoni E, Trevisani L, Sartori S, Alvisi V, Plebani M, et al. Diagnosis of Helicobacter pylori infection by HPSA test. Lancet 1999;354(9185):1209‐11.

Caspary 1995

Caspary WF. 13C‐urea breath test. Patient‐friendly gold standard in the diagnosis of Helicobacter pylori infection with long term cost control potential. Deutsche Medizinische Wochenschrift 1995;120(27):976‐8.

Casswall 1999

Casswall TH, Nilsson HO, Bergstrom M, Aleljung P, Wadstrom T, Dahlstrom AK, et al. Evaluation of serology, 13C‐urea breath test, and polymerase chain reaction of stool samples to detect Helicobacter pylori in Bangladeshi children. Journal of Pediatric Gastroenterology & Nutrition 1999;28(1):31‐6.

Castro 2004

Castro Fernández M, Sánchez Muñoz D, García Díaz E, Galán Jurado MV, Rodríguez Alonso C. Diagnosis of Helicobacter pylori infection using urease rapid test in patients with bleeding duodenal ulcer: Influence of endoscopic signs and simultaneous corporal and antral biopsies. Revista Espanola De Enfermedades Digestivas 2004;96(9):599‐602; 605.

Castro‐Fernandez 2004

Castro‐Fernández M, Sanchez‐Muñoz D, García‐Díaz E, Miralles‐Sanchiz J, Vargas‐Romero J. Diagnosis of Helicobacter pylori infection in patients with bleeding ulcer disease: Rapid urease test and histology. Revista Espanola De Enfermedades Digestivas 2004;96(6):395‐8; 398‐401.

Cave 1999

Cave DR, Zanten SV, Carter E, Halpern EF, Klein S, Prather C, et al. A multicentre evaluation of the laser assisted ratio analyser (LARA): A novel device for measurement of 13CO2 in the 13C‐urea breath test for the detection of Helicobacter pylori infection. Alimentary Pharmacology & Therapeutics 1999;13(6):747‐52.

Cevrioglu 2004

Cevrioglu AS, Altindis M, Yilmazer M, Fenkci IV, Ellidokuz E, Kose S. Efficient and non‐invasive method for investigating Helicobacter pylori in gravida with hyperemesis gravidarum: Helicobacter pylori stool antigen test. Journal of Obstetrics & Gynaecology Research 2004;30(2):136‐41.

Chacon 1995

Chacon EP, Correnti M, Salma N, Serrano N, Pinero R, Cavazza ME, et al. Immunoenzymatic assay for serodiagnosis of Helicobacter pylori infections. GEN 1995;49(3):208‐11.

Chalkias 2011

Chalkias A, Nikotian G, Koutsovasilis A, Bramis J, Manouras A, Mystrioti D, et al. Patients with colorectal cancer are characterized by increased concentration of fecal Hb‐Hp complex, myeloperoxidase, and secretory IgA. American Journal of Clinical Oncology: Cancer Clinical Trials 2011;34(6):561‐6.

Chang 1999

Chang MC, Wu MS, Wang HH, Wang HP, Lin JT. Helicobacter pylori stool antigen (HPSA) test ‐ a simple, accurate and non‐invasive test for detection of Helicobacter pylori infection. Hepato‐Gastroenterology 1999;46(25):299‐302.

Chang 2000

Chang YW, Kim KJ, Min SK, Dong SH, Kim HJ, Kim BH, et al. Quantitative result of C‐13‐urea breath test does not correlate with Helicobacter pylori density in the stomach by assessing histopathology and grade of phenol red staining. Gastroenterology 2000;118(4):A1221.

Chang 2002

Chang MC, Chang YT, Sun CT, Wu MS, Wang HP, Lin JT. Quantitative correlation of Helicobacter pylori stool antigen (HPSA) test with C‐13‐urea breath test (C‐13‐UBT) by the updated Sydney Grading System of gastritis. Hepato‐Gastroenterology 2002;49(44):576‐9.

Chang 2003

Chang YW, Min SK, Kim KJ, Han YS, Lee JH, Dong SH, et al. Delta (13)C‐urea breath test value is a useful indicator for Helicobacter pylori eradication in patients with functional dyspepsia. Journal of Gastroenterology & Hepatology 2003;18(6):726‐31.

Chang 2012

Chang WT, Lin CC, Lin YH, Wang CC, Wang SH, Liu YW, et al. The potential role of using C‐13 urea breath test as a routine perioperative evaluation of Helicobacter pylori infection in living‐related liver donors. Liver Transplantation 2012;18:S205‐S.

Chang 2013

Chang C, Xie H, Ni Y, Ting Q, Bo Z. The clinical studies to the diagnostic value of serum pepsinogen levels in gastric cancer. Journal of Gastroenterology and Hepatology 2013;28:742.

Chattopadhyay 2002

Chattopadhyay UK. Coagglutination test for rapid noncultural diagnosis of human campylobacteriosis. European Review for Medical and Pharmacological Sciences 2002;6(1):9‐11.

Chattopadhyay 2004

Chattopadhyay S, Patra R, Ramamurthy T, Chowdhury A, Santra A, Dhali GK, et al. Multiplex PCR assay for rapid detection and genotyping of Helicobacter pylori directly from biopsy specimens. Journal of Clinical Microbiology 2004;42(6):2821‐4.

Checchi 2000

Checchi L, Felice P, Acciardi C, Ricci C, Gatta L, Polacci R, et al. Absence of Helicobacter pylori in dental plaque assessed by stool test. American Journal of Gastroenterology 2000;95(10):3005‐6.

Chehter 2013

Chehter EZ, Bacci MR, Fonseca FLA, Goncalves JAC, Buchalla G, Shiraichi SAR, et al. Diagnosis of the infection by the Helicobacter pylori through stool examination: Method standardization in adults. Clinical Biochemistry 2013;46(15):1622‐4.

Chen 1994

Chen JJ, Changchien CS, Tai DI, Chiou SS, Lee CM, Kuo CH. Role of Helicobacter pylori in cirrhotic patients with peptic ulcer. A serological study. Digestive Diseases & Sciences 1994;39(7):1565‐8.

Chen 1996

Chen JJ, Yang ZX, Jiang XG. A comparison of purified urease antigen and whole cell antigen of Helicobacter pylori by ELISA test‐‐study on the application and serum diagnoses of Helicobacter pylori urease diagnostic reagent. Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi 1996;17(1):44‐6.

Chen 1997

Chen TS, Chang FY, Lee SD. Serodiagnosis of Helicobacter pylori infection: Comparison and correlation between enzyme‐linked immunosorbent assay and rapid serological test results. Journal of Clinical Microbiology 1997;35(1):184‐6.

Chen 2000

Chen X, Haruma K, Kamada T, Mihara M, Komoto K, Yoshihara M, et al. Factors that affect results of the C‐13 urea breath test in Japanese patients. Helicobacter 2000;5(2):98‐103.

Chen 2001a

Chen X, Haruma K, Kamada T, Hartori N, Yoshihara M, Kitadai Y, et al. A low 13C‐urea breath test value is associated with increased risk of gastric cancer. Journal of Gastroenterology 2001;36(9):601‐5.

Chen 2001b

Chen TS, Chang FY, Lee SD. Extending the reading time increases the accuracy of rapid whole blood test for diagnosis of Helicobacter pylori infection. Journal of Gastroenterology & Hepatology 2001;16(12):1341‐5.

Chen 2002a

Chen TS, Li FY, Chang FY, Lee SD. Immunoglobulin G antibody against Helicobacter pylori: Clinical implications of levels found in serum. Clinical & Diagnostic Laboratory Immunology 2002;9(5):1044‐8.

Chen 2002b

Chen TS, Chang FY, Lee SD. No difference of accuracy between capillary and venous blood in rapid whole blood test for diagnosis of Helicobacter pylori infection. Digestive Diseases & Sciences 2002;47(11):2519‐22.

Chen 2003

Chen TS, Chang FY, Chen PC, Huang TW, Ou JT, Tsai MH, et al. Simplified C‐13‐urea breath test with a new infrared spectrometer for diagnosis of Helicobacter pylori infection. Journal of Gastroenterology and Hepatology 2003;18(11):1237‐43.

Chen 2009a

Chen CC, Liou JM, Hsu YC, Fang JY, Wang HP, Wu MS. Rabeprazole therapeutic trial in patients with uninvestigated dyspepsia. Journal of Gastroenterology and Hepatology 2009;24:A45.

Chen 2009b

Chen LW, Chang JJ, Chiu CJ, Fang KM, Chien RN, Chang LC, et al. 14C urea breath test in patients with peptic ulcer: The correlations with clinical factors, histology, rapid urease test and endoscopic findings. Journal of Gastroenterology and Hepatology 2009;24:A86.

Cheng 2004

Cheng H, Hu FL. The value of Helicobacter pylori stool antigen immunocard stat in diagnosis of HP infection and assessing of eradication of HP. Zhonghua Yi Xue Za Zhi 2004;84(14):1166‐70.

Cherian 2008

Cherian S, Burgner DP, Carson CF, Sanfilippo FM, Cook AG, Forbes DA. Diagnosis of Helicobacter pylori infection in a high‐prevalence pediatric population: A comparison of 2 fecal antigen testing methods and serology. Journal of Pediatric Gastroenterology and Nutrition 2008;47(2):130‐5.

Chey 1997a

Chey WD, Woods M, Scheiman JM, Nostrant TT, DelValle J. Lansoprazole and ranitidine affect the accuracy of the C‐14‐urea breath test by a pH‐dependent mechanism. American Journal of Gastroenterology 1997;92(3):446‐50.

Chey 1997b

Chey WD. Proton pump inhibitors and the urea breath test: How long is long enough?. American Journal of Gastroenterology 1997;92(4):720‐1.

Chey 1999a

Chey WD, Shaw S, Montague J, Jones M, Murthy U. Appropriate timing of the C‐14‐urea breath test to establish eradication of H‐pylori infection: An interim analysis. Gastroenterology 1999;116(4 (suppl)):A136.

Chey 1999b

Chey WD, Murthy U, Toskes P, Carpenter S, Laine L. The 13C‐urea blood test accurately detects active Helicobacter pylori infection: A United States, multicenter trial. American Journal of Gastroenterology 1999;94(6):1522‐4.

Chey 2000a

Chey WD, Metz DC, Shaw S, Kearney D, Montague J, Murthy U. Appropriate timing of the C‐14‐urea breath test to establish eradication of Helicobacter pylori infection. American Journal of Gastroenterology 2000;95(5):1171‐4.

Chey 2000b

Chey WD. Accurate diagnosis of Helicobacter pylori ‐ C‐14‐urea breath test. Gastroenterology Clinics of North America 2000;29(4):895.

Chey 2007

Chey WD, Wong BC. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. American Journal of Gastroenterology 2007;102(8):1808‐25.

Chiang 2010

Chiang TH, Tu CH, Lee YC, Wu MS. Clinical predictors of significant esophagogastroduodenoscopy findings for asymptomatic subjects with positive immunochemical fecal occult blood test and negative colonoscopy. Gastrointestinal Endoscopy 2010;71 (5):AB357.

Chiba 1999

Chiba N, Veldhuyzen Van Zanten SJ. 13C‐urea breath tests are the noninvasive method of choice for Helicobacter pylori detection. Canadian Journal of Gastroenterology 1999;13(8):681‐3.

Ching 1991a

Ching CK, Thompson S, Buxton C, Holgate C, Hill P, Freeman JG, et al. Evaluation of the new Helico‐G ELISA for serological diagnosis of Helicobacter‐pylori infection. Gut 1991;32(5):A570.

Ching 1991b

Ching CK. A simplified diagnostic approach to Helicobacter pylori infection‐‐is it adequate?. American Journal of Gastroenterology 1991;86(9):1276‐8.

Ching 1993

Ching CK, Thompson S, Buxton C, Holgate C, Holmes GKT. Evaluation of a commercial enzyme‐linked immunosorbent assay (ELISA) kit for serological diagnosis of Helicobacter pylori infection in a group of non‐ulcer dyspepsia sufferers. Postgraduate Medical Journal 1993;69(812):456‐60.

Chisholm 2004

Chisholm SA, Watson CL, Teare ELS, Saverymuttu S, Owen RJ. Non‐invasive diagnosis of Helicobacter pylori infection in adult dyspeptic patients by stool antigen detection: Does the rapid immunochromatography test provide a reliable alternative to conventional ELISA kits?. Journal of Medical Microbiology 2004;53(7):623‐7.

Chmiela 2003

Chmiela M, Wisniewska M, Bak‐Romaniszyn L, Rechcinski T, Planeta‐Malecka I, Bielanski W, et al. Serological differentiation of Helicobacter pylori CagA(+) and CagA(‐) infections. Archivum Immunologiae et Therapiae Experimentalis 2003;51(2):131‐6.

Cho 2000

Cho HS, Kang DH, Kim EA, Park DK, Park HC, Choi DJ, et al. The usefulness of C‐13‐urea breath test for the diagnosis of Helicobacter pylori infection in operative stomach. Gastroenterology 2000;118(4):A505.

Cho 2003

Cho YS, Kim SS, Chae HS, Han SW, Lee CD, Chung IS. The correlation between the DOB30 value of 13C‐urea breath test and the staining pattern of endoscopic phenol red test in the diagnosis of Helicobacter pylori infection. Gastroenterology 2003;124(4 (Suppl)):A176.

Cho 2008

Cho YS, Chae HS, Jang SN, Kim JS, Son HS, Kim HK, et al. Comparison of the 13C‐urea breath test and the endoscopic phenol red mucosal pH test in the quantification of Helicobacter pylori infection loading. Korean Journal of Internal Medicine 2008;23(3):134‐9.

Choi 2010

Choi J, Kim D, Park M. A prospective evaluation of new stool antigen test for detection of H‐pylori, in comparison with histology, rapid urease test, C‐13‐urea breath test, and serology. Helicobacter 2010;15(4):359.

Choi 2011

Choi J, Kim CH, Kim D, Chung SJ, Song JH, Kang JM, et al. Prospective evaluation of a new stool antigen test for the detection of Helicobacter pylori, in comparison with histology, rapid urease test, 13C‐urea breath test, and serology. Journal of Gastroenterology and Hepatology (Australia) 2011;26(6):1053‐9.

Chong 1994

Chong J, Marshall BJ, Barkin JS, McCallum RW, Reiner DK, Hoffman SR, et al. Occupational exposure to Helicobacter pylori for the endoscopy professional: A sera epidemiological study. American Journal of Gastroenterology 1994;89(11):1987‐92.

Chong 1995

Chong SK, Lou Q, Asnicar MA, Zimmerman SE, Croffie JM, Lee CH, et al. Helicobacter pylori infection in recurrent abdominal pain in childhood: Comparison of diagnostic tests and therapy. Pediatrics 1995;96(2 Pt 1):211‐5.

Chou 1997

Chou CH, Sheu BS, Yang HB, Cheng PN, Shin JS, Chen CY, et al. Clinical assessment of the bacterial load of Helicobacter pylori on gastric mucosa by a new multi‐scaled rapid urease test. Journal of Gastroenterology and Hepatology 1997;12(1):1‐6.

Christensen 1992

Christensen AH, Gjorup T, Hilden J, Fenger C, Henriksen B, Vyberg M, et al. Observer homogeneity in the histologic diagnosis of Helicobacter‐pylori ‐ latent class analysis, kappa‐coefficient, and repeat frequency. Scandinavian Journal of Gastroenterology 1992;27(11):933‐9.

Christie 1996

Christie JM, McNulty CA, Shepherd NA, Valori RM. Is saliva serology useful for the diagnosis of Helicobacter pylori?. Gut 1996;39(1):27‐30.

Chua 2002

Chua TS, Fock KM, Teo EK, Ng TM. Validation of 13C‐urea breathtest for the diagnosis of Helicobacter pylori infection in the Singapore population. Singapore Medical Journal 2002;43(8):408‐11.

Chung 2001a

Chung IK, Hong SJ, Kim EJ, Cho JY, Kim HS, Park SH, et al. What is the best method to diagnose Helicobacter infection in bleeding peptic ulcers?: A prospective trial. Korean Journal of Internal Medicine 2001;16(3):147‐52.

Chung 2001b

Chung AYF, Chow PKH, Yu WK, Ho JMS, Chan HS, Wong WK, et al. Prevalence of Helicobacter pylori in gastric cancer in a South‐East Asian population by C‐14‐urea breath test. ANZ Journal of Surgery 2001;71(10):574‐6.

Churchill 1998

Churchill RD, Hill PG, Holmes GK. Management of dyspepsia in primary care. Breath test is better than near patient blood tests. BMJ 1998;316(7141):1389.

Chvalova 1990

Chvalova M, Sedlackova M, Souckova A, Soucek A, Jirasek A. Assessment of antibodies against Campylobacter‐pylori in children and adolescents with gastroduodenal complaints. Sbornik Lekarsky 1990;92(11‐12):343‐8.

Cinar 2004

Cinar K, Soykan I, Ozden A. The effect of Helicobacter pylori eradication in patients with functional dyspepsia: Assessment of different diagnostic tests. Turkish Journal of Gastroenterology 2004;15(3):159‐63.

Ciok 2003

Ciok J, Tacikowski T, Bujko J, Dzieniszewski J. Urea breath test (UBT) in the diagnosis of Helicobacter pylori infection. Gastroenterologia Polska 2003;10(3):241‐6.

Cirak 2007

Cirak MY, Akyon Y, Megraud F. Diagnosis of Helicobacter pylori . Helicobacter 2007;12 Suppl 1:4‐9.

Clancy 1994

Clancy RL, Cripps AW, Taylor DC, McShane LA, Webster VJ. Detection of antibody against Helicobacter pylori in the saliva of patients with dyspepsia. Canadian Journal of Gastroenterology 1994;8(7):408‐12.

Clayton 1992

Clayton CL, Kleanthous H, Coates PJ, Morgan DD, Tabaqchali S. Sensitive detection of Helicobacter‐pylori by using polymerase chain‐reaction. Journal of Clinical Microbiology 1992;30(1):192‐200.

Cockburn 2001

Cockburn M, Collett J, Cox B. Validation of the saliva‐based H. pylori test, helisal, and its use in prevalence surveys. Epidemiology & Infection 2001;126(2):191‐6.

Coelho 1990

Coelho LGV, Chausson Y, Passos MCF, Sadala RU, Costa EL, Sabino CVS, et al. C‐14 urea breath test as a noninvasive method to detect gastric Helicobacter‐pylori colonization. Gastroenterologie Clinique et Biologique 1990;14(11):801‐5.

Coelho 1997

Coelho LGV, Passos MCF, Chausson Y, Simal CJR, Aguiar ROA, Gallo MA, et al. Standard‐dose (5‐mu Ci) vs mini‐dose (1‐mu Ci) 14c‐urea breath test for H‐pylori detection. Gastroenterology 1997;112(4 (suppl)):A92.

Coelho 1999

Coelho LG, Reber M, Passos MC, Aguiar RO, Casaes PE, Bueno ML, et al. Application of isotope‐selective non‐dispersive infrared spectrometry for the evaluation of the 13C‐urea breath test: Comparison with three concordant methods. Brazilian Journal of Medical & Biological Research 1999;32(12):1493‐7.

Coelho 2003

Coelho LGV, Rocha Z, Boechat LC, Aguiar ROA, Aragao ALA, Dias EES, et al. 13C‐urea breath test for H‐pylori detection in children: Determination of the cutoff value by graphic method, independent of gold standard comparison. Gastroenterology 2003;124(4 (suppl)):A177.

Coelho 2009a

Coelho LGV, Coelho MCF, Oliveira SM, Santa‐Cecilia EV, Moreira MR, Bomfim IM, et al. Does low dosage of 13C‐urea keep good accuracy for diagnosis of H. pylori infection?. Helicobacter 2009;14 (4):340.

Coelho 2009b

Coelho LG, Silva‐Junior AE, Coelho MC, Santa‐Cecilia EV, Ferreira RO, Bomfim IM, et al. Does low dosage of 13C‐urea keep good accuracy for diagnosis of Helicobacter pylori infection. Gastroenterology 2009;136(5 (Suppl)):A345.

Coelho 2011

Coelho LG, Silva AE, Coelho MC, Penna FG, Ferreira RO, Santa‐Cecilia EV. Does low dose (13)C‐urea breath test maintain a satisfactory accuracy in diagnosing Helicobacter pylori infection?. Arquivos de Gastroenterologia 2011;48(2):104‐8.

Cohen 1999

Cohen H, Rose S, Lewin DN, Retama B, Naritoku W, Johnson C, et al. Accuracy of four commercially available serologic tests, including two office‐based tests and a commercially available C‐13 urea breath test, for diagnosis of Helicobacter pylori . Helicobacter 1999;4(1):49‐53.

Colaiocco 1999

Colaiocco Ferrante L, Papponetti M, Marcuccitti J, Neri M, Festi D. 13C‐urea breath test for Helicobacter pylori infection: Stability of samples over time. Scandinavian Journal of Gastroenterology 1999;34(9):942‐3.

Collins 1992

Collins JSA, Bamford KB, Sloan JM, Collins BJ, Moorehead RJ, Love AHG. Screening for Helicobacter pylori antibody could reduce endoscopy workload in young dyspeptic patients. European Journal of Gastroenterology and Hepatology 1992;4(12):991‐3.

Con 2007

Con SA, Con‐Wong R, Con‐Chin GR, Con‐Chin VG, Takeuchi H, Valerin AL, et al. Serum pepsinogen levels, Helicobacter pylori CagA status, and cytokine gene polymorphisms associated with gastric premalignant lesions in Costa Rica. Cancer Epidemiology, Biomarkers & Prevention 2007;16(12):2631‐6.

Connor 1999

Connor SJ, Seow F, Ngu MC, Katelaris PH. The effect of dosing with omeprazole on the accuracy of the C‐13‐urea breath test in Helicobacter pylori‐infected subjects. Alimentary Pharmacology & Therapeutics 1999;13(10):1287‐93.

Conti‐Nibali 1990

Conti‐Nibali S, Baldari S, Vitulo F, Sferlazzas C, Russo E, Tedeschi A, et al. The 14CO2 urea breath test for Helicobacter pylori infection. Journal of Pediatric Gastroenterology & Nutrition 1990;11(2):284‐5.

Continibali 1991

Continibali S, Sferlazzas C, Fera MT, Saitta G, Tedeschi A, Magazzu G. A simplified diagnostic‐approach to Helicobacter‐pylori infection ‐ is it adequate ‐ reply. American Journal of Gastroenterology 1991;86(9):1277‐8.

Contreras 2006

Contreras M, Amado MAG, Rodriguez MJ, Landaez PB, Zambrano Y, Alvarez M, et al. Validation of a fast immunochroniatographic test for H. pylori detection in stool. Interciencia 2006;31(2):136‐9.

Coombs 2001

Coombs GW, Foster NM, Pearman JW, Forbes GM. Detection of Helicobacter pylori antigen in faeces by enzyme immunoassay. Pathology 2001;33(4):496‐7.

Cooreman 1990

Cooreman M, Hengels KJ, Krausgrill P, Strohmeyer G. 13C‐urea breath test as a noninvasive means of diagnosing the presence of Helicobacter (Campylobacter) pylori . Deutsche Medizinische Wochenschrift 1990;115(10):367‐71.

Corti 2007

Corti RE. The accuracy of the breath test with C‐urea to diagnose Helicobacter pylori infection. Salud I Ciencia 2007;15(5):914.

Corvaglia 1997

Corvaglia L, Bontems P, Keppens E, Vandenborre C, DePrez C. HP infection in children: Comparison of results with serology and C‐13‐urea breath test. Gut 1997;41(suppl):A68.

Corvaglia 1999

Corvaglia L, Bontems P, Devaster JM, Heimann P, Glupczynski Y, Keppens E, et al. Accuracy of serology and C‐13‐urea breath test for detection of Helicobacter pylori in children. Pediatric Infectious Disease Journal 1999;18(11):976‐9.

Costa 2001

Costa F, Mumolo MG, Bellini M, Romano MR, Manghetti M, Paci A, et al. Post‐treatment diagnostic accuracy of a new enzyme immunoassay to detect Helicobacter pylori in stools. Alimentary Pharmacology & Therapeutics 2001;15(3):395‐401.

Couturier 2014

Couturier MR, Marshall BJ, Goodman KJ, Megraud F. Helicobacter pylori diagnostics and treatment: Could a lack of universal consensus be the best consensus?. Clinical Chemistry 2014;60(4):589‐94.

Crabtree 1990

Crabtree JE, Shallcross TM, Wyatt JI, Heatley RV. Validation of a commercial ELISA for serodiagnosis of Helicobacter‐pylori infection. Gut 1990;31(10):A1176.

Crabtree 1991a

Crabtree JE, Taylor JD, Shallcross TM, Wyatt JI, Rathbone BJ, Heatley RV. Western blotting analysis of mucosal and systemic immune‐responses to Helicobacter‐pylori . Gut 1991;32(5):A564.

Crabtree 1991b

Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI. Evaluation of a commercial ELISA for serodiagnosis of Helicobacter pylori infection. Journal of Clinical Pathology 1991;44(4):326‐8.

Cremonini 2000

Cremonini F, Zocco MA, Armuzzi A, Bartolozzi F, Santarelli L, Ojetti V, et al. C‐13 urea breath test for predicting resistance to therapy in Helicobacter pylori infection. Gut 2000;47(Suppl 1):A117.

Cremonini 2005

Cremonini F, Bartolozzi F, Armuzzi A, Zocco MA, Santarelli L, Gabrielli M, et al. Can 13C urea breath test predict resistance to therapy in Helicobacter pylori infection?. Hepato‐Gastroenterology 2005;52(64):1119‐21.

Crespo 2009

Crespo Medina M, Sanchez Sanchez C, Morales JL, Huber LB, Mendiola I. Valuation of non‐invasive tests to detect Helicobacter pylori infection in children. Acta Pediatrica Espanola 2009;67(7):319‐24.

Crispino 2013

Crispino P, Colarusso D, Minervini G, Schiava A, Tripodi B, Cimmino G, et al. Diagnosis of Helicobacter pylori infection: Comparison between invasive and non invasive tests. Italian Journal of Medicine 2013;7(2S):33.

Cullen 1992

Cullen DJ, Cullen KJ, Collins BJ, Christiansen KJ, Epis J. Serological assessment of Helicobacter pylori eradication. Lancet 1992;340(8828):1161‐2.

Cullen 2002

Cullen KP, Broderick BM, Jayaram J, Flynn B, O'Connor HJ. Evaluation of the Helicobacter pylori stool antigen (HPSA) test in routine clinical practice‐‐is it patient‐friendly?. Irish Medical Journal 2002;95(10):305‐6.

Cunningham 2010

Cunningham SA, Sloan LM, Nyre LM, Vetter EA, Mandrekar J, Patel R. Three‐hour molecular detection of Campylobacter, Salmonella, Yersinia, and Shigella species in feces with accuracy as high as that of culture. Journal of Clinical Microbiology 2010;48(8):2929‐33.

Cutler 1993

Cutler A, Schubert A, Schubert T. Role of Helicobacter pylori serology in evaluating treatment success. Digestive Diseases & Sciences 1993;38(12):2262‐6.

Cutler 1995a

Cutler AF, Havstad S, Ma CK, Blaser MJ, Perez‐Perez GI, Schubert TT. Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology 1995;109(1):136‐41.

Cutler 1995b

Cutler AF. Re ‐ C‐13 urea breath test ‐ response. American Journal of Gastroenterology 1995;90(11):2070.

Cutler 1996

Cutler AF, Prasad VM. Long‐term follow‐up of Helicobacter pylori serology after successful eradication. American Journal of Gastroenterology 1996;91(1):85‐8.

Cutler 1997

Cutler AF. Diagnostic tests for H. pylori: A prospective evaluation of their accuracy, without selecting a single test as the gold standard. American Journal of Gastroenterology 1997;92(3):538‐9.

Cutler 1998

Cutler AF, Miller S. Comparison of C‐13 urea blood test to C‐13 urea breath test for diagnosis of H‐pylori . Gastroenterology 1998;114(4 (suppl)):A97.

Cutler 1999

Cutler AF, Toskes P. Comparison of 13C‐urea blood test to 13C‐urea breath test for the diagnosis of Helicobacter pylori . American Journal of Gastroenterology 1999;94(4):959‐61.

Czinn 1991

Czinn SJ, Carr HS, Speck WT. Diagnosis of gastritis caused by Helicobacter pylori in children by means of an ELISA. Reviews of Infectious Diseases 1991;13 Suppl 8:S700‐3.

Czkwianianc 1997

Czkwianianc E, Chmiela M, Lawnik M, Planeta‐Malecka I, Rudnicka W. Serodiagnosis of Helicobacter pylori in children with gastroduodenitis. Central‐European Journal of Immunology 1997;22(4):240‐7.

Da Silva 2010

Da Silva JMK, Villares CA, Monteiro MS, Colauto C, Dos Santos AF, Mattar R. Validation of a rapid stool antigen test for diagnosis of Helicobacter pylori infection. Revista Do Instituto De Medicina Tropical De Sao Paulo 2010;52(3):125‐8.

Dahlberg 1998

Dahlberg M, Schjonsby H. 13C‐urea breath test as diagnostic method in Helicobacter pylori infection. Tidsskrift for Den Norske Laegeforening 1998;118(24):3762‐5.

Daino 2015

Daino DF, Soifer L, Pedesta J, Rome J. Pilot test for Helicobacter pylori detection with ammonia breath test. Acta Gastroenterologica Latinoamericana 2015;45(1):12‐7.

Dan 2013

Dan W, Jing W, Libo W, Hong X. Detection and analysis of Helicobacter pylori antibodies by protein chip technology. Journal of Gastroenterology and Hepatology 2013;28:541.

Danielli 1993

Danielli E. A fluorometric enzyme‐linked‐immunosorbent‐assay for serological diagnosis of Helicobacter‐pylori infection. European Journal of Gastroenterology & Hepatology 1993;5:S57‐S59.

Datta 2003

Datta D, Gazzard B, Stebbing J. The diagnostic yield of stool analysis in 525 HIV‐1‐infected individuals. Aids 2003;17(11):1711‐3.

Datta 2005

Datta S, Chattopadhyay S, Chowdhury A, Santra A, Saha DR, Ramamurthy T, et al. Diagnosis and genotyping of Helicobacter pylori by polymerase chain reaction of bacterial DNA from gastric juice. Journal of Gastroenterology and Hepatology 2005;20(8):1253‐9.

Day 2002

Day AS, Sherman PM. Accuracy of office‐based immunoassays for the diagnosis of Helicobacter pylori infection in children. Helicobacter 2002;7(3):205‐9.

Day 2003

Day AS, Veldhuyzen van Zanten S, Otley AR, Best L, Griffiths A, Sherman PM. Use of LARA‐urea breath test in the diagnosis of Helicobacter pylori infection in children and adolescents: A preliminary study. Canadian Journal of Gastroenterology 2003;17(12):701‐6.

De Angelis 2007

De Angelis GL, Cavallaro LG, Maffini V, Moussa AM, Fornaroli F, Liatopoulou S, et al. Usefulness of a serological panel test in the assessment of gastritis in symptomatic children. Digestive Diseases 2007;25(3):206‐13.

De Argila 2001

de Argila CM, Boixeda D. Practical considerations for the diagnosis of Helicobacter pylori infection. Medicina Clinica 2001;117(10):386‐91.

De Arruda 2001

De Arruda SMB, Passaro DJ, Yang S, Parsonnet J. Variability of serologic testing for H. pylori using U.S. and Peruvian antigens. Gastroenterology 2001;120(1):325‐6.

De Boer 1995

De Boer WA. Re: 13C urea breath test. American Journal of Gastroenterology 1995;90(11):2069‐70.

De Bustillo 1998

De Bustillo EM, Tomero JAS, Sanz JC, Moreno JA, Jimenez I, Lopez‐Brea M, et al. Eradication and follow‐up of Helicobacter pylori infection in hemodialysis patients. Nephron 1998;79(1):55‐60.

De Carvalho 2003

De Carvalho Costa Cardinali L, Rocha GA, Rocha AM, De Moura SB, De Figueiredo Soares T, Esteves AM, et al. Evaluation of 13C urea breath test and Helicobacter pylori stool antigen test for diagnosis of H. pylori infection in children from a developing country. Journal of Clinical Microbiology 2003;41(7):3334‐5.

De Giacomo 1991

De Giacomo C, Lisato L, Negrini R, Licardi G, Maggiore G. Serum immune response to Helicobacter pylori in children: Epidemiologic and clinical applications. Journal of Pediatrics 1991;119(2):205‐10.

De Laat 2001

De Laat LE, De Boer WA, Megraud F. The CLO test as a reference method for Helicobacter pylori infection. European Journal of Gastroenterology & Hepatology 2001;13(10):1269‐70.

De Oliveira 1999

De Oliveira AMR, Rocha GA, De Magalhaes Queiroz DM, Mendes EN, De Carvalho AST, Ferrari TCA, et al. Evaluation of enzyme‐linked immunosorbent assay for the diagnosis of Helicobacter pylori infection in children from different age groups with and without duodenal ulcer. Journal of Pediatric Gastroenterology and Nutrition 1999;28(2):157‐61.

De Pascalis 1999

De Pascalis R, Del Pezzo M, Nardone G, Budillon G, Lavitola A. Performance characteristics of an enzyme‐linked immunosorbent assay for determining salivary immunoglobulin G response to Helicobacter pylori . Journal of Clinical Microbiology 1999;37(2):430‐2.

Deankanob 2006

Deankanob W, Chomvarin C, Hahnvajanawong C, Intapan PM, Wongwajana S, Mairiang P, et al. Enzyme‐linked immunosorbent assay for serodiagnosis of Helicobacter pylori in dyspeptic patients and volunteer blood donors. Southeast Asian Journal of Tropical Medicine & Public Health 2006;37(5):958‐65.

Debongnie 1993

Debongnie JC, Durez P, Luyasu V. Validation of a commercial serologic test in the diagnosis of Helicobacter‐pylori infection ‐ clinical and epidemiologic use. Gastroenterologie Clinique et Biologique 1993;17(2):98‐102.

Dediste 2003

Dediste A, Vandenberg O, Vlaes L, Ebraert A, Douat N, Bahwere P, et al. Evaluation of the prospect microplate assay for detection of Campylobacter: A routine laboratory perspective. Clinical Microbiology & Infection 2003;9(11):1085‐90.

Deguchi 2009

Deguchi R, Matsushima M, Suzuki T, Mine T, Fukuda R, Nishina M, et al. Comparison of a monoclonal with a polyclonal antibody‐based enzyme immunoassay stool test in diagnosing Helicobacter pylori infection after eradication therapy. Journal of Gastroenterology 2009;44(7):713‐6.

Del Pozo Garcia 2006

Del Pozo Garcia AJ, Gisbert JP. Is the string test a useful alternative to gastroscopy with biopsy for H. pylori identification?. Revista Espanola De Enfermedades Digestivas 2006;98(7):542‐9.

Del Zompo 2014

Del Zompo F, Feliciani D, Mangiola F, D'Angelo G, Di Rienzo T, Vanella G, et al. Gas production during lactulose breath test is associated with Helicobacter pylori infection. Helicobacter 2014;19:82.

Delaney 2003

Delaney BC, Holder RL, Allan TF, Kenkre JE, Hobbs FDR. A comparison of Bayesian and maximum likelihood methods to determine the performance of a point of care test for Helicobacter pylori in the office setting. Medical Decision Making 2003;23(1):21‐30.

Demir 2001

Demir H, Ercis S, Kocak N, Hascelik G, Ozen H, Yuce A, et al. Detection of Helicobacter pylori with stool antigen test in children with gastroesophageal reflux disease. American Journal of Gastroenterology 2001;96(6):1944.

Demiray 2006

Demiray E, Yilmaz O, Sarkis C, Soyturk M, Simsek I. Comparison of invasive methods and two different stool antigen tests for diagnosis of H‐pylori infection in patients with gastric bleeding. World Journal of Gastroenterology 2006;12(26):4206‐10.

Demiray 2012

Demiray Gurbuz E, Gonen C, Bekmen N, Dolek D, Soyturk M, Sagol O, et al. The diagnostic accuracy of urine IgG antibody tests for the detection of Helicobacter pylori infection in Turkish dyspeptic patients. Turkish Journal of Gastroenterology 2012;23(6):753‐8.

Demiray‐Gurbuz 2012

Demiray‐Gurbuz E, Bekmen N, Erci T, Dotan Y, Yilmaz O. Evaluation of Helicobacter pylori stool antigen test results required from different outpatient clinics at university hospital. Helicobacter 2012;17:87‐8.

Demirturk 2003

Demirturk L, Yazgan Y, Tarcin O, Ozel M, Diler M, Oncul O, et al. Does N‐acetyl cysteine affect the sensitivity and specificity of Helicobacter pylori stool antigen test?. Helicobacter 2003;8(2):120‐3.

Desroches 1997

Desroches JJ, Lahaie RG, Picard M, Morais J, Dumont A, Gaudreau C, et al. Methodological validation and clinical usefulness of carbon‐14‐urea breath test for documentation of presence and eradication of Helicobacter pylori infection. Journal of Nuclear Medicine 1997;38(7):1141‐5.

Devenish 2005

Devenish J, Brooks B, Perry K, Milnes D, Burke T, McCabe D, et al. Validation of a monoclonal antibody‐based capture enzyme‐linked immunosorbent assay for detection of Campylobacter fetus . Clinical and Diagnostic Laboratory Immunology 2005;12(11):1261‐8.

Dewan 2000

Dewan R, Sachdev GK. Diagnosis of Helicobacter pylori infection in primary and tertiary care centers. Indian Journal of Gastroenterology 2000;19 Suppl 1:S11‐4; discussion S5.

Dhar 1998

Dhar R, Mustafa AS, Dhar PM, Khan MS, Al‐Rashidi FJS, Al‐Shamali AAA, et al. Evaluation and comparison of two immunodiagnostic assays for Helicobacter pylori antibodies with culture results. Diagnostic Microbiology and Infectious Disease 1998;30(1):1‐6.

Dhesi 2015

Dhesi E, White B, Chitembwe A, Alisa A, Musa S, Besherdas K. Is there any value in performing a CLO test at endoscopy in patients previously having a stool antigen test?. Gut 2015;64:A78.

Di Fulvio 2003

Di Fulvio A, Ierfone N, Standoli M, Trancassini M, Giordano A, Magni A, et al. Study of fecal antigens against Helicobacter pylori as non‐invasive test compared with the 13C‐urea breath‐test. Personal experience. Il Giornale di Chirurgia 2003;24(8‐9):312‐4.

Di Mario 2009

Di Mario F, Gatta L, Franze A, Rugge M, Scarpignato C, Dal Bo N, et al. Effects of H. pylori eradication on serum pepsinogen i, ii, ratio and gastrin‐17 in Italian and immigrant patients. Helicobacter 2009;14 (4):408.

Di Mario 2010

Di Mario F. Diagnostic accuracy of serum pepsinogens and gastrin to follow‐up H. pylori infection. Helicobacter 2010;15(4):350.

Di Rienzo 2013

Di Rienzo TA, D'Angelo G, Ojetti V, Campanale MC, Tortora A, Cesario V, et al. 13C‐urea breath test for the diagnosis of Helicobacter pylori infection. European Review for Medical & Pharmacological Sciences 2013;17 Suppl 2:51‐8.

Di Silvio 1998

Di Silvio M, Larisch J, Dibildox M, Almaguer I, Gitler R, Dehesa M, et al. Breath tests as a noninvasive diagnostic method in Helicobacter pylori infection. Revista de Gastroenterologia de Mexico 1998;63(3):135‐42.

Dietz 2001

Dietz J, Sekine S, Segal F, Kulczynski JMU, Chaves ALH, Costa JD, et al. "Helicobacter pylori" diagnosis: Comparison between invasive methods. Gastrenterologia Endoscopia Digestiva 2001;20(2):36‐40.

Dill 1989

Dill S, Paynejames JJ, McSwiggan D, Scrimgeour CM, Rennie MJ, Misiewicz JJ. Sensitivity and specificity of the C‐13 urea breath test in detecting Campylobacter‐pylori . Gut 1989;30(5):A752.

Dill 1990

Dill S, Payne‐James JJ, Misiewicz JJ, Grimble GK, McSwiggan D, Pathak K, et al. Evaluation of 13C‐urea breath test in the detection of Helicobacter pylori and in monitoring the effect of tripotassium dicitratobismuthate in non‐ulcer dyspepsia. Gut 1990;31(11):1237‐41.

Ding 1993

Ding SZ, Jia BQ, Liu XG. An urease enzyme linked immunosorbent assay for detection of Helicobacter pylori infection. Zhonghua Nei Ke Za Zhi [Chinese Journal of Internal Medicine] 1993;32(5):298‐301.

Ding 2000

Ding SL, Ring JA, Hebbard GS, Morcom JM, Young GP. Lansoprazole but not ranitidine interferes with C‐13 urea breath test detection of Helicobacter pylori infection. Gastroenterology 2000;118(4):A1228.

Djurasinovic 2014

Djurasinovic MZ, Sokic‐Milutinovic A, Filipovic B, Basara S, Krstic M, Milosavljevic T. The role of non‐invasive assessment of the secretory function of the gastric mucosa in dyspepsia. Helicobacter 2014;19:112.

Dmitrienko 2009

Dmitrienko M, Bykov S. Method of breath sampling for noninvasive H. pylori analysis. Helicobacter 2009;14 (4):341.

Dmitrienko 2011

Dmitrienko M, Bykov S, Parolova N, Karaseva G. Ammonia breath test ‐ transportation way of ammonia. Helicobacter 2011;16:115.

Dolek 2007

Dolek D, Soyturk M, Bekmen N, Yilmaz O, Demiray E, Sarioglu S, et al. Urine‐based ELISA testing for the diagnosis and confirmation of eradication of Helicobacter pylori infection. Helicobacter 2007;12(4):444.

Dominguez 2006

Dominguez J, Forne M, Blanco S, Prat C, Gali N, Latorre I, et al. Comparison of a monoclonal with a polyclonal antibody‐based enzyme immunoassay stool test in diagnosing Helicobacter pylori infection before and after eradication therapy. Alimentary Pharmacology & Therapeutics 2006;23(12):1735‐40.

Dominguezmunoz 1995

Dominguezmunoz JE, Linke A, Sauerbruch T, Malfertheiner P. How to improve the C‐13‐urea breath test (UBT) for the diagnosis of Helicobacter‐pylori infection. Gastroenterology 1995;108(4 (suppl)):A84.

Domínguez‐Muñoz 1997

Domínguez‐Muñoz JE, Leodolter A, Sauerbruch T, Malfertheiner P. A citric acid solution is an optimal test drink in the 13C‐urea breath test for the diagnosis of Helicobacter pylori infection. Gut 1997;40(4):459‐62.

Donati 1997

Donati M, Moreno S, Storni E, Tuccia A, Poli L, Sambri V, et al. Study of anti‐Helicobacter pylori antibodies with use of latex agglutination test. Microbiologia Medica 1997;12(3):130‐1.

Donati 2000

Donati M, Sambri V, Ranucci L, De Orsi D, Tucci A, Poli L, et al. Recombinant CagA enzyme‐linked immunosorbent assay and western immunoblot for the detection of serum antibodies to Helicobacter pylori . Clinical Microbiology & Infection 2000;6(3):164‐6.

Dondi 2006

Dondi E, Rapa A, Boldorini R, Fonio P, Zanetta S, Oderda G. High accuracy of noninvasive tests to diagnose Helicobacter pylori infection in very young children. Journal of Pediatrics 2006;149(6):817‐21.

Dong 2015

Dong FY, Ji DN, Huang RX, Zhang F, Huang YQ, Xiang P, et al. Multiple genetic analysis system‐based antibiotic susceptibility testing in Helicobacter pylori and high eradication rate with phenotypic resistance‐guided quadruple therapy. Medicine2015 [Epub ahead of print]; Vol. 94, issue 47. [DOI: 10.1097/MD.0000000000002056]

Dore 1997

Dore SP, Krupadas S, Borgonha S, Kurpad AV. The 13C urea breath test to assess Helicobacter pylori infection in school children. National Medical Journal of India 1997;10(2):57‐60.

Dore 2003

Dore MP, Realdi G, Sepulveda AR, Graham DY. Detection of genomic Helicobacter pylori DNA in the blood of patients positive for the infection. Digestive and Liver Disease 2003;35(11):839‐40.

Dore 2004

Dore MP, Negrini R, Tadeu V, Marras L, Maragkoudakis E, Nieddu S, et al. Novel monoclonal antibody‐based Helicobacter pylori stool antigen test. Helicobacter 2004;9(3):228‐32.

Dorta 2005

Dorta G. Helicobacter pylori detection revisited. Endoscopy 2005;37(6):579‐80; author reply 581‐2.

Dou 2008

Dou YC, Wang JB. Detection of H. pylori infection in patients with pancreatic cancer and clinical significance. Journal of Jilin University Medicine Edition 2008;34(2):317‐9.

Douraghi 2013

Douraghi M, Rostami MN, Goudarzi H, Ghalavand Z. Comparison of stool antigen immunoassay and serology for screening for Helicobacter pylori infection in intellectually disabled children. Microbiology and Immunology 2013;57(11):772‐7.

Doweck 1997

Doweck J, Quintana C, Barrios A, Monastra L, Lopetegui G, Zerbo O, et al. Evaluation of sensitivity, specificity and predictive value of six qualitative serological methods for the detection of Helicobacter pylori antibodies. Acta Gastroenterologica Latinoamericana 1997;27(4):259‐61.

Dowlatshahi 2002

Dowlatshahi S. Effect of gastrointestinal bleeding on the sensitivity of diagnostic tests for Helicobacter pylori infection. Archives of Iranian Medicine 2002;5(3):201‐2.

Drew 1988

Drew H, Lafrance ND, Mertz H, Hernandez J, Ravich W, Milligan F, et al. C‐14 urea breath test in Campylobacter pyloridis gastric disorders ‐ comparison with biopsy with comparison and sensitivity of 20, 40, 60 and 120 minute sampling. Clinical Nuclear Medicine 1988;13(5):394.

Drumm 1999

Drumm B, Rowland M, Imrie C. Sensitivity of urease‐based test on diagnosis of Helicobacter pylori in children and the elderly. Gastroenterology 1999;116(6):1506.

Drzymala‐Czy 2014

Drzymala‐Czy S, Stawinska‐Witoszynska B, Madry E, Krzywinska‐Wiewiorowska M, Szczepanik M, Walkowiak J, et al. Non‐invasive detection of Helicobacter pylori in cystic fibrosis ‐ the fecal test vs. the urea breath test. European Review for Medical and Pharmacological Sciences 2014;18(16):2343‐8.

Du 2004

Du JX, Watkins T, Bravo LE, Fontham ET, Camargo MC, Correa P, et al. 13C‐urea breath test for Helicobacter pylori in young children: Cut‐off point determination by finite mixture model. Statistics in Medicine 2004;23(13):2049‐60.

Duan 1994

Duan LP, Braden B, Lembcke B, Caspary WF. C‐13‐urea breath test after breakfast still meets the criteria for valid diagnosis of Helicobacter‐pylori . Gastroenterology 1994;106(4 (suppl)):A71.

DuBois 2005

DuBois S, Kearney DJ. Iron‐deficiency anemia and Helicobacter pylori infection: a review of the evidence. American Journal of Gastroenterology 2005;100(2):453‐9.

Duggan 1998

Duggan AE, Hardy E, Hawkey CJ. Evaluation of a new near patient test for the detection of Helicobacter pylori . European Journal of Gastroenterology & Hepatology 1998;10(2):133‐6.

Duggan 1999

Duggan AE, Elliott C, Logan RFA. Testing for Helicobacter pylori infection: Validation and diagnostic yield of a near patient test in primary care. BMJ 1999;319(7219):1236‐9.

Dulbecco 2001

Dulbecco P, Gambaro C, Zentilin P, Bilardi C, Biagini R, Savarino V. The impact of long‐term ranitidine and pantoprazole on the precision of C‐13‐urea breath test (UBT) in subjects infected with Helicobacter pylori . Gastroenterology 2001;120(5 (suppl)):A578.

Dulbecco 2003

Dulbecco P, Gambaro C, Bilardi C, Zentilin P, Mele MR, Mansi C, et al. Impact of long‐term ranitidine and pantoprazole on accuracy of 13C urea breath test. Digestive Diseases & Sciences 2003;48(2):315‐21.

Dumont 1989

Dumont A, Abramovici J, Muller C, Trolin C, Barbier P. Diagnostic efficiency of the 14C‐urea breath test in the detection of antral Campylobacter pylori infection. Gastroduodenal pathology and Campylobacter pylori: European Campylobacter Pylori Study Group ICS847. 1989:73‐5.

Dun 2001

Dun CDR, Blac M, Cowell DC, Penaul C, Ratcliffe NM, Spence R, et al. Ammonia vapour in the mouth as a diagnostic marker for Helicobacter pylori infection: Preliminary 'proof of principle' pharmacological investigations. British Journal of Biomedical Science 2001;58(2):66‐75.

Durdal 2002

Durdal US, Engin D, Hascelik G. Evaluation of western blot method for the serological diagnosis of Helicobacter pylori infections. Mikrobiyoloji Bulteni 2002;36(2):153‐60.

Dy‐Limquiaco 2006

Dy‐Limquiaco LA, Florendo WO, Labio ME, Banez V, Daez ML. Validation of the new 14‐carbon urea breath test (14‐C UBT) in the diagnosis of Helicobacter pylori infection. Journal of Gastroenterology and Hepatology 2006;21:A505.

Dyrla 2015

Dyrla P, Gil J, Wojtun S, Korszun K, Kasinska E, Mackiewicz A. Helicobacter pylori infection. Diagnosis and treatment. Pediatria i Medycyna Rodzinna 2015;11(1):68‐74.

Ebara 2000

Ebara S, Aoyama N, Sakai T, Ikemura T, Shirasaka D, Sakashita M, et al. A study of gastric emptying in H‐pylori negative healthy volunteers using the C‐13‐octanoic acid breath test. Gastroenterology 2000;118(4):A1169.

Ebell 1998

Ebell MH. Breath test and serologic testing for Helicobacter pylori . Journal of the American Board of Family Practice 1998;11(2):170‐1.

Edwards 1997

Edwards CN, Douglin CP, Prussia PR, Garriques SA, Levett PN. Epidemiology of Helicobacter pylori infection in Barbados. West Indian Medical Journal 1997;46(1):3‐7.

El‐Nujumi 1996

El‐Nujumi A, Hilditch TE, McColl KEL. Effect of omeprazole therapy on determination of Helicobacter pylori status by C‐14 urea breath test. Gastroenterology 1996;110(4 (suppl)):A102.

El‐Nujumi 1998

El‐Nujumi A, Hilditch TE, Williams C, McColl KE. Current or recent proton pump inhibitor therapy markedly impairs the accuracy of the 14C urea breath test. European Journal of Gastroenterology & Hepatology 1998;10(9):759‐64.

El‐Zaatari 1995

El‐Zaatari FA, Nguyen AM, Genta RM, Klein PD, Graham DY. Determination of Helicobacter pylori status by reverse transcription‐polymerase chain reaction. Comparison with urea breath test. Digestive Diseases & Sciences 1995;40(1):109‐13.

El‐Zimaity 1998

El‐Zimaity HMT, Segura AM, Genta RM, Graham DY. Histologic assessment of Helicobacter pylori status after therapy: Comparison of Giemsa, Diff‐Quik, and Genta stains. Modern Pathology 1998;11(3):288‐91.

Elbast 1999

Elbast W, Brazier JL. Nondispersive infrared spectroscopy, an alternative to isotope ratio mass spectrometry: Case of the C‐13 urea breath test. Analusis 1999;27(3):228‐31.

Elitsur 1997

Elitsur Y, Neace C, Triest WE. Comparison between a rapid office‐based and ELISA serologic test in screening for Helicobacter pylori in children. Helicobacter 1997;2(4):180‐4.

Elitsur 1999a

Elitsur Y, Neace C, Werthammer MC, Triest WE. Prevalence of CagA, VacA antibodies in symptomatic and asymptomatic children with Helicobacter pylori infection. Helicobacter 1999;4(2):100‐5.

Elitsur 1999b

Elitsur Y, Neace C. Detection of Helicobacter pylori organisms by HP‐Fast in children. Digestive Diseases and Sciences 1999;44(6):1169‐72.

Elitsur 2000

Elitsur Y, Aflak R, Neace C, Triest WE. Helicobacter pylori serology and the diagnosis of H. pylori infection in children. West Virginia Medical Journal 2000;96(5):564‐6.

Elitsur 2004

Elitsur Y, Lawrence Z, Hill I. Stool antigen test for diagnosis of Helicobacter pylori infection in children with symptomatic disease: A prospective study. Journal of Pediatric Gastroenterology & Nutrition 2004;39(1):64‐7.

Elitsur 2005

Elitsur Y. Helicobacter pylori diagnostic tools: Is it in the stool?. Journal of Pediatrics 2005;146(2):164‐7.

Elitsur 2009

Elitsur Y, Tolia V, Gilger MA, Reeves‐Garcia J, Schmidt‐Sommerfeld E, Opekun AR, et al. Urea breath test in children: The United States prospective, multicenter study. Helicobacter 2009;14(2):134‐40.

Ellenrieder 1997

Ellenrieder V, Glasbrenner B, Stoffels C, Weiler S, Bode G, Moller P, et al. Qualitative and semi‐quantitative value of a modified 13C‐urea breath test for identification of Helicobacter pylori infection. European Journal of Gastroenterology & Hepatology 1997;9(11):1085‐9.

Elnujumi 1991

Elnujumi AM, Rowe P, Dorrian CA, McColl KEL. Value of C‐14 urea breath test and urease slide test (CLO test) to diagnose Helicobacter‐pylori in uremic patients. Gut 1991;32(10):A1220.

Eloubeidi 2001

Eloubeidi MA, Wade SB, Provenzale D. Factors associated with acceptance and full publication of GI endoscopic research originally published in abstract form. Gastrointestinal Endoscopy 2001;53(3):275‐82.

Endtz 2000

Endtz HP, Ang CW, Van den Braak N, Luijendijk A, Jacobs BC, De Man P, et al. Evaluation of a new commercial immunoassay for rapid detection of Campylobacter jejuni in stool samples. European Journal of Clinical Microbiology and Infectious Diseases 2000;19(10):794‐7.

Engberg 2003

Engberg JH, Strid MA, Molbak K, Krogfelt KA. Antibody response following infection with Campylobacter determined by enzyme‐linked immunosorbent assay (ELISA). Ugeskrift for Laeger 2003;165(24):2485‐6.

Engstrand 1992

Engstrand L, Nguyen AM, Graham DY, el‐Zaatari FA. Reverse transcription and polymerase chain reaction amplification of rRNA for detection of Helicobacter species. Journal of Clinical Microbiology 1992;30(9):2295‐301.

Enroth 1997a

Enroth H, Rigo R, Hulten K, Engstrand L. Diagnostic accuracy of a rapid whole‐blood test for detection of Helicobacter pylori . Journal of Clinical Microbiology 1997;35(10):2695‐7.

Enroth 1997b

Enroth H, Engstrand L. Rapid detection of Helicobacter pylori infection in serum and whole‐blood samples. APMIS 1997;105(12):951‐5.

Enroth 2002

Enroth H, Kraaz W, Rohan T, Nyren O, Engstrand L. Does the method of Helicobacter pylori detection influence the association with gastric cancer risk?. Scandinavian Journal of Gastroenterology 2002;37(8):884‐90.

Erzin 2004

Erzin Y, Altun S, Dobrucali A, Aslan M, Erdamar S, Dirican A, et al. Comparison of two different stool antigen tests for the primary diagnosis of Helicobacter pylori infection in Turkish patients with dyspepsia. Helicobacter 2004;9(6):657‐62.

Erzin 2005

Erzin Y, Altun S, Dobrucali A, Aslan M, Erdamar S, Dirican A, et al. Evaluation of two enzyme immunoassays for detecting Helicobacter pylori in stool specimens of dyspeptic patients after eradication therapy. Journal of Medical Microbiology 2005;54(Pt 9):863‐6.

Evans 1989

Evans DJ, Evans DG, Graham DY, Klein PD. A sensitive and specific serologic test for detection of Campylobacter pylori infection. Gastroenterology 1989;96(4):1004‐8.

Everts 1996

Everts B, Hamlet A, Pettersson A. A 10 minutes solid dosage C‐13‐urea breath test for diagnosis of Helicobacter pylori infection. Gastroenterology 1996;110(4 suppl):A105.

Faigel 1996a

Faigel DO, Furth EE, Childs M, Goin J, Metz DC. Histological predictors of active Helicobacter pylori infection. Digestive Diseases & Sciences 1996;41(5):937‐43.

Faigel 1996b

Faigel DO, Childs M, Furth EE, Alavi A, Metz DC. New noninvasive tests for Helicobacter pylori gastritis ‐ comparison with tissue‐based gold standard. Digestive Diseases and Sciences 1996;41(4):740‐8.

Faigel 2000

Faigel DO, Magaret N, Corless C, Lieberman DA, Fennerty MB. Evaluation of rapid antibody tests for the diagnosis of Helicobacter pylori infection. American Journal of Gastroenterology 2000;95(1):72‐7.

Faigel 2001

Faigel DO, Hahn M. Urea breath test for the diagnosis of Helicobacter pylori ‐ response. Gastrointestinal Endoscopy 2001;53(6):700‐1.

Fakhrjou 2011

Fakhrjou A, Somi MH, Fattahi E, Koohbanani SS, Shadravan S. Rapid urease test, touch cytology and histopathologic assessment in determining infection by Helicobacter pylori in outpatient setting. Pakistan Journal of Biological Sciences 2011;14(12):698‐702.

Falaknazi 2010

Falaknazi K, Jalalzadeh M, Vafaeimanesh J. Noninvasive stool antigen assay for screening of Helicobacter pylori infection and assessing success of eradication therapy in patients on hemodialysis. Iranian Journal of Kidney Diseases 2010;4(4):317‐21.

Falk 1997

Falk GW. Best tests for detecting Helicobacter pylori . Consultant 1997;37(7):1765.

Fallone 1998

Fallone CA, Loo VG, Barkun AN. Utility of serology in determining Helicobacter pylori eradication after therapy. Canadian Journal of Gastroenterology 1998;12(2):117‐24.

Fallone 2000

Fallone CA, Veldhuyzen van Zanten SJ, Chiba N. The urea breath test for Helicobacter pylori infection: Taking the wind out of the sails of endoscopy. CMAJ Canadian Medical Association Journal 2000;162(3):371‐2.

Falsafi 2005

Falsafi T, Valizadeh N, Sepehr S, Najafi M. Application of a stool antigen test to evaluate the incidence of Helicobacter pylori infection in children and adolescents from Tehran, Iran. Clinical & Diagnostic Laboratory Immunology 2005;12(9):1094‐7.

Falsafi 2009

Falsafi T, Favaedi R, Mahjoub F, Najafi M. Application of stool‐PCR test for diagnosis of Helicobacter pylori infection in children. World Journal of Gastroenterology 2009;15(4):484‐8.

Falsafi 2014

Falsafi T, Lavasani P, Basardeh I, Massarrat S, Landarani Z. Evaluation of an Iranian home Helicobacter pylori stool antigen ELISA kit. Jundishapur Journal of Microbiology2014; Vol. 7, issue 6:e10629. [DOI: 10.5812/jjm.10629]

Fanti 2001

Fanti L, Ieri R, Mezzi G, Testoni PA, Passaretti S, Guslandi M. Long‐term follow‐up and serologic assessment after triple therapy with omeprazole or lansoprazole of Helicobacter‐associated duodenal ulcer. Journal of Clinical Gastroenterology 2001;32(1):45‐8.

Farkkila 1996

Farkkila M. Active Campylobacter pylori infection diagnosed by the urea breath test. Duodecim; Laaketieteellinen Aikakauskirja 1996;112(5):349‐50.

Faulde 1991

Faulde M, Putzker M, Mertes T, Sobe D. Evaluation of an immunofluorescence assay for specific detection of immunoglobulin‐G antibodies directed against Helicobacter‐pylori, and antigenic cross‐reactivity between Helicobacter‐pylori and Campylobacter‐jejuni . Journal of Clinical Microbiology 1991;29(2):323‐7.

Fayaz 2014

Fayaz F, Gachkar L, Roodsari SR, Pourkaveh B. Prevalence of Helicobacter pylori infection in patients with down syndrome and mental retardation. Archives of Clinical Infectious Diseases 2014 Sep 25 [Epub ahead of print]; Vol. 9, issue 4. [ 10.5812/archcid.22064]

Fayed 2008

Fayed SB, Aref MI, Fathy HM, El Dayem SMA, Emara NA, Maklof A, et al. Prevalence of celiac disease, Helicobacter pylori and gastroesophageal reflux in patients with refractory iron deficiency anemia. Journal of Tropical Pediatrics 2008;54(1):43‐53.

Fazulzyanova 2012

Fazulzyanova A, Isaeva G, Ivanovskaya K. Evaluation of effectiveness of different methods of Helicobacter pylori detection in patients with chronic HCV‐infection. Helicobacter 2012;17:95.

Fazzio 1995

Fazzio S, Vazquez G, Ardao G, Blanco J, Vivero E, Gualco G, et al. Helicobacter pylori: Comparative study of different diagnostic techniques. Acta Gastroenterologica Latinoamericana 1995;25(5):269‐76.

Feldman 1995

Feldman RA, Deeks JJ, Evans SJW. Multilaboratory comparison of 8 commercially available Helicobacter‐pylori serology kits. European Journal of Clinical Microbiology & Infectious Diseases 1995;14(5):428‐33.

Felz 1997

Felz MW, Burke GJ, Schuman BM. Breath test diagnosis of Helicobacter pylori in peptic ulcer disease: A noninvasive primary care option. Journal of the American Board of Family Practice 1997;10(6):385‐9.

Ferrante 1999

Ferrante LC, Papponetti M, Marcuccitti J, Neri M, Festi D. C‐13‐urea breath test for Helicobacter pylori infection: Stability of samples over time. Scandinavian Journal of Gastroenterology 1999;34(9):942‐3.

Ferwana 2015

Ferwana M, Abdulmajeed I, Alhajiahmed A, Madani W, Firwana B, Hasan R, et al. Accuracy of urea breath test in Helicobacter pylori infection: Meta‐analysis. World Journal of Gastroenterology 2015;21(4):1305‐14.

Festi 1999

Festi D, Marcuccitti J, Papponetti M, Colaiocco‐Ferrante L, Bonitatibua A, Di Ilio C, et al. C‐13‐urea breath test for Helicobacter pylori infection: A repeatability study. Gastroenterology 1999;116(4 (suppl)):A162.

Feteih 2009

Feteih R, Abdel‐Salam M, Jamjoom H, Akbar H. Salivary anti‐Helicobacter pylori positivity among endoscopy patients with chronic liver disease. Eastern Mediterranean Health Journal 2009;15(6):1371‐8.

Feydt‐Schmidt 2002

Feydt‐Schmidt A, Russmann H, Lehn N, Fischer A, Antoni I, Stork D, et al. Fluorescence in situ hybridization vs. Epsilometer test for detection of clarithromycin‐susceptible and clarithromycin‐resistant Helicobacter pylori strains in gastric biopsies from children. Alimentary Pharmacology & Therapeutics 2002;16(12):2073‐9.

Figura 1994

Figura N, Oderda G, Verdiani S. Evaluation of a commercial ELISA kit for the serological diagnosis of Helicobacter pylori infection. New Microbiologica 1994;17(4):319‐25.

Figura 2005

Figura N, Santucci A, Lahner E, Mini R, Bernardini G, Vaira D, et al. Western blotting for the diagnosis of Helicobacter pylori infection in patients with atrophic body gastritis. Helicobacter 2005;10(5):521.

Figura 2014

Figura N, Marini L, Macchiarelli R, Moretti E. Latex agglutination test for detection of H. pylori in gastric biopsies. Helicobacter 2014;19:125.

Finderle 2013

Finderle P, Suhadolc K, Osredkar J. Determination of Helicobacter pylori antigen in stool in comparison to breath test. Biochimica Clinica 2013;37:S665.

Floch 2012

Floch P, Goret J, Bessede E, Lehours P, Megraud F. Evaluation of the positive predictive value of a rapid immunochromatographic test to detect Campylobacter in stools. Gut Pathogens 2012 Dec 4; Vol. 4, issue 1:17. [10.1186/1757‐4749‐4‐17]

Foertsch 2010

Foertsch S, Neumann H, Vieth M, Guldi DM, Neurath MF, Kuth R. Development of a new electrochemical device for rapid Helicobacter pylori detection. Gastroenterology 2010;138(5 (suppl 1)):S512.

Folwaczny 1999

Folwaczny C, Reichardt B, Klauser A, Klose J, Blendinger C, Wiebecke B, et al. Accuracy of C‐13‐urea breath test for diagnosis of Helicobacter pylori infection in clinical routine. Gastroenterology 1999;116(4 (suppl)):A164.

Fontana 2000

Fontana C, Pietroiusti A, Mastino A, Pistoia ES, Marino D, Magrini A, et al. Comparison of an enzyme immunoassay versus a rapid latex test for serodiagnosis of Helicobacter pylori infection. European Journal of Clinical Microbiology & Infectious Diseases 2000;19(3):239‐40.

Ford 2014

Ford AC, Forman D, Hunt RH, Yuan Y, Moayyedi P. Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta‐analysis of randomised controlled trials. BMJ 2014;348:g3174.

Formichella 2012

Formichella L, Romberg L, Bolz C, Vieth M, Geppert M, Gottner G, et al. A novel line blot system to detect an infection with pathogenic H. pylori . International Journal of Medical Microbiology 2012;302:6.

Forne 2000

Forne M, Dominguez J, Fernandez‐Banares F, Lite J, Esteve M, Gali N, et al. Accuracy of an enzyme immunoassay for the detection of Helicobacter pylori in stool specimens in the diagnosis of infection and posttreatment check‐up. American Journal of Gastroenterology 2000;95(9):2200‐5.

Fowora 2012

Fowora MA, Breithaupt U, Otegbayo JA, Akere A, Onyekwere CA, Ndububa D, et al. Molecular characterization of Helicobacter pylori infections in Nigeria. Helicobacter 2012;17:88.

Fox 1989

Fox JG, Correa P, Taylor NS, Zavala D, Fontham E, Janney F, et al. Campylobacter pylori‐associated gastritis and immune response in a population at increased risk of gastric carcinoma. American Journal of Gastroenterology 1989;84(7):775‐81.

Fradkin 1997

Fradkin A, Yahav Y, DiverHaber A, Weisselberg B, Jonas A. The value of anti‐Helicobacter pylori IgG antibodies in establishing eradication of infection in children. Israel Journal of Medical Sciences 1997;33(2):87‐92.

Franceschi 1999

Franceschi F, Armuzzi A, Maniccia E, Ojetti V, Torre ES, Candelli M, et al. Delta(CO2)‐C‐13 excretion and prevalence of gastrointestinal symptoms in subjects evaluated for H‐pylori infection through C‐13‐urea breath test. Gastroenterology 1999;116(4 (suppl)):A164.

Franchini 2007

Franchini M, Cruciani M, Mengoli C, Pizzolo G, Veneri D. Effect of Helicobacter pylori eradication on platelet count in idiopathic thrombocytopenic purpura: a systematic review and meta‐analysis. Journal of Antimicrobial Chemotherapy 2007;60(2):237‐46.

Fraser 1996a

Fraser AG, Moore L, Rafiq Ali M, Chua LE, Hollis B, Little SV. An audit of low dose triple therapy for eradication of Helicobacter pylori . New Zealand Medical Journal 1996;109(1027):290‐2.

Fraser 1996b

Fraser AG, Ali MR, McCullough S, Yeates NJ, Haystead A. Diagnostic tests for Helicobacter pylori ‐ can they help select patients for endoscopy. New Zealand Medical Journal 1996;109(1018):95‐8.

Fraser 1997

Fraser AG, McIntosh C, Berry S, Moore L. The urea breath test (UBT) for H‐pylori (HP) in the initial assessment of dyspepsia in primary care. Gut 1997;41(suppl):A77‐A8.

Fraser 1998

Fraser AG, McIntosh C, Berry S, Moore L. Can the urea breath test for H. pylori replace endoscopy for the assessment of dyspepsia in primary care?. New Zealand Medical Journal 1998;111(1058):11‐4.

Fraser 2003

Fraser A, Williamson S, Lane M, Hollis B. Nurse‐led dyspepsia clinic using the urea breath test for Helicobacter pylori . New Zealand Medical Journal 2003;116(1176):U479.

Frenck 2006

Frenck RW, Fathy HM, Sherif M, Mohran Z, El Mohammedy H, Francis W, et al. Sensitivity and specificity of various tests for the diagnosis of Helicobacter pylori in Egyptian children. Pediatrics 2006;118(4):e1195‐e202.

Fruehauf 2003

Fruehauf H, Lindenmann N, Volkart K, Bauerfeind P, Ben‐Oren I, Fried M. The gastroscopic C‐13‐urea breath test: A new rapid online test for Helicobacter pylori (HP) detection during routine upper endoscopy. Gastroenterology 2003;124(4 (suppl)):A176.

Fry 2005

Fry LC, Curioso WH, Rickes S, Horton G, Hirschowitz BI, Monkemuller K. Comparison of 13C‐ urea blood test to 13C‐breath test and rapid urease test for the diagnosis of Helicobacter pylori infection. Acta Gastroenterologica Latinoamericana 2005;35(4):225‐9.

Fujisawa 2001

Fujisawa T, Kaneko T, Kumagai T, Akamatsu T, Katsuyama T, Kiyosawa K, et al. Evaluation of urinary rapid test for Helicobacter pylori in general practice. Journal of Clinical Laboratory Analysis 2001;15(3):154‐9.

Fukuda 1996

Fukuda Y, Fukuda S, Munakata A, Yoshida Y, Shimoyama T. Validity of various diagnostic tests to evaluate cure of Helicobacter pylori infection. Journal of Gastroenterology 1996;31(2):171‐4.

Fukuda 2002

Fukuda Y, Yoshida K, Ezaki H, Tomita T, Kosaka T, Hori K, et al. Diagnosis of Helicobacter pylori infection. Nihon Rinsho [Japanese Journal of Clinical Medicine] 2002;60(8):1543‐8.

Fukuda 2003a

Fukuda Y, Tamura K, Tomita T, Hori K, Tanida N, Shimoyama T. Validation of the accuracy of the H. pylori stool antigen test (HPSA) in the Japanese population. Digestive and Liver Disease 2003;35(1):62‐3.

Fukuda 2003b

Fukuda Y, Hori K, Sakagami T, Shimoyama T. Suitable diagnostic methods for H. pylori infection after eradication therapy. Nihon Rinsho [Japanese Journal of Clinical Medicine] 2003;61(1):102‐8.

Fukuda 2005

Fukuda S, Tanaka M, Shimoyama T, Sato M, Takahashi R, Munakata A. Applicability of a Helicobacter pylori stool antigen test to determine the results of eradication therapy. Helicobacter 2005;10(5):524.

Fukuda 2006

Fukuda S, Shimoyama T, Nishiya D, Munakata A. Applicability of a Helicobacter pylori stool antigen test to determine the results of eradication therapy. Gastroenterology 2006;130(4 (suppl)):A571.

Fukuda 2007

Fukuda Y, Shimoyama T, Takahashi R, Nakabayashi N, Koizuka H, Abe D, et al. Evaluation of a new monoclonal antibody (HRII‐51)‐antigen capture ELISA with high specificity for Helicobacter hepaticus using sera from mice inoculated with Helicobacter species. Helicobacter 2007;12(4):388‐9.

Fukuda 2009

Fukuda Y, Shimoyama T, Ohmura T, Sano Y, Nakabayashi N, Takahashi R, et al. Characterization and application of a new monoclonal antibody with high specificity for Helicobacter hepaticus . Helicobacter 2009;14(1):66‐71.

Fusconi 1997

Fusconi M, Farinelli S, Menegatti M, Figura N, Landi F, Quan S, et al. Western immunoblotting (WB) and a recombinant immunoblotting assay (RIBA(TM)) for detection of H‐pylori (HP) anti Cag‐A reactivity (anti‐HP Cag‐A). Gut 1997;41(suppl):A73‐A4.

Fusconi 1999

Fusconi M, Vaira D, Menegatti M, Farinelli S, Figura N, Holton J, et al. Anti‐caga reactivity in Helicobacter pylori‐negative subjects ‐ a comparison of three different methods. Digestive Diseases and Sciences 1999;44(8):1691‐5.

Galleguillos 1998

Galleguillos C, Gonzalez P, Massardo T, Morales A, Pimentel C, Gil C, et al. Low specificity of carbon‐14‐urea breath test is the gold standard adequate for Helicobacter pylori infection C. Journal of Nuclear Medicine 1998;39(5 Suppl):57P‐8P.

Gallo 2001

Gallo N, Basso D, Zambon CF, Navaglia F, Di Mario F, Rugge M, et al. Diagnosis of Helicobacter pylori infection: Comparison of techniques. Recenti Progressi in Medicina 2001;92(5):332‐5.

Ganga‐Zandzou 2001

Ganga‐Zandzou PS, Vincent P, Michaud L, Guimber D, Turck D, Gottrand F. C‐13‐urea breath test in children with Helicobacter pylori infection: Validity of the use of a mask to collect exhaled breath samples. Acta Paediatrica 2001;90(2):232‐3.

Gangaidzo 1995

Gangaidzo I, Mason PR, Kiire CF, Bak‐Jensen E, Willen R, Lelwala‐Guruge J, et al. Helicobacter pylori in endoscopy patients in Zimbabwe: Value of enzyme‐linked immunosorbent assay and a rapid urease test. Transactions of the Royal Society of Tropical Medicine & Hygiene 1995;89(5):502‐5.

Gao 2015

Gao F, Li W. Investigation on causes of false‐negative 14‐C‐urea breath test. Chinese Journal of Gastroenterology 2015;20(3):151‐4.

Garces 2012

Garces HRH, Gonzalez VVC, Fabian LG, Velazquez MI, Pena K, Sierra YA. Chromoendoscopy with red phenol in the diagnosis of Helicobacter pylori infection. Revista Espanola De Enfermedades Digestivas 2012;104(1):4‐9.

Garcia 1996

Garcia JIP, Garcia JMP, Alonso IJ. C13 urea breath test for Helicobacter pylori. Validation of the method. Revista Espanola De Enfermedades Digestivas 1996;88(3):202‐8.

Garcia 2000

Garcia Valriberas R, Gisbert JP, Hermida C, Cabrera MM, Diaz Blasco J, Pajares JM. Antibodies against Helicobacter pylori in saliva. Study of their validity versus breath test and its agreement with serology. Atencion Primaria / Sociedad Espanola de Medicina de Familia y Comunitaria 2000;25(6):390‐4.

Garcia 2006

Garcia AJD, Gisbert JP. Is the string test a useful alternative to gastroscopy with biopsy for h‐pylori identification?. Revista Espanola De Enfermedades Digestivas 2006;98(7):542‐6.

Garcia‐Diaz 2002

Garcia‐Diaz E, Castro‐Fernandez M, Romero‐Gomez M, Vargas‐Romero J. The effectiveness of (IgG‐ELISA) serology as an alternative diagnostic method for detecting Helicobacter pylori infection in patients with gastro‐intestinal bleeding due to gastro‐duodenal ulcer. Revista Espanola De Enfermedades Digestivas 2002;94(12):725‐36.

Garza‐Gonzalez 2002

Garza‐Gonzalez E, Perez‐Perez GI, Tijerina‐Menchaca R, Maldonado‐Garza HJ, Bosques‐Padilla FJ. Helicobacter pylori genotypes and their association with host's immune response. Revista de Gastroenterologia de Mexico 2002;67(3):155‐60.

Garza‐Gonzalez 2003

Garza‐Gonzalez E, Bosques‐Padilla FJ, Tijerina‐Menchaca R, Flores‐Gutierrez JP, Maldonado‐Garza HJ, Perez‐Perez GI. Comparison of endoscopy‐based and serum‐based methods for the diagnosis of Helicobacter pylori. Canadian Journal of Gastroenterology 2003;17(2):101‐6.

Gatta 2003a

Gatta L, Ricci C, Tampieri A. Noninvasive tests to diagnose Helicobacter pylori infection. Current Gastroenterology Reports 2003;5(5):351‐2.

Gatta 2003b

Gatta L, Vakil N, Ricci C, Osborn JF, Tampieri A, Perna F, et al. A rapid, low‐dose, c‐13‐urea tablet for the detection of Helicobacter pylori infection before and after treatment. Alimentary Pharmacology & Therapeutics 2003;17(6):793‐8.

Gatta 2003c

Gatta L, Vakil N, Tampieri A, Ricci C, Perna F, Miglioli M, et al. Effects of proton pump inhibitor therapy (ppi) on 13C breath test (ubt) & stool antigen test (st) in h pylori (hp): Effects of citric acid & orange juice. Gastroenterology 2003;124(4 (suppl)):A58.

Gatta 2003d

Gatta L, Ricci C, Stanghellini V, Ali A, Menegatti M, Labate AMM, et al. Best cut‐off values for c‐14 ‐urea breath tests for Helicobacter pylori detection. Scandinavian Journal of Gastroenterology 2003;38(11):1144‐8.

Gatta 2004a

Gatta L, Vakil N, Ricci C, Osborn JF, Tampieri A, Perna F, et al. Effect of proton pump inhibitors and antacid therapy on 13C urea breath tests and stool test for Helicobacter pylori infection. American Journal of Gastroenterology 2004;99(5):823‐9.

Gatta 2004b

Gatta L, Perna F, Ricci C, Osborn JF, Tampieri A, Bernabucci V, et al. A rapid immunochromatographic assay for Helicobacter pylori in stool before and after treatment. Alimentary Pharmacology & Therapeutics 2004;20(4):469‐74.

Gatta 2006

Gatta L, Ricci C, Tampieri A, Osborn J, Perna F, Bernabucci V, et al. Accuracy of breath tests using low doses of 13C‐urea to diagnose Helicobacter pylori infection: A randomised controlled trial. Gut 2006;55(4):457‐62.

Gatta 2010a

Gatta L, Vaira D, Scarpignato C, Mario P, Cavestro G, Cavallaro L, et al. Diagnostic accuracy of serum pepsinogens and gastrin in the follow‐up of Helicobacter pylori infection: A pilot study. Digestive and Liver Disease 2010;42:S112.

Gatta 2010b

Gatta L, Di Mario F, Vaira D, Rugge M, Scarpignato C, Malfertheiner P, et al. Diagnostic accuracy of serum pepsinogens and gastrin to follow‐up Helicobacter pylori infection: A pilot study. Gastroenterology 2010;138(5 (suppl 1)):S340.

Gatta 2011

Gatta L, Di Mario F, Vaira D, Rugge M, Franze A, Plebani M, et al. Quantification of serum levels of pepsinogens and gastrin to assess eradication of Helicobacter pylori. Clinical Gastroenterology & Hepatology 2011;9(5):440‐2.

Geletneky 1996

Geletneky JV, Meineke I, Ludtke FE, Schauer A, Bauer FE. Long‐term investigation using the 13C‐urea breath test (13C‐UBT) for the noninvasive semiquantitative assessment of the extent of the mucosal lesion. Verdauungskrankheiten 1996;14(4):125‐32.

Gemignani 2013

Gemignani L, Savarino E, Corbo M, Dulbecco P, Giacchino M, Giambruno E, et al. The diagnostic value of narrow‐band imaging with magnifying endoscopy in the detection of gastric intestinal metaplasia: A prospective study in an unselected population. Digestive and Liver Disease 2013;45:S206.

Gene 2000

Gene E, Calvet X, Azagra R. Diagnosis of Helicobacter pylori after triple therapy in uncomplicated duodenal ulcers‐‐a cost‐effectiveness analysis. Alimentary Pharmacology & Therapeutics 2000;14(4):433‐42.

Gerards 1999

Gerards C, Leodolter A, Nilius M, Peitz U, Malfertheiner P. Should we rely on serology or c‐13‐urea breath test (c‐13‐ubt) for therapy decision in h. Pylori infection?. Gut 1999;45(Suppl 3):A129.

Gerstenecker 1992

Gerstenecker B, Eschweiler B, Vogele H, Koch HK, Hellerich U, Kist M. Serodiagnosis of Helicobacter pylori infections with an enzyme immunoassay using the chromatographically purified 120 kilodalton protein. European Journal of Clinical Microbiology & Infectious Diseases 1992;11(7):595‐601.

Ghasemian 2005

Ghasemian Safaei H, Fazeli A, Tamizifar H, Rashidi N. Comparison of salivary anti Helicobacter pylori IgG with serum IgG and bacteriological tests in detecting Helicobacter pylori infections. Journal of Research in Medical Sciences 2005;10(1):1‐5.

Ghosh 2014

Ghosh R, Uppal B, Aggarwal P, Chakravarti A, Jha AK, Dubey AP. A comparative study of conventional and molecular techniques in diagnosis of campylobacter gastroenteritis in children. Annals of Clinical and Laboratory Science 2014;44(1):42‐8.

Ghoshal 2010

Ghoshal UC, Kumar S, Krishnani N, Chourasia D, Tripathi S. Evaluation of utility of pepsinogen (pg)‐i, pg‐ii and gastrin‐17 serum levels in diagnosis of cancer‐associated gastric mucosal lesions like intestinal metaplasia in patients with h. Pylori infection in india. Indian Journal of Gastroenterology 2010;29(1 Suppl):A25‐A6.

Gilger 2002

Gilger MA, Tolia V, Johnson A, Rabinowitz S, Jibaly R, Elitsur Y, et al. The use of an oral fluid immunoglobulin g ELISA for the detection of Helicobacter pylori infection in children. Helicobacter 2002;7(2):105‐10.

Gill 2007

Gill P, Amini M, Ghaemi A, Shokouhizadeh L, Abdul‐Tehrani H, Karami A, et al. Detection of Helicobacter pylori by enzyme‐linked immunosorbent assay of thermophilic helicase‐dependent isothermal DNA amplification. Diagnostic Microbiology & Infectious Disease 2007;59(3):243‐9.

Girdalidze 2013

Girdalidze AM, Elisabedashvili GV, Sharvadze LG, Dzhorbenadze TA. Comparative diagnostic value of Helicobacter pylori infection testing methods. Georgian Medical News 2013;225:53‐60.

Gisbert 1996

Gisbert JP, Boixeda D, Redondo C, Alvarez Baleriola I, Jimenez I, Perez Garcia JI, et al. Breath test in the diagnosis of Helicobacter pylori infection: concordance with histological methods and correlation with anatomopathological lesions of the gastric mucosa. Revista Espanola de Enfermedades Digestivas 1996;88(4):259‐64.

Gisbert 1997

Gisbert JP, Boixeda D, deArgila CM, Barba M, Bermejo F, Plaza AG, et al. Long‐term follow‐up after h‐pylori eradication: Reinfection incidence and evolution of urea breath test. Gut 1997;41(suppl):A78.

Gisbert 1999a

Gisbert JP, Vazquez MA, Jimenez I, Carpio D, Cruzado AI, Del Castillo E, et al. C‐13‐urea breath test for the diagnosis of h‐pylori infection: Is citric acid necessary?. Gut 1999;45(Suppl 3):A129.

Gisbert 1999b

Gisbert JP, Vazquez MA, Jimenez I, Del Castillo E, Martin MJ, Morales A, et al. C‐13‐urea breath test for the diagnosis of h‐pylori infection: Is citric acid necessary?. Gastroenterology 1999;116(4 (suppl)):A171.

Gisbert 1999c

Gisbert JP, Boixeda D, Al‐Mostafa A, Vila T, De Rafael L, Baleriola IA, et al. Basal and stimulated gastrin and pepsinogen levels after eradication of Helicobacter pylori: A 1‐year follow‐up study. European Journal of Gastroenterology & Hepatology 1999;11(2):189‐200.

Gisbert 2000a

Gisbert J, Gonzalez L, De Pedro A, Vaibuena M, Prieto B, Llorca I, et al. C‐13‐urea breath test for the diagnosis of h‐pylori infection: Are basal samples necessary?. Gastroenterology 2000;118(4):A1238.

Gisbert 2000b

Gisbert JP. Diagnosis of Helicobacter pylori infection. Revista Clinica Espanola 2000;200(7):370‐2.

Gisbert 2000c

Gisbert JP, Benito LM, Lara S, Vazquez A, Jimenez I, Pajares JM. C‐13‐urea breath test for the diagnosis of Helicobacter pylori infection: Are basal samples necessary?. European Journal of Gastroenterology & Hepatology 2000;12(11):1201‐5.

Gisbert 2000d

Gisbert JP, Blanco M, Benito LM, Pajares JM. Value of quantitative serology for confirmation of Helicobacter pylori eradication: An 18‐month follow‐up study. Clinical Infectious Diseases 2000;30(6):976‐80.

Gisbert 2000e

Gisbert JP, Cruzado AI, Cabrera MM, Carpio D, Benito LM, Perez Poveda JJ, et al. "Rapid" serology for the diagnosis of Helicobacter pylori infection. Evaluation of its accuracy compared with a gold‐standard and its concordance with "classic" serology. Gastroenterologia Y Hepatologia 2000;23(4):159‐64.

Gisbert 2000f

Gisbert JP, Vazquez MA, Jimenez I, Cruzado AI, Carpio D, Del Castillo E, et al. 13C‐urea breath test for the diagnosis of Helicobacter pylori infection before treatment: Is citric acid necessary?. Digestive & Liver Disease 2000;32(1):20‐4.

Gisbert 2000g

Gisbert J, Cruzado A, Cabrera M, Carpio D, Benito L, Perez‐Poveda J, et al. Rapid whole blood test for diagnosing H. pylori infection. Validation against a gold standard and study of its concordance with ELISA serology. Gastroenterology 2000;118(4):A1238.

Gisbert 2001

Gisbert JP, Pajares JM. Diagnosis of Helicobacter pylori infection by stool antigen determination: A systematic review. American Journal of Gastroenterology 2001;96(10):2829‐38.

Gisbert 2002a

Gisbert JP, Ducons J, Gomollon F, Dominguez‐Muñoz E, Borda F, Mino G, et al. Validation of c‐13‐urea breath test for the initial diagnosis of Helicobacter pylori infection and for the confirmation of its eradication after treatment. Gut 2002;51(Suppl):A109.

Gisbert 2002b

Gisbert JP, Gomollon F, Dominguez‐Muñoz E, Borda F, Jimenez I, Vazquez MA, et al. Isotope ratio mass spectrometry (irms) versus nondispersive infrared spectrometry (ndirs) c‐13‐urea breath test for the diagnosis of Helicobacter pylori infection. Gut 2002;51(Suppl):A111.

Gisbert 2002c

Gisbert JP, Vazquez MA, Cantero J, Pajares JM. Study of the validity of <<rapid>> serology in diagnosing Helicobacter pylori infection. Atencion Primaria 2002;30(8):501‐6.

Gisbert 2002d

Gisbert JP, Cabrera Md Mdel M, Pajares JM. Stool antigen test for initial Helicobacter pylori diagnosis and for confirmation of eradication after therapy. Medicina Clinica 2002;118(11):401‐4.

Gisbert 2003a

Gisbert JP, Gomollon F, Dominguez‐Muñoz JE, Borda F, Jimenez I, Vazquez MA, et al. Comparison between two 13C‐urea breath tests for the diagnosis of Helicobacter pylori infection: Isotope ratio mass spectrometer versus infrared spectrometer. Gastroenterologia Y Hepatologia 2003;26(3):141‐6.

Gisbert 2003b

Gisbert JP, Ducons J, Gomollon F, Dominguez‐Muñoz JE, Borda F, Mino G, et al. Validation of the c‐13‐urea breath test for the initial diagnosis of Helicobacter pylori infection and to confirm eradication after treatment. Revista Espanola De Enfermedades Digestivas 2003;95(2):121‐6.

Gisbert 2004a

Gisbert JP, Pajares JM. Stool antigen test for the diagnosis of Helicobacter pylori infection: A systematic review. Helicobacter 2004;9(4):347‐68.

Gisbert 2004b

Gisbert JP, Khorrami S, Carballo F, Calvet X, Gene E, Dominguez‐Muñoz E. Meta‐analysis: Helicobacter pylori eradication therapy vs. antisecretory non‐eradication therapy for the prevention of recurrent bleeding from peptic ulcer. Alimentary Pharmacology and Therapeutics 2004;19(6):617‐29.

Gisbert 2005

Gisbert JP, Trapero M, Pajares JM. Evaluation of 3 different tests for the detection of stool antigens to confirm Helicobacter pylori eradication after treatment. A pilot study. Gastroenterologia Y Hepatologia 2005;28(10):615‐8.

Gisbert 2006a

Gisbert JP, Abraira V. Accuracy of Helicobacter pylori diagnostic tests in patients with bleeding peptic ulcer: A systematic review and meta‐analysis. American Journal of Gastroenterology 2006;101(4):848‐63.

Gisbert 2006b

Gisbert JP, De la Morena F, Abraira V. Accuracy of monoclonal stool antigen test for the diagnosis of Helicobacter pylori infection: A systematic review and meta‐analysis. Helicobacter 2006;11(4):380.

Gisbert 2006c

Gisbert JP, Esteban C, Jimenez I, Moreno‐Otero R, Pajares JM. C‐13‐urea breath test during hospitalization for the diagnosis of Helicobacter pylori infection in peptic ulcer bleeding. Helicobacter 2006;11(4):382.

Gisbert 2006d

Gisbert JP, Olivares D, Jimenez I, Pajares JM. Is there any correlation between 13C‐urea breath test values and response to first‐line and rescue Helicobacter pylori eradication therapies?. Digestive & Liver Disease 2006;38(4):254‐9.

Gisbert 2006e

Gisbert JP, Olivares D, Jimenez I, Pajares JM. Is there any correlation between c‐13‐urea breath test values and response to first‐line and rescue Helicobacter pylori eradication therapies?. Helicobacter 2006;11(4):380‐1.

Gisbert 2006f

Gisbert JP, Olivares D, Jimenez I, Pajares JM. Long‐term follow‐up of 13C‐urea breath test results after Helicobacter pylori eradication: Frequency and significance of borderline delta13Co2 values. Alimentary Pharmacology & Therapeutics 2006;23(2):275‐80.

Gisbert 2006g

Gisbert JR, De la Morena F, Abraira V. Accuracy of monoclonal stool antigen test for the diagnosis of h‐pylori infection: A systematic review and meta‐analysis. American Journal of Gastroenterology 2006;101(8):1921‐30.

Gisbert 2006h

Gisbert JP. Breath test with c‐13‐urea for h. Pylori infection diagnosis by means of mass spectrometry and infrared spectrophotometry. Salud I Ciencia 2006;15(1):461‐3.

Gisbert 2007

Gisbert JP, Esteban C, Jimenez I, Moreno‐Otero R. 13C‐urea breath test during hospitalization for the diagnosis of Helicobacter pylori infection in peptic ulcer bleeding. Helicobacter 2007;12(3):231‐7.

Glassman 1990

Glassman MS, Dallal S, Berezin SH, Bostwick HE, Newman LJ, Perez‐Perez GI, et al. Helicobacter pylori‐related gastroduodenal disease in children. Diagnostic utility of enzyme‐linked immunosorbent assay. Digestive Diseases & Sciences 1990;35(8):993‐7.

Glupczynski 1992

Glupczynski Y, Bourdeaux L, Verhas M, DePrez C, DeVos D, Devreker T. Use of a urea breath test versus invasive methods to determine the prevalence of Helicobacter pylori in Zaire. European Journal of Clinical Microbiology & Infectious Diseases 1992;11(4):322‐7.

Gobert 1988

Gobert B, Bene MC, Faure G, Dekorwin JD, Conroy MC, Mole C, et al. Detection of antibodies to campylobacter pyloridis by immunoprint and by quantitative ELISA test. Annales De Biologie Clinique 1988;46(7):523.

Gobert 1989

Gobert B, Bene MC, Faure G, Denis JJ, De Korwin JD, Conroy MC, et al. IgG, IgA and IgM antibodies to campylobacter pylori detected by dot‐ELISA and ELISA. Gastroduodenal pathology and Campylobacter pylori: European Campylobacter Pylori Study Group ICS847. 1989:219‐22.

Goel 2003

Goel N, Sherwal BL, Patwari AK, Bajaj P, Choudhury M. Evaluation of invasive and non‐invasive diagnostic modalities for Helicobacter pylori infection in children. Indian Pediatrics 2003;40(2):141‐6.

Goettner 2012

Goettner G, Formicella L, Romberg L, Bolz C, Nolting C, Soutschek E, et al. Novel immuno‐line system to detect infections with pathogenic h. Pylori. Helicobacter 2012;17:70.

Goh 1995

Goh KL, Parasakthi N, Peh SC, Ong KK. 14c‐urea breath test: A useful non‐invasive test in the diagnosis of Helicobacter pylori infection. Medical Journal of Malaysia 1995;50(3):208‐11.

Goji 2015

Goji S, Tamura Y, Sasaki M, Nakamura M, Matsui H, Yamagata Murayama S, et al. Helicobacter suis‐infected nodular gastritis and a review of diagnostic sensitivity for Helicobacter heilmannii‐like organisms. Case Reports in Gastroenterology 2015;9:179‐87.

Gold 2000

Gold BD, Colletti RB, Abbott M, Czinn SJ, Elitsur Y, Hassall E, et al. Helicobacter pylori infection in children: Recommendations for diagnosis and treatment. Journal of Pediatric Gastroenterology and Nutrition 2000;31(5):490‐7.

Gold 2014

Gold BD, Elfant AB. Helicobacter pylori detection and eradication in pediatric and adult patients. Gastroenterology and Hepatology 2014;10(7):447‐50.

Gomes 2002

Gomes AT, Coelho LK, Secaf M, Modena JL, Troncon LE, Oliveira RB. Accuracy of the 14c‐urea breath test for the diagnosis of Helicobacter pylori. Sao Paulo Medical Journal [Revista Paulista de Medicina] 2002;120(3):68‐71.

Gomes 2005

Gomes CAR, Catapani WR, Mader AMAA, Locatelli A, Silva CBP, Waisberg J. Antral exfoliative cytology for the detection of Helicobacter pylori in the stomach. World Journal of Gastroenterology 2005;11(18):2784‐8.

Gomez 2000

Gomez MR, Vargas J, Grande L, Otero MA, Bernal S, Fernandez MC. Usefulness of Helicobacter pylori antigens detection in stools for infection diagnosis and confirming eradication. Medicina Clinica 2000;114(15):571‐3.

Gomez 2011

Gomez PP, Rodriguez CG, Meleiro JI, Rodriguez MM, Sanchez FM. Helicobacter pylori infection in children diagnosed via the urea breath test. Helicobacter 2011;16:111.

Gomez‐Camarasa 2014

Gomez‐Camarasa C, Gutierrez‐Fernandez J, Rodriguez‐Granger JM, Sampedro‐Martinez A, Sorlozano‐Puerto A, Navarro‐Mari JM. Evaluation of the rapid ridaquick campylobacter test in a general hospital. Diagnostic Microbiology and Infectious Disease 2014;78(2):101‐4.

Gomollon 2003

Gomollon F, Ducons JA, Santolaria S, Omiste IL, Guirao R, Ferrero A, et al. Breath test is very reliable for diagnosis of Helicobacter pylori infection in real clinical practice. Digestive and Liver Disease 2003;35(9):612‐8.

Gong 2010

Gong YH, Sun LP, Jin SG, Yuan Y. Comparative study of serology and histology based detection of Helicobacter pylori infections: A large population‐based study of 7,241 subjects from China. European Journal of Clinical Microbiology & Infectious Diseases 2010;29(7):907‐11.

Gong 2014

Gong YH, Wei W, Yuan Y. Association between abnormal gastric function risk and Helicobacter pylori infection assessed by ELISA and C‐14‐urea breath test. Diagnostic Microbiology and Infectious Disease 2014;80(4):316‐20.

Gonzalez 2003

Gonzalez P, Galleguillos C, Massardo T, Rivera M, Morales A, Smok G, et al. Could the [14c]urea breath test be proposed as a 'gold standard' for detection of Helicobacter pylori infection ?. Medical Science Monitor 2003;9(8):CR363‐8.

Gonzalez 2004

Gonzalez P. 14c‐urea breath test as a 'gold standard' for detection of Helicobacter pylori infection ‐ in reply. Medical Science Monitor 2004;10(9):LE17‐LE8.

Gonzalez 2007

Gonzalez FCG, Serrano C, Harris PR. Diagnosis of Helicobacter pylori infection in children based on stool antigen test. Revista Medica De Chile 2007;135(2):182‐8.

Gonzalez 2012

Gonzalez CA, Megraud F, Buissonniere A, Lujan Barroso L, Agudo A, Duell EJ, et al. Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: The eurgast‐epic project. Annals of Oncology 2012;23(5):1320‐4.

Gonzalez 2013

Gonzalez L, Marrero K, Reyes O, Rodriguez E, Martinez L, Rodriguez BL. Cloning and expression of a recombinant caga ‐gene fragment of Helicobacter pylori and its preliminary evaluation in serodiagnosis. Biomedica 2013;33(4):546‐53.

Gonzalez‐Cuevas 2001

Gonzalez‐Cuevas A, Juncosa T, Jene M, Varea V, Gene A, Muñoz C, et al. Helicobacter pylori infections: Antigen detection in stool samples. Enfermedades Infecciosas Y Microbiologia Clinica 2001;19(2):49‐52.

Good 1991

Good DJ, Dill S, Mossi S, Frey R, Beglinger C, Stalder GA, et al. Sensitivity and specificity of a simplified, standardized 13C‐urea breath test for the demonstration of Helicobacter pylori. Schweizerische Medizinische Wochenschrift Journal Suisse de Medecine 1991;121(20):764‐6.

Goodwin 1987

Goodwin CS, Blincow E, Peterson G. Enzyme‐linked immunosorbent assay for campylobacter pyloridis: Correlation with presence of c. Pyloridis in the gastric mucosa. Journal of Infectious Diseases 1987;155(3):488‐94.

Gosciniak 1993

Gosciniak G, Matysiak‐Budnik T, Przondo‐Mordarska A. Evaluation of three serological tests for the detection of Helicobacter pylori associated infection. Archivum Immunologiae et Therapiae Experimentalis 1993;41(5‐6):315‐9.

Gosciniak 1996

Gosciniak G, Poniewierka E, Iwanczak B, Grzeszek T. Iga antibodies against Helicobacter pylori in serum and saliva of patients with upper gastrointestinal tract diseases. Gastroenterologia Polska 1996;3(2):119‐24.

Gosciniak 2000

Gosciniak G, Przondo‐Mordarska A, Iwanczak B, Poniewierka E. Neutralisation of vacuolating activity of cytotoxin by serum antibodies of Helicobacter pylori infected patients. Acta Microbiologica Polonica 2000;49(2):113‐20.

Gosciniak 2002

Gosciniak G, Przondo‐Mordarska A, Iwanczak B, Blitek A. Detection of Helicobacter pylori antigen in stool specimens taken from children with chronic gastritis. Polski Merkuriusz Lekarski 2002;12(68):104‐7.

Gosciniak 2003

Gosciniak G, Przondo‐Mordarska A, Iwanczak B, Blitek A. Helicobacter pylori antigens in stool specimens of gastritis children before and after treatment. Journal of Pediatric Gastroenterology & Nutrition 2003;36(3):376‐80.

Goto 1995

Goto Y, Ogihara Y, Taniguchi Y, Satoh K, Kimura K, Takatori K, et al. Simple rapid and inexpensive diagnosis of Helicobacter‐pylori infection in c‐13‐urea breath test ‐ ir spectrometric analysis. Gastroenterology 1995;108(4 (suppl)):A103.

Goto 1998

Goto A, Fujimori K, Kaneko T, Akamatsu T. Diagnosis of Helicobacter infections by serodiagnosis, analysis of serum pepsinogen, and urea breath tests. Nihon Naika Gakkai Zasshi [Journal of the Japanese Society of Internal Medicine] 1998;87(5):863‐7.

Gotoh 1997

Gotoh T, Nishizono A, Mifune K, Fujioka T, Nasu M, Azumi J. Validity of the new ELISA system of serodiagnosis for eradication of Helicobacter pylori infection. Gastroenterology 1997;112(4 (suppl)):A131.

Gottrand 2001

Gottrand F. Diagnostic tests and treatment of helicopter pylori gastritis in children. Archives De Pediatrie 2001;8:396S‐8S.

Graham 1986

Graham DY, Klein PD, Evans DG, Opekun AR, Evans DG, Alpert LC, et al. Rapid noninvasive diagnosis of gastric campylobacter by a c‐13 urea breath test. Gastroenterology 1986;90(5):1435.

Graham 1987

Graham DY, Evans DJ, Alpert LC, Klein PD, Evans DG, Opekun AR, et al. Campylobacter‐pylori detected noninvasively by the c‐13 urea breath test. Lancet 1987;1(8543):1174‐7.

Graham 1991

Graham DY, Malaty HM, Evans DG, Evans DJ, Klein PD, Adam E. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology 1991;100(6):1495‐501.

Graham 1996b

Graham DY, Malaty HM, ElZimaity HM, Genta RM, Yousfi MM, Klein PD. 20 minute fasting version of the us c‐13‐urea breath test for the diagnosis of h‐pylori infection. Gastroenterology 1996;110(4 (suppl)):A122.

Graham 2000

Graham DY, Klein PD. Accurate diagnosis of Helicobacter pylori ‐ c‐13‐urea breath test. Gastroenterology Clinics of North America 2000;29(4):885.

Graham 2001a

Graham DY, Malaty HM, Cole RA, Martin RF, Klein PD. Simplified 13C‐urea breath test for detection of Helicobacter pylori infection. American Journal of Gastroenterology 2001;96(6):1741‐5.

Graham 2001b

Graham DY, Reddy S. Rapid detection of anti‐Helicobacter pylori igg in urine using immunochromatography. Alimentary Pharmacology & Therapeutics 2001;15(5):699‐702.

Graham 2001c

Graham DY. An alternate explanation of the effect of citric acid on proton pump inhibitor‐associated false negative urea breath tests. American Journal of Gastroenterology 2001;96(10):3037‐9.

Graham 2010

Graham DY. Monoclonal stool antigen testing for diagnosing Helicobacter pylori in young children: Revisited. Journal of Pediatric Gastroenterology and Nutrition 2010;51(3):373.

Granberg 1993

Granberg C, Mansikka A, Lehtonen OP, Kujari H, Gronfors R, Nurmi H, et al. Diagnosis of Helicobacter pylori infection by using Pyloriset EIA‐G and EIA‐A for detection of serum immunoglobulin G (IgG) and IgA antibodies. Journal of Clinical Microbiology 1993;31(6):1450‐3.

Grino 2001

Grino P, Pascual S, Such J, Casellas JA, Niveiro M, Andreu M, et al. Comparison of diagnostic methods for Helicobacter pylori infection in patients with upper gastrointestinal bleeding. Scandinavian Journal of Gastroenterology 2001;36(12):1254‐8.

Grino 2003

Grino P, Pascual S, Such J, Casellas JA, Niveiro M, Andreu M, et al. Comparison of stool immunoassay with standard methods for detection of Helicobacter pylori infection in patients with upper‐gastrointestinal bleeding of peptic origin. European Journal of Gastroenterology & Hepatology 2003;15(5):525‐9.

Grossi 2000

Grossi C, Mombelli B, Capurso G, Martino G, Gismondo M, Lahner E, et al. Low sensitivity of c‐13‐urea breath test (ubt) in the diagnosis of h‐pylori infection in atrophic body gastritis patients (abg). Gut 2000;47(Suppl 1):A117.

Grossi 2012

Grossi L, Di Tullio AM, Pagliaro M, Tavani R, Cocciolillo S, Ciccaglione AF, et al. Relationship between Helicobacter pylori infection and gerd symptoms. Digestive and Liver Disease 2012;44:S152.

Grotowski 1998

Grotowski M, Winnicki L, Trawinski J, Gancarz A, Domaniecki J. Prevalence of Helicobacter pylori infection after surgery of gastric or duodenal peptic ulcer. Gastroenterologia Polska 1998;5(6):525‐30.

Groves 1997

Groves FD, Zhang L, Li JY, You WC, Chang YS, Zhao L, et al. Comparison of two enzyme‐linked immunosorbent assay tests for diagnosis of Helicobacter pylori infection in China. Cancer Epidemiology, Biomarkers & Prevention 1997;6(7):551‐2.

Groves 2002

Groves FD, Perez‐Perez G, Zhang L, You WC, Lipsitz SR, Gail MH, et al. Serum antibodies to Helicobacter pylori and the caga antigen do not explain differences in the prevalence of precancerous gastric lesions in two Chinese populations with contrasting gastric cancer rates. Cancer Epidemiology Biomarkers and Prevention 2002;11(10 I):1091‐4.

Guducuoglu 2010

Guducuoglu H, Berktas M, Bozkurt H, Toka Ozer T, Bulut G, Ozturk O, et al. Evaluation of western blot method for the detection of antibodies to Helicobacter pylori antigens in patients with gastric carcinoma and cases with epigastric complaints. Mikrobiyoloji Bulteni 2010;44(1):21‐8.

Guell 2006

Guell M, Artigau E, Esteve V, Sanchez‐Delgado J, Junquera F, Calvet X. Usefulness of a delayed test for the diagnosis of Helicobacter pylori infection in bleeding peptic ulcer. Alimentary Pharmacology & Therapeutics 2006;23(1):53‐9.

Guja 1999

Guja M, Lombardo L, Andrini L, Della Monica P, Vicari S, Sallio F, et al. Is Helicobacter pylori stool antigen assay comparable to urea breath test in the diagnosis of h‐pylori infection?. Gastroenterology 1999;116(4 (suppl)):A178.

Gulcan 2005

Gulcan EM, Varol A, Kutlu T, Cullu F, Erkan T, Adal E, et al. Helicobacter pylori stool antigen test. Indian Journal of Pediatrics 2005;72(8):675‐8.

Gunay 2009

Gunay EC, Yengel E, Ucblek E, Altintas E, Sezgin O. C‐14 urea breath test values do not correlate with the degree of colonization by Helicobacter pylori in adults. European Journal of Nuclear Medicine and Molecular Imaging 2009;36:S442.

Guo 2005

Guo YY, Zhang ST, Peng XX, Zhan SY. A systematic review of diagnosis of Helicobacter pylori infection by Helicobacter pylori stool antigen test.. National Medical Journal of China 2005;85(22):1564‐7.

Gupta 2003

Gupta P, Pandey LB, Behra RN, Rai MK, Chandra R. Role of ELISA in H. pylori detection and its correlation with urease test. Indian Journal of Pathology & Microbiology 2003;46(3):511‐4.

Gurbuz 2009

Gurbuz ED, Soyturk M, Yilmaz O, Bekmen N, Guvenir M, Ellidokuz H, et al. The importance of stool antigen test for the diagnosis of Helicobacter pylori infection and eradication follow‐up. Clinical Microbiology and Infection 2009;15:S316.

Guslandi 2000

Guslandi M. Stool immunoassay for Helicobacter pylori is not specific enough. BMJ 2000;320(7248):1541.

Gutierrez 1999

Gutierrez A, Celdran MT, Bonilla F, Vazquez N, Royo G, Sillero C. Use of Helicobacter pylori (hp) antigen test in stool samples to detect hp infection. Gastroenterologia y Hepatologia 1999;22(10):533.

Gutierrez 2005

Gutierrez S, Chacon‐Petrola M, Flores M, Pinto A, Pacheco M. Evaluation of infection by Helicobacter pylori in hiv positive patients trough enzyme immunoassay and specific amplification of DNA. Investigacion Clinica 2005;46(1):43‐52.

Guven 2011

Guven MA, Ertas IE, Coskun A, Ciragil P. Serologic and stool antigen assay of Helicobacter pylori infection in hyperemesis gravidarum: Which test is useful during early pregnancy?. Taiwanese Journal of Obstetrics & Gynecology 2011;50(1):37‐41.

Hackelsberger 1998

Hackelsberger A, Schultze V, Peitz U, Gunther T, Nilius M, Diete U, et al. Performance of a rapid whole blood test for Helicobacter pylori in primary care: A German multicenter study. Helicobacter 1998;3(3):179‐83.

Haggerty 2005

Haggerty TD, Perry S, Sanchez L, Perez‐Perez G, Parsonnet J. Significance of transiently positive enzyme‐linked immunosorbent assay results in detection of Helicobacter pylori in stool samples from children. Journal of Clinical Microbiology 2005;43(5):2220‐3.

Hahn 2000

Hahn M, Fennerty MB, Corless CL, Magaret N, Lieberman DA, Faigel DO. Noninvasive tests as a substitute for histology in the diagnosis of Helicobacter pylori infection. Gastrointestinal Endoscopy 2000;52(1):20‐6.

Hamlet 1995

Hamlet AK, Erlandsson KIM, Olbe L, Svennerholm AM, Backman VEM, Pettersson AB. A simple, rapid, and highly reliable capsule‐based 14C urea breath test for diagnosis of Helicobacter pylori infection. Scandinavian Journal of Gastroenterology 1995;30(11):1058‐63.

Hamlet 1999

Hamlet A, Stage L, Lonroth H, Cahlin C, Nystrom C, Pettersson A. A novel tablet‐based c‐13 urea breath test for Helicobacter pylori with enhanced performance during acid suppression therapy. Scandinavian Journal of Gastroenterology 1999;34(4):367‐74.

Han 2006

Han FC, Li XJ, Jiang H, Qin LP, Li D, Guo YH, et al. Detection of h. Pylori antibody profile in serum by protein array. World Journal of Gastroenterology 2006;12(25):4044‐8.

Hanvivatvong 2004

Hanvivatvong O, Pongpanich A, Thong‐Ngam D, Thammacharoenrach N, Kullavanijaya P. Evaluation of commercial immunoassays for detection of antibody against Helicobacter pylori in thai dyspeptic patients. Clinical and Diagnostic Laboratory Immunology 2004;11(3):618‐20.

Hanvivatvong 2006

Hanvivatvong O, Thong‐Ngam D, Kuakarn S, Mahachai V. Evaluation of Helicobacter pylori stool antigen test in Thai patients with upper gastrointestinal bleeding. Journal of the Medical Association of Thailand 2006;89 Suppl 3:S98‐103.

Harde 2008

Harde H, Dressler M, Helmrich G, Wolff M, Groninga H. New optical analyzer for c‐13‐breath test. Biophotonics: photonic solutions for better health care. Progress in biomedical optics and imaging; 2008 April 8‐10; Strasbourg. Bellingham (DC): SPIE, 2008; Vol. 6691:69910T. [DOI: 10.1117/12.781271; 69910T]

Harde 2010

Harde H, Helmrich G, Wolff M. Optoacoustic c‐13‐breath test analyzer. Photons plus ultrasound: imaging and sensing 2010. International Society for Optical Engineering; 2010 Jan 24‐26; San Francisco (CA). Bellingham (WA): SPIE, 2010; Vol. 7564:75641E. [DOI: 10.1117/12.841660]

Harries 1992

Harries AD, Stewart M, Deegan KM, Mughogho GK, Wirima JJ, Hommel M, et al. Helicobacter pyrlori in Malawi, central africa. Journal of Infection 1992;24(3):269‐76.

Harris 1995

Harris AW. Helicobacter pylori testing at home. European Journal of Gastroenterology & Hepatology 1995;7(7):595‐6.

Harris 1998

Harris AW. Helicobacter pylori and urea breath testing. Can the breath test result predict the outcome of treatment?. Italian Journal of Gastroenterology & Hepatology 1998;30(2):151‐2.

Harrison 1998

Harrison JR, Bevan J, Furth EE, Metz DC. Accustat whole blood fingerstick test for Helicobacter pylori infection ‐ a reliable screening method. Journal of Clinical Gastroenterology 1998;27(1):50‐3.

Hart 1999

Hart GC, Avison MP. 13C‐urea versus 14c‐urea breath test: Is there still a need for 14c‐urea?. Nuclear Medicine Communications 1999;20(5):495‐6.

Hartman 1992

Hartman NG, Jay M, Hill DB, Bera RK, Nickl NJ, Ryo UY. Noninvasive detection of Helicobacter pylori colonization in stomach using 11C‐urea. Digestive Diseases and Sciences 1992;37(4):618‐21.

Hartmann 2003

Hartmann D, Schilling D, Riemann JF. New nondispersive infrared spectrometry in c‐13‐urea breath tests. Deutsche Medizinische Wochenschrift 2003;128(31‐32):1645‐8.

Hashemi 2008

Hashemi MR, Rahnavardi M, Bikdeli B, Zahedani MD, Iranmanesh F. Touch cytology in diagnosing Helicobacter pylori: Comparison of four staining methods. Cytopathology 2008;19(3):179‐84.

Hassan 2013

Hassan K, Haq M. To study the frequency of h pylori in patients presenting with functional dyspepsia using stool antigen test and its comparison with serology. Journal of Gastroenterology and Hepatology 2013;28:547.

Hauser 2006

Hauser B, Wybo I, Tshibuabua G, Pierard D, Vandenplas Y. Multiple‐step polyclonal versus one‐step monoclonal enzyme immunoassay in the detection of Helicobacter pylori antigen in the stools of children. Acta Paediatrica 2006;95(3):297‐301.

Havlasova 1998

Havlasova J, Bures J, Rejchrt S, Voxova B, Krejsek J. Helicobacter pylori caga antigen antibodies. Casopis Lekaru Ceskych 1998;137(13):404‐9.

Hawthorne 1999

Hawthorne Barney A, Morgan S, Westmoreland D, Stenson R, Thomas GAO, Newcombe RG. A comparison of two rapid whole‐blood tests and laboratory serology, in the diagnosis of Helicobacter pylori infection. European Journal of Gastroenterology & Hepatology 1999;11(8):863‐5.

Hawtin 1999

Hawtin PR. Serology and urea breath test in the diagnosis of h‐pylori infection. Molecular Biotechnology 1999;11(1):85‐92.

Hayashi 2003

Hayashi T, Karasawa T, Nagase H, Kinami S, Fujimura T, Miwa K, et al. Timing of sampling in endoscopic 13C‐urea breath test for H. pylori infection. Japanese Pharmacology and Therapeutics 2003;31(8):667‐70.

He 1997

He YN, Chen HY, Zheng JJ, Zhang GY, Chen ZL. Differential pulse voltammetric enzyme‐linked immunoassay for the determination of Helicobacter pylori specific immunoglobulin g (igg) antibody. Talanta 1997;44(5):823‐30.

Heaney 1998

Heaney A, Collins JS, Watson RG, McFarland RJ, Bamford KB. Rapid serological diagnosis of Helicobacter pylori: A need for caution and re‐evaluation. Irish Journal of Medical Science 1998;167(3):152‐4.

Heanhean 2013

Heanhean Ng T, Rosaida R. Evaluation of serology and urea breath test as reliable diagnostic test for h.Pylori infection. Journal of Gastroenterology and Hepatology 2013;28:97.

Heenan 1989

Heenan A. Breath tester. Nursing Times 1989;85(36):23.

Hegedus 2001a

Hegedus O, Rehnberg AS, Bengtsson C, Befrits R, Granstrom M, Hellstrom PM. Refinement and development of a "dry" novel 14c‐urea breath test (heliprobe (tm)) for detection of Helicobacter pylori. Gastroenterology 2001;120(5 (suppl)):A653.

Hegedus 2001b

Hegedus O, Mjornell U, Prior C, Ryden J, Hellstrom PM. Rapid urea breath test (heliprobe) for detection of Helicobacter pylori by use of encapsulated acidified solid c‐14‐urea: Validation of test accuracy. Gut 2001;49(Suppl):A101.

Hegedus 2002

Hegedus O, Ryden J, Rehnberg AS, Nilsson S, Hellstrom PM. Validated accuracy of a novel urea breath test for rapid Helicobacter pylori detection and in‐office analysis. European Journal of Gastroenterology & Hepatology 2002;14(5):513‐20.

Helvaci 1993

Helvaci S, Akdis C, Gulten M, Yerci O. Evaluation of the ELISA method for the diagnosis of Helicobacter pylori. Mikrobiyoloji Bulteni 1993;27(4):294‐8.

Henze 1988

Henze E, Malfertheiner P, Burkhardt H, Clausen M, Adam WE. The c‐14 urea breath test for detecting colonization of campylobacter pylori invivo. European Journal of Nuclear Medicine 1988;14(5‐6):245.

Henze 1989

Henze E, Malfertheiner P, Clausen M, Lietzenmaier R, Burkhardt H, Adam WE. Diagnostic accuracy of a 14C‐urea breath test for detecting campylobacter pylori infection. Gastroduodenal pathology and Campylobacter pylori: European Campylobacter Pylori Study Group ICS847. 1989:85‐8.

Henze 1990

Henze E, Malfertheiner P, Clausen M, Burkhardt H, Adam WE. Validation of a simplified carbon‐14‐urea breath test for routine use for detecting Helicobacter [correction of heliobacter] pylori noninvasively. Journal of Nuclear Medicine 1990;31(12):1940‐4.

Herbrink 1988

Herbrink P, Vandenmunckhof HAM, Bumkens M, Lindeman J, Vandijk WC. Human‐serum antibody‐response in campylobacter‐jejuni enteritis as measured by enzyme‐linked immunosorbent‐assay. European Journal of Clinical Microbiology & Infectious Diseases 1988;7(3):388‐93.

Herold 2002

Herold R, Becker M. 13C‐urea breath test threshold calculation and evaluation for the detection of Helicobacter pylori infection in children. BMC Gastroenterology 2002;2:12.

Hidaka 2010

Hidaka N, Nakayama Y, Horiuchi A, Kato S, Sano K. Endoscopic identification of Helicobacter pylori gastritis in children. Digestive Endoscopy 2010;22(2):90‐4.

Higazy 2000

Higazy E, Al‐Saeedi F, Loutfi I, Heiba S, Kalaoui M, Al‐Nakib B, et al. The impact of brushing teeth on carbon‐14 urea breath test results. Journal of Nuclear Medicine Technology 2000;28(3):162‐4.

Hildebrand 1997

Hildebrand P, Beglinger C. Nondispersive infrared spectrometry: A new method for the detection of Helicobacter pylori infection with the c‐13‐urea breath test. Clinical Infectious Diseases 1997;25(5):1003‐5.

Hilker 1994

Hilker E, Stoll R, Domschke W. Quantitative assessment of Helicobacter‐pylori (hp) colonization of the gastric‐mucosa by c‐13‐urea breath test. Gastroenterology 1994;106(4 (suppl)):A93.

Hilker 1996

Hilker E, Domschke W, Stoll R. C‐13‐urea breath test for detection of Helicobacter pylori and its correlation with endoscopic and histologic findings. Journal of Physiology and Pharmacology 1996;47(1):79‐90.

Hino 2004

Hino B, Eliakim T, Levine A, Sprecher H, Berkowitz D, Hartman C, et al. Comparison of invasive and non‐invasive tests diagnosis and monitoring of Helicobacter pylori infection in children. Journal of Pediatric Gastroenterology and Nutrition 2004;39(5):519‐23.

Hirschl 1990

Hirschl AM, Rathbone BJ, Wyatt JI, Berger J, Rotter ML. Comparison of ELISA antigen preparations alone or in combination for serodiagnosing Helicobacter pylori infections. Journal of Clinical Pathology 1990;43(6):511‐3.

Hirschl 1991

Hirschl AM, Hirschl MM, Berger J, Rotter ML. Evaluation of a commercial latex test for serological diagnosis of Helicobacter pylori infection in treated and untreated patients. European Journal of Clinical Microbiology & Infectious Diseases 1991;10(11):971‐4.

Hirschl 1993

Hirschl AM, Brandstatter G, Dragosics B, Hentschel E, Kundi M, Rotter ML, et al. Kinetics of specific igg antibodies for monitoring the effect of anti‐Helicobacter pylori chemotherapy. Journal of Infectious Diseases 1993;168(3):763‐6.

Hirschl 1996

Hirschl AM, Rotter ML. Serological tests for monitoring Helicobacter pylori eradication treatment. Journal of Gastroenterology 1996;31 Suppl 9:33‐6.

Hirschl 2005

Hirschl AM, Makristathis A. Non‐invasive Helicobacter pylori diagnosis: Stool or breath tests?. Digestive & Liver Disease 2005;37(10):732‐4.

Ho 1996

Ho AS, Young TH, Shyu RY, Yeh C, Tseng HH, Lee SC, et al. The accuracy of the rapid urease test and 13C‐urea breath test in the diagnosis of Helicobacter pylori infection. Chung Hua i Hsueh Tsa Chih [Chinese Medical Journal] 1996;58(6):400‐6.

Ho 2000

Ho B, Marshall BJ. Accurate diagnosis of Helicobacter pylori ‐ serologic testing. Gastroenterology Clinics of North America 2000;29(4):853.

Ho 2004

Ho CY, Chen TS, Chang FY, Lee SD. Rapid urease test from non‐ulcer part of stomach is superior to histology from ulcer in detection of Helicobacter pylori infection in patients with gastric ulcer. Hepato‐Gastroenterology 2004;51(60):1877‐80.

Hoang 2006

Hoang TT, Rehnberg AS, Wheeldon TU, Bengtsson C, Phung DC, Befrits R, et al. Comparison of the performance of serological kits for Helicobacter pylori infection with european and asian study populations. Clinical Microbiology & Infection 2006;12(11):1112‐7.

Hoek 1992

Hoek FJ, Noach LA, Rauws EAJ, Tytgat GNJ. Evaluation of the performance of commercial test kits for detection of Helicobacter pylori antibodies in serum. Journal of Clinical Microbiology 1992;30(6):1525‐8.

Hollenz 1999

Hollenz M, Stolte M, Labenz J. Helicobacter pylori screening in a general practice. Deutsche Medizinische Wochenschrift 1999;124(7):171‐5.

Hong 2008

Hong WD, Zhu QH, Chen XR. Study on the value of helieobacter pylori (h. Pylori) stool antigen immunocard stat in the diagnosis of h. Pylori infection: A meta‐analysis.. Zhonghua Liu Xing Bing Xue Za Zhi 2008;29(1):71‐4.

Hooton 2006

Hooton C, Keohane J, Clair J, Azam M, O'Mahony S, Crosbie O, et al. Comparison of three stool antigen assays with the c‐13‐urea breath test for the primary diagnosis of Helicobacter pylori infection and monitoring treatment outcome. European Journal of Gastroenterology & Hepatology 2006;18(6):595‐9.

Hoshiya 2001

Hoshiya S, Tokunaga K, Tanaka A, Takahashi S. Serological diagnosis of Helicobacter pylori infection. Nihon Rinsho [Japanese Journal of Clinical Medicine] 2001;59(2):259‐64.

Houben 1998

Houben M, Hensen EF, Stam P, Van't Hoff BWM, Van der Hulst RWM, Van der Ende A, et al. Post‐eradication evaluation of h‐pylori (hp) status: The c‐13 urea laser assisted ratio analyzer (lara) breath test. Gastroenterology 1998;114(4 (suppl)):A153.

Houben 1999

Houben M, Vaira D, Lam K, Hensen EF, Stam P, Van 't Hoff BWM, et al. Usefulness of the c‐13 lara (tm) urea breath test in confirming eradication of Helicobacter pylori (hp). Gastroenterology 1999;116(4 (suppl)):A190.

Hsu 2010

Hsu PI. Application of serology in the diagnosis of Helicobacter pylori infection in patients with atrophic gastritis. Journal of the Chinese Medical Association 2010;73(11):561‐2.

Hu 1995

Hu P, Cui Y, Chen M. Application of serology and 14c‐urea breath test to monitoring of the effect of anti‐Helicobacter pylori chemotheraphy.. Zhonghua Nei Ke Za Zhi [Chinese journal of internal medicine] 1995;34(12):819‐22.

Hu 2000

Hu F, Cheng H, Li J. Evaluation and comparison of the Helicobacter pylori stool antigen test and the gastric mucosal antigen test.. Zhonghua Yi Xue Za Zhi 2000;80(11):820‐2.

Hu 2007

Hu HM, Kuo CH, Lo YC, Wu MT, Wu IC, Lu CY, et al. Evaluation of the two immunochromatographic methods for detecting urine and serum igg antibodies to Helicobacter pylori and comparison of accuracy and clinical utility. Hepato‐Gastroenterology 2007;54(73):119‐23.

Hu 2011

Hu FL. Performance of current infection marker test for the diagnosis of Helicobacter pylori current infection: A multicenter clinical trial. National Medical Journal of China 2011;91(27):1891‐4.

Huang 1993

Huang CK, Chen GH, Kao CH, Wang SJ, Leu JF, Shir JM, et al. A 10‐minute carbon‐14 urea breath test for the detection of Helicobacter pylori. Chinese Journal of Gastroenterology 1993;10(3):212‐20.

Huang 1996

Huang MS, Wang WM, Wu DC, Chen LT, Jan CM, Chen CY, et al. Utility of brushing cytology in the diagnosis of Helicobacter pylori infection. Acta Cytologica 1996;40(4):714‐8.

Huang 1998

Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta‐analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998;114(6):1169‐79.

Huang 2000

Huang JJ, Huang CJ, Ruaan MK, Chen KW, Yen TS, Sheu BS. Diagnostic efficacy of (13)c‐urea breath test for Helicobacter pylori infection in hemodialysis patients. American Journal of Kidney Diseases 2000;36(1):124‐9.

Huang 2002

Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter pylori infection and non‐steroidal anti‐inflammatory drugs in peptic‐ulcer disease: a meta‐analysis. Lancet 2002;359(9300):14‐22.

Huang 2003

Huang JQ, Zheng GF, Sumanac K, Irvine EJ, Hunt RH. Meta‐analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology 2003;125(6):1636‐44.

Huelin 1996

Huelin J, Sanchez‐Galdon S, Cardenas A, Ibanez J, Espana P, De la Cruz J, et al. Comparative study of Helisal™ rapid blood and ELISA, Jatrox and pathologic anatomy in the diagnosis of Helicobacter pylori infection [Spanish]. Revista Espanola de Enfermedades Digestivas 1996;88(12):825‐7.

Huijsdens 2004

Huijsdens XW, Linskens RK, Koppes J, Tang YL, Meuwissen SGM, Vandenbroucke‐Grauls CMJE, et al. Detection of Helicobacter species DNA by quantitative PCR in the gastrointestinal tract of healthy individuals and of patients with inflammatory bowel disease. FEMS Immunology and Medical Microbiology 2004;41(1):79‐84.

Hung 2002

Hung CT, Leung WK, Chan FKL, Sung JJY. Comparison of two new rapid serology tests for diagnosis of Helicobacter pylori infection in Chinese patients. Digestive and Liver Disease 2002;34(2):111‐5.

Hung 2010

Hung HH, Chen TS, Lin HC. Immunoglobulin g antibody against Helicobacter pylori is an accurate test for atrophic gastritis. Journal of the Chinese Medical Association 2010;73(7):355‐9.

Husson 2000

Husson MO, Rolland C, Gottrand F, Guimber D, Kalach N, Spyckerelle C, et al. Evaluation of a Helicobacter pylori stool antigen test for the diagnosis and follow‐up of infections in children. European Journal of Clinical Microbiology & Infectious Diseases 2000;19(10):787‐9.

Hynes 1998

Hynes SO, Moran AP. Comparison of enzyme‐linked immunosorbent assay, immunodot and western blot techniques for detecting lewis antigen expression on Helicobacter pylori clinical isolates. Gut 1998;43(Suppl 2):A20.

Hynes 2000

Hynes SO, Moran AP. Comparison of three serological methods for detection of lewis antigens on the surface of Helicobacter pylori. FEMS Microbiology Letters 2000;190(1):67‐72.

Ibrahim 2012

Ibrahim NH, Gomaa AA, Abu‐Sief MA, Hifnawy TM, Tohamy MAE. The use of different laboratory methods in diagnosis of Helicobacter pylori infection; a comparative study. Life Science Journal‐Acta Zhengzhou University Overseas Edition 2012;9(4):249‐59.

Ichinose 1998

Ichinose Y, Kanai E, Yamasawa F, Nishi I, Toyama K. Simultaneous continuous 13C, 12c analysis of expired gas in the 13C breath test. Respirology 1998;3(1):21‐4.

Ierardi 2002

Ierardi E, Margiotta M, Monno R, De Francesco V, Minenna MF, Burattini O, et al. A new semiquantitative method of quantifying Helicobacter pylori in antigen stools. Journal of Clinical Gastroenterology 2002;35(5):375‐8.

Ierfone 2003

Ierfone N, Di Fulvio A, Standoli M, Pontone S, Tonda M, Pontone P. Breath test as non‐invasive assessment for the initial screening of non‐ulcerous dyspepsia. Giornale di Chirurgia 2003;24(10):357‐63.

Ignys 2006

Ignys I, Klincewicz B, Malewski W, Cichy W. The non‐invasive diagnostic test for detection of Helicobacter pylori infection in children ‐ the value of Helicobacter pylori stool antigen test. Pediatria Wspolczesna 2006;8(4):234‐6.

Iijima 1998

Iijima K, Ohara S, Sekine H, Moriyama S, Kato K, Koike T, et al. Correlation between 13C‐urea breath test and gastric histological findings in Helicobacter pylori positive patients. Nippon Shokakibyo Gakkai Zasshi [Japanese Journal of Gastroenterology] 1998;95(1):18‐25.

Ilan 1998

Ilan Y, Israelit YY, Bar Meir S, Yudchack S, Goldin E. A novel method & device for Helicobacter pylori detection: Continuous, fast c‐13‐urea breath test. Gastroenterology 1998;114(4):A157.

Ilga 2008

Ilga U, Ozyurt M, Yildirim S, Ergunay K, Ardic N, Demirturk L, et al. Helicobacter pylori isolation, serology and caga, cage and virb11 detection in patients with non‐ulcer dyspepsia from Turkey: Correlation with histopathologic findings. Central European Journal of Medicine 2008;3(1):41‐6.

Imperiale 1996

Imperiale TF, McCullough AJ. C‐13 urea breath test for Helicobacter pylori infection. American Journal of Gastroenterology 1996;91(1):175‐6.

Imrie 2001

Imrie C, Rowland M, Bourke B, Drumm B. Limitations to carbon 13‐labeled urea breath testing for Helicobacter pylori in infants. Journal of Pediatrics 2001;139(5):734‐7.

Inaba 2002

Inaba T, Mizuno M, Kawai K, Takaguchi K, Yoshida Y, Kita K, et al. Effect of antiulcer agents on the urea breath test ‐ comparison between rebamipide and ecabet sodium. Japanese Journal of Gastroenterology 2002;99(1):27‐33.

Iranikhah 2013

Iranikhah A, Ghadir MR, Sarkeshikian S, Saneian H, Heidari A, Mahvari M. Stool antigen tests for the detection of Helicobacter pylori in children. Iranian Journal of Pediatrics 2013;23(2):138‐42.

Ishihara 2000

Ishihara S, Kaji T, Kawamura A, Rumi MAK, Sato H, Okuyama T, et al. Diagnostic accuracy of a new non‐invasive enzyme immunoassay for detecting Helicobacter pylori in stools after eradication therapy. Alimentary Pharmacology and Therapeutics 2000;14(5):611‐4.

Ishizuka 1999

Ishizuka J. Clinical evaluation of Helicobacter pylori stool antigen (HPSA) assay for assessment of diagnosis and eradication. Japanese Journal of Gastroenterology 1999;96(10):1196.

Islami 2008

Islami F, Kamangar F. Helicobacter pylori and esophageal cancer risk: a meta‐analysis. Cancer Prevention Research 2008;1(5):329‐38.

Ismail 2016

Ismail H, Morgan C, Griffiths P, Williams J, Jenkins G. A newly developed nested PCR assay for the detection of Helicobacter pylori in the oral cavity. Journal of Clinical Gastroenterology 2016;50(1):17‐22.

Isomoto 2002

Isomoto H, Inoue K, Shikuwa S, Furusu H, Nishiyama T, Omagari K, et al. Five minute endoscopic urea breath test with 25 mg of c‐13‐urea in the management of Helicobacter pylori infection. European Journal of Gastroenterology & Hepatology 2002;14(10):1093‐100.

Isomoto 2003

Isomoto H, Inoue KI, Mizuta Y, Nakazato M, Kanazawa Y, Nishiyama H, et al. Validation of endoscopic 13C‐urea breath test with nondispersive infrared spectrometric analysis in the management of Helicobacter pylori infection. Hepato‐Gastroenterology 2003;50(50):422‐5.

Isomoto 2006

Isomoto H, Kawazoe K, Inoue K, Kohno S. Usefulness of the immunological rapid urease test for detection of Helicobacter pylori in patients who are reluctant to undergo endoscopic biopsies. Digestive Diseases & Sciences 2006;51(12):2302‐5.

Israeli 2003

Israeli E, Ilan Y, Meir SB, Buenavida C, Goldin E. A novel 13C‐urea breath test device for the diagnosis of Helicobacter pylori infection: Continuous online measurements allow for faster test results with high accuracy. Journal of Clinical Gastroenterology 2003;37(2):139‐41.

Ito 2002

Ito M, Haruma K, Kaya S, Kamada T, Kim S, Sasaki A, et al. Role of anti‐parietal cell antibody in Helicobacter pylori‐associated atrophic gastritis: Evaluation in a country of high prevalence of atrophic gastritis. Scandinavian Journal of Gastroenterology 2002;37(3):287‐93.

Ito 2005

Ito M, Tanaka S, Kim SJ, Tahara K, Kawamura Y, Sumii M, et al. A combination of the Helicobacter pylori stool antigen test and urea breath test is useful for clinical evaluation of eradication therapy: A multicenter study. Journal of Gastroenterology and Hepatology 2005;20(8):1241‐5.

Iwanczak 2005

Iwanczak F, Pytrus T, Iwanczak B, Gosciniak G, Witkowska‐Vogtt E, Dzierzanowska D, et al. Assessment of selected tests in diagnostics of Helicobacter pylori infections. Polski Merkuriusz Lekarski 2005;19(109):52‐6.

Jaakkimainen 1999

Jaakkimainen RL, Boyle E, Tudiver F. Is Helicobacter pylori associated with non‐ulcer dyspepsia and will eradication improve symptoms? A meta‐analysis. BMJ 1999;319(7216):1040‐4.

Jabbari 2009

Jabbari Moghaddam Y, Rafeey M, Radfar R. Comparative assessment of Helicobacter pylori colonization in children tonsillar tissues. International Journal of Pediatric Otorhinolaryngology 2009;73(9):1199‐201.

Jadresin 2000

Jadresin O, Kolacek S, Percl M, Tambic A, Dasovic I, Grguric J. Detection of Helicobacter pylori antigen in stools ‐ an alternative method of verifying hp infection in children. Paediatria Croatica 2000;44(4):141‐4.

Jaff 2011

Jaff MS. Relation between ABO blood groups and Helicobacter pylori infection in symptomatic patients. Clinical and Experimental Gastroenterology 2011;4(1):221‐6.

Jafri 2010

Jafri W, Yakoob J, Abid S, Siddiqui S, Awan S, Nizami SQ. Helicobacter pylori infection in children: Population‐based age‐specific prevalence and risk factors in a developing country. Acta Paediatrica 2010;99(2):279‐82.

Jaime 2013

Jaime F, Villagran A, Serrano C, Cerda J, Harris PR. Frequency of Helicobacter pylori infection in 144 school age Chilean children. Revista Medica de Chile 2013;141(10):1249‐54.

Jain 1999

Jain A, Buddhiraja S, Khurana B, Singhal R, Nair D, Arora P, et al. Risk factors for duodenal ulcer in north India. Tropical Gastroenterology 1999;20(1):36‐9.

Jalali 1988

Jalali S, Hollingsworth J, Vanzanten SV, Tytgat K, Goldie J, Bowen B, et al. C‐14 urea breath test for the detection of C pylori (cp) infections. Gastroenterology 1988;94(5):A205.

Jane 1999

Jane Santamaria M, Varea Calderon V, Camacho E. Concordance between breath test and histologic damage in Helicobacter pylori associated infections in infancy. Revista Espanola De Enfermedades Digestivas 1999;91(10):703‐10.

Janjetic 2010

Janjetic MA, Goldman CG, Balcarce NE, Rua EC, Gonzalez AB, Fuda JA, et al. Iron, zinc, and copper nutritional status in children infected with Helicobacter pylori. Journal of Pediatric Gastroenterology & Nutrition 2010;51(1):85‐9.

Janjetic 2011

Janjetic MA, Goldman CG, Barrado DA, Rua EC, Balcarce N, Mantero P, et al. Decreasing trend of Helicobacter pylori infection in children with gastrointestinal symptoms from Buenos Aires, Argentina. Helicobacter 2011;16(4):316‐9.

Janjetic 2015

Janjetic MA, Mantero P, Rua EC, Balcarce N, De Palma GZ, Catalano M, et al. Dietary and anthropometric indicators of nutritional status in relation to Helicobacter pylori infection in a paediatric population. British Journal of Nutrition 2015;113(7):1113‐9.

Janssen 2001

Janssen K. Diagnostic series. Helicobacter pylori infections rapidly recognized. MMW Fortschritte der Medizin 2001;143(13):41‐2.

Janulaityte 1998

Janulaityte D, Kupcinskas L, Pavilonis A, Wadstrom T, Andersen L. Western blot analysis of Helicobacter pylori infection in patients with and without gastric cancer. Gut 1998;43(Suppl 2):A69.

Janus 1991

Janus G, Hammermeister I, Prignet JM, Saccharin C, Kist M, Koch HK. Helicobacter pylori: A serological study of young soldiers with endoscopic. Microbiologic and histologic study of ten cases with positive serology. Medecine et Maladies Infectieuses 1991;21(5):308‐12.

Jarbol 2006

Jarbol DE, Kragstrup J, Stovring H, Havelund T, Schaffalitzky de Muckadell OB. Proton pump inhibitor or testing for Helicobacter pylori as the first step for patients presenting with dyspepsia? A cluster‐randomized trial. American Journal of Gastroenterology 2006;101(6):1200‐8.

Jensen 1993

Jensen AKV, Andersen LP, Wachmann CH. Evaluation of eight commercial kits for Helicobacter pylori IgG antibody detection. APMIS 1993;101(10):795‐801.

Ji 1993

Ji J, Li XM, Jiang GH. Diagnosis of Helicobacter pylori infection by 13C‐urea breath test. Zhonghua Nei Ke za Zhi [Chinese Journal of Internal Medicine] 1993;32(3):170‐2.

Jiang 2004

Jiang Z, Huang AL, Tao XH, Wang PL. Diagnosis of Helicobacter pylori infection and diseases associated with Helicobacter pylori by Helicobacter pylori outer membrane proteins. World Journal of Gastroenterology 2004;10(23):3464‐9.

Jo 2008

Jo Y, Chung M, Lim C, Son B, Jun D, Kim S, et al. Urea breath test is the most reliable h. Pylori diagnostic test in patients with upper gastrointestinal bleeding in high h. Pylori prevalent population. Helicobacter 2008;13(5):451.

Jo 2014

Jo Y, Lee J, Kim J, Kim T. Urea breath test and serological test have equivalent accuracy to detect Helicobacter pylori in patients with gastroduodenal ulcer bleeding. Helicobacter 2014;19:124.

Johansen 2004

Johansen JK, Sehested A, Myrhoj T, Ladefoged K, Krogfelt KA. Helicobacter pylori infection in Greenlandic patients with dyspepsia. International Journal of Circumpolar Health 2004;63 Suppl 2:219‐20.

Johnston 1998

Johnston BJ, Gruer N, Johnson P. Effect of patient position on the performance of the c‐13‐urea breath test for the detection of Helicobacter pylori. Gut 1998;43(Suppl 2):A57.

Jolley 2007

Jolley CD, Wagner DA. Comparison of the c‐13‐urea blood test to histology and rapid urease testing in the diagnosis of Helicobacter pylori infection in children. Journal of Pediatric Gastroenterology and Nutrition 2007;44(1):68‐70.

Jonaitis 2007

Jonaitis LV, Kiudelis G, Kupcinskas L. Evaluation of a novel c‐14‐urea breath test "heliprobe" in diagnosis of Helicobacter pylori infection. Medicina‐Lithuania 2007;43(1):32‐5.

Jones 1997a

Jones R, Phillips I, Felix G, Tait C. An evaluation of near‐patient testing for Helicobacter pylori in general practice. Alimentary Pharmacology & Therapeutics 1997;11(1):101‐5.

Jones 1997b

Jones NL, Bourke B, Sherman PM. Breath testing for Helicobacter pylori infection in children: A breath of fresh air?. Journal of Pediatrics 1997;131(6):791‐3.

Jones 2007

Jones RT, Darboe MK, Doherty CP, MacKay WG, Weaver LT, Campbell DI, et al. Evaluation of c‐13‐urea breath test and fecal antigen immunoassay to detect Helicobacter pylori infection in Gambian infants. Journal of Pediatric Gastroenterology and Nutrition 2007;44(5):650‐2.

Juhasz 2000

Juhasz M, Pronai L, Zagoni T, Nemeth A, Herszenyi L, Schandl L, et al. Comparison of various methods in the detection of Helicobacter pylori infection. Orvosi Hetilap 2000;141(17):911‐4.

Juncal 1998

Juncal AR, Garea MT, Cid A, Penalver MD, Vazquez R, Montero E, et al. Evaluation of four commercial enzyme immunoassays for the serologic diagnosis of infection by Helicobacter pylori. Enfermedades Infecciosas y Microbiologia Clinica 1998;16(4):185‐9.

Jung 2002

Jung A, Wasilewska‐Radwanska M, Kopanski Z. Semiempirical model for diagnostication Helicobacter pylori infection by use of c‐14 labelled urea. Nukleonika 2002;47(3):95‐9.

Jung 2013

Jung H, Moon J, Park K, Kwon M, Jeong S, Park Y, et al. Detection rates of clarithromycin resistance and eradication rates of Helicobacter pylori infection: efficacy of Panplex™ Clar‐H. pylori detection. Helicobacter 2013;18:132.

Kabir 2001

Kabir S. Detection of Helicobacter pylori in faeces by culture, PCR and enzyme immunoassay. Journal of Medical Microbiology 2001;50(12):1021‐9.

Kajiwara 1997

Kajiwara M, Iida K, Takatori K, Taniguchi Y, Kimura K. Validity of the c‐13‐urea breath test for the diagnosis of Helicobacter pylori infection. Chemical & Pharmaceutical Bulletin 1997;45(4):741‐3.

Kajiwara 1998

Kajiwara M, Iida K, Takatori K, Taniguchi Y, Kimura K. Validity of the c‐13‐urea breath test for the diagnosis of Helicobacter pylori infection. In: Heys JR, Melillo DG editor(s). Synthesis and Applications of Isotopically Labelled Compounds 1997. 1st Edition. Chichester: John Wiley & Sons, 1998:627‐31.

Kakinoki 2001

Kakinoki K, Takemori Y, Noda Y. Efficacy of the urine antibody test for detection of Helicobacter pylori: Comparison with serum antibody tests. Japanese Journal of Gastroenterology 2001;98(8):935‐41.

Kaklikkaya 2006

Kaklikkaya N, Akdogan RA, Ozgur O, Uzun DY, Cobanoglu U, Dinc U, et al. Evaluation of a new rapid lateral flow chromatography test for the diagnosis of Helicobacter pylori. Saudi Medical Journal 2006;27(6):799‐803.

Kalach 1996

Kalach N, Briet F, Raymond J, Benhamou P, Senouci L, Bergert M, et al. Time course analysis and simplification of the c‐13‐urea breath test (c‐13‐ubt) in the detection of Helicobacter pylori infection (h‐pylori) in children. Gastroenterology 1996;110(4 (suppl)):A148.

Kalach 1998b

Kalach N, Benhamou PH, Briet F, Raymond J, Dupont C. The urea‐c‐13 breath test in the course of Helicobacter pylori gastric infection in children. Archives De Pediatrie 1998;5(12):1359‐65.

Kalach 2005

Kalach N, Nguyen V, Bergeret M, Boutros N, Dupont C, Raymond J. Usefulness and influence of age of a novel rapid monoclonal enzyme immunoassay stool antigen for the diagnosis of Helicobacter pylori infection in children. Diagnostic Microbiology and Infectious Disease 2005;52(2):157‐60.

Kalach 2009

Kalach N, Dehecq E, Gosset P, Decoster A, Bergeret M, Dupont C, et al. Usefulness and influence of age of a novel rapid Hpstar™ stool antigen for the diagnosis of Helicobacter pylori infection in children. Diagnostic Microbiology and Infectious Disease 2009;65(4):450‐3.

Kalem 2010

Kalem F, Ozdemir M, Baysal B. Investigation of the presence of Helicobacter pylori by different methods in patients with dyspeptic complaints. Mikrobiyoloji Bulteni 2010;44(1):29‐34.

Kang 1999

Kang G, Rajan DP, Patra S, Chacko A, Mathan MM. Use of serology, the urease test & histology in diagnosis of Helicobacter pylori infection in symptomatic & asymptomatic Indians. Indian Journal of Medical Research 1999;110:86‐90.

Kannath 2007

Kannath A, Rutt HN. Development of low cost instrumentation for non‐invasive detection of Helicobacter pylori ‐ art. No. 64300l. Advanced Biomedical and Clinical Diagnostic Systems 2007;6430:L4300.

Kao 1993

Kao CH, Huang CK, Wang SJ, Hsu CY, Lin WY, Chen GH. Accuracy of a rapid 10‐minute carbon‐14 urea breath test for the diagnosis of Helicobacter pylori‐associated peptic ulcer disease. European Journal of Nuclear Medicine 1993;20(8):708‐11.

Kaore 2012

Kaore NM, Nagdeo NV, Thombare VR. Comparative evaluation of the diagnostic tests for Helicobacter pylori and dietary influence for its acquisition in dyspeptic patients: a rural hospital based study in central India. Journal of Clinical and Diagnostic Research 2012;6(4 SUPPL 2):636‐41.

Kaptan 2009

Kaptan ZK, Emir H, Uzunkulaoglu H, Yucel M, Karakoc E, Koca G, et al. Determination of Helicobacter pylori in patients with chronic nonspecific pharyngitis. Laryngoscope 2009;119(8):1479‐83.

Karakus 2013

Karakus C, Salih BA. Comparison of the lateral flow immunoassays (LFIA) for the diagnosis of Helicobacter pylori infection. Journal of Immunological Methods 2013;396(1‐2):8‐14.

Karsligil 2010

Karsligil T, Mehli M, Koruk M, Eksi F. Urea breath test and specific IgA in Helicobacter pylori infection. Nobel Medicus 2010;6(3):46‐50.

Kasho 1996

Kasho VN, Cheng S, Jensen DM, Ajie H, Lee WNP, Faller LD. Feasibility of analysing c‐13 urea breath tests for Helicobacter pylori by gas chromatography‐mass spectrometry in the selected ion monitoring mode. Alimentary Pharmacology & Therapeutics 1996;10(6):985‐95.

Kassa 1996

Kassa E, Tsega E, Gebre W. Comparison of diagnostic methods for detection of Helicobacter pylori. East African Medical Journal 1996;73(4):239‐41.

Katelaris 1997

Katelaris PH, Jones DB. Testing for Helicobacter pylori infection after antibiotic treatment. American Journal of Gastroenterology 1997;92(8):1245‐7.

Katelaris 1998

Katelaris PH, Connor SJ, Seow F, Huntley S, Ngu MC. The effect of short term omeprazole use on the accuracy of the c‐13‐urea breath test in Helicobacter pylori infected subjects. Gut 1998;43(Suppl 2):A53.

Kato 1997

Kato M, Ohara S, Asaka M, Toyota T. New, on‐the‐spot infrared analyzer for c‐13‐urea breath test: A simple, easy‐to‐use method for detecting Helicobacter pylori in the physician's office. Gastroenterology 1997;112(4 (suppl)):A169.

Kato 1998

Kato M, Kobayashi T, Ishizuka J, Kudo T, Katagiri M, Komatsu Y, et al. Detection of h‐pylori infections by urine‐based enzyme‐linked immunosorbent assay. Gastroenterology 1998;114(4):A169.

Kato 1999

Kato M, Asaka M, Saito M, Ohara S, Toyota T, Akamatsu T, et al. Clinical usefulness of a urine‐based ELISA for detection of anti‐Helicobacter pylori antibody. Gastroenterology 1999;116(4 (suppl)):A206‐A7.

Kato 2000a

Kato M, Hokari K, Ishizuka J, Mizushima T, Sukegawa M, Komatsu Y, et al. Assessment of Helicobacter pylori eradication using a urine‐based ELISA of anti‐Helicobacter pylori antibody. Gastroenterology 2000;118(4 Part 1):A505.

Kato 2000b

Kato S, Tachikawa T, Ozawa K, Konno M, Oyake Y, Nakazato Y, et al. Usefulness of urine‐based ELISA for detection of IgG antibodies to Helicobacter pylori in children. Gastroenterology 2000;118(4):A506.

Kato 2000c

Kato M, Asaka M, Saito M, Sekine H, Ohara S, Toyota T, et al. Clinical usefulness of urine‐based enzyme‐linked immunosorbent assay for detection of antibody to Helicobacter pylori: A collaborative study in nine medical institutions in Japan. Helicobacter 2000;5(2):109‐19.

Kato 2001a

Kato M. Evaluation of a new 13co2 infrared analyzer (ubit‐ir300) for 13C‐urea breath test. Japanese Journal of Gastroenterology 2001;98(7):853.

Kato 2001b

Kato S, Tachikawa T, Ozawa K, Konno M, Okuda M, Fujisawa T, et al. Urine‐based enzyme‐linked immunosorbent assay for the detection of Helicobacter pylori infection in children. Pediatrics 2001;107(6):E87.

Kato 2001c

Kato C, Yamaguchi T, Yusa K, Sasaki H, Suzuki K, Sato K, et al. 13C‐urea breath test. Nippon Rinsho [Japanese Journal of Clinical Medicine] 2001;59(2):267‐71.

Kato 2002a

Kato M, Iwasaki T, Miyazaki H, Ohira K, Oizumi S, Kawarazaki M, et al. Urea breath test for diagnosis of Helicobacter pylori infection. Nippon Rinsho [Japanese Journal of Clinical Medicine] 2002;60(Suppl 2):332‐8.

Kato 2002b

Kato S, Ozawa K, Konno M, Kagimoto S, Okuda M, Fujisawa T, et al. Usefulness of the stool antigen test (HPSA) for diagnosis of Helicobacter pylori infection in Japanese children: A multicenter study. Gastroenterology 2002;122(4 (suppl)):A202‐A3.

Kato 2002c

Kato S, Ozawa K, Konno M, Tajiri H, Yoshimura N, Shimizu T, et al. Diagnostic accuracy of the c‐13‐urea breath test for childhood Helicobacter pylori infection: A multicenter Japanese study. American Journal of Gastroenterology 2002;97(7):1668‐73.

Kato 2002d

Kato S, Ozawa K, Minoura T, Iinuma K. A simplified c‐13‐urea breath test for diagnosis of Helicobacter pylori infection in children. Gastroenterology 2002;122(4 (Suppl)):A206.

Kato 2002e

Kato C, Kasugai S, Fukuda Y, Yusa K, Kudara N, Iwasaki M, et al. Diagnosis of Helicobacter pylori infection by the antigen analysis of stools. Nippon Rinsho [Japanese Journal of Clinical Medicine] 2002;60(Suppl 2):347‐9.

Kato 2003a

Kato C, Sugiyama T, Sato K, Saito S, Kudara N, Abiko Y, et al. Appropriate cut‐off value of 13C‐urea breath test after eradication of Helicobacter pylori infection in Japan. Journal of Gastroenterology & Hepatology 2003;18(12):1379‐83.

Kato 2003b

Kato S, Ozawa K, Okuda M, Fujisawa T, Kagimoto S, Konno M, et al. Accuracy of the stool antigen test for the diagnosis of childhood Helicobacter pylori infection: A multicenter Japanese study. American Journal of Gastroenterology 2003;98(2):296‐300.

Kato 2004a

Kato S, Nakayama K, Minoura T, Konno M, Tajiri H, Matsuhisa T, et al. Comparison between the 13C‐urea breath test and stool antigen test for the diagnosis of childhood Helicobacter pylori infection. Journal of Gastroenterology 2004;39(11):1045‐50.

Kato 2004b

Kato S, Ozawa K, Okuda M, Nakayama Y, Yoshimura N, Konno M, et al. Multicenter comparison of rapid lateral flow stool antigen immunoassay and stool antigen enzyme immunoassay for the diagnosis of Helicobacter pylori infection in children. Helicobacter 2004;9(6):669‐73.

Kato 2004c

Kato M, Saito M, Fukuda S, Kato C, Ohara S, Hamada S, et al. C‐13‐urea breath test, using a new compact nondispersive isotope‐selective infrared spectrophotometer: Comparison with mass spectrometry. Journal of Gastroenterology 2004;39(7):629‐34.

Kato 2005a

Kato M, Shimizu Y, Nakagawa S, Nakagawa M, Ono Y, Ono S, et al. Prevention of false‐positive result of 13C‐urea breath test after eradication of h. Pylori using film‐coated 13C‐urea tablet. Gastroenterology 2005;128(4 (suppl)):A561.

Kato 2005b

Kato M, Shimizu Y, Shouji E, Takeda H, Asaka M. Problem of 13C‐urea breath test in the diagnosis of h. Pylori after eradication. Nippon Rinsho [Japanese Journal of Clinical Medicine] 2005;63(Suppl 11):221‐5.

Kato 2005c

Kato M, Asaka M. Helicobacter pylori igg antibody, urea breath test, Helicobacter pylori antigen in the stool. Nippon Rinsho [Japanese Journal of Clinical Medicine] 2005;63(Suppl 7):175‐9.

Kato 2007

Kato C, Sugiyama T, Horie A, Igarashi M, Takayanagi N, Tsuchida Y. Diagnostic accuracy of a novel Helicobacter pylori stool antigen test using monoclonal antibody after eradication therapy in Japanese population. Helicobacter 2007;12(4):442‐3.

Kato 2010

Kato M, Asaka M. Helicobacter pylori (igg antibody test, urea breath test, stool antigen test). Nippon Rinsho [Japanese Journal of Clinical Medicine] 2010;68(Suppl 6):183‐8.

Katsuragi 1998

Katsuragi K, Noda A, Tachikawa T, Azuma A, Mukai F, Murakami K, et al. Highly sensitive urine‐based enzyme‐linked immunosorbent assay for detection of antibody to Helicobacter pylori. Helicobacter 1998;3(4):289‐95.

Kaul 1998

Kaul A, Bhasin DK, Pathak CM, Ray P, Vaiphei K, Sharma BC, et al. Normal limits of 14c‐urea breath test. Tropical Gastroenterology 1998;19(3):110‐3.

Kawai 2008

Kawai T, Kawakami K, Kataoka M, Itoi T, Takei K, Moriyasu F, et al. A study of the relationship between Helicobacter pylori microbial susceptibility, 13C‐urea breath test values. Hepato‐Gastroenterology 2008;55(82‐83):786‐90.

Kawakami 2002

Kawakami E, Machado RS, Reber M, Patricio FR. 13 c‐urea breath test with infrared spectroscopy for diagnosing Helicobacter pylori infection in children and adolescents. Journal of Pediatric Gastroenterology & Nutrition 2002;35(1):39‐43.

Kazemi 2011

Kazemi S, Tavakkoli H, Habizadeh MR, Emami MH. Diagnostic values of Helicobacter pylori diagnostic tests: Stool antigen test, urea breath test, rapid urease test, serology and histology. Journal of Research in Medical Sciences 2011;16(9):1097‐104.

Kearney 1999

Kearney DJ, Boes L, Peacock JS. Use of a dried plasma collection card for simplified diagnosis of Helicobacter pylori infection. Alimentary Pharmacology & Therapeutics 1999;13(11):1531‐4.

Kearney 2002

Kearney DJ, Hubbard T, Putnam D. Breath ammonia measurement in Helicobacter pylori infection. Digestive Diseases & Sciences 2002;47(11):2523‐30.

Ken 2013

Ken Dror S, Barak M. Evaluation of the diasorin liaison automatic stool antigen test for the diagnosis of Helicobacter pylori infection. Biochimica Clinica 2013;37:S659.

Kesli 2010

Kesli R, Gokturk HS, Erbayrak M, Karabagli P, Terzi Y. Comparison of the diagnostic values of the 3 different stool antigen tests for the noninvasive diagnosis of Helicobacter pylori infection. Journal of Investigative Medicine 2010;58(8):982‐6.

Kessenich 2012

Kessenich CR, Erigo‐Backsman RC. Gastritis and noninvasive testing for Helicobacter pylori. Nurse Practitioner 2012;37(4):7‐9.

Khafri 2005

Khafri A, Van yousefi J, Madani R, Pourdian M, Khaki P. Designing an ELISA technique for h.Pylori antibody detection using water extracted antigens. Iranian Journal of Public Health 2005;34(2):14‐9.

Khalifehgholi 2013

Khalifehgholi M, Shamsipour F, Ajhdarkosh H, Daryani NE, Reza Pourmand M, Hosseini M, et al. Comparison of five diagnostic methods for Helicobacter pylori. Iranian Journal of Microbiology 2013;5(4):396‐401.

Kharchenko 2012

Kharchenko N, Lopukh I, Janelidze D. Helicobacter pylori immediate detection with helic breath test: Diagnostic value comparison with c‐13 breath test and PCR DNA in feces. Journal of Gastroenterology and Hepatology 2012;27:297‐8.

Khorovskaya 2003

Khorovskaya LA, Kornienko EA, Dmitrienko MA, Nazhiganov ON. Experience of a modified non‐isotopic, non‐invasive breath test for Helicobacter pylori in pediatric practice. Clinical Chemistry 2003;49(6 (suppl)):A52.

Kias 2011

Kias F, Taleb F, Mouffok F, Matougui N, Boudjella M, Lamri A, et al. Helicobacter pylori: diagnosis of infection in adults in Algeria. Helicobacter 2011;16:116.

Kikuchi 1999

Kikuchi H, Ichinose Y, Ishii H, Mori M, Yamaguchi K, Igari K. Influence on diagnosis of Helicobacter pylori infection in 13C urea breath test of existence of dead space gas. Journal of Occupational Health 1999;41(6):183‐9.

Kim 1996

Kim J, Bank S, Bailey B. Comparison of C14 breath test with clo test in detecting Helicobacter pylori. Gastroenterology 1996;110(4 (suppl)):A155.

Kim 1997

Kim MJ, Michener R, Triadafilopoulos G. Serum c‐13‐bicarbonate assay for the diagnosis of gastric Helicobacter pylori infection and response to treatment. Gastroenterology 1997;113(1):31‐7.

Kim 1999

Kim PS, Lee JW, Pai SH, Choe YH, Shin YW, Kim YS. Detection of H. pylori antigen in stool by ELISA. Gut 1999;45(Suppl 3):A133.

Kim 2001

Kim I, Kim P, Kwon K, Lee D, Kim H, Shin Y, et al. Comparison of urine‐based enzyme‐linked immunosorbent assay and c‐14 ubt test for detection of Helicobacter pylori. Gut 2001;49(suppl):A102‐A3.

Kim 2002

Kim PS, Lee J, Pai SH, Kim YB, Cho JK, Lee JW, et al. Detection of Helicobacter pylori antigen in stool by enzyme immunoassay. Yonsei Medical Journal 2002;43(1):7‐13.

Kim 2009

Kim D. The detection of Helicobacter pylori in the terminal ileum and rectum from urea breath test positive healthy adults with culture and PCR during colonoscopy. American Journal of Gastroenterology 2009;104:S514.

Kim 2012

Kim WJ, Kim HD. The efficacy of monoclonal antibody‐based test as addictive tool to detect h. Pylori. Journal of Gastroenterology and Hepatology 2012;27:65.

Kim 2013

Kim HD, Kim DH, Park H, Kim WJ, Ahn YS, Lee YJ, et al. Detection of Helicobacter pylori in gastric aspirates using a monoclonal antibody‐based test. Gut and Liver 2013;7(1):30‐4.

Kim 2014

Kim H, Choi S, Beom J. New monoclonal antibody‐based test for Helicobacter pylori urease in gastric tissue. Journal of Gastroenterology and Hepatology (Australia) 2014;29:228‐9.

Kindermann 2000

Kindermann A, Demmelmair H, Koletzko B, Krauss‐Etschmann S, Wiebecke B, Koletzko S. Influence of age on c‐13‐urea breath test results in children. Journal of Pediatric Gastroenterology and Nutrition 2000;30(1):85‐91.

Kindermann 2001a

Kindermann A, Konstantopoulos N, Lehn N, Demmelmair H, Koletzko S. Evaluation of two commercial enzyme immunoassays, testing immunoglobulin g (igg) and iga responses, for diagnosis of Helicobacter priori infection in children. Journal of Clinical Microbiology 2001;39(10):3591‐6.

Kindermann 2001b

Kindermann A, Faus‐Kessler T, Ballauff A, Findeisen A, Laske G, Demmelmair H, et al. Evaluation of a rapid whole blood test to detect Helicobacter pylori infection in children. Scandinavian Journal of Gastroenterology 2001;36(6):572‐6.

Kishkun 2002

Kishkun AA, Sadokov VM, Arsenin SL, Budzinskii AA, Klimkova MA, Kuchin GA, et al. Significance of the operational test parameters in selection of a diagnostic test for Helicobacter infection. Eksperimental'naia i Klinicheskaia Gastroenterologiia [Experimental & Clinical Gastroenterology] 2002;4:103‐8, 34‐35.

Kist 1999

Kist M, Strobel S, Kirchner T, Dammann HG. Impact of ELISA and immunoblot as diagnostic tools one year after eradication of Helicobacter pylori in a multicentre treatment study. FEMS Immunology & Medical Microbiology 1999;24(2):239‐42.

Klein 1996

Klein PD, Malaty HM, Martin RF, Graham KS, Genta RM, Graham DY. Noninvasive detection of Helicobacter pylori infection in clinical practice: The c‐13 urea breath test. American Journal of Gastroenterology 1996;91(4):690‐4.

Klein 1999

Klein PD, Malaty HM, Czinn SJ, Emmons SC, Martin RF, Graham DY. Normalizing results of 13C‐urea breath testing for co2 production rates in children. Journal of Pediatric Gastroenterology & Nutrition 1999;29(3):297‐301.

Klyucharova 2013

Klyucharova A, Garipova E, Skorohodkina O. Comparison of the urea breath test with bacteriological investigation in detecting of Helicobacter pylori in patients with chronic urticaria. Allergy: European Journal of Allergy and Clinical Immunology 2013;68:604‐5.

Kobayashi 2002

Kobayashi D, Eishi Y, Ohkusa T, Ishige I, Suzuki T, Minami J, et al. Gastric mucosal density of Helicobacter pylori estimated by real‐time PCR compared with results of urea breath test and histological grading. Journal of Medical Microbiology 2002;51(4):305‐11.

Koca 2005

Koca G, Ozdemir E, Cakal E, Culha C, Turkolmez S, Korkmaz M, et al. Comparison of c‐14 urea‐breath test, Helicobacter pylori igg and cytotoxin associated gene a findings in diabetic patients with dyspeptic complaints. European Journal of Nuclear Medicine and Molecular Imaging 2005;32:S218.

Kodama 2004

Kodama M, Fujioka T, Okimoto T, Kagawa J, Murakami K, Sato R, et al. Evaluation of the Helicobacter pylori stool antigen (HPSA) assay for diagnosing infection and confirming eradication after treatment. Journal of Gastroenterology 2004;39(12):1219‐20.

Kodama 2012

Kodama M, Murakami K, Okimoto T, Fukuda Y, Shimoyama T, Okuda M, et al. Infuence of proton pump inhibitor treatment on Helicobacter pylori stool antigen test. World Journal of Gastroenterology 2012;18(1):44‐8.

Koizumi 2003

Koizumi W, Tanabe S, Imaizumi H, Hibi KI, Kida M, Ohida M, et al. Effect of anti‐Helicobacter pylori igg antibody titer following eradication of Helicobacter pylori infection. Hepato‐Gastroenterology 2003;50(49):293‐6.

Kokkola 1998

Kokkola A, Puolakkainen P, Rautelin H, Sipponen P, Farkkila M, Haapiainen R, et al. Positive serology indicates an active h‐pylori infection in patients with atrophic gastritis in spite of negative histology and c‐13‐urea breath test. Gastroenterology 1998;114(4):A183.

Kokkola 2000

Kokkola A, Rautelin H, Puolakkainen P, Sipponen P, Farkkila M, Haapiainen R, et al. Diagnosis of Helicobacter pylori infection in patients with atrophic gastritis: Comparison of histology, c‐13‐urea breath test, and serology. Scandinavian Journal of Gastroenterology 2000;35(2):138‐41.

Koletzko 1995

Koletzko S, Haisch M, Seeboth I, Braden B, Hengels K, Koletzko B, et al. Isotope‐selective non‐dispersive infrared spectrometry for detection of Helicobacter pylori infection with 13C‐urea breath test. Lancet 1995;345(8955):961‐2.

Koletzko 2003

Koletzko S, Konstantopoulos N, Bosman D, Feydt‐Schmidt A, Van der Ende A, Kalach N, et al. Evaluation of a novel monoclonal enzyme immunoassay for detection of Helicobacter pylori antigen in stool from children. Gut 2003;52(6):804‐6.

Kolho 2002

Kolho KL, Korhonen J, Verkasalo M, Lindahl H, Savilahti E, Rautelin H. Helicobacter pylori serology at diagnosis and follow‐up of biopsy‐verified infection in children. Scandinavian Journal of Infectious Diseases 2002;34(3):177‐82.

Kolho 2006

Kolho KL, Klemola T, Koivusalo A, Rautelin H. Stool antigen tests for the detection of Helicobacter pylori in children. Diagnostic Microbiology and Infectious Disease 2006;55(4):269‐73.

Kolt 1997

Kolt SD, Dow C, Elliott SL, Yeomans ND. Effect of omeprazole on the accuracy of the i mu ci c‐14‐urea breath test for h‐pylori. Gastroenterology 1997;112(4 (suppl)):A180.

Kolts 1993

Kolts BE, Joseph B, Achem SR, Bianchi T, Monteiro C. Helicobacter‐pylori detection ‐ a quality and cost‐analysis. American Journal of Gastroenterology 1993;88(5):650‐5.

Kondo 2000

Kondo T, Mitsui T, Kitagawa M, Nakae Y. Association of fasting breath nitrous oxide concentration with gastric juice nitrate and nitrite concentrations and Helicobacter pylori infection. Digestive Diseases & Sciences 2000;45(10):2054‐7.

Konorev 2013

Konorev MR, Matveenko ME, Komleva EN. Comparative evaluation of efficiency of helic ammonia breath test for diagnostics of h. Pylori infection in gastric mucous. Helicobacter 2013;18:122.

Konorev 2014

Konorev MR, Komleva EN, Matveenko ME. Evaluation of efficiency of helic ammonia breath test for diagnostics of h. Pylori infection in stomach in rheumatoid arthritis patients taking nsaids. Helicobacter 2014;19:123.

Konstantopoulos 2001

Konstantopoulos N, Russmann H, Tasch C, Sauerwald T, Demmelmair H, Autenrieth I, et al. Evaluation of the Helicobacter pylori stool antigen test (HPSA) for detection of Helicobacter pylori infection in children. American Journal of Gastroenterology 2001;96(3):677‐83.

Konturek 1999

Konturek SJ, Bielanski W, Bobrzynski A, Rembiarz K, Winiarski M, Karczewska E, et al. Upper gastrointestinal bleeding does not interfere with the effectiveness of urea breath test in detecting of Helicobacter pylori in humans. Gastroenterology 1999;116(4 (suppl)):A220.

Kopacova 1999

Kopacova M, Bures J, Vorisek V, Konstacky M, Rejchrt S, Zivny P, et al. Detection of Helicobacter pylori by means of 13C‐urea breath test: Clinical reproducibility of the test. Klinicka Biochemie a Metabolismus 1999;7(4):213‐6.

Kopacova 2005

Kopacova M, Bures J, Vorisek V, Konstacky M, Rejchrt S, Zivny P, et al. Comparison of different protocols for c‐13‐urea breath test for the diagnosis of Helicobacter pylori infection in healthy volunteers. Scandinavian Journal of Clinical & Laboratory Investigation 2005;65(6):491‐8.

Kopanski 1993a

Kopanski Z, Cienciata A. Serologic detection of Helicobacter pylori antibodies after surgery for stomach and duodenal ulcer. Wiener Klinische Wochenschrift 1993;105(14):408‐11.

Kopanski 1993b

Kopanski Z, Cienciala A, Slowakiewicz E, Witkowska B, Ulatowski Z. Serological diagnosis of infection by Helicobacter pylori in chronic ulcer disease. Materia Medica Polona 1993;25(2):81‐2.

Kopanski 1996

Kopanski Z, Schlegel‐Zawadzka M, Witkowska B, Cienciala A, Szczerba J. Role of the enterotest in the diagnosis of the Helicobacter pylori infections. European Journal of Medical Research 1996;1(11):520‐2.

Kopanski 1997

Kopanski Z, Niziol J, Micherdzinski J, Wasilewska‐Radwanska H, Schlegel‐Zawadzka M, Lasa J, et al. Significance of the 14c‐urea breath test in the determination of the location infected by Helicobacter pylori in the alimentary canal. European Journal of Medical Research 1997;2(3):136‐8.

Kopanski 2002

Kopanski Z, Jung A, Wasilewska‐Radwanska M, Kuc T, Schlegel‐Zawadzka M, Witkowska B. Comparative diagnostic value of the breath test and the urine test with 14C‐urea in the detection of the Helicobacter pylori infection. Nuclear Medicine Review 2002;5(1):21‐4.

Korkmaz 2013

Korkmaz H, Kesli R, Karabagli P, Terzi Y. Comparison of the diagnostic accuracy of five different stool antigen tests for the diagnosis of Helicobacter pylori infection. Helicobacter 2013;18(5):384‐91.

Korkmaz 2015

Korkmaz H, Findik D, Ugurluoglu C, Terzi Y. Reliability of stool antigen tests: Investigation of the diagnostic value of a new immunochromatographic Helicobacter pylori approach in dyspeptic patients. Asian Pacific Journal of Cancer Prevention: Apjcp 2015;16(2):657‐60.

Korzonek 1997

Korzonek M. Diagnostic value of different methods applied for detecting Helicobacter pylori infection in gastric mucosa. Annales Academiae Medicae Stetinensis 1997;43:143‐59.

Koumi 2011

Koumi A, Filippidis T, Leontara V, Makri L, Panos MZ. Detection of Helicobacter pylori: A faster urease test can save resources. World Journal of Gastroenterology 2011;17(3):349‐53.

Kountouras 1996

Kountouras J, Boura P, Iliadis M, Giannouli P, Tsapas G. Saliva urease test and serological surveillance of Helicobacter pylori infection during treatment of peptic ulcer disease. Hellenic Journal of Gastroenterology 1996;9(1):67‐71.

Kowalski 1990

Kowalski AJ, Cuan J, Chiang CS, Grove T, Perezperez G, Blaser M. Detection of antibodies to Helicobacter‐pylori by ELISA. Clinical Chemistry 1990;36(6):1092.

Kozaiwa 1997

Kozaiwa K, Tajiri H, Sawada A, Miyoshi Y, Tada K, Etani Y, et al. Usefulness of c‐13 urea breath test in diagnosis and monitoring of Helicobacter pylori infection in children with recurrent abdominal pain. Gastroenterology 1997;112(4 (suppl)):A184.

Kozlov 2006

Kozlov AV, Evstratova Iu S, Novikova VP, Tkachenko EI, Khochinskaia O. Gas analyzer "helicosense" as a new device for diagnosis of the Helicobacter infection. Meditsinskaia Tekhnika 2006;3:44‐6.

Krausse 2008

Krausse R, Muller G, Doniec M. Evaluation of a rapid new stool antigen test for diagnosis of Helicobacter pylori infection in adult patients. Journal of Clinical Microbiology 2008;46(6):2062‐5.

Kroser 1998

Kroser JA, Faigel DO, Furth EE, Metz DC. Comparison of rapid office‐based serology with formal laboratory‐based ELISA testing for diagnosis of Helicobacter pylori gastritis. Digestive Diseases & Sciences 1998;43(1):103‐8.

Krumbiegel 2000a

Krumbiegel P, Muller DM. Helicobacter pylori in vivo diagnosis after food intake: Results of simultaneous n‐15 urea urine and c‐13 acetate breath tests. Isotopes in Environmental and Health Studies 2000;36(2):99‐110.

Krumbiegel 2000b

Krumbiegel P, Herbarth O, Kiess W, Muller DM, Richter T. Diagnosis of Helicobacter pylori infection in children: Is the n‐15 urine test more reliable than the c‐13 breath test?. Scandinavian Journal of Gastroenterology 2000;35(4):353‐8.

Kryvy 2012

Kryvy V, Klyaryts'ka I. Modified 13C‐urea breath test in the diagnosis of infection h. Pylori in crimean population patients with gastritis. Helicobacter 2012;17:94.

Kuang 1998

Kuang A, Liang Z, Tan T, Chen D, Ma H, Si K, et al. Rapid microdose 14c‐urea breath test for detection of Helicobacter pylori infection.. Hua Xi Yi Ke Da Xue Xue Bao [Journal of West China University of Medical Sciences] 1998;29(4):435‐8.

Kubo 2001

Kubo Y, Matsui H, Ninomiya T, Mizukami Y, Onji M. Non‐invasive approach for diagnosing atrophic gastritis using the c‐13‐bicarbonate breath test. International Journal of Molecular Medicine 2001;7(4):381‐4.

Kubota 2002

Kubota K, Shimoyama S, Shimizu N, Noguchi C, Mafune K, Kaminishi M, et al. Studies of c‐13‐urea breath test for diagnosis of Helicobacter pylori infection in patients after partial gastrectomy. Digestion 2002;65(2):82‐6.

Kubota 2003

Kubota K, Hiki N, Shimizu N, Shimoyama S, Noguchi C, Tange T, et al. Utility of [13C] urea breath test for Helicobacter pylori detection in partial gastrectomy patients. Digestive Diseases & Sciences 2003;48(11):2135‐8.

Kumbhari 2012

Kumbhari V, Rahme N, Meredith CG. Evaluation of a novel office‐based c‐14 urea breath test 'heliprobe (r)' for the rapid detection of Helicobacter pylori. Journal of Gastroenterology and Hepatology 2012;27:58.

Kumbhari 2013

Kumbhari V, Rahme N, Meredith C. Evaluation of a novel office based 14c urea breath test, heliprobe, in patients undergoing endoscopy. Gastroenterology 2013;1:S334.

Kuo 2002

Kuo CH, Wu DC, Lu CY, Su YC, Yu FJ, Lee YC, et al. The media of rapid urease test influence the diagnosis of Helicobacter pylori. Hepato‐Gastroenterology 2002;49(47):1191‐4.

Kuo 2005

Kuo FC, Wang SW, Wu IC, Yu FJ, Yang YC, Wu JY, et al. Evaluation of urine ELISA test for detecting Helicobacter pylori infection in Taiwan: a prospective study. World Journal of Gastroenterology 2005;11(35):5545‐8.

Kushch 2009

Kushch I, Korenev N, Kamarchuk L, Pospelov A, Alexandrov J, Kamarchuk G. Non‐urease recognition of Helicobacter pylori infection using novel sensor technique for breath gas analysis. Scandinavian Journal of Gastroenterology 2009;44:25.

Kwon 2004

Kwon KT, Lee DS, Chung IK, Park MJ, Park CK, Cho CM, et al. The diagnostic validity of Helicobacter pylori stool antigen test in the pre‐ and post‐eradication. Taehan Sohwagi Hakhoe C [Korean Journal of Gastroenterology] 2004;44(4):199‐205.

Kwon 2015

Kwon YH, Kim N, Lee JY, Choi YJ, Yoon K, Hwang JJ, et al. The diagnostic validity of citric acid‐free, high dose c‐13‐urea breath test after Helicobacter pylori eradication in Korea. Helicobacter 2015;20(3):159‐68.

Kyrlagkitsis 2007

Kyrlagkitsis I, Ladas SD, Mallass EG, Raptis S, Mentis A, Delliou E, et al. Evaluation of a conventional ELISA (Novitec) and a near patient immunochromatographic test (Stick H. pyl) for Helicobacter pylori antigen detection in stool. Hepato‐Gastroenterology 2007;54(75):799‐802.

Labenz 1996

Labenz J, Barsch G, Peitz U, Aygen S, Hennemann O, Tillenburg B, et al. Validity of a novel biopsy urease test (hut) and a simplified 13C‐urea breath test for diagnosis of Helicobacter pylori infection and estimation of the severity of gastritis. Digestion 1996;57(6):391‐7.

Labenz 1997

Labenz J, Peitz U, Aygen S, Hennemann O, Stolte M. Accuracy of rapid urease test and urea breath test for diagnosis of Helicobacter pylori infection after treatment ‐ an investigator blind multicenter study. Gastroenterology 1997;112(4 (suppl)):A188.

Ladas 2000

Ladas SD, Malamou H, Giota G, Varzakakos I, Kitsanta P, Georgopoulos S, et al. Prospective evaluation of a whole‐blood antibody test (flexpack hp) for in‐office diagnosis of Helicobacter pylori infection in untreated patients. European Journal of Gastroenterology & Hepatology 2000;12(7):727‐31.

Ladas 2002b

Ladas SD, Varzakakos I, Malamou H, Georgopoulos S, Giota G, Triantafyllou K, et al. Evaluation of a single‐step serological assay for laboratory diagnosis of Helicobacter pylori infection. European Journal of Clinical Microbiology & Infectious Diseases 2002;21(1):56‐9.

Lahaie 1995

Lahaie RG, Desroches J, Picard M, Lemoyne M, Poitras P, Gagnon M, et al. Value of one‐step, 20 min c‐14 urea breath test in diagnosis and proof of eradication of Helicobacter‐pylori infection. Gastroenterology 1995;108(4):A141.

Laheij 2006

Laheij RJ. Assessment of a new rapid urease test (gut test) to diagnose Helicobacter pylori infection. Netherlands Journal of Medicine 2006;64(9):317‐8.

Lai 1997

Lai KC, Chu KM, Hui WM, Wong BCY, Lam SK. Non‐invasive tests before endoscopy in area with high prevalence of gastric carcinoma ‐ Helicobacter pylori serology or urea breath test?. Gastroenterology 1997;112(4 (Suppl)):A599.

Laine 1997

Laine L, Lewin DN, Naritoku W, Cohen H. Prospective comparison of H&E, Giemsa, and Genta stains for the diagnosis of Helicobacter pylori. Gastrointestinal Endoscopy 1997;45(6):463‐7.

Laine 1999

Laine L, Knigge K, Faigel D, Margaret N, Marquis SP, Vartan G, et al. Fingerstick Helicobacter pylori antibody test: Better than laboratory serological testing?. American Journal of Gastroenterology 1999;94(12):3464‐7.

Lamarque 1996

Lamarque D, Tankovic J, Benamouzig R, Mahe S, Chaumette MT, Auroux J, et al. Quantification of Helicobacter pylori (hp) infection in antrum: Comparison of culture, histological examination and c‐13‐urea breath test. Gastroenterology 1996;110(4 (suppl)):A169.

Langhorst 2002

Langhorst J, Heuer S, Drouven FU, Schwobel HD, Reichenberger S, Neuhaus H. Evaluation of a new immunochromatographic based whole blood near patient test for the diagnosis of Helicobacter pylori infection. Zeitschrift Fur Gastroenterologie 2002;40(6):389‐93.

Larras 2009

Larras R, Moubri M, Berrah H, Mouffok F, Bouhadef A, Bouzid K, et al. Evaluation of a monoclonal stool antigen test for the diagnosis of H. pylori infection in preschool Algerian children. Helicobacter 2009;14(4):347.

Lassnig 1988

Lassnig C, Umlauft F, Schaber E, Stoffler G, Aigner F. The value of indirect immunofluorescence, ELISA and western blots for diagnosis and epidemiology of campylobacter pylori infections. Biological Chemistry Hoppe‐Seyler 1988;369(9):862.

Laszewicz 2014

Laszewicz W, Iwanczak F, Iwanczak B, Task Force of the Polish Society of Gastroenterology. Seroprevalence of Helicobacter pylori infection in Polish children and adults depending on socioeconomic status and living conditions. Advances in Medical Sciences 2014;59(1):147‐50.

Lee 1999

Lee CL, Lee SC, Wu CH, Chen TK. Diagnosis of h. Pylori infection by urea breath test: Comparison of 50 mg vs 100 mg of c‐13 urea. Gut 1999;45(Suppl 3):A131.

Lee 2000a

Lee SC, Sheu BS, Huang JJ, Yang HB, Lin XZ. Diagnostic efficacy of c‐13‐urea breath test for Helicobacter pylori infection in hemodialysis patients. Gut 2000;47(Suppl 1):A120.

Lee 2000b

Lee JM, Breslin NP, Fallon C, O'Morain CA. Rapid urease tests lack sensitivity in Helicobacter pylori diagnosis when peptic ulcer disease presents with bleeding. American Journal of Gastroenterology 2000;95(5):1166‐70.

Lee 2003

Lee YH, Lee SY, Kim YT, Park CK, Jo CM, Tak WY, et al. Diagnosis of Helicobacter pylori infection with urine and stool. Taehan Sohwagi Hakhoe Chi [Korean Journal of Gastroenterology] 2003;42(2):115‐20.

Lee 2013

Lee YC, Chiu HM, Chiang TH, Yen AMF, Chiu SYH, Chen SLS, et al. Accuracy of faecal occult blood test and Helicobacter pylori stool antigen test for detection of upper gastrointestinal lesions. BMJ Open2013; Vol. 3, issue 10:e003989. [DOI: 10.1136/bmjopen‐2013‐003989]

Lee 2014

Lee YC, Tseng PH, Liou JM, Chen MJ, Chen CC, Tu CH, et al. Performance of a one‐step fecal sample‐based test for diagnosis of Helicobacter pylori infection in primary care and mass screening settings. Journal of the Formosan Medical Association 2014;113(12):899‐907.

Lee 2015a

Lee SY, Moon HW, Hur M, Yun YM. Validation of western Helicobacter pylori igg antibody assays in Korean adults. Journal of Medical Microbiology 2015;64(Pt 5):513‐8.

Lee 2015b

Lee JY, Kim N. Diagnosis of Helicobacter pylori by invasive test: histology. Annals of Translational Medicine 2015;3(1):10.

Leja 2009

Leja M, Kupcinskas L, Funka K, Sudraba A, Jonaitis L, Ivanauskas A, et al. The validity of a biomarker method for indirect detection of gastric mucosal atrophy versus standard histopathology. Digestive Diseases & Sciences 2009;54(11):2377‐84.

Lelwala 1990

Lelwala Guruge J, Schalen C, Nilsson I, Ljungh A, Tyskiewicz T, Wikander M, et al. Detection of antibodies to Helicobacter pylori cell surface antigens. Scandinavian Journal of Infectious Diseases 1990;22(4):457‐65.

Lemus 2004

Lemus SMV, Acar MR, Ponce MC, Torres J, Rodriguez OO. Detection of antibodies against Helicobacter pylori and positivity to the 13 carbon urea breath test in patients with rosacea. Dermatologia Revista Mexicana 2004;48(4):189‐96.

Leodolter 1997

Leodolter A, DominguezMunoz JE, Nilius M, VonArnim U, Malfertheiner P. Non‐invasive primary diagnosis of h‐pylori infection: 13C‐urea breath test or serology?. Gastroenterology 1997;112(4 (suppl)):A197.

Leodolter 1998a

Leodolter A, Dominguez‐Muñoz JE, Von Arnim U, Manes G, Malfertheiner P. 13C‐urea breath test for the diagnosis of Helicobacter pylori infection. A further simplification for clinical practice. Scandinavian Journal of Gastroenterology 1998;33(3):267‐70.

Leodolter 1998b

Leodolter A, Dominguez‐Muñoz JE, Gerards C, Von Arnim U, Malfertheiner P. Validity of a modified c‐13‐urea breath test (c‐13‐ubt) for pre‐ and post‐treatment diagnosis of Helicobacter pylori infection in clinical routine. Gut 1998;43(Suppl 2):A52.

Leodolter 1999a

Leodolter A, Dominguez‐Muñoz JE, Von Arnim U, Malfertheiner P. Citric acid or orange juice for the c‐13‐urea breath test: The impact of ph and gastric emptying. Alimentary Pharmacology & Therapeutics 1999;13(8):1057‐62.

Leodolter 1999b

Leodolter A, Dominguez‐Muñoz JE, Von Arnim U, Kahl S, Peitz U, Malfertheiner P. Validity of a modified c‐13‐urea breath test for pre‐ and posttreatment diagnosis of Helicobacter pylori infection in the routine clinical setting. American Journal of Gastroenterology 1999;94(8):2100‐4.

Leodolter 2000

Leodolter A, Von Arnim U, Gerards C, Kahl S, Malfertheiner P. Pre‐ and post‐treatment diagnosis of h‐pylori infection by the c‐13‐urea breath test (13C‐ubt): Validation of a new isotope‐selective infrared spectrometer (isis). Gastroenterology 2000;118(4 Part 1):A506.

Leodolter 2001a

Leodolter A, Vaira D, Bazzoli F, Hirschl A, Megraud F, Malfertheiner P. European multicentre validation trial of two new non‐invasive tests for detection of antibody to H. pylori: urine‐based ELISA and rapid urine test. Gastroenterology 2001;120(5):A491.

Leodolter 2001b

Leodolter A, Ziegler K, Lehn N, Malfertheiner P. The h‐pylori antigen stool test for determination of h‐pylori status in general practice: Is unfrozen delivery of stool specimens sufficient using a regular postal service?. Gut 2001;49(suppl):A97.

Leodolter 2001c

Leodolter A, Agha‐Amiri K, Peitz U, Gerards C, Ebert MP, Malfertheiner P. Validity of a Helicobacter pylori stool antigen assay for the assessment of h‐pylori status following eradication therapy. European Journal of Gastroenterology & Hepatology 2001;13(6):673‐6.

Leodolter 2002

Leodolter A, Peitz U, Ebert MP, Agha‐Amiri K, Malfertheiner P. Comparison of two enzyme immunoassays for the assessment of Helicobacter pylori status in stool specimens after eradication therapy. American Journal of Gastroenterology 2002;97(7):1682‐6.

Leodolter 2003a

Leodolter A, Wolle K, Wex T, Peitz U, Malfertheiner P. Evaluation of a novel rapid H. pylori stool antigen test: Is a reliable diagnosis now possible in the doctor's office?. Gastroenterology 2003;124(4):A58.

Leodolter 2003b

Leodolter A, Vaira D, Bazzoli F, Schutze K, Hirschl A, Megraud F, et al. European multicentre validation trial of two new non‐invasive tests for the detection of Helicobacter pylori antibodies: urine‐based ELISA and rapid urine test. Alimentary Pharmacology & Therapeutics 2003;18(9):927‐31.

Leodolter 2004

Leodolter A, Wolle K, Peitz U, Schaffranke A, Wex T, Malfertheiner P. Evaluation of a near‐patient fecal antigen test for the assessment of Helicobacter pylori status. Diagnostic Microbiology & Infectious Disease 2004;48(2):145‐7.

Leodolter 2005

Leodolter A, Wolle K, Von Arnim U, Kahl S, Treiber G, Ebert MP, et al. Breath and string test: A diagnostic package for the identification of treatment failure and antibiotic resistance of Helicobacter pylori without the necessity of upper gastrointestinal endoscopy. World Journal of Gastroenterology 2005;11(4):584‐6.

Lepper 2004

Lepper PM, Moricke A, Vogt K, Bode G, Trautmann M. Comparison of different criteria for interpretation of immunoglobulin g immunoblotting results for diagnosis of Helicobacter pylori infection. Clinical & Diagnostic Laboratory Immunology 2004;11(3):569‐76.

Lerang 1998a

Lerang F, Moum B, Mowinckel P, Haug JB, Ragnhildstveit E, Berge T, et al. Accuracy of seven different tests for the diagnosis of Helicobacter pylori infection and the impact of H2 receptor antagonists on test results. Scandinavian Journal of Gastroenterology 1998;33(4):364‐9.

Lerang 1998b

Lerang F, Haug JB, Moum B, Mowinckel P, Berge T, Ragnhildstveit E, et al. Accuracy of IgG serology and other tests in confirming Helicobacter pylori eradication. Scandinavian Journal of Gastroenterology 1998;33(7):710‐5.

Leszczynska 2009

Leszczynska K, Namiot DB, Namiot Z, Leszczynska JK, Jakoniuk P, Kemona A. Application of immunoassay for detection of Helicobacter pylori antigens in the dental plaque. Advances in Medical Sciences 2009;54(2):194‐8.

Leung 1998a

Leung WK, Ng EKW, Sung JY. Performance of commercially available serological ELISA test for H. pylori infection: discrepancy between east and west. Gastroenterology 1998;114(4 (suppl)):A201.

Leung 1998b

Leung WK, Chan FKL, Falk MS, Suen R, Sung JJY. Comparison of two rapid whole‐blood tests for Helicobacter pylori infection in Chinese patients. Journal of Clinical Microbiology 1998;36(11):3441‐2.

Leung 1999

Leung WK, Ng EKW, Chan FKL, Chung SCS, Sung JJY. Evaluation of three commercial enzyme‐linked immunosorbent assay kits for diagnosis of Helicobacter pylori in Chinese patients. Diagnostic Microbiology and Infectious Disease 1999;34(1):13‐7.

Leung 2001

Leung WK, Chow TP, Ng EKW, Chan FKL, Chung SCS, Sung JJY. Validation of a new immunoblot assay for the diagnosis of Helicobacter pylori in the asian population. Alimentary Pharmacology and Therapeutics 2001;15(3):423‐8.

Leunk 1990

Leunk RD, Ferguson MA, Morgan DR, Low DE, Simor AE. Antibody to cytotoxin in infection by Helicobacter pylori. Journal of Clinical Microbiology 1990;28(6):1181‐4.

Levine 2004a

Levine A, Shevah O, Shabat‐Sehayek V, Aeed H, Boaz M, Moss SF, et al. Masking of c‐13 urea breath test by proton pump inhibitors is dependent on type of medication: Comparison between omeprazole, pantoprazole, lansoprazole and esomeprazole. Alimentary Pharmacology & Therapeutics 2004;20(1):117‐22.

Levine 2004b

Levine A, Shevah O, Miloh T, Wine F, Niv Y, Bujanover Y, et al. Validation of a novel real time c‐13 urea breath test for rapid evaluation of Helicobacter pylori in children and adolescents. Journal of Pediatrics 2004;145(1):112‐4.

Lew 1999

Lew EA, Pisegna JR, Ohning GV, Faller LD, David S, Walsh JH, et al. Intragastric ph titration affects the accuracy of uc urea breath test in the diagnosis of Helicobacter pylori. Gastroenterology 1999;116(4 (suppl)):A235.

Lewin‐van 1999

Lewin‐van den Broek NT, Numans ME, Buskens E, De Wit NJ, Smout AJPM, Verheij TJM. Validation and value of an enzyme‐linked immunosorbent assay for Helicobacter pylori in primary care. Scandinavian Journal of Gastroenterology 1999;34(4):391‐5.

Lewis 1997

Lewis JD, Kroser J, Bevan J, Furth EE, Metz DC. Urease‐based tests for Helicobacter pylori gastritis ‐ accurate for diagnosis but poor correlation with disease severity. Journal of Clinical Gastroenterology 1997;25(2):415‐20.

Li 1995

Li C, Ha T, Ferguson DA, Zhao RG, Chi DS, Patel NR, et al. Comparison of PCR detection of Helicobacter‐pylori infection using gastric biopsy, saliva and stool specimens with other established techniques (ELISA, culture and histology). Gastroenterology 1995;108(4):A147.

Li 1996

Li C, Ha T, Ferguson DA, Jr, Chi DS, Zhao R, et al. A newly developed PCR assay of h. Pylori in gastric biopsy, saliva, and feces. Evidence of high prevalence of h. Pylori in saliva supports oral transmission. Digestive Diseases & Sciences 1996;41(11):2142‐9.

Li 2004

Li YH, Guo H, Zhang PB, Zhao XY, Da SP. Clinical value of Helicobacter pylori stool antigen test, immunocard stat HPSA, for detecting h pylori infection. World Journal of Gastroenterology 2004;10(6):913‐4.

Liao 2002

Liao CC, Lee CL, Chiang TC, Lee SC, Huang SH, Tu TC, et al. The c‐13‐urea breath test to detect Helicobacter pylori injection: A validated simple methodology with 50 mg c‐13‐urea. Alimentary Pharmacology & Therapeutics 2002;16(4):787‐92.

Liao 2003

Liao CC, Lee CL, Lai YC, Huang SH, Lee SC, Wu CH, et al. Accuracy of three diagnostic tests used alone and in combination for detecting Helicobacter pylori infection in patients with bleeding gastric ulcers. Chinese Medical Journal 2003;116(12):1821‐6.

Lie 2012

Lie MR, Ganesh S, Haringsma J, Francke J, Kuipers EJ. Analytical equivalence study of ndirs versus irms in breath test analysis. Gastroenterology 2012;142(5 (Suppl 1)):S487.

Lim 2005

Lim LG, Yeoh KG, Ho B, Lim SG. Validation of four Helicobacter pylori rapid blood tests in a multi‐ethnic asian population. World Journal of Gastroenterology 2005;11(42):6681‐3.

Lin 1992

Lin SK, Lambert JR, Schembri M, Nicholson L, Finlay M, Wong C, et al. A comparison of diagnostic tests to determine Helicobacter pylori infection. Journal of Gastroenterology & Hepatology 1992;7(2):203‐9.

Lin 2004a

Lin HJ, Lo WC, Perng CL, Li AF, Tseng GY, Sun IC, et al. Helicobacter pylori stool antigen test in patients with bleeding peptic ulcers. Helicobacter 2004;9(6):663‐8.

Lin 2004b

Lin HJ, Sun IC, Lo WC. Helicobacter pylori stool antigen test is not reliable in patients with bleeding peptic ulcers. Gastroenterology 2004;126(4 (Suppl)):A184.

Lin 2004c

Lin FY, Sabri M, Erickson D, Alirezaie J, Li D, Sherman PM. Development of a novel microfluidic immunoassay for the detection of Helicobacter pylori infection. Analyst 2004;129(9):823‐8.

Lin 2015

Lin Z, Cheng SL, Yan Q, Liu XF, Zheng W, Hu XM, et al. Development of an immunochromatographic lateral flow device for rapid detection of Helicobacter pylori stool antigen. Clinical Biochemistry 2015;48(18):1298‐303.

Lindsetmo 2008

Lindsetmo RO, Johnsen R, Eide TJ, Gutteberg T, Husum HH, Revhaug A. Accuracy of Helicobacter pylori serology in two peptic ulcer populations and in healthy controls. World Journal of Gastroenterology 2008;14(32):5039‐45.

Ling 2013

Ling D. Carbon‐13 urea breath test for Helicobacter pylori infection in patients with uninvestigated ulcer‐like dyspepsia: An evidence‐based analysis. Ontario Health Technology Assessment Series 2013;13(19):1‐30.

Liquornik 1998

Liquornik KN, Liacouras CA, Ruchelli ED, Metz DC. The c13‐urea breath test: An excellent noninvasive method for detection of h‐pylori infection in pediatric patients. Gastroenterology 1998;114(4 (suppl)):A205.

Liston 1996

Liston R, Pitt MA, Banerjee AK. IgG ELISA antibodies and detection of Helicobacter pylori in elderly patients. Lancet 1996;347(8996):269.

Liu 2002

Liu W, Xiao S, Wang J, Zhao Z, Qian J, Hu F, et al. Evaluation of Helicobacter pylori stool antigen test for detection of Helicobacter pylori: A multicenter study. Chinese Journal of Gastroenterology 2002;7(3):136‐9.

Llor 2014

Llor C, Bjerrum L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Therapeutic Advances in Drug Safety 2014;5(6):229‐41.

Lo 2005

Lo CC, Lai KH, Peng NJ, Lo GH, Tseng HH, Lin CK, et al. Polymerase chain reaction: A sensitive method for detecting Helicobacter pylori infection in bleeding peptic ulcers. World Journal of Gastroenterology 2005;11(25):3909‐14.

Locatelli 2004

Locatelli A, Catapani WR, Gomes CR, Silva CBP, Waisberg J. Detection of anti‐Helicobacter pylori antibodies in serum and duodenal fluid in peptic gastroduodenal disease. World Journal of Gastroenterology 2004;10(20):2997‐3000.

Loeb 1997

Loeb MB, Riddell RH, James C, Hunt R, Smaill FM. Evaluation of salivary antibodies to detect infection with Helicobacter pylori. Canadian Journal of Gastroenterology 1997;11(5):437‐40.

Loffeld 1989

Loffeld RJ, Stobberingh E, Flendrig JA, Van Spreeuwel JP, Arends JW. Diagnostic value of an immunoassay to detect anti campylobacter pylori antibodies in non‐ulcer dyspepsia. Lancet 1989;1(8648):1182‐5.

Loffeld 1993

Loffeld RJLF, Vriese WTJ, Stobberingh EE. Usefulness of several commercial enzyme‐linked; immunoassays for detection of Helicobacter pylori infection in clinical medicine. European Journal of Gastroenterology & Hepatology 1993;5(5):333‐7.

Logan 1990

Logan RPH, Dill S, Walker MM, Bauer FE, Rathbone BP, Johnson P, et al. Evaluation of European standard c‐13 urea breath test for the detection of Helicobacter‐pylori. Gut 1990;31(10):A1177.

Logan 1991b

Logan RPH, Dill S, Bauer FE, Walker MM, Hirschl AM, Gummett PA, et al. The European c‐13‐urea breath test for the detection of Helicobacter‐pylori. European Journal of Gastroenterology & Hepatology 1991;3(12):915‐21.

Lombardo 1999

Lombardo L, Masoero G, Della Monica P, Taraglio S, Motta M, Ravarino N, et al. Six‐time points c‐13‐urea breath test is a suitable method for Helicobacter pylori diagnosis in postgastrectomy patients. Gut 1999;45(Suppl 3):A131.

Lopez 2001

Lopez Penas D, Naranjo Rodriguez A, Munoz Molinero J, Rodriguez Lopez F, Galvez Calderon C, Chicano Gallardo M, et al. Efficacy of fecal detection of Helicobacter pylori with the HPSA technique in patients with upper digestive hemorrhage. Gastroenterologia y Hepatologia 2001;24(1):5‐8.

Lopez 2004

Lopez T, Quesada M, Almirall J, Sanfeliu I, Segura F, Calvet X. Usefulness of non‐invasive tests for diagnosing Helicobacter pylori infection in patients undergoing dialysis for chronic renal failure. Helicobacter 2004;9(6):674‐80.

Lopez‐Brea 1998

Lopez‐Brea M, Alarcon T, Domingo D, Sanchez I, Martinez MJ, Sanz JC. Evaluation of a western‐blot technique (helicoblot 2.0) for the detection of antibodies versus specific antigens of Helicobacter in children. Enfermedades Infecciosas Y Microbiologia Clinica 1998;16(6):275‐9.

Lotterer 1991

Lotterer E, Ramaker J, Ludtke FE, Tegeler R, Geletneky JV, Bauer FE. The simplified 13C‐urea breath test‐‐one point analysis for detection of Helicobacter pylori infection. Zeitschrift Fur Gastroenterologie 1991;29(11):590‐4.

Lotterer 1993a

Lotterer E, Ludtke FE, Tegeler R, Lepsien G, Bauer FE. The 13C‐urea breath test‐‐detection of Helicobacter pylori infection in patients with partial gastrectomy. Zeitschrift Fur Gastroenterologie 1993;31(2):115‐9.

Lotterer 1993b

Lotterer E, Ludtke FE, Tegeler R, Bauer FE. The c‐13‐urea breath test, Helicobacter‐pylori infection, and the operated stomach. Journal of Clinical Gastroenterology 1993;16(1):82‐3.

Loy 1996

Loy CT, Irwig LM, Katelaris PH, Talley NJ. Do commercial serological kits for Helicobacter pylori infection differ in accuracy? A meta‐analysis. American Journal of Gastroenterology 1996;91(6):1138‐44.

Lozniewski 1996

Lozniewski A, DeKorwin JD, Conroy MC, Plenat F, Weber M. Evaluation of Pyloriset dry, a new rapid agglutination test for Helicobacter pylori antibody detection. Journal of Clinical Microbiology 1996;34(7):1773‐5.

Lu 2005

Lu CY, Kuo CH, Lo YC, Chuang HY, Yang YC, Wu IC, et al. The best method of detecting prior Helicobacter pylori infection. World Journal of Gastroenterology 2005;11(36):5672‐6.

Lu 2006

Lu CY, Kuo FC, Wang SW, Lo YC, Wu IC, Chang LL, et al. The clinical applications and accuracy of 2 rapid near‐patient tests in detecting Helicobacter pylori infection. Diagnostic Microbiology & Infectious Disease 2006;56(3):241‐6.

Lucio 1999

Lucio L, Masoero G, Della Monica P, Taraglio S, Motta M, Ravarino N, et al. Six‐time points c‐13‐urea breath test is a suitable method for Helicobacter pilory diagnosis in post‐gastrectomy patients. Gastroenterology 1999;116(4 (suppl)):A240.

Luzza 1995

Luzza F, Maletta M, Imeneo M, Doldo P, Marasco R, Biancone L, et al. Salivary specific igg is a sensitive indicator of the humoral immune response to Helicobacter pylori. FEMS Immunology & Medical Microbiology 1995;10(3‐4):281‐3.

Luzza 1997

Luzza F, Oderda G, Maletta M, Imeneo M, Mesuraca L, Chioboli E, et al. Salivary immunoglobulin g assay to diagnose Helicobacter pylori infection in children. Journal of Clinical Microbiology 1997;35(12):3358‐60.

Luzza 2000

Luzza F, Imeneo M, Marasco A, Crotta S, Ierardi E, Usai P, et al. Evaluation of a commercial serological kit for detection of salivary immunoglobulin g to Helicobacter pylori: A multicentre study. European Journal of Gastroenterology & Hepatology 2000;12(10):1117‐20.

Ma 2006

Ma YJ, Liu GQ, Zhang HD, Fang QB, Zhao HG. Feasibility of ammonia breath test in diagnosis of Helicobacter pylori infection.. World Chinese Journal of Digestology 2006;14(36):3504‐8.

Maaroos 2004

Maaroos HI, Andreson H, Loivukene K, Hutt P, Kolk H, Kull I, et al. The diagnostic value of endoscopy and Helicobacter pylori tests for peptic ulcer patients in late post‐treatment setting. BMC Gastroenterology 2004;4:27.

Macaskill 2013

Macaskill P, Gatsonis C, Deeks JJ, Harbord RM, Takwoingi Y, editor(s). Chapter 10: Analysing and Presenting Results. In: Deeks JJ, Bossuyt PM, Gatsonis C, editor(s). Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0.0. The Cochrane Collaboration, 2013. Available from srdta.cochrane.org.

Machado 2004

Machado RS, Patricio FRD, Kawakami E. C‐13‐urea breath test to diagnose Helicobacter pylori infection in children aged up to 6 years. Helicobacter 2004;9(1):39‐45.

Machado 2006

Machado RS, Kawakami E, Patricio FRD, Reber M. Urease activity does not reflect the degree of colonization by Helicobacter pylori in children. Pediatrics International 2006;48(4):398‐402.

MacKay 2003

MacKay WG, Williams CL, McMillan M, Ndip RN, Shepherd AJ, Weaver LT. Evaluation of protocol using gene capture and PCR for detection of Helicobacter pylori DNA in feces. Journal of Clinical Microbiology 2003;41(10):4589‐93.

Madico 1995

Madico G, Verastegui M. Serodiagnosis of Helicobacter pylori infection by enzyme‐linked immunoelectrotransfer blot. Gastrointestinal physiology working group of Cayetano Heredia University. Journal of Diarrhoeal Diseases Research 1995;13(2):122‐6.

Mahmood 2010

Mahmood S, Hamid A. Comparison between invasive and noninvasive tests in diagnosis of Helicobacter pylori infection. Pakistan Journal of Biological Sciences 2010;13(10):509‐12.

Mahony 1988

Mahony MJ, Littlewood JM. Diagnosis of campylobacter pylori gastritis by IgG ELISA. Pediatric Research 1988;24(3):416.

Maity 2014

Maity A, Banik GD, Ghosh C, Som S, Chaudhuri S, Daschakraborty SB, et al. Residual gas analyzer mass spectrometry for human breath analysis: A new tool for the non‐invasive diagnosis of Helicobacter pylori infection. Journal of Breath Research 2014;8(1):016005.

Makristathis 1998

Makristathis A, Pasching E, Schutze K, Wimmer M, Rotter ML, Hirschl AM. Detection of Helicobacter pylori in stool specimens by PCR and antigen enzyme immunoassay. Journal of Clinical Microbiology 1998;36(9):2772‐4.

Makristathis 2000

Makristathis A, Barousch W, Pasching E, Binder C, Kuderna C, Apfalter P, et al. Two enzyme immunoassays and PCR for detection of Helicobacter pylori in stool specimens from pediatric patients before and after eradication therapy. Journal of Clinical Microbiology 2000;38(10):3710‐4.

Malaty 1996

Malaty HM, El‐Zimaity HM, Genta RM, Klein PD, Graham DY. Twenty‐minute fasting version of the us 13C‐urea breath test for the diagnosis of h. Pylori infection. Helicobacter 1996;1(3):165‐7.

Malaty 2000

Malaty HM, Logan ND, Graham DY, Ramchatesingh JE, Reddy SG. Helicobacter pylori infection in asymptomatic children: Comparison of diagnostic tests. Helicobacter 2000;5(3):155‐9.

Malaty 2002

Malaty HM, Haveman T, Graham DY, Fraley JK. Helicobacter pylori infection in asymptomatic children: Impact of epidemiologic factors on accuracy of diagnostic tests. Journal of Pediatric Gastroenterology & Nutrition 2002;35(1):59‐63.

Malfertheiner 1988

Malfertheiner P, Henze E, Stanescu A, Glasbrenner B, Schoetensack C, Ditschuneit H. C‐14‐breath‐test to identify campylobacter‐pylori colonization of the mucous‐membrane of the stomach. Zeitschrift fur Gastroenterologie 1988;26(9):528.

Malfertheiner 2002

Malfertheiner P, Axon A, O'Morain C, Pajares‐Garcia JM, Ekstrom P, Schutze K, et al. Evaluation of a new Helicobacter pylori catalase based stool antigen test (femtolab h. Pylori cnx): A European multicenter study. Gastroenterology 2002;122(4 (Suppl)):A205.

Malfertheiner 2005

Malfertheiner P. 13C‐urea breath test: Further modification towards an unrestricted use. Digestion 2005;71(4):206‐7.

Malfertheiner 2012

Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, et al. Management of Helicobacter pylori infection ‐ the Maastricht IV/ Florence Consensus Report. Gut 2012;61(5):646‐64.

Mana 2000a

Mana F, Lacor P, Urbain D. 13C urea breath test for the diagnosis of Helicobacter pylori infection: Contribution of an infrared spectrometer. Tijdschrift voor Geneeskunde 2000;56(17):1240‐6.

Mana 2000b

Mana F, Franken PR, Ham HR, Reynaert H, Urbain D. C‐13 urea breath test with nondispersive isotope‐selective infrared spectrometry: Reproducibility and importance of the fasting status. Helicobacter 2000;5(2):104‐8.

Mana 2001b

Mana F, Ham HR, Reynaert H, Franken P, Urbain D. Urea breath test for the diagnosis of Helicobacter pylori. Gastrointestinal Endoscopy 2001;53(6):700‐1.

Mana 2005

Mana F, Van Laer W, Bossuyt A, Urbain D. The early effect of proton pump inhibitor therapy on the accuracy of the 13C‐urea breath test [erratum appears in Digestive & Liver Disease 2009;41(8):613 note: Van laere, w [corrected to van laer, w]]. Digestive & Liver Disease 2005;37(1):28‐32.

Manes 2000

Manes G, Balzano A, Iaquinto G, Ricci C, Giardullo N, Lioniello M, et al. Accuracy of the h‐pylori stool antigen test in the pre‐ and post‐eradication assessment and in patients on omeprazole treatment. Gut 2000;47(Suppl 1):A113.

Manes 2001

Manes G, Balzano A, Iaquinto G, Ricci C, Piccirillo MM, Giardullo N, et al. Accuracy of the stool antigen test in the diagnosis of Helicobacter pylori infection before treatment and in patients on omeprazole therapy. Alimentary Pharmacology & Therapeutics 2001;15(1):73‐9.

Manes 2005

Manes G, Zanetti MV, Piccirillo MM, Lombardi G, Balzano A, Pieramico O. Accuracy of a new monoclonal stool antigen test in post‐eradication assessment of Helicobacter pylori infection: Comparison with the polyclonal stool antigen test and urea breath test. Digestive & Liver Disease 2005;37(10):751‐5.

Mansour‐Ghanaei 2013

Mansour‐Ghanaei F, Joukar F, Sheykhian MR, Soati F, Rafatzand AM. Effect of gastric acidification on the c‐14‐ubt heliprobe (r) accuracy during pantoprazole treatment in Helicobacter pylori positive patients. International Journal of Clinical and Experimental Medicine 2013;6(3):185‐91.

Marchildon 1996

Marchildon PA, Ciota LM, Zamaniyan FZ, Peacock JS, Graham DY. Evaluation of three commercial enzyme immunoassays compared with the c‐13 urea breath test for detection of Helicobacter pylori infection. Journal of Clinical Microbiology 1996;34(5):1147‐52.

Marchildon 1999

Marchildon P, Balaban DH, Sue M, Charles C, Doobay R, Passaretti N, et al. Usefulness of serological igg antibody determinations for confirming eradication of Helicobacter pylori infection. American Journal of Gastroenterology 1999;94(8):2105‐8.

Marchildon 2003

Marchildon PA, Sugiyama T, Fukuda Y, Peacock JS, Asaka M, Shimoyama T, et al. Evaluation of the effects of strain‐specific antigen variation on the accuracy of serologic diagnosis of Helicobacter pylori infection [erratum appears in Journal of Clinical Microbiology 2003;41(7):3462 note: Fukada, y [corrected to fukuda, y]]. Journal of Clinical Microbiology 2003;41(4):1480‐5.

Marshall 1988a

Marshall BJ, Surveyor I. Carbon‐14 urea breath test for the diagnosis of campylobacter pylori associated gastritis. Journal of Nuclear Medicine 1988;29(1):11‐6.

Marshall 1988b

Marshall BJ, Guerrant RL, Plankey MW, Dye KR, Barrett L, Frierson HF, et al. Comparison of c‐14‐urea breath test, microbiology and histology for the diagnosis of campylobacter pylori. Gastroenterology 1988;94(5):A284.

Marshall 1988c

Marshall BJ, Plankey MW, Dye KR, Frierson H, Hoffman SR, Barrett L, et al. A rapid c‐14 urea breath test for the diagnosis of c‐pylori associated gastritis. Clinical Research 1988;36(1):A14.

Marshall 1991

Marshall BJ, Plankey MW, Hoffman SR, Boyd CL, Dye KR, Frierson HF, et al. A 20‐minute breath test for Helicobacter pylori. American Journal of Gastroenterology 1991;86(4):438‐45.

Marshall 1999

Marshall JK, O'Brien BJ, Armstrong D. C‐13‐urea breath test or h‐pylori serology for the initial evaluation of young patients with ulcer‐like dyspepsia: A decision analysis. Gastroenterology 1999;116(4 (suppl)):A78.

Marusic 2006

Marusic M, Presecki V, Katicic M, Dominis M, Kalenic S. The place and role of serologic methods in detecting Helicobacter pylori infection. Collegium Antropologicum 2006;30(3):529‐33.

Masoero 2000

Masoero G, Lombardo L, Della Monica P, Vicari S, Crocilla C, Duglio A, et al. Discrepancy between Helicobacter pylori stool antigen assay and urea breath test in the detection of Helicobacter pylori infection. Digestive & Liver Disease 2000;32(4):285‐90.

Massarrat 2012

Massarrat S, Sheykholeslami A. Serum pepsinogen ii as a good marker for mass screening and eradication of h. Pylori infection in populations at risk for gastric cancer. Archives of Iranian Medicine 2012;15(4):265‐6.

Matougui 2007

Matougui N, Boudjella MA, Oumnia N, Lahcene M, Tebaibia A, Mouffok F, et al. Evaluation of pronto‐dry test versus c‐13 urea breath test in determining Helicobacter pylori status after treatment. Helicobacter 2007;12(4):445.

Matsuda 2003a

Matsuda M, Noda Y, Takemori Y. Utility and limitations of a method for detecting Helicobacter pylori‐specific antigens in the stool. Journal of Gastroenterology 2003;38(3):222‐8.

Matsuda 2003b

Matsuda M, Noda Y, Takemori Y. Novel diagnostic method of testing for Helicobacter pylori infection using the rapid leukocyte strip test, leukostix. Journal of Gastroenterology and Hepatology 2003;18(10):1196‐201.

Matsukura 1995

Matsukura N, Onda M, Tokunaga A, Kato S, Yamashita K, Ohbayashi M. Detection of Helicobacter pylori DNA in gastric juice by the polymerase chain reaction: Comparison with findings in bacterial culture and the detection of tissue iga and serum igg antibodies against Helicobacter pylori. Journal of Gastroenterology 1995;30(6):689‐95.

Matsukura 2004

Matsukura N, Tajiri T, Kato S, Togashi A, Masuda G, Tokunaga A, et al. Diagnostic value of culture, histology and PCR for Helicobacter pylori in the remnant stomach after surgery. Alimentary Pharmacology & Therapeutics 2004;20 Suppl 1:33‐8.

Matsuo 2000

Matsuo K, Hamajima N, Tominaga S, Suzuki T, Nakamura T, Matsuura A, et al. Helicobacter pylori igg antibody test established in the United States showed a substantially lower sensitivity for Japanese population. American Journal of Gastroenterology 2000;95(6):1597‐8.

Mattar 1999

Mattar R, Silva FM, Alexandrino AM, Laudanna AA. Validation of 14c‐urea breath test for diagnosis of Helicobacter pylori. Revista do Instituto de Medicina Tropical de Sao Paulo 1999;41(1):3‐8.

Mattar 2014

Mattar R, Villares CA, Marostegam PF, Chaves CE, Pinto VB, Carrilho FJ. Low dose capsule based 13C‐urea breath test compared with the conventional 13C‐urea breath test and invasive tests. Arquivos de Gastroenterologia 2014;51(2):133‐8.

Matthews 2000

Matthews GM, Butler RN, Cummins AG, Lawrence A, Johnson B, Campbell F. The c‐13‐urea breath test reflects the severity of Helicobacter pylori associated antral inflammation. Gastroenterology 2000;118(4 (Part 2)):A1272.

Matthews 2005

Matthews GM, Cummins AG, Lawrence A, Johnson B, Campbell F, Butler RN. 13C‐urea breath test: Reproducibility and association with the severity of Helicobacter pylori‐associated antral gastritis. Journal of Gastroenterology and Hepatology 2005;20(2):270‐4.

Mauro 2006a

Mauro M, Radovic V, Zhou P, Wolfe M, Kamath M, Bercik P, et al. 13C urea breath test for Helicobacter pylori: determination of the optimal cut‐off point in a Canadian community population. Canadian Journal of Gastroenterology 2006;20(12):770‐4.

Mauro 2006b

Mauro M, Radovic V, Wolfe M, Kamath M, Bercik P, Armstrong D. C‐13 urea breath test for Helicobacter pylori: Evaluation of 10‐minute breath collection. Canadian Journal of Gastroenterology 2006;20(12):775‐8.

McColl 1997

McColl KE, El‐Nujumi A, Murray L, El‐Omar E, Gillen D, Dickson A, et al. The Helicobacter pylori breath test: A surrogate marker for peptic ulcer disease in dyspeptic patients. Gut 1997;40(3):302‐6.

McColl 2003

McColl KE, Murray LS, Gillen D, Delaney B. Noninvasive Helicobacter pylori testing was as effective as endoscopy for managing dyspepsia. Evidence‐Based Medicine 2003;8(1):20‐1.

McNamara 1999

McNamara D, Whelan H, Hamilton H, Beattie S, O'Morain C. Hpsa: Assessment of a new non‐invasive diagnostic assay for Helicobacter pylori infection in an Irish population. Irish Journal of Medical Science 1999;168(2):111‐3.

McNulty 1999

McNulty CA, Nair P, Watson BE, Uff JS, Valori RM. A comparison of six commercial kits for Helicobacter pylori detection. Communicable Disease & Public Health 1999;2(1):59‐63.

McNulty 2005

McNulty C, Teare L, Owen R, Tompkins D, Hawtin P, McColl K. Test and treat for dyspepsia ‐ but which test?. BMJ 2005;330(7483):105‐6.

Mediero 2007

Mediero GG, Ramos JM, Garcia JI, Varela IO, Del Blanco T, Conde JAS. Evaluation of Helicobacter pylori stool antigen test for the detection of h‐pylori infection in paediatric patients. International Journal of Antimicrobial Agents 2007;29:S641.

Megraud 1988

Megraud F. Comparison of different tests for campylobacter pylori. Scandinavian Journal of Gastroenterology ‐ Supplement 1988;142:64‐8.

Megraud 2000

Megraud F, Burette A, Glupczynski Y, Fiocca R, Logan R, Quina M, et al. Comparison of tests for assessment of Helicobacter pylori eradication: Results of a multi‐centre study using centralized facility testing. European Journal of Gastroenterology & Hepatology 2000;12(6):629‐33.

Megraud 2005

Megraud F, European PTFonHp. Comparison of non‐invasive tests to detect Helicobacter pylori infection in children and adolescents: Results of a multicenter European study. Journal of Pediatrics 2005;146(2):198‐203.

Mehrazma 2014

Mehrazma M, Nakhaii S, Talachian E, Harahdashti AL. Diagnostic accuracy of Helicobacter pylori stool antigen test in iranian children. Infectious Diseases in Clinical Practice 2014;22(3):154‐6.

Meijer 1997

Meijer BC, Thijs JC, Kleibeuker JH, Van Zwet AA, Berrelkamp RJP. Evaluation of eight enzyme immunoassays for detection of immunoglobulin g against Helicobacter pylori. Journal of Clinical Microbiology 1997;35(1):292‐4.

Meltzer 2013

Meltzer AC, Pierce R, Cummings DAT, Pines JM, May L, Smith MA, et al. Rapid 13C urea breath test to identify Helicobacter pylori infection in emergency department patients with upper abdominal pain. Western Journal of Emergency Medicine 2013;14(3):278‐82.

Mendall 1992

Mendall MA, Goggin PM, Marrero JM, Molineaux N, Levy J, Badve S, et al. Role of Helicobacter pylori serology in screening prior to endoscopy. European Journal of Gastroenterology & Hepatology 1992;4(9):713‐7.

Mendoza 2006

Mendoza RB, Sio‐Aguilar JO. The validity of Helicobacter pylori immunochromatographic stool antigen test and campylobacter urease test in the diagnosis of Helicobacter pylori infection among pediatric patients. Journal of Gastroenterology and Hepatology 2006;21:A392.

Menegatti 1997a

Menegatti M, Vaira D, Stanghellini V, Ali A, Landi F, Ricci C, et al. Comparison of c‐13‐ vs c‐14‐urea breath test (ubt) for Helicobacter pylori (hp). Gastroenterology 1997;112(4 (suppl)):A218.

Menegatti 1997b

Menegatti M, Stanghellini V, Landi F, Farinelli S, Mucci F, Ali A, et al. C‐13 with and without test meal vs c‐14 urea breath test (ubt) to detect h‐pylori before and after treatment. Gut 1997;41(Suppl):A162‐A3.

Metz 1998

Metz DC, Furth EE, Faigel DO, Kroser JA, Alavi A, Barrett DM, et al. Realities of diagnosing Helicobacter pylori infection in clinical practice: A case for non‐invasive indirect methodologies. Yale Journal of Biology & Medicine 1998;71(2):81‐90.

Metz 2000

Metz DC. Stool testing for Helicobacter pylori infection: Yet another noninvasive alternative. American Journal of Gastroenterology 2000;95(2):546‐8.

Midolo 1995

Midolo PD, Lambert JR, Russell EG, Lin SK. A practical single sample dry latex agglutination test for Helicobacter pylori antibody detection. Journal of Clinical Pathology 1995;48(10):969‐71.

Miehlke 1996

Miehlke S, Figura N, Kim JG, Small SM, Graham DY, Do MF. Western blotting for detection of Helicobacter pylori anti‐caga antibodies strongly correlates with presence of the caga gene. Gastroenterology 1996;110(4 (suppl)):A197.

Miftahussurur 2016

Miftahussurur M, Yamaoka Y. Diagnostic methods of Helicobacter pylori infection for epidemiological studies: Critical importance of indirect test validation. BioMed Research International2016; Vol. 2016:4819423. [DOI: 10.1155/2016/4819423]

Minoli 1998

Minoli G, Prada A, Schuman R, Murnick D, Rigas B. A simplified urea breath test for the diagnosis of Helicobacter pylori infection using the lara system. Journal of Clinical Gastroenterology 1998;26(4):264‐6.

Mion 1996

Mion F, Rousseau M. Diagnostic tests to document Helicobacter pylori eradication. Gastroenterology 1996;110(1 (suppl)):324‐5.

Mion 1997a

Mion F, Rosner G, Rousseau M, Minaire Y. 13C‐urea breath test for Helicobacter pylori: Cut‐off point determination by cluster analysis. Clinical Science 1997;93(1):3‐6.

Mion 1997b

Mion F, Rosner G, Rousseau M, Brazier JL. C‐13‐urea breath test for Helicobacter pylori: Optimal cutoff point determination by roc curve and cluster analysis. Clinical Chemistry 1997;43(6 (Suppl 2)):17.

Mion 2001

Mion F, Ecochard R, Guitton J, Ponchon T. (co2)‐c‐13 breath tests: Comparison of isotope ratio mass spectrometry and non‐dispersive infrared spectrometry results. Gastroenterologie Clinique Et Biologique 2001;25(4):375‐9.

Mirbagheri 2005

Mirbagheri SA, Sohrabpour AA, Hasibi M, Moghimi B, Mohamadnejad M. 14c‐urea breath test in patients undergoing anti‐tuberculosis therapy. World Journal of Gastroenterology 2005;11(11):1712‐4.

Mitchell 1988

Mitchell HM, Lee A, Berkowicz J, Borody T. The use of serology to diagnose active campylobacter pylori infection. Medical Journal of Australia 1988;149(11‐12):604‐9.

Miwa 1997

Miwa H, Murai T, Ohkura R, Kawabe M, Tanaka H, Ogihara T, et al. Effect of fasting subjects' posture on c‐13‐urea breath test for detection of Helicobacter pylori infection. Helicobacter 1997;2(2):82‐5.

Miwa 1998a

Miwa H, Ohkura R, Nagahara A, Murai T, Ogihara T, Watanabe S, et al. C‐13 ‐urea breath test for assessment of cure of Helicobacter pylori infection at 1 month after treatment. Journal of Clinical Gastroenterology 1998;27:S150‐S3.

Miwa 1998b

Miwa H, Murai T, Ohkura R, Nagahara A, Watanabe H, Terai T, et al. Usefulness of the c‐13 ‐urea breath test for detection of Helicobacter pylori infection in fasting patients. Journal of Gastroenterology and Hepatology 1998;13(10):1039‐43.

Miwa 1999

Miwa H, Hirose M, Kikuchi S, Terai T, Iwazaki R, Kobayashi O, et al. How useful is the detection kit for antibody to Helicobacter pylori in urine (urinelisa) in clinical practice?. American Journal of Gastroenterology 1999;94(12):3460‐3.

Miwa 2000

Miwa H, Kikuchi S, Ohtaka K, Kobayashi O, Ogihara A, Hojo M, et al. Insufficient diagnostic accuracy of imported serological kits for Helicobacter pylori infection in Japanese population. Diagnostic Microbiology & Infectious Disease 2000;36(2):95‐9.

Miwa 2001

Miwa H, Akamatsu S, Tachikawa T, Sogabe T, Ohtaka K, Nagahara A, et al. On‐site diagnosis of h‐pylori infection by urine. Diagnostic Microbiology and Infectious Disease 2001;39(2):95‐7.

Mizukami 1994

Mizukami T, Osawa T, Niwa M, Oya A, Masubuchi N, Takahashi S. An enzyme‐linked immunosorbent assay for the detection of igg antibodies against urease of Helicobacter pylori. Rinsho Byori [Japanese Journal of Clinical Pathology] 1994;42(11):1188‐93.

Moayyedi 1997

Moayyedi P, Braunholtz D, Heminbrough E, Clough M, Tompkins DS, Mapstone NP, et al. Do patients need to fast for a c‐13‐urea breath test?. European Journal of Gastroenterology & Hepatology 1997;9(3):275‐7.

Mock 1999

Mock T, Yatscoff R, Foster R, Hyun JH, Chung IS, Shim CS, et al. Clinical validation of the helikit™: A c‐13 urea breath test used for the diagnosis of Helicobacter pylori infection. Clinical Biochemistry 1999;32(1):59‐63.

Mohammadi 2008

Mohammadi M, Talebkhan Y, Khalili G, Mahboudi F, Massarrat S, Zamaninia L, et al. Advantage of using a home‐made ELISA kit for detection of Helicobacter pylori infection over commercially imported kits. Indian Journal of Medical Microbiology 2008;26(2):127‐31.

Moncayo 2006

Moncayo JI, Santacruz JJ, Alvarez AL, Franco B, Lopez MA, Angel A, et al. Comparison of methods in the diagnosis of Helicobacter pylori infection in Quindio, Colombia. Colombia Medica 2006;37(3):203‐12.

Monteiro 2001b

Monteiro L, Gras N, Megraud F. Magnetic immuno‐PCR assay with inhibitor removal for direct detection of Helicobacter pylori in human feces. Journal of Clinical Microbiology 2001;39(10):3778‐80.

Morales 2002

Morales A, Hurtado C, Madrid AM, Pimentel C, Espinosa MN. An ELISA stool test to detect Helicobacter pylori infection. Revista Medica de Chile 2002;130(1):61‐5.

Moshkowitz 1993

Moshkowitz M, Peled Y, Baratz M, Halpern Z, Tiomny E, Gilat T. 14c‐urea breath test‐‐a simple, noninvasive method for the detection of Helicobacter pylori infection. Israel Journal of Medical Sciences 1993;29(2‐3):94‐7.

Motta 2009

Motta O, De Caro F, Quarto F, Proto A. New FTIR methodology for the evaluation of (13)C/(12)C isotope ratio in Helicobacter pylori infection diagnosis. Journal of Infection 2009;59(2):90‐4.

Moulton‐Barrett 1993

Moulton‐Barrett R, Triadafilopoulos G, Michener R, Gologorsky D. Serum 13C‐bicarbonate in the assessment of gastric Helicobacter pylori urease activity. American Journal of Gastroenterology 1993;88(3):369‐74.

Mowat 1997

Mowat C, Murray L, Hilditch TE, Kelman A, Oien K, McColl KEI. Comparison of helisal test kit and c‐14‐urea breath test in determining h‐pylori status and predicting ulcer disease in dyspeptic patients. Gastroenterology 1997;112(4 (suppl)):A226.

Mowat 1998

Mowat C, Murray L, Hilditch TE, Kelman A, Oien K, McColl KE. Comparison of helisal rapid blood test and 14c‐urea breath test in determining Helicobacter pylori status and predicting ulcer disease in dyspeptic patients. American Journal of Gastroenterology 1998;93(1):20‐5.

Mrevlje 2012

Mrevlje Z, Plut S, Jeverica S, Osredkar J, Stabuc B. Comparison of success rates of noninvasive and invasive methods in diagnosis of Helicobacter pylori infection. Helicobacter 2012;17:94.

Muhsen 2006

Muhsen K, Athamna A, Athamna M, Spungin‐Bialik A, Cohen D. Evaluation of a urine‐based enzyme‐linked immunosorbent assay test for the detection of Helicobacter pylori infection among 3‐ to 5‐year‐old Israeli Arab healthy children. Journal of Pediatric Gastroenterology & Nutrition 2006;43(3):398‐401.

Muhsen 2012

Muhsen K, Jurban M, Goren S, Cohen D. Incidence, age of acquisition and risk factors of Helicobacter pylori infection among Israeli Arab infants. Journal of Tropical Pediatrics 2012;58(3):208‐13.

Munster 1993

Munster DJ, Chapman BA, Burt MJ, Dobbs BR, Allardyce RA, Bagshaw PF, et al. The fate of ingested 14c‐urea in the urea breath test for Helicobacter pylori infection. Scandinavian Journal of Gastroenterology 1993;28(8):661‐6.

Murakami 2003

Murakami K, Sato R, Okimoto T, Watanabe K, Nasu M, Fujioka T, et al. Influence of anti‐ulcer drugs used in Japan on the result of c‐13‐urea breath test for the diagnosis of Helicobacter pylori infection. Journal of Gastroenterology 2003;38(10):937‐41.

Murakami 2011

Murakami K, Kamada T, Ishikawa H, Imamura H, Matsumoto H, Fujita M, et al. An evaluation of the performance of a novel stick‐type kit for rapid detection of Helicobacter pylori antibodies in urine. Clinical Laboratory 2011;57(7‐8):481‐7.

Murata 2002

Murata Y, Kojyo A, Ikeda A, Yamanaka K. Study on the detection methods of Helicobacter pylori from clinical specimens. Rinsho Biseibutsu Jinsoku Shindan Kenkyukai Shi [JARMAM : Journal of the Association for Rapid Method and Automation in Microbiology] 2002;12(2):105‐19.

Murphy 2015

Murphy C, Yamaguchi D, Rainey PM. Helicobacter pylori c‐13‐urea breath test: The unique challenges of validating a clia‐waived test. American Journal of Clinical Pathology 2015;143:A11.

Murugesan 2011

Murugesan SV, Steele I, Tiszlavicz L, Farragher T, Moore AR, Varro A, et al. Factors that determine the sensitivity of rapid urease tests for the detection of Helicobacter pylori infection. Gastroenterology 2011;140(5 (suppl)):S879.

Muñoz 1998

Muñoz E, Corcuera M, Roldán M, Gómez F, Picazo A, Baquero M, et al. Comparative study of microbiological and histopathological techniques used for the detection of Helicobacter pylori. European Journal of Histochemistry 1998;42(4):297‐302.

Muñoz 1999

Muñoz C, Jane M, Gonzalez‐Cuevas A, Juncosa T, Gene A, Varea V, et al. Evaluation of a simple, rapid polymerase chain reaction (PCR) technique for the diagnosis of Helicobacter pylori infection in infancy. Enfermedades Infecciosas Y Microbiologia Clinica 1999;17(3):119‐25.

Myllyniemi 2007

Myllyniemi M, Linnala A, Paloheimo LI, Hendolin P, Engstrand L, Perez GP, et al. Improved specificity of Helicobacter pylori IgA/IgG ELISA over other H. pylori tests. Helicobacter 2007;12(4):447.

Myllyniemi 2008

Myllyniemi M, Hendolin P, Telaranta‐Keerie A, Nikulin M, Paloheimo LI, Engstrand L, et al. New specific H. pylori IgG ELISA test. Helicobacter 2008;13(5):472‐3.

Nagahara 2003

Nagahara Y, Mizuno M, Maga T, Ishiki K, Okuno T, Yoshida T, et al. Outcome of patients with inconsistent results from c‐13‐urea breath test and bacterial culture at the time of assessment of heliclobacter pylori eradication therapy in Japan. Hepato‐Gastroenterology 2003;50(53):1700‐3.

Nair 1995

Nair P, Stephens JC, Mackay EH, West K, Mayberry JF, Wicks ACB, et al. A simple 3‐minute latex agglutination‐test for rapid Helicobacter‐pylori serodiagnosis. Gastroenterology 1995;108(4):A174.

Nakagawa 1995

Nakagawa T, Ohara H, Yamamoto M, Yoneshima M, Suzuki T, Murai S, et al. 13C‐urea breath test for the detection of Helicobacter pylori infection and the assessment of therapeutic effect. Nippon Shokakibyo Gakkai Zasshi [Japanese Journal of Gastroenterology] 1995;92(3):264.

Nakata 1995

Nakata H, Itoh H, Yokoya Y, Kawai J, Nishioka S, Miyamoto K, et al. Serum antibody against Helicobacter pylori assayed by a new capture ELISA. Journal of Gastroenterology 1995;30(3):295‐300.

Nakata 2004

Nakata H, Itoh H, Ishiguchi T, Iwata T, Sato H, Higashimoto Y, et al. Immunological rapid urease test using monoclonal antibody for Helicobacter pylori. Journal of Gastroenterology and Hepatology 2004;19(9):970‐4.

Nakayama 2004

Nakayama K, Konno M, Tajiri H, Matsuhisa T, Kato S, Minoura T, et al. Comparison between the 13C‐urea breath test and stool antigen test for the diagnosis of childhood Helicobacter pylori infection. Journal of Gastroenterology 2004;39(11):1045‐50.

Naruki 1996

Naruki Y, Koyama H, Kurita T, Nishino M, Higashi Y, Otsuka S, et al. Evaluation of c‐13 urea breath test in a diagnosis of Helicobacter pylori. Journal of Nuclear Medicine 1996;37(5 (suppl)):246 (abstract 1103).

Navarro 1992

Navarro F, Coll P, Sainz S, Mirelis B, Cardenosa N, Alonso C, et al. Evaluation of two different commercial kits for Helicobacter pylori specific antibodies detection in patients undergoing gastrointestinal endoscopic procedures. A seroprevalence study in asymptomatic population. Enfermedades Infecciosas Y Microbiologia Clinica 1992;10(4):190‐4.

NCBI 2014

NCBI. MeSH. NLM Controlled Vocabulary. Helicobacter pylori. www.ncbi.nlm.nih.gov/mesh/68016480 (accessed 3 August 2014).

Negayama 1992

Negayama K, Terada S, Kawanishi K. Clinical significance of anti‐Helicobacter pylori antibody in the diagnosis of Helicobacter pylori infection in chronic gastritis. Kansenshogaku Zasshi [Journal of the Japanese Association for Infectious Diseases] 1992;66(11):1597‐8.

Negrini 1992

Negrini R, Zanella I, Savio A, Poiesi C, Verardi R, Ghielmi S, et al. Serodiagnosis of Helicobacter pylori‐associated gastritis with a monoclonal antibody competitive enzyme‐linked immunosorbent assay. Scandinavian Journal of Gastroenterology 1992;27(7):599‐605.

Neri 1999

Neri M, Angelucci D, Laterza F, Ricciuti M, Del Duca L, Di Matteo S, et al. False negativity of c‐13 urea breath test in the presence of coccoid forms of h.Pylori: Effects on the sensitivity of the test. Gastroenterology 1999;116(4 (suppl)):A265.

Neumann 2010

Neumann H, Foertsch S, Vieth M, Mudter J, Kuth R, Neurath MF. Immediate detection of Helicobacter infection with a novel electrochemical system: Feasibility and comparison of diagnostic yield with immunohistochemistry, 13C urea breath test and Helicobacter urease test. Gastroenterology 2010;138(5 (suppl 1)):S114.

Neumann 2011

Neumann H, Foertsch S, Vieth M, Kuth R, Roll S, Neurath MF. A newly developed electrochemical device enables accurate and immediate detection of h. Pylori infection within 10 seconds. Gastroenterology 2011;140(5 (suppl)):S58.

Neumann 2012

Neumann H, Foertsch S, Ritter B, Vieth M, Kuth R, Neurath MF. Final data of a new electrochemical device that enables rapid and accurate detection of Helicobacter pylori infection. Gastroenterology 2012;142(5 (Suppl 1)):S484.

Newell 1988

Newell DG, Johnston BJ, Ali MH, Reed PI. An enzyme‐linked immunosorbent assay for the serodiagnosis of campylobacter pylori‐associated gastritis. Scandinavian Journal of Gastroenterology ‐ Supplement 1988;142:53‐7.

Newell 1989a

Newell DG, Rathbone BJ. The serodiagnosis of campylobacter pylori infection. Serodiagnosis and Immunotherapy in Infectious Disease 1989;3(1):1‐6.

Newell 1989b

Newell DG, Stacey A. Antigens for the serodiagnosis of campylobacter pylori infections. Gastroenterologie Clinique et Biologique 1989;13(1 Pt 1):37B‐41B.

Newell 1991

Newell DG, Hawtin PR, Stacey AR, MacDougall MH, Ruddle AC. Estimation of prevalence of Helicobacter pylori infection in an asymptomatic elderly population comparing [14c] urea breath test and serology. Journal of Clinical Pathology 1991;44(5):385‐7.

Ng 2002

Ng FH, Lai KC, Wong BC, Wong WM, Wong SY, Chow KC, et al. [13C]‐urea breath test without prior fasting and without test meal is accurate for the detection of Helicobacter pylori infection in Chinese. Journal of Gastroenterology and Hepatology 2002;17(8):834‐8.

Ng 2013

Ng TH, Rosaida R. Evaluation of serology and urea breath test as reliable diagnostic test for h.Pylori infection. Journal of Gastroenterology and Hepatology 2013;28:97.

Nguyen 2008a

Nguyen TV, Bengtsson C, Nguyen GK, Granstrom M. Evaluation of a novel monoclonal‐based antigen‐in‐stool enzyme immunoassay (premier platinum HPSA plus) for diagnosis of Helicobacter pylori infection in Vietnamese children. Helicobacter 2008;13(4):269‐73.

Nguyen 2008b

Nguyen TVH, Bengtsson C, Nguyen GK, Granstrom M. Evaluation of a novel monoclonal‐based antigen‐in‐stool enzyme immunoassay (premier platinum HPSA plus) for diagnosis of Helicobacter pylori infection in Vietnamese children. Helicobacter 2008;13(4):269‐73.

Nguyen 2010

Nguyen LT, Uchida T, Tsukamoto Y, Trinh TD, Ta L, Ho DQD, et al. Evaluation of rapid urine test for the detection of Helicobacter pylori infection in the Vietnamese population. Digestive Diseases and Sciences 2010;55(1):89‐93.

Nguyen 2012

Nguyen VB, Nguyen GK, Ha Nguyen TV, Ha Hoang TT, Anh Le TL, Xuan Nguyen TA, et al. Helicobacter pylori (hp) infection in Vietnam: Epidemiology, symptomatology, diagnosis and treatment in children. Journal of Gastroenterology and Hepatology 2012;27:46.

Nguyen 2013

Nguyen B, Anhthi Nguyen V, Nguyen K, Anhthi Le L, Hathi Nguyen V, Hathi Hoang T, et al. Helicobacter pylori (hp) infection in Vietnam: Epidemiology, symptomatology, diagnosis and treatment in children. Journal of Gastroenterology and Hepatology 2013;28:550‐1.

Ni 2000

Ni YH, Lin JT, Huang SF, Yang JC, Chang MH. Accurate diagnosis of Helicobacter pylori infection by stool antigen test and six other currently available tests in children. Gastroenterology 2000;118(4):A1283.

Nightingale 1996

Nightingale SL. Breath test for Helicobacter pylori collection kit approved. Journal of the American Medical Association 1996;276(21):1710.

Nijevitch 2001

Nijevitch AA, Sataev VU. The reliability of urease tests for Helicobacter pylori in childhood. Journal of Clinical Gastroenterology 2001;32(3):277‐9.

Nilius 2001

Nilius M, Wex T, Muller‐Dietz G, Leodolter A, Schilling D, Malfertheiner P. Comparative evaluation of two hemagglutination tests for the detection of anti‐Helicobacter pylori antibodies. Diagnostic Microbiology & Infectious Disease 2001;41(4):221‐3.

Nishi 1998

Nishi I, Irie H, Watanabe N, Futami J, Suzuki H, Ichinose Y, et al. Urea breath test "breath by breath measurement" of (v)over‐dot(13)co(2) and (v)over‐dot(12)co(2): An approach to the quantitative evaluation for the therapeutic elimination of h‐pylori. Gastroenterology 1998;114(4 (suppl)):A243.

Nishikawa 1996

Nishikawa K, Katagiri M, Kagaya H, Kudo M, Kato M, Takeda H, et al. Evaluation of rapid urease tests for Helicobacter pylori in biopsy specimens, compared with culture and c‐13‐urea breath test. Gastroenterology 1996;110(4 (suppl)):A212.

Nishikawa 1999

Nishikawa K, Kato M, Sugiyama T, Asaka M. Helicobacter pylori, serum igg antibody, urea breath test. Nippon Rinsho 1999;57(Suppl):154‐6.

Nishikawa 2000

Nishikawa K, Sugiyama T, Kato M, Ishizuka J, Kagaya H, Hokari K, et al. A prospective evaluation of new rapid urease tests before and after eradication treatment of Helicobacter pylori, in comparison with histology, culture and c‐13‐urea breath test. Gastrointestinal Endoscopy 2000;51(2):164‐8.

Nishizono 1998

Nishizono A, Gotoh T, Fujioka T, Murakami K, Kubota T, Nasu M, et al. Serological assessment of the early response to eradication therapy using an immunodominant outer membrane protein of Helicobacter pylori. Clinical & Diagnostic Laboratory Immunology 1998;5(6):856‐61.

Niv 1998

Niv Y, Sperber AD, Scapa E, Maoz E, Fraser G, Druzd T, et al. A comparison of new rapid urease tests for detection of Helicobacter pylori: Test characteristics and factors affecting positivity and time to positivity. Journal of Clinical Gastroenterology 1998;27(4):327‐30.

Niv 2000

Niv Y, Abuksis G, Ben‐Gur S, Koren K. 13C‐urea breath test (13C‐ubt) for validation of successful Helicobacter pylori eradication. Evaluation of 1371 patients. Gastroenterology 2000;118(4 (part 2)):A1284.

Niv 2003

Niv Y, Abuksis G, Koren R. 13C urea breath test (13C ubt) for Helicobacter pylori (hp) diagnosis in geriatrics. Gastroenterology 2003;124(4 (suppl)):A625.

Noguchi 2007

Noguchi N, Rimbara E, Kato A, Tanaka A, Tokunaga K, Kawai T, et al. Detection of mixed clarithromycin‐resistant and ‐susceptible Helicobacter pylori using nested PCR and direct sequencing of DNA extracted from faeces. Journal of Medical Microbiology 2007;56(9):1174‐80.

Notarnicola 1996

Notarnicola M, Russo F, Cavallini A, Bianco M, Jirillo E, Pece S, et al. PCR identification of Helicobacter pylori DNA in faeces from patients with gastroduodenal pathology. Medical Science Research 1996;24(11):785‐7.

Nugalieva 2006

Nugalieva ZZ, Opekun AR, Graham DY. Problem of distinguishing false‐positive tests from acute or transient Helicobacter pylori infections. Helicobacter 2006;11(2):69‐74.

Nurgalieva 2003

Nurgalieva Z, Goodman KJ, Wang C, Day RS, Campos A, de la Rosa J. Detection of Helicobacter pylori infection in children followed from birth: Correspondence of serology and the urea breath test. American Journal of Epidemiology 2003;157(11):S85‐S.

Nurgalieva 2008

Nurgalieva Z, Goodman KJ, Phillips CV, Fischbach L, de la Rosa JM, Gold BD. Correspondence between Helicobacter pylori antibodies and urea breath test results in a US‐Mexico birth cohort. Paediatric and Perinatal Epidemiology 2008;22(3):302‐12.

Nysaeter 1992

Nysaeter G, Berstad K, Weberg R, Berstad A, Hardardottir H. Diagnosis of Helicobacter pylori infection. Rapid urease test, microscopy of smears and culture from ventricular biopsy compared with the 14c‐urea breath test. Tidsskrift for Den Norske Laegeforening 1992;112(18):2356‐8.

O'Connor 2010

O'Connor A, O'Morain NR, Dobson M, Qasim A, Ryan BM, Breslin N, et al. Helicobacter pylori eradication treatment is more successful when diagnosis is made after urea breath test than after rapid urease testing at endoscopy in patients with dyspepsia. Gastroenterology 2010;138(5 (suppl 1)):S340.

Oak 2011

Oak JH, Chung WC, Jung SH, Choi KH, Kim EJ, Kang BK, et al. Effect of acid pump antagonist (revaprazan, revanex(r)) on result of 13C urea breath test in patients with Helicobacter pylori associated peptic ulcer disease. Taehan Sohwagi Hakhoe Chi Korean Journal of Gastroenterology] 2011;57(1):8‐13.

Obata 2003

Obata Y, Kikuchi S, Miwa H, Yagyu K, Lin YS, Ogihara A. Diagnostic accuracy of serological kits for Helicobacter pylori infection with the same assay system but different antigens in a Japanese patient population. Journal of Medical Microbiology 2003;52(10):889‐92.

Obradovic 2001

Obradovic V, Artiko V, Petrovic M, Petrovic N, Davidovic B, Bosnjakovic V, et al. Detection of Helicobacter pylori infection using 14‐c urea breath test. European Journal of Nuclear Medicine 2001;28(8):1188.

Odaka 2002

Odaka T, Yamaguchi T, Koyama H, Saisho H, Nomura F. Evaluation of the Helicobacter pylori stool antigen test for monitoring eradication therapy. American Journal of Gastroenterology 2002;97(3):594‐9.

Oderda 1989

Oderda G, Vaira D, Holton J, Dowsett JF, Ansaldi N. Serum pepsinogen i and igg antibody to campylobacter pylori in non‐specific abdominal pain in childhood. Gut 1989;30(7):912‐6.

Oderda 1998a

Oderda G, Garisio P, Harding M, Thomas JE. Use of the c‐13 urea breath test for the diagnosis of Helicobacter pylori infection in childhood. Gut 1998;43:S11‐S2.

Oderda 1998b

Oderda G, Harding M, Thomas JE, Coward WA, Bazzoli F, Zagari M, et al. The c‐13 urea breath test to assess Helicobacter pylori eradication in childhood h pylori gastritis. Gut 1998;43(Suppl 3):S9‐S10.

Oderda 1999

Oderda G, Rapa A, Ronchi B, Lerro P, Pastore M, Staiano A, et al. Evaluation of the Helicobacter pylori stool antigen test (HPSA) for detection of h‐pylori infection in children. A multicentre Italian study. Gut 1999;45(Suppl 3):A93‐A4.

Oderda 2000

Oderda G, Rapa A, Ronchi B, Lerro P, Pastore M, Staiano A, et al. Detection of Helicobacter pylori in stool specimens by non‐invasive antigen enzyme immunoassay in children: Multicentre Italian study. BMJ 2000;320(7231):347‐8.

Oderda 2004

Oderda G, Rapa A, Bona G. Diagnostic tests for childhood Helicobacter pylori infection: Invasive, noninvasive or both?. Journal of Pediatric Gastroenterology and Nutrition 2004;39(5):482‐4.

Ogunc 2003

Ogunc D, Artan R, Ongut G, Gelen T, Colak D, Donmez L, et al. Evaluation of a western blot technique (helicoblot 2.1) for the diagnosis of Helicobacter pylori infection in children. Pathology 2003;35(2):157‐60.

Ohara 1995

Ohara H, Suzuki T, Nakagawa T, Yoneshima M, Yamamoto M, Tsujino D, et al. 13C‐ubt using an infrared spectrometer for detection of Helicobacter pylori and for monitoring the effects of lansoprazole. Journal of Clinical Gastroenterology 1995;20 Suppl 2:S115‐7.

Ohara 1996

Ohara S, Sekine H, Moriyama S, Sugiyama K, Arikawa T, Iijima K, et al. Methodological study of 13C urea breath test for detection of Helicobacter pylori infection. Japanese Journal of Gastroenterology 1996;93(8):530‐6.

Ohara 1997

Ohara S, Kato M, Asaka M, Toyota T. Cut‐off vague and clinical utility of c‐13‐urea breath test for diagnosis of Helicobacter pylori infection. Gastroenterology 1997;112(4 (suppl)):A241.

Ohara 1998a

Ohara S, Kato M, Asaka M, Toyota T. Studies of 13C‐urea breath test for diagnosis of Helicobacter pylori infection in Japan. Journal of Gastroenterology 1998;33(1):6‐13.

Ohara 1998b

Ohara S, Kato M, Asaka M, Toyota T. The ubit‐100 13Co2 infrared analyzer: Comparison between infrared spectrometric analysis and mass spectrometric analysis. Helicobacter 1998;3(1):49‐53.

Ohara 2004

Ohara S, Kato M, Saito M, Fukuda S, Kato C, Hamada S, et al. Comparison between a new c‐13‐urea breath test, using a film‐coated tablet, and the conventional c‐13‐urea breath test for the detection of Helicobacter pylori infection. Journal of Gastroenterology 2004;39(7):621‐8.

Ohkura 1998

Ohkura R. Usefulness of Helicobacter pylori stool antigen (HPSA) assay for detection of Helicobacter pylori infection. Japanese Journal of Gastroenterology 1998;95(12):1397.

Ohkura 2000

Ohkura R, Miwa H, Murai T, Nagahara A, Ohta K, Sato K, et al. Usefulness of a novel enzyme immunoassay for the detection of Helicobacter pylori in feces. Scandinavian Journal of Gastroenterology 2000;35(1):49‐53.

Oksanen 1997

Oksanen A, Bergstrom M, Sjostedt S, Gad A, Hammarlund B, Seensalu R. Accurate detection of Helicobacter pylori infection with a simplified c‐13 urea breath test. Scandinavian Journal of Clinical & Laboratory Investigation 1997;57(8):689‐94.

Oksanen 1998

Oksanen A, Veijola L, Sipponen P, Schauman KO, Rautelin H. Evaluation of Pyloriset screen, a rapid whole‐blood diagnostic test for Helicobacter pylori infection. Journal of Clinical Microbiology 1998;36(4):955‐7.

Oksanen 2001

Oksanen A, Sipponen P, Sarna S, Rautelin H. Serologic diagnosis of Helicobacter pylori infection in outpatients aged 45 years or less. European Journal of Clinical Microbiology & Infectious Diseases 2001;20(8):554‐7.

Okuda 2002

Okuda M, Miyashiro E, Koike M, Tanaka T, Bouoka M, Okuda S, et al. Serodiagnosis of Helicobacter pylori infection is not accurate for children aged below 10. Pediatrics International 2002;44(4):387‐90.

Okuda 2004

Okuda M, Nakazawa T, Booka M, Miyashiro E, Yosikawa N. Evaluation of a urine antibody test for Helicobacter pylori in Japanese children. Journal of Pediatrics 2004;144(2):196‐9.

Okuda 2005

Okuda M, Sugiyama T, Fukunaga K, Kondou M, Miyashiro E, Nakazawa T. A strain‐specific antigen in Japanese Helicobacter pylori recognized in sera of Japanese children. Clinical & Diagnostic Laboratory Immunology 2005;12(11):1280‐4.

Okuda 2010

Okuda M, Oomatsu H, Kotake J, Fukuda N, Yamamoto N, Sakaedani N, et al. Evaluation of urine antibody test for h. pylori in Japanese children. Helicobacter 2010;15(4):361.

Okuda 2013

Okuda M, Kamiya S, Booka M, Kikuchi S, Osaki T, Hiwatani T, et al. Diagnostic accuracy of urine‐based kits for detection of Helicobacter pylori antibody in children. Pediatrics International 2013;55(3):337‐41.

Okuda 2014

Okuda M, Osaki T, Kikuchi S, Ueda J, Lin YS, Yonezawa H, et al. Evaluation of a stool antigen test using a mab for native catalase for diagnosis of Helicobacter pylori infection in children and adults. Journal of Medical Microbiology 2014;63:1621‐5.

Olafsson 2012

Olafsson S, Patel B, Jackson C, Cai J. Helicobacter pylori breath testing in an open access system has a high rate of potentially false negative results due to protocol violations. Helicobacter 2012;17(5):391‐5.

Oleastro 2000

Oleastro M, Monteiro L, Matos R, Lopes AI, Cabral J, Cabrita J. Evaluation of a western blot test, helico blot 2.1, in the diagnosis of Helicobacter pylori infection in a Portuguese paediatric population. Gut 2000;47(Suppl 1):A98.

Oleastro 2002

Oleastro M, Matos R, Cabral J, Barros R, Lopes AI, Ramalho P, et al. Evaluation of a western blot test, helico blot 2.1, in the diagnosis of Helicobacter pylori infection in a pediatric population. Helicobacter 2002;7(3):210‐5.

Oliaro 2000

Oliaro J, Johnson RD, Chen WX, Chadwick VS, Murray A. Identification of an immunogenic 18‐kda protein of Helicobacter pylori by alkaline phosphatase gene fusions. Journal of Medical Microbiology 2000;49(7):643‐50.

Olsson 1993

Olsson K, Wadstrom T, Tyskiewicz T. PCR identification of Helicobacter pylori in gastritis patients. Lancet 1993;341(8853):1155.

Omorogbe 2015

Omorogbe JA, Brennan D, Alsaffar M, Smith S, McNamara D, Trinity Acad Gastroenterology G. Comparison of non‐invasive tests; stool HpSA ELISA and c13urea breath test in the diagnosis of Helicobacter pylori infection in a low prevalence cohort. Helicobacter 2015;20:89.

Ong 1993

Ong KK, Goh KL, Parasakthi N. C‐14 urea breath test ‐ a useful noninvasive test in the diagnosis of Helicobacter‐pylori infection. Gastroenterology 1993;104(4 suppl):A165.

Opekun 2002

Opekun AR, Abdalla N, Sutton FM, Hammoud F, Kuo GM, Torres E, et al. Urea breath testing and analysis in the primary care office. Journal of Family Practice 2002;51(12):1030‐2.

Opekun 2006

Opekun AR, Luu P, Gotschall AB, Abdalla N, Torres E, Rudd SB, et al. Point‐of‐care Helicobacter pylori urine antibody detection in a multi‐ethnic adult population in the United States. Translational Research: The Journal Of Laboratory & Clinical Medicine 2006;148(1):13‐8.

Ormand 1990

Ormand JE, Talley NJ, Carpenter HA, Shorter RG, Conley CR, Wilson WR, et al. [14c]urea breath test for diagnosis of Helicobacter pylori. Digestive Diseases & Sciences 1990;35(7):879‐84.

Ortiz‐Olvera 2007

Ortiz‐Olvera Nayeli NX, Moran Villota S, Gallardo Wong I, Blancas Valencia JM, Cabrera Muñoz L. Validation of a simplified method of the 13C urea breath test for diagnosis of Helicobacter pylori. Revista Espanola de Enfermedades Digestivas 2007;99(7):392‐7.

Osaki 2008

Osaki T, Mabe K, Hanawa T, Kamiya S. Urease‐positive bacteria in the stomach induce a false‐positive reaction in a urea breath test for diagnosis of Helicobacter pylori infection. Journal of Medical Microbiology 2008;57(Pt 7):814‐9.

Osman 2014

Osman HA, Hasan H, Suppian R, Bahar N, Hussin NSC, Rahim AA, et al. Evaluation of the atlas Helicobacter pylori stool antigen test for diagnosis of infection in adult patients. Asian Pacific Journal of Cancer Prevention 2014;15(13):5245‐7.

Osoba 2004

Osoba AO, Ibrahim MB, Al‐Shareef BA, Yassen AA, Hussein BA. Comparison of Helicobacter pylori stool antigen test with clo test in the diagnosis of Helicobacter pylori associated dyspepsia in a Saudi population. Saudi Medical Journal 2004;25(12):1906‐8.

Ou 2013

Ou ZY, Xiong LY, Li DY, Geng LL, Li LX, Chen PY, et al. Evaluation of a new fluorescence quantitative PCR test for diagnosing Helicobacter pylori infection in children. BMC Gastroenterology 2013 Jan 14; Vol. 13:7. [DOI: 10.1186/1471‐230X‐13‐7]

Ozdemir 2008

Ozdemir E, Karabacak NI, Degertekin B, Cirak M, Dursun A, Engin D, et al. Could the simplified 14C urea breath test be a new standard in noninvasive diagnosis of Helicobacter pylori infection?. Annals of Nuclear Medicine 2008;22(7):611‐6.

Ozturk 2009

Ozturk E, Yesilova Z, Ilgan S, Ozguven M, Dagalp K. Performance of acidified c‐14‐urea capsule breath test during pantoprazole and ranitidine treatment. Journal of Gastroenterology and Hepatology 2009;24(7):1248‐51.

Pacheco 2001

Pacheco N, Mago V, Gomez I, Gueneau P, Guelrud M, Reyes N, et al. Comparison of PCR and common clinical tests for the diagnosis of h‐pylori in dyspeptic patients. Diagnostic Microbiology and Infectious Disease 2001;39(4):207‐10.

Pacheco 2013

Pacheco SLM, Ogata SK, Machado RS, Patricio FRDS, Pardo MLE, Kawakami E. Diagnosis of Helicobacter pylori infection by means of reduced‐dose 13C‐urea breath test and early sampling of exhaled breath. Journal of Pediatric Gastroenterology and Nutrition 2013;57(5):607‐11.

Paimela 2006

Paimela HM, Oksala NK, Kaariainen IP, Carlson PJ, Kostiala AA, Sipponen PI. Faecal antigen tests in the confirmation of the effect of Helicobacter eradication therapy. Annals of Medicine 2006;38(5):352‐6.

Palka 2010

Palka M, Tomasik T, Windak A, Margas G, Mach T, Bohonos A. The reliability of ELISA in predicting H. pylori infection in dyspeptic populations under age 45. Medical Science Monitor 2010;16(1):PH24‐8.

Pandya 2014

Pandya HB, Patel JS, Agravat HH, Singh NKR. Non‐invasive diagnosis of Helicobacter pylori: Evaluation of two enzyme immunoassays, testing serum igg and iga response in the Anand district of central Gujarat, india. Journal of Clinical and Diagnostic Research 2014;8(6):D12‐D5.

Pantoflickova 1999

Pantoflickova D, Blum AL, Blackmon K, Dorta G. Optimization of c‐13 urea breath test (ubt) for diagnosis of h‐pylori (hp) infection. Gastroenterology 1999;116(4 (suppl)):A276.

Pantoflickova 2000

Pantoflickova D, Lew EA, Dorta G, Pisegna JR, Ohning GV, Faller LV, et al. Intragastric ph affects the results of the c‐13‐urea breath test (ubt) in the diagnosis of h‐pylori (hp). Gastroenterology 2000;118(4 (part 1)):A507.

Pantoflickova 2003

Pantoflickova D, Scott DR, Sachs G, Dorta G, Blum AL. 13C urea breath test (ubt) in the diagnosis of Helicobacter pylori: Why does it work better with acid test meals?. Gut 2003;52(7):933‐7.

Paoluzi 2001

Paoluzi OA, Rossi P, Montesano C, Bernardi S, Carnieri E, Marchione OP, et al. Discrepancy between polymerase chain reaction assay and western blot analysis in the assessment of caga status in dyspeptic patients. Helicobacter 2001;6(2):130‐5.

Parejo 1998

Parejo Carranza R, Olivares Miguel F, Escobar Castro H, Jimenez Alonso I, De Rafael Nerpell L, Camarero Salces C. Comparative analysis of diagnostic methods for Helicobacter pylori infection in children. Anales Espanoles de Pediatria 1998;49(3):257‐63.

Parente 2000a

Parente F, Maconi G, Sainaghi M, Imbesi V, Vago L, Porro GB. Pretreatment c‐13‐urea breath test values but not h‐pylori antigen levels in stool correlate well with bacterial density and gastritis activity in the gastric body. Gut 2000;47(Suppl 1):A114.

Parente 2000b

Parente F, Sainaghi M, Maconi G, Imbesi V, Cucino C, Porro GB. Not all short‐term proton pump inhibitors (ppi) impair the accuracy of c‐13‐urea breath test and h.Pylori stool antigen assay. Gut 2000;46(Suppl 2):A86.

Parente 2001

Parente F, Bianchi Porro G. The (13)c‐urea breath test for non‐invasive diagnosis of Helicobacter pylori infection: Which procedure and which measuring equipment?. European Journal of Gastroenterology & Hepatology 2001;13(7):803‐6.

Parente 2002a

Parente F, Maconi G, Porro GB, Caselli M. Stool test with polyclonal antibodies for monitoring Helicobacter pylori eradication in adults: A critical reappraisal. Scandinavian Journal of Gastroenterology 2002;37(7):747‐9.

Parente 2002b

Parente F, Sainaghi M, Sangaletti O, Imbesi V, Maconi G, Anderloni A, et al. Different effects of short‐term omeprazole, lansoprazole or pantoprazole on the accuracy of the c‐13‐urea breath test. Alimentary Pharmacology & Therapeutics 2002;16(3):553‐7.

Park 2001

Park D, Kang D, Jung M, Park H, Kim J. Patients factors, dob value of c‐13‐urea breath test and clinical diagnosis do not affect eradication of Helicobacter pylori with omeprazole based triple therapy. Gut 2001;49(suppl):A95.

Park 2006

Park YB. Diagnostic value of rapid urine test (Rapirun) compared with biopsy, C‐13‐UBT, and serum IgG‐ELISA in Helicobacter pylori. Helicobacter 2006;11:40.

Park 2009

Park S, Park J, Kim Y, Seol S, Moon J, Jee S, et al. The clinical usefulness of the noninvasive rapid urine test to h. Pylori: Rapirun. Helicobacter 2009;14 (4):342‐3.

Park 2015

Park YH, Kim N, Shim YK, Lee CM, Kyuahn B, Jaepark S, et al. The effect of pre‐intake of citric acid on the delta value of the 13C‐urea breath test. Journal of Gastroenterology and Hepatology 2015;30:120.

Parolova 2012

Parolova N, Dmitrienko M. The effectiveness of non‐invasive tests in diagnosis of Helicobacter pylori infection in children. Helicobacter 2012;17:94.

Patel 1994

Patel P, Mendall MA, Khulusi S, Molineaux N, Levy J, Maxwell JD, et al. Salivary antibodies to Helicobacter pylori: Screening dyspeptic patients before endoscopy. Lancet 1994;344(8921):511‐2.

Pathak 1992

Pathak CM, Panigrahi D, Bhasin DK, Rana SV, Malik AK, Mehta SK. Advantage of use of dpm for 14C‐urea breath test for the detection of Helicobacter pylori. American Journal of Gastroenterology 1992;87(12):1887‐8.

Pathak 1994

Pathak CM, Bhasin DK, Panigrahi D, Goel RC. Evaluation of 14c‐urinary excretion and its comparison with 14co2 in breath after 14c‐urea administration in Helicobacter pylori infection. American Journal of Gastroenterology 1994;89(5):734‐8.

Pathak 2008

Pathak CM, Avti PK, Bunger D, Khanduja KL. Kinetics of 14carbon dioxide excretion from 14c‐urea by oral commensal flora. Journal of Gastroenterology and Hepatology 2008;23(10):1603‐7.

Pathak 2011

Pathak CM, Kaur B, Bhasin DK, Mittal BR, Sharma S, Khanduja KL. Comparative performance of capsulated vs noncapsulated 14c‐urea breath test for the detection of Helicobacter pylori infection. Indian Journal of Nuclear Medicine 2011;26(Suppl 1):S20.

Pathak 2012

Pathak CM, Kaur B, Bhasin DK, Mittal BR, Sharma S, Khanduja KL, et al. Superiority of non‐capsulated 14c‐urea breath test over capsule based method for detection of Helicobacter pylori infection ‐ a preliminary report. Tropical Gastroenterology 2012;33(2):123‐8.

Pathak 2013

Pathak CM, Kaur B, Bhasin DK, Mittal BR, Sharma S, Khanduja KL, et al. Comparison of capsulated versus non‐capsulated 14c‐urea breath test for the detection of Helicobacter pylori infection: A scintigraphy study. Indian Journal of Gastroenterology 2013;32(1 SUPPL):A18‐A9.

Pathak 2014

Pathak CM, Kaur B, Bhasin DK, Mittal BR, Sharma S, Khanduja KL, et al. Comparison of encapsulated versus nonencapsulated (14) c‐urea breath test for the detection of Helicobacter pylori infection: A scintigraphy study. Helicobacter 2014;19(2):116‐23.

Pattison 1996

Pattison CP, Marshall L. C‐13‐urea breath test for Helicobacter pylori: A second look analysis. American Journal of Gastroenterology 1996;91(11):2447.

Pattison 1997

Pattison CP, Kaczmarski DR, Bruggen JT, Oconnor MC. Comparison of c‐14‐urea breath test (c‐14‐ubt) and serology for detection of Helicobacter pylori in hiv positive patients. Gastroenterology 1997;112(4 (suppl)):A1060.

Pavlitou 1998

Pavlitou K, Pastore F, Moldovanidou K, Gioula G, Routsinas C, Polidorou F, et al. Rapid immunochromatographic assay for detection of Helicobacter pylori antibodies. Acta Microbiologica Hellenica 1998;43(3):267‐70.

Pavlitou 2000

Pavlitou K, Pastore F, Konias A, Chrisohoidou S, Tsintarakis E, Polydorou F, et al. Evaluation of a rapid serological test for the detection of igg antibodies to Helicobacter pylori. [greek]. Acta Microbiologica Hellenica 2000;45(3):293‐7.

Pawar 2014

Pawar S, Reddy SR, Chelluri LK, Prasad CE. Detection of Helicobacter pylori infection in patients with obstructive airway diseases with sero techniques using highly specific igg antibodies for Helicobacter pylori antigen. Asian Pacific Journal of Tropical Disease 2014;4:S366‐S72.

Payne 2006

Payne I, Mold JW. What is the most sensitive non‐invasive test for initial diagnosis of h. Pylori infection in adults?. Journal Oklahoma State Medical Association 2006;99(6):368‐9.

Peitz 2000

Peitz U, Agha‐Amiri K, Glasbrenner B, Leodolter A, Kahl S, Maertens D, et al. High specificity, but reduced sensitivity of h‐pylori stool test in upper gastrointestinal bleeding. Gut 2000;47(Suppl 1):A121‐A2.

Peitz 2003

Peitz U, Leodolter A, Kahl S, Agha‐Amiri K, Wex T, Wolle K, et al. Antigen stool test for assessment of Helicobacter pylori infection in patients with upper gastrointestinal bleeding. Alimentary Pharmacology & Therapeutics 2003;17(8):1075‐84.

Peitz 2004

Peitz U, Leodolter A, Wex T, Schutze D, Wolle K, Welte T, et al. Diagnostics of Helicobacter pylori infection in patients with peptic ulcer bleeding. Zeitschrift fur Gastroenterologie 2004;42(2):141‐6.

Peleteiro 2014

Peleteiro B, Bastos A, Ferro A, Lunet N. Prevalence of Helicobacter pylori Infection worldwide: a systematic review of studies with national coverage. Digestive Diseases and Sciences 2014;59(8):1698‐709.

Pena 1989

Pena AS, Endtz HP, Offerhaus GJ, Hoogenboom‐Verdegaal A, Van Duijn W, De Vargas N, et al. Value of serology (ELISA and immunoblotting) for the diagnosis of campylobacter pylori infection. Digestion 1989;44(3):131‐41.

Peng 2000a

Peng NJ, Hsu PI, Lee SC, Tseng HH, Huang WK, Tsay DG, et al. A 15‐minute c‐13 ‐urea breath test for the diagnosis of Helicobacter pylori infection in patients with non‐ulcer dyspepsia. Journal of Gastroenterology and Hepatology 2000;15(3):284‐9.

Peng 2000b

Peng NJ, Hsu PI, Lee SC, Tsay DW, Lai KH, Lin LC, et al. Ultrarapid endoscopic c‐13‐urea breath test for the diagnosis of Helicobacter pylori infection. Journal of Nuclear Medicine 2000;41(5):317P.

Peng 2001a

Peng NJ, Lai KH, Liu RS, Lee SC, Tsay DG, Lo CC, et al. Clinical significance of oral urease in diagnosis of Helicobacter pylori infection by c‐13 urea breath test. Digestive Diseases and Sciences 2001;46(8):1772‐8.

Peng 2001b

Peng NJ, Hsu PI, Lee SC, Tsay DG, Lai KH, Liu RS. Ultrarapid capsule‐based c‐13‐urea breath test for the diagnosis of Helicobacter pylori infection. Journal of Nuclear Medicine 2001;42(5):329P.

Peng 2002

Peng NJ, Hsu PI, Lee SC, Tsay DG, Lai KH, Liu RS. Comparison of 100 mg and 50 mg endoscopic c‐13‐urea breath test for the diagnosis of Helicobacter pylori infection. Journal of Nuclear Medicine 2002;43(5):333P.

Peng 2003

Peng NJ, Lai KH, Liu RS, Lee SC, Tsay DG, Lo CC, et al. Endoscopic c‐13‐urea breath test for the diagnosis of Helicobacter pylori infection. Digestive and Liver Disease 2003;35(2):73‐7.

Peng 2005

Peng NJ, Lai KH, Liu RS, Lee SC, Tsay DG, Lo CC, et al. Capsule 13C‐urea breath test for the diagnosis of Helicobacter pylori infection. World Journal of Gastroenterology 2005;11(9):1361‐4.

Peng 2009

Peng NJ, Lai KH, Lo GH, Hsu PI. Comparison of noninvasive diagnostic tests for Helicobacter pylori infection. Medical Principles & Practice 2009;18(1):57‐61.

Perets 2014

Perets TT, Shporn E, Hamouda D, Niv Y, Dickman R. Can we achieve the same results from repetitive testing of 13Co2 breath samples for the diagnosis of Helicobacter pylori?. Gastroenterology 2014;146(5 (suppl)):S397‐S8.

Perets 2015

Perets TT, Shporn E, Dickman R, Niv Y. Stability of 13Co2 breath tests samples over time in the diagnosis of Helicobacter pylori. Clinical Chemistry and Laboratory Medicine 2015;53:S1268.

Perez 1996

Perez Paramo M, Albillos Martinez A, Calleja Panero JL, Marin Rojas MC, Marcos Moreno ML, Freile Garcia I, et al. Effectiveness of the breath test with 14C‐urea in the diagnosis of Helicobacter pylori infection. Revista Espanola de Medicina Nuclear 1996;15(1):15‐20.

Perez 1998

Perez Paramo M, Albillos Martinez A, Ortiz Berrocal J. The breath test with labled urea for the diagnosis of Helicobacter pylori infection. Revista Espanola de Medicina Nuclear 1998;17(6):455‐67.

Perez‐Perez 1997

Perez‐Perez GI, Cutler AF, Blaser MJ. Value of serology as a noninvasive method for evaluating the efficacy of treatment of Helicobacter pylori infection. Clinical Infectious Diseases 1997;25(5):1038‐43.

Perezperez 1994

Perezperez GI, Brown WR, Cover TL, Dunn BE, Cao P, Blaser MJ. Correlation between serological and mucosal inflammatory responses to Helicobacter‐pylori. Clinical and Diagnostic Laboratory Immunology 1994;1(3):325‐9.

Perna 2002

Perna F, Tampieri A, Ricci C, Gatta L, Miglioli M, Vaira D. Evaluation of a new rapid one step stool antigen test for Helicobacter pylori (hp) infection diagnosis. Gut 2002;51(Suppl):A106.

Perna 2005

Perna F, Ricci C, Gatta L, Bernabucci V, Cavina M, Miglioli M, et al. Diagnostic accuracy of a new rapid urease test (pronto dry) before and after treatment of Helicobacter pylori infection. Minerva Gastroenterologica e Dietologica 2005;51(3):247‐54.

Perri 1994

Perri F, Ghoos Y, Maes B, Annese V, Geypens B, Hiele M, et al. Urea breath test in Helicobacter‐pylori infected subjects is influenced by gastric‐emptying rate. Gastroenterology 1994;106(4 (suppl)):A160.

Perri 1995

Perri F, Ghoos Y, Hiele M, Andriulli A, Rutgeerts P. The urea breath test: A non‐invasive clinical tool for detecting Helicobacter pylori infection. Italian Journal of Gastroenterology 1995;27(2):55‐63.

Perri 1997a

Perri F, Clemente R, Bisceglia M, Annese V, Niro G, Ghoos Y, et al. The c‐13‐urea breath test (ubt) predicts intragastric bacterial load and correlates with the depth of inflammation in h‐pylori related gastritis. Gastroenterology 1997;112(4 (suppl)):A256.

Perri 1997b

Perri F, Clemente R, Bisceglia M, Quitadamo M, Festa V, Niro G, et al. The c‐13‐urea breath test (ubt) correlates with the bacterial load ansi the severity of inflammation in h‐pylori (hp) gastritis. Gut 1997;41(Suppl):A80‐A1.

Perri 1998a

Perri F, Clemente R, Pastore M, Quitadamo M, Festa V, Bisceglia M, et al. The c‐13‐urea breath test as a predictor of intragastric bacterial load and severity of Helicobacter pylori gastritis. Scandinavian Journal of Clinical & Laboratory Investigation 1998;58(1):19‐27.

Perri 1998b

Perri F, Clemente R, Festa V, Quitadamo M, Conoscitore P, Niro G, et al. Relationship between the results of pre‐treatment urea breath test and efficacy of eradication of Helicobacter pylori infection. Italian Journal of Gastroenterology & Hepatology 1998;30(2):146‐50.

Perri 1998c

Perri F, Clemente R, Quitadamo M, Annese V, Andriulli A. C‐13 urea breath test is a very accurate clinical tool in the diagnosis of intragastric Helicobacter pylori infection. Gut 1998;43(Suppl 3):S8‐9.

Perri 2000

Perri F. Diagnosis of Helicobacter pylori infection: Which is the best test? The urea breath test. Digestive & Liver Disease 2000;32 Suppl 3:S196‐8.

Perri 2002a

Perri F, Manes G, Neri M, Vaira D, Nardone G. Helicobacter pylori antigen stool test and 13C‐urea breath test in patients after eradication treatments. American Journal of Gastroenterology 2002;97(11):2756‐62.

Perri 2002b

Perri F, Manes G, Nardone G, Neri M, Vaira D. Helicobacter pylori antigen stool test (HPSA) and 13C‐urea breath test (ubt) in patients after eradicating treatments. Gastroenterology 2002;122(4 (suppl)):A206.

Perri 2002c

Perri F, Ricciardi R, Merla A, Piepoli A, Gasperi V, Quitadamo M, et al. Appropriateness of urea breath test: A prospective observational study based on maastricht 2000 guidelines. Alimentary Pharmacology & Therapeutics 2002;16(8):1443‐7.

Perri 2005

Perri F, Quitadamo M, Ricciardi R, Piepoli A, Cotugno R, Gentile A, et al. Comparison of a monoclonal antigen stool test (hp star) with the c‐13‐urea breath test (ubt) in monitoring Helicobacter pylori eradication therapy. World Journal of Gastroenterology 2005;11(37):5878‐81.

Perrone 2005

Perrone M, Muñoz L, Camorlinga M, Correnti M, Cavazza ME, Lecuna V, et al. Importance of IgG anti‐caga antibodies of Helicobacter pylori in Venezuelan patients with gastric diseases. Investigacion Clinica 2005;46(4):357‐67.

Petrovic 2011

Petrovic M, Artiko V, Novosel S, Ille T, Sobic‐Saranovic D, Pavlovic S, et al. Relationship between Helicobacter pylori infection estimated by c‐14‐urea breath test and gender, blood groups and rhesus factor. Hellenic Journal of Nuclear Medicine 2011;14(1):21‐4.

Pettersson 2001

Pettersson A, Rasmusson M, Kyronpalo S, Sipponen P, Rautilin H, Farkkila M, et al. A 10 minutes tablet based 13C‐urea breath test for the diagnosis of Helicobacter pylori. Gastroenterology 2001;120(5 (suppl)):A579.

Pianko 1999

Pianko S, Petterson A, Lundqvist T, Stringer C, Sievert W, Korman M. Evaluation of a novel tablet based carbon 13 urea breath test for the rapid diagnosis of Helicobacter pylori infection. Gastroenterology 1999;116(4 (Suppl)):A282.

Pilotto 1999

Pilotto A, Franceschi M, Leandro G, Rassu M, Zagari RM, Bazzoli F, et al. The non‐invasive diagnosis of h‐pylori infection in older subjects: Comparison of c‐13‐urea breath test with serology. Gastroenterology 1999;116(4 (suppl)):A283.

Pilotto 2000a

Pilotto A, Franceschi M, Leandro G, Rassu M, Zagari RM, Bozzola L, et al. Noninvasive diagnosis of Helicobacter pylori infection in older subjects: Comparison of the c‐13‐urea breath test with serology. Journals of Gerontology Series A‐Biological Sciences and Medical Sciences 2000;55(3):M163‐M7.

Pilotto 2000b

Pilotto A, Franceschi M, Rassu M, Novello R, Brusarosco G, Bozzola L, et al. Stool antigen test (HPSA) for detection of h‐pylori infection in elderly subjects: Comparison with serology and influence of concomitant treatments on diagnostic accuracy. Gut 2000;47(Suppl 1):A117‐A8.

Pilotto 2002

Pilotto A, Franceschi M, Furlan F, Bozzola L, Fucito L, Rassu M, et al. The noninvasive diagnosis of h‐pylori infection in geriatric subjects by the c‐13‐urea breath test (c‐13‐ubt) and the stool antigen test (HPSA): The role of disability and cognitive status. Gut 2002;51(Suppl):A108.

Plebani 1999

Plebani M, Basso D. Diagnosis of Helicobacter pylori infection by HPSA test. Lancet 1999;354(9185):1210.

Ploier 1995

Ploier R, Rezanka E, Emhofer J, Dorninger L, Feichtinger J, Haidinger R, et al. Predictive value of latex agglutination on Helicobacter pylori in children with recurrent abdominal pain. Klinische Padiatrie 1995;207(1):8‐11.

Ploier 1996

Ploier R, Dorninger L, Emhofer J, Franz V, Feichtinger J. Predictive value of an ELISA for Helicobacter pylori infection in children. Monatsschrift fur Kinderheilkunde 1996;144(12):1326‐9.

Ploier 1997

Ploier R, Doringer I, Emhofer J, Franz V, Feichtinger J. Predictive value of an ELISA for the detection of Helicobacter pylori infection in children ‐ reply. Monatsschrift fur Kinderheilkunde 1997;145(10):1094.

Polat 2010

Polat TB, Urganci N, Selcukcan F, Yenici FN. Efficacy of non‐invasive tests in the diagnosis and post‐treatment follow‐up of Helicobacter pylori infection in pediatric patients. Gazi Medical Journal 2010;21(1):17‐22.

Pons 2014

Pons C, Maisterra S, Salord S, Pla A, Asensio D, Fernandez FJ, et al. Almagate interference in breath test results for the diagnosis of Helicobacter pylori infection. Revista Espanola De Enfermedades Digestivas 2014;106(7):448‐51.

Porter 2009a

Porter V, Macdonald JC, Zahid MA, Mackie B, McNamara D. Validation of a low dose tablet formulation 13C urea and citric acid breath test employing an automated non dispersive isotope selective infrared spectroscopy analyser (helifan/fan as) for the diagnosis of Helicobacter pylori infection in a Scottish population. Gastroenterology 2009;136(5 (suppl )):A346.

Porter 2009b

Porter V, Zahid A, Mackie B, McNamara DA. Results of a prospective comparison pilot validation study of a low‐dose tablet formulation c‐13 urea and citric acid breath test employing a novel automated nondispersive isotope selective infrared spectroscopy analyser for the diagnosis of Helicobacter pylori infection. European Journal of Gastroenterology & Hepatology 2009;21(11):1321‐2.

Portorreal 2002

Portorreal A, Kawakami E. Evaluation of enzyme‐linked immunosorbent assay for the diagnosis of Helicobacter pylori infection in children and adolescents. Arquivos de Gastroenterologia 2002;39(3):198‐203.

Posteraro 2006

Posteraro P, Branca G, Sanguinetti M, Ranno S, Cammarota G, Rahimi S, et al. Rapid detection of clarithromycin resistance in Helicobacter pylori using a PCR‐based denaturing hplc assay. Journal of Antimicrobial Chemotherapy 2006;57(1):71‐8.

Potashov 1996

Potashov LV, Morozov VP, Kudrevatykh IP, Savranskii VM, Aurtiunian AA, Did‐Zurabova ES, et al. The diagnosis of Helicobacter infections in patients with gastric and duodenal peptic ulcers. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii 1996;6:11‐3.

Pourakbari 2011a

Pourakbari B, Mirsalehian A, Maleknejad P, Mamishi S, Azhdarkosh H, Daryani NE, et al. Evaluation of a new antigen for diagnosis of Helicobacter pylori infection in stool of adult and children. Helicobacter 2011;16(1):42‐6.

Pourakbari 2011b

Pourakbari B, Mirsalehian A, Mamishi S, Najafi M, Kazemi B, Paknejad M, et al. Diagnosis of Helicobacter pylori infection by invasive and noninvasive methods. Tropical Medicine and International Health 2011;16:264‐5.

Pourakbari 2013

Pourakbari B, Ghazi M, Mahmoudi S, Mamishi S, Azhdarkosh H, Najafi M, et al. Diagnosis of Helicobacter pylori infection by invasive and noninvasive tests. Brazilian Journal of Microbiology 2013;44(3):795‐8.

Prabakaran 1997

Prabakaran K, Fernandes V, McDonald J, Jones RC. Single sample c‐14 urea breath test for the diagnosis of Helicobacter pylori infection. Journal of Nuclear Medicine 1997;38(5 Suppl):Abstract 261.

Prell 2009

Prell C, Osterrieder S, Schwarzer A, Lottspeich C, Rusmann H, Ossiander G, et al. Improved performance of a novel rapid one‐step monoclonal chromatographic immunoassay for detection of Helicobacter pylori antigen in stool in children. Journal of Pediatric Gastroenterology and Nutrition 2009;48(Suppl 3):E47‐E8.

Presecki 1997

Presecki V, Katicic M, Kalenic S, Marusic M, Ticak M, Prskalo M, et al. Evaluation of commercial cf and ELISA tests for diagnosis of H‐pylori infection in gastric carcinoma and non Hodgkin lymphoma patients. Gut 1997;41:A164.

Prieto 1994

Prieto Bozano G. Clinical diagnosis of Helicobacter pylori infection in the child. Enfermedades Infecciosas Y Microbiologia Clinica 1994;12 Suppl 1:18‐22.

Pronovost 1994

Pronovost AD, Rose SL, Pawlak JW, Robin H, Schneider R. Evaluation of a new immunodiagnostic assay for Helicobacter pylori antibody detection: Correlation with histopathological and microbiological results. Journal of Clinical Microbiology 1994;32(1):46‐50.

Przyklenk 1990

Przyklenk B, Bauernfeind A, Bornschein W, Gabor M. Evaluation of an IgG‐ELISA‐kit for diagnosing Helicobacter pylori associated gastroduodenal disease. Serodiagnosis and Immunotherapy in Infectious Disease 1990;4(4):263‐9.

Pu 2005

Pu XH, Guo XQ, Shi YL, An T, Qiu M, Qiu XX. Values of Helicobacter pylori stool antigen test in the etiological diagnosis of recurrent abdominal pain in children. Chinese Journal of Contemporary Pediatrics 2005;7(5):426‐8.

Puolakkainen 1997

Puolakkainen P, Rautelin H, Sipponen P, Farkkila M, Kosunen T, Haapiainen R, et al. Comparison of histology, c‐13 urea breath test (ubt) and serology for detecting h‐pylori infection in patients with atrophic gastritis. Gastroenterology 1997;112(4 (suppl)):A262.

Puz 2006

Puz S, Kovach Z, Hirschl AM, Hafner M, Innerhofer A, Rotter M, et al. Evaluation of the novel Helicobacter pylori clarires real‐time PCR assay for detection and clarithromycin susceptibility testing of h‐pylori in stool specimens and gastric biopsies; comparison with the stool antigen test drug resistance. Helicobacter 2006;11(4):396.

Puz 2008

Puz S, Innerhofer A, Ramharter M, Haefner M, Hirschl AM, Kovach Z, et al. A novel noninvasive genotyping method of Helicobacter pylori using stool specimens. Gastroenterology 2008;135(5):1543‐51.

Qibi 2008

Qibi EM, Abdulla ZA. Detection of Helicobacter pylori infection in dyspeptic patients by different sero‐bacteriological methods. Qatar Medical Journal 2008;17(2):17‐21.

Quach 2014

Quach DT, Hiyama T, Shimamoto F, Le QD, Ho LX, Vu NH, et al. Value of a new stick‐type rapid urine test for the diagnosis of Helicobacter pylori infection in the Vietnamese population. World Journal of Gastroenterology 2014;20(17):5087‐91.

Queiroz 1999

Queiroz DMM, Mendes EN, Rocha GA, Oliveira AMR, Oliveira CA, Cabral MMDA, et al. Serological and direct diagnosis of Helicobacter pylori in gastric carcinoma: A case‐control study. Journal of Medical Microbiology 1999;48(5):501‐6.

Queiroz 2000

Queiroz DMM, Rocha AMC, Rocha GA, Mendes EN, Carvalho AST, Nogueira AMF, et al. Validation of a commercial ELIS to detect anti‐caga antibodies in children with H. pylori (hp) infection. Gut 2000;47(Suppl 1):A96.

Queiroz 2013

Queiroz DM, Saito M, Rocha GA, Rocha AM, Melo FF, Checkley W, et al. Helicobacter pylori infection in infants and toddlers in South America: concordance between [13C]urea breath test and monoclonal H. pylori stool antigen test. Journal of Clinical Microbiology 2013;51(11):3735‐40.

Queralt 2005

Queralt N, Bartolome R, Araujo R. Detection of Helicobacter pylori DNA in human faeces and water with different levels of faecal pollution in the north‐east of Spain. Journal of Applied Microbiology 2005;98(4):889‐95.

Quesada 2006a

Quesada M, Calvet X, Dosal A, Calvet V, Sanfeliu I, Ribera L, et al. Evaluation of four different fecal tests for determination of cure after Helicobacter pylori treatment. Journal of Clinical Gastroenterology 2006;40(9):790‐4.

Quesada 2006b

Quesada M, Calvet X, Calvet V, Choat T, Fallowfield B, Sanfeliu I, et al. Usefulness of rapid hp star, a new immumochromatographic, monoclonal antigen‐based faecal test, for diagnosing Helicobacter pylori infection in dyspeptic patients. Gastroenterology 2006;130(4 (suppl)):A458.

Rabbe 1988

Rabbe MP, Megraud F. Anti‐campylobacter‐pylori antibody titer by ELISA. Gastroenterologie Clinique et Biologique 1988;12(6‐7):587‐8.

Radke 1997

Radke M. Predictive value of an ELISA for the detection of Helicobacter pylori infection in children. Monatsschrift fur Kinderheilkunde 1997;145(10):1093.

Rae 1995

Rae AJ, Belzberg A, Cleator IGM, Caglar M. Use of the c‐14 breath test in the treatment of Helicobacter‐pylori. Canadian Journal of Gastroenterology 1995;9(4):191‐4.

Raedsch 1992

Raedsch R. Serological screening for Helicobacter pylori. Deutsche Medizinische Wochenschrift 1992;117(21):844‐5.

Raguza 2005

Raguza D, Granato CFH, Kawakami E. Evaluation of the stool antigen test for Helicobacter pylori in children and adolescents. Digestive Diseases and Sciences 2005;50(3):453‐7.

Raguza 2010

Raguza D, MacHado RS, Ogata SK, Granato CFH, Patricio FRS, Kawakami E. Validation of a monoclonal stool antigen test for diagnosing Helicobacter pylori infection in young children. Journal of Pediatric Gastroenterology and Nutrition 2010;50(4):400‐3.

Rahman 2008

Rahman SHZ, Azam MG, Rahman MA, Arfin MS, Alam MM, Bhuiyan TM, et al. Non‐invasive diagnosis of h pylori infection: Evaluation of serological tests with and without current infection marker cim. World Journal of Gastroenterology 2008;14(8):1231‐6.

Raju 1994

Raju GS, Smith MJ, Morton D, Bardhan KD. Mini‐dose (1‐microci) 14c‐urea breath test for the detection of Helicobacter pylori. American Journal of Gastroenterology 1994;89(7):1027‐31.

Ramírez‐Lázaro 2011

Ramírez‐Lázaro MJ, Lario S, Casalots A, Sanfeliu E, Boix L, García‐Iglesias P, et al. Real‐time PCR improves Helicobacter pylori detection in patients with peptic ulcer bleeding. PLoS ONE2011; Vol. 6, issue 5:e20009. [DOI: 10.1371/journal.pone.002000]

Ramírez‐Lázaro 2015

Ramírez‐Lázaro MJ, Lario S, Calvet X, Sánchez‐Delgado J, Montserrat A, Quilez EM, et al. Occult h‐pylori infection partially explains "false‐positive' results of c‐13‐urea breath test. United European Gastroenterology Journal 2015;3(5):437‐42.

Rao 2001

Rao P, Sarkar A, Shivananda PG, Pai G. Comparison of ELISA for antibody detection and biopsy urease test against h. Pylori in cases of gastroduodenal disorders. Indian Journal of Medical Sciences 2001;55(7):366‐70.

Rapoport 2014

Rapoport SI, Shubina NA. 13‐year period of application of the 13C‐urease breath test for determining Helicobacter pylori in Russian clinical practice. Klinicheskaia Meditsina 2014;92(11):59‐64.

Rasheed 2014

Rasheed F, Khalid A, Saadia A, Habib S, Khan SM, Saeed F, et al. Correlation of c‐13 urea breath test values with Helicobacter pylori load among positive patients. Hepato‐Gastroenterology 2014;61(129):125‐8.

Ratnaraj 2015

Ratnaraj F, Hamdeh S, Salih M, Ayan M, Mansour G, Reddymasu S. Urea breath test (ubt) versus stool antigen test in post‐treatment eradication of Helicobacter pylori infection: A meta‐analysis. American Journal of Gastroenterology 2015;110:S1038.

Rauws 1987

Rauws EAJ, Langenberg W, Houthoff HJ, Tytgat GN. Histology, culture, breath test and therapeutic attempts in campylobacter pylori gastritis. Zeitschrift fur Gastroenterologie 1987;25(SUPPl. 4):24‐8.

Rauws 1989a

Rauws EAJ. Detecting campylobacter‐pylori with the c‐13 urea and c‐14‐urea breath test. Scandinavian Journal of Gastroenterology 1989;24:25‐6.

Rauws 1989b

Rauws EA, Van Royen EA, Tytgat GN. 14c‐urea breath test as a method to detect campylobacter pylori colonization. Gastroenterologie Clinique et Biologique 1989;13(1 Pt 1):42B‐3B.

Rauws 1989c

Rauws EAJ, Royen EAV, Langenberg W, Woensel JV, Vrij AA, Tytgat GN. 14C‐urea breath test in C pylori gastritis. Gut 1989;30(6):798‐803.

Raymond 1999

Raymond J, Sauvestre C, Kalach N, De Korwin JD, Valverde V. Evaluation of a new serologic test for diagnosis of Helicobacter pylori infection in children. European Journal of Clinical Microbiology & Infectious Diseases 1999;18(3):192‐8.

Raymond 2000

Raymond J, Sauvestre C, Kalach N, Bergeret M, Dupont C. Immunoblotting and serology for diagnosis of Helicobacter pylori infection in children. Pediatric Infectious Disease Journal 2000;19(2):118‐21.

Razaghi 2010

Razaghi M, Boutorabi SM, Mirjalili A, Norolahi S, Hashemi M, Jalalian M. Diagnosis of Helicobacter pylori infection by ELISA stool antigen and comparison with the other diagnostic methods. Healthmed 2010;4(3):545‐51.

Rechcinski 1997

Rechcinski T, Chmiela M, Malecka‐Panas E, Planeta‐Malecka I, Rudnicka W. Serological indicators of Helicobacter pylori infection in adult dyspeptic patients and healthy blood donors. Microbiology & Immunology 1997;41(5):387‐93.

Redéen 2011

Redéen S, Petersson F, Törnkrantz E, Levander H, Mårdh E, Borch K. Reliability of diagnostic tests for Helicobacter pylori infection. Gastroenterology Research and Practice2011; Vol. 2011:940650. [DOI: 10.1155/2011/940650]

Rehnberg 2001

Rehnberg AS, Bengtsson C, Befrits R, Granstrom M, Hellstrom PM. Refinement of the c‐14‐urea breath test for detection of Helicobacter pylori. Scandinavian Journal of Gastroenterology 2001;36(8):822‐6.

Reilly 1997

Reilly TG, Poxon V, Sanders DSA, Elliott TSJ, Walt RP. Comparison of serum, salivary, and rapid whole blood diagnostic tests for Helicobacter pylori and their validation against endoscopy based tests. Gut 1997;40(4):454‐8.

Rejchrt 2004

Rejchrt S, Havlasova J, Bures J, Siroky M, Kopacova M, Voxova B, et al. Evaluation of serum anti‐Helicobacter pylori IgG antibodies against p120 antigen (caga) and investigation of specific antibody response against Helicobacter pylori by means of western blotting. Klinicka Biochemie a Metabolismus 2004;12(1):19‐23.

Ren 2005

Ren Z, Borody T, Pang G, Dunkley M, Clancy R, Xia HHX, et al. Evaluation of anti‐Helicobacter pylori igg2 antibody for the diagnosis of Helicobacter pylori infection in western and Chinese populations. Alimentary Pharmacology and Therapeutics 2005;21(1):83‐9.

Ren 2010

Ren HT, Xu XW, Li AH. Diagnostic value of gene chip test for detection of h.Pylori infection and relationship between H.pylori virulence factors and the severity of gastroduodenal lesions. World Chinese Journal of Digestology 2010;18(26):2826‐30.

Reshetnikov 2007

Reshetnikov OV, Kurilovich SA, Krotov SA, Krotova VA. Comparison of two ELISA kits for Helicobacter pylori detection in Siberian populations. Helicobacter 2007;12(4):441.

Reynders 2012

Reynders MBML, Deyi VYM, Dahma H, Scheper T, Hanke M, Decolvenaer M, et al. Performance of individual Helicobacter pylori antigens in the immunoblot‐based detection of h. Pylori infection. FEMS Immunology and Medical Microbiology 2012;64(3):352‐63.

Riaz 2011

Riaz S, Munir I, Nawaz MK, Bashir H, Muzahir S, Saadullah M, et al. C‐14 ‐ urea breath test in the diagnosis of Helicobacter pylori infection in Pakistani population. European Journal of Nuclear Medicine and Molecular Imaging 2011;38:S403.

Ricci 2007

Ricci C, Holton J, Vaira D. Diagnosis of Helicobacter pylori: invasive and non‐invasive tests. Best Practice & Research: Clinical Gastroenterology 2007;21(2):299‐313.

Richter 2002

Richter J, Stiborova I, Kral V, Jilek D. Direct evidence of the Helicobacter pylori antigen in faeces. Prakticky Lekar 2002;82(4):205‐7.

Riepl 2000

Riepl RL, Folwaczny C, Otto B, Klauser A, Blendinger C, Wiebecke B, et al. Accuracy of c‐13‐urea breath test in clinical use for diagnosis of Helicobacter pylori infection. Zeitschrift fur Gastroenterologie 2000;38(1):13‐9.

Ritchie 2009

Ritchie B, Brewster D, Tran CD, McNeil Y, Zacharakis B, Davidson GP, et al. Lack of diagnostic accuracy of the monoclonal stool antigen test for detection of Helicobacter pylori infection in young Australian aboriginal children. Pediatric Infectious Disease Journal 2009;28(4):287‐9.

Rocha 1998

Rocha GA, Oliveira AM, Queiroz DM, Mendes EN, Moura SB, Oliveira CA, et al. Serodiagnosis of Helicobacter pylori infection by cobas core ELISA in adults from Minas Gerais, Brazil. Brazilian Journal of Medical & Biological Research 1998;31(10):1263‐8.

Rocha 2002

Rocha GA, Cardinali LCC, Queiroz DMM, Rocha AMC, Moura SB, Soares TF, et al. The performance of the c‐13‐urea breath test for the diagnosis of Helicobacter pylori infection in children from a developing country. Gut 2002;51(Suppl):A82.

Rocha 2004

Rocha AM, Rocha GA, Leite JL, Lisboa RL, Silva PV, Queiroz DM. Immunoblotting for the serodiagnosis of Helicobacter pylori infection in Brazilian patients with and without gastric carcinoma. Memorias do Instituto Oswaldo Cruz 2004;99(2):189‐93.

Rogge 1995

Rogge JD, Wagner DR, Carrico RJ, Glowinski EA, Mahoney SJ, Boguslaski RC, et al. Evaluation of a new urease reagent strip for detection of Helicobacter‐pylori in gastric biopsy specimens. American Journal of Gastroenterology 1995;90(11):1965‐8.

Roggero 2002

Roggero P, Bonfiglio A, Luzzani S, Valade A, Cataliotti E, Corno G, et al. Helicobacter pylori stool antigen test: A method to confirm eradication in children. Journal of Pediatrics 2002;140(6):775‐7.

Rollan 1997

Rollan A, Giancaspero R, Arrese M, Figueroa C, Vollrath V, Schultz M, et al. Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection after antibiotic treatment. American Journal of Gastroenterology 1997;92(8):1268‐74.

Roma‐Giannikou 2010

Roma‐Giannikou E, Roubani A, Sgouras DN, Panayiotou J, Van‐Vliet C, Polyzos A, et al. Endoscopic tests for the diagnosis of Helicobacter pylori infection in children: Validation of rapid urease test. Helicobacter 2010;15(3):227‐32.

Romaozinho 2011

Romaozinho JGM, Donato MRSR, Ferreira J, Sofia C. Detection of Helicobacter pylori infection: clinical validation of 14C (37 kbq) urea breath test. Helicobacter 2011;16:115.

Roth 2001

Roth DE, Taylor DN, Gilman RH, Meza R, Katz U, Bautista C, et al. Posttreatment follow‐up of Helicobacter pylori infection using a stool antigen immunoassay. Clinical & Diagnostic Laboratory Immunology 2001;8(4):718‐23.

Rothenbacher 2000a

Rothenbacher D, Marchildon P, Peacock J, Bode G, Brenner H. Diagnosis of h‐pylori infection in children: Comparison of a salivary igg antibody test with c‐13‐urea breath test. Gut 2000;47(Suppl 1):A116.

Rothenbacher 2000b

Rothenbacher D, Bode G, Brenner H. Diagnosis of Helicobacter pylori infection with a novel stool antigen‐based assay in children. Pediatric Infectious Disease Journal 2000;19(4):364‐6.

Rowland 1997a

Rowland M, Lambert I, Gormally S, Thomas JE, Daly LE, Durnin M, et al. C‐13‐urea breath test for the diagnosis of Helicobacter pylori in children. Gastroenterology 1997;112(4 (suppl)):A272.

Rowland 1997b

Rowland M, Lambert I, Gormally S, Daly LE, Thomas JE, Hetherington C, et al. Carbon 13‐labeled urea breath test for the diagnosis Helicobacter pylori infection in children. Journal of Pediatrics 1997;131(6):815‐20.

Rutter 2001

Rutter CM, Gatsonis CA. A hierarchical regression approach to meta‐analysis of diagnostic test accuracy evaluations. Statistics in Medicine 2001;20(19):2865‐84.

Sabbi 2005

Sabbi T, De Angelis P, Colistro F, Dall'Oglio L, Di Abriola GF, Castro M. Efficacy of noninvasive tests in the diagnosis of Helicobacter pylori infection in pediatric patients. Archives of Pediatrics & Adolescent Medicine 2005;159(3):238‐41.

Sadowski 1998

Sadowski D, Cohen H, Laine L, Greenberg P, Goldstein J, Mihalov M, et al. Evaluation of the flexsure hp whole blood antibody test for diagnosis of Helicobacter pylori infection. American Journal of Gastroenterology 1998;93(11):2119‐23.

Saez 2012

Saez J, Belda S, Santibanez M, Rodriguez JC, Sola‐Vera J, Galiana A, et al. Real‐time PCR for diagnosing Helicobacter pylori infection in patients with upper gastrointestinal bleeding: Comparison with other classical diagnostic methods. Journal of Clinical Microbiology 2012;50(10):3233‐7.

Saffari 2003

Saffari M, Motavalii MA, Fazeli A. Immunoblot assay in determination of serum antibody profile of Helicobacter pylori infection. Iranian Journal of Medical Sciences 2003;28(2):90‐2.

Salama 1993

Salama SM, Wefuan JN, Shiro‐Koulla S, Mbakop A, Tagni‐Sartre M, Ndam EC, et al. Value of whole‐cell antigen extracts for serologic detection of Helicobacter pylori. Journal of Clinical Microbiology 1993;31(12):3331‐2.

Salih 2013

Salih BA, Karakus C, Ulupinar Z, Akbas F. A novel lateral flow test strip (lfts) for the detection of Helicobacter pylori infection. Helicobacter 2013;18:124.

Salles‐Montaudon 2001

Salles‐Montaudon N, Dertheil S, Broutet N, Monteiro L, Gras N, Pereira E, et al. How should Helicobacter pylori infection be diagnosed in the elderly?. Revue de Medecine Interne 2001;22(4):339‐47.

Salomaa‐Rasanen 2004

Salomaa‐Rasanen A, Kosunen TU, Mattila J, Sarna S, Rautelin H. Age‐dependent accuracy of Helicobacter pylori antibody assays for adults, with special emphasis on atrophic gastritis. Clinical and Diagnostic Laboratory Immunology 2004;11(6):1185‐8.

Saltik 2001

Saltik IN, Ercis S, Kocak N, Hascelik G, Ozen H, Yuce A, et al. Helicobacter pylori stool antigen (HpSA) test in children with recurrent abdominal pain. American Journal of Gastroenterology 2001;96(8):2514‐5.

Saltik 2003

Saltik IN, Demir H, Kocak N, Ozen H, Gurakan F, Yuce A. Diagnostic accuracy of c‐13‐urea breath test for Turkish children with Helicobacter pylori infection. American Journal of Gastroenterology 2003;98(1):222‐3.

Sampson 2008

Sampson M, Shojania KG, McGowan J, Daniel R, Rader T, Iansavichene AE, et al. Surveillance search techniques identified the need to update systematic reviews. Journal of Clinical Epidemiology 2008;61(8):755‐62.

Sanches 2013

Sanches BSF, Martins GM, Pinto HAF, Meira ACD, Alves EJ, Trindade OR, et al. Evaluation of stool antigen test on initial diagnosis and control test of Helicobacter pylori eradication. Helicobacter 2013;18:122.

Saneian 2013

Saneian H, Rahimi H, Mahmoodi NS. Comparison of the sensitivity and specificity of available methods in Helicobacter pylori infection detection in children. Journal of Isfahan Medical School2013; Vol. 30, issue 212.

Sano 2004

Sano N, Ohara S, Koike T, Sekine H, Imatani A, Kitagawa Y, et al. Influence of urease activity of the oral cavity and oropharynx on 13C‐urea breath test. Japanese Journal of Gastroenterology 2004;101(12):1302‐8.

Santogade 1990

Santogade PJ, Bokkenheuser VD, Faisal MA, Kotler DP, Scholes JV, Holt PR. Evaluation of methods for identification of campylobacter pyloris infection. New York State Journal of Medicine 1990;90(1):4‐7.

Sarker 2003

Sarker SA, Bardhan PK, Rahaman M, Beglinger C, Gyr N. Usefulness of the Helicobacter pylori stool antigen test for detection of Helicobacter pylori infection in young Bangladeshi children. Gastroenterology 2003;124(4 suppl):A178.

SAS [Computer program]

SAS Institute Inc. SAS. Version 9.4. Cary, NC, USA: SAS Institute Inc, 2013.

Sastry 1997

Sastry A, Flynn K, Mehra M. Development of an ELISA method for the measurement of H. pylori in human serum using a single reagent tmb system. Clinical Chemistry 1997;43(6 (Suppl 2)):628.

Sato 2012

Sato M, Shimoyama T, Takahashi R, Kajiyama H, Sano Y, Sakaedani N, et al. Characterization and usefulness of stool antigen tests using a monoclonal antibody to Helicobacter pylori catalase. Journal of Gastroenterology and Hepatology (Australia) 2012;27(SUPPL.3):23‐8.

Satoh 1993

Satoh K, Yoshida Y, Taniguchi Y, Kimura K. Elisa tests for detection of Helicobacter pylori antibodies. Nihon Rinsho [Japanese Journal of Clinical Medicine] 1993;51(12):3201‐4.

Savarino 1999

Savarino V, Mela GS, Zentilin P, Bisso G, Pivari M, Mansi C, et al. Comparison of isotope ratio mass spectrometry and nondispersive isotope‐selective infrared spectroscopy for c‐13‐urea breath test. American Journal of Gastroenterology 1999;94(5):1203‐8.

Savarino 2000a

Savarino V, Bisso G, Pivari M, Zentilin P, Bilardi C, Dulbecco P, et al. Effect of gastric acid suppression on c‐13‐urea breath test: Comparison of ranitidine with omeprazole. Alimentary Pharmacology & Therapeutics 2000;14(3):291‐7.

Savarino 2000b

Savarino V, Landi F, Dulbecco P, Ricci C, Tessieri L, Biagini R, et al. Isotope ratio mass spectrometry (irms) versus laser‐assisted ratio analyzer (lara) ‐ a comparative study using two doses of c‐13 urea and two test meals for pre‐ and posttreatment diagnosis of Helicobacter pylori infection. Digestive Diseases and Sciences 2000;45(11):2168‐74.

Savarino 2001

Savarino V, Tracci D, Dulbecco P, Mele MR, Zentilin P, Mansi C, et al. Negative effect of ranitidine on the results of urea breath test for the diagnosis of Helicobacter pylori. American Journal of Gastroenterology 2001;96(2):348‐52.

Savio 1999

Savio A, Buffoli F, Landi F, Ricci C, Acciardi C, Gatta L, et al. The value of a new capture ELISA system for the diagnosis and the follow‐up of Helicobacter pylori (hp) infection. Gut 1999;45(Suppl 3):A128.

Sawada 2001

Sawada A, Tajiri H, Yoshimura N, Kozaiwa K, Ida S, Fujisawa T, et al. A simplified C‐13‐urea breath test in children with Helicobacter pylori infection: Assessment of eradication therapy and follow‐up after treatment. Gastroenterology 2001;120(5 suppl):A579.

Sayed 2011

Sayed MM, Ibrahim WA, Abdel‐Bary SA, Abdelhakam SM, El‐Masry SA, Ghoraba D. Salivary PCR detection of Helicobacter pylori DNA in Egyptian patients with dyspepsia. Egyptian Journal of Medical Human Genetics 2011;12(2):211‐6.

Schaefer 1999

Schaefer R, Bugno M, Auer P, Ramp U, Gabbert HE, Erckenbrecht JF. Does quantitative c‐13‐urea breath test reflect intensity of gastric Helicobacter pylori colonization or mucosal inflammation?. Gastroenterology 1999;116(4 (suppl)):A304.

Scherbakov 2001

Scherbakov PL, Belousov B, Govorun VM, Filin VA, Isakov VA, Kaganov BS, et al. Diagnosis of Helicobacter pylori infection in children by PCR in stool: comparative study with antigen stool test. Gut 2001;49(suppl):A81.

Schilling 2003

Schilling D, Demel A, Adamek HE, Nusse T, Weidmann E, Riemann JF. A negative rapid urease test is unreliable for exclusion of Helicobacter pylori infection during acute phase of ulcer bleeding ‐ a prospective case control study. Digestive and Liver Disease 2003;35(4):217‐21.

Schmitt 1996

Schmitt B, Bartel J. Comparison of a new rapid blood assay for detection of antibodies to Helicobacter pylori (bm‐test Helicobacter pylori rapid assay, boehringer mannheim) with an enzyme‐linked immunosorbent assay (enzygnost, behringwerke marburg). Klinisches Labor 1996;42(7‐8):601‐6.

Schuman 1995

Schuman R, Rigas B, Prada A, Minoli G. Diagnosis of Helicobacter‐pylori infection by the Lara™ system ‐ towards a simplified breath test. Gastroenterology 1995;108(4 suppl):A215.

Schumann 2006

Schumann C, Triantafilou K, Rasche FM, Moricke A, Vogt K, Triantafilou M, et al. Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease. Ijmm International Journal of Medical Microbiology 2006;296(4‐5):223‐8.

Schwarzer 2007

Schwarzer A, Lottspeich C, Russmann H, Ossiander G, Koletzko S. Evaluation of a novel rapid one‐step monoclonal chromatographic immunoassay for detection of Helicobacter pylori in stool from children. European Journal of Clinical Microbiology & Infectious Diseases 2007;26(7):475‐80.

Sedlackova 1992

Sedlackova M, Soucek A, Mucksova J. Serologic detection of antibodies to Helicobacter pylori in children and adolescents using ELISA. Ceskoslovenska Pediatrie 1992;47(10):577‐80.

Sen 2005

Sen N, Yilmaz O, Simsek I, Kupelioglu AA, Ellidokuz H. Detection of Helicobacter pylori DNA by a simple stool PCR method in adult dyspeptic patients. Helicobacter 2005;10(4):353‐9.

Sen 2011

Sen N, Demiray‐Gurbuz E, Yilmaz O, Kupeliotlu A, Simsek I. Comparing the accuracy of stool antigen tests for the detection of Helicobacter pylori infection in Turkish dyspeptic patients. Helicobacter 2011;16:114‐5.

Seo 2004

Seo JK. Diagnostic validity of the Helicobacter pylori stool antigen test before and after eradication treatment. Taehan Sohwagi Hakhoe Chi [Korean Journal of Gastroenterology] 2004;44(4):229‐35.

Seo 2013

Seo JH, Jun JS, Youn HS, Yeom JS, Park JS, Park CH, et al. Development of an ELISA for quantitative detection of immunoglobulin g (IgG) and IgA antibodies to Helicobacter pylori for use in Korean patients with H. pylori‐associated diseases. Gut and Liver 2013;7(4):437‐42.

Serrano 2008

Serrano CA, Gonzalez CG, Rollan AR, Duarte I, Torres J, Pena AJ, et al. Lack of diagnostic utility of specific immunoglobulin m in Helicobacter pylori infection in children. Journal of Pediatric Gastroenterology and Nutrition 2008;47(5):612‐7.

Sfarti 2009

Sfarti C, Stanciu C, Cojocariu C, Trifan A. 13C‐urea breath test for the diagnosis of Helicobacter pylori infection in bleeding duodenal ulcer. Revista Medico‐Chirurgicala a Societatii de Medici si Naturalisti Din Lasi 2009;113(3):704‐9.

Shaikh 2005

Shaikh S, Khaled MA, Islam A, Kurpad AV, Mahalanabis D. Evaluation of stool antigen test for Helicobacter pylori infection in asymptomatic children from a developing country using 13C‐urea breath test as a standard. Journal of Pediatric Gastroenterology & Nutrition 2005;40(5):552‐4.

Sharma 1995

Sharma TK, Cutler AF. Relationship between the magnitude of c‐13 urea breath test‐results and endoscopic diagnoses in Helicobacter‐pylori infected individuals. Gastroenterology 1995;108(4 (suppl)):A217.

Sharma 1997

Sharma TK, Young EL, Miller S, Cutler AF. Evaluation of a rapid, new method for detecting serum igg antibodies to Helicobacter pylori. Clinical Chemistry 1997;43(5):832‐6.

Sharma 1999

Sharma BC, Bhasin DK, Pathak CM, Sinha SK, Ray P, Vaiphei K, et al. C‐14 ‐urea breath test to confirm eradication of Helicobacter pylori. Journal of Gastroenterology and Hepatology 1999;14(4):309‐12.

Sharma 2015

Sharma U, Rehmani B, Shirazi N, Mittal G. A study of Helicobacter pylori infection in perforated peptic ulcer disease. International Journal of Surgery 2015;23:S119‐S20.

She 2009

She RC, Wilson AR, Litwin CM. Evaluation of Helicobacter pylori immunoglobulin g (igg), iga, and igm serologic testing compared to stool antigen testing. Clinical and Vaccine Immunology 2009;16(8):1253‐5.

Sheikhian 2007

Sheikhian A, Hassan Zuhair M, Mostafaie A. Detection of Helicobacter pylori diagnostic antigens in the stool of infected patients. Iranian Journal of Medical Sciences 2007;32(4):198‐204.

Shepherd 2000

Shepherd AJ, Williams CL, Doherty CP, Hossack M, Preston T, McColl KEL, et al. Comparison of an enzyme immunoassay for the detection of Helicobacter pylori antigens in the faeces with the urea breath test. Archives of Disease in Childhood 2000;83(3):268‐70.

Sheu 1997

Sheu BS, Lee SC, Lin XZ. Quantitative result of c‐13 urea breath test can predict the bacterial density of h‐pylori. Gut 1997;41:A84.

Sheu 1999a

Sheu BS, Lee SC, Yang HB, Lin XZ. Quantitative result of c‐13 urea breath test at 15 minutes may correlate with the bacterial density of h‐pylori in the stomach. Hepato‐Gastroenterology 1999;46(27):2057‐62.

Sheu 1999b

Sheu BS, Lee SC, Wang YL, Shiesh SC, Yang HB, Lin XZ. A lower cut‐off point of c‐13 urea breath test is more suitable to monitor the success of h‐pylori eradication. Gut 1999;45(Suppl 3):A125.

Sheu 2000a

Sheu BS, Lee SC, Yang HB, Kuo AW, Wang YL, Shiesh SC, et al. Selection of lower cutoff point of c‐13 urea breath test is helpful to monitor h‐pylori eradication after proton pump inhibitor‐based triple therapy. Digestive Diseases and Sciences 2000;45(7):1330‐6.

Sheu 2000b

Sheu BS, Lee SC, Yang HB, Wu HW, Wu CS, Lin XZ, et al. Lower‐dose c‐13‐urea breath test to detect Helicobacter pylori infection ‐ comparison between infrared spectrometer and mass spectrometry analysis. Alimentary Pharmacology & Therapeutics 2000;14(10):1359‐63.

Sheu 2000c

Sheu BS, Lee SC, Lin PW, Wang ST, Chang YC, Yang HB, et al. (13)carbon urea breath test is not as accurate as endoscopy to detect Helicobacter pylori after gastrectomy. Gastrointestinal Endoscopy 2000;51(6):670‐5.

Sheu 2002

Sheu BS, Yang HB, Wang YL, Kao AW, Chuang CH, Lin PW, et al. Stool antigen assay to screen h‐pylori infection and to assess the success of 3‐day and 7‐day eradication therapy in the patients with partial gastrectomy. Helicobacter 2002;7(3):199‐204.

Shiba 1998

Shiba K. The rapid method in microbiology using chemical method and immunochemical method. Rinsho Biseibutsu Jinsoku Shindan Kenkyukai Shi [Journal of the Association for Rapid Method and Automation in Microbiology] 1998;9(2):73‐81.

Shimada 1994

Shimada T, Ogura K, Ota S, Terano A, Takahashi M, Hamada E, et al. Identification of Helicobacter pylori in gastric specimens, gastric juice, saliva, and faeces of Japanese patients. Lancet 1994;343(8913):1636‐7.

Shimizu 2003a

Shimizu T, Yarita Y, Haruna H, Kaneko K, Yamashiro Y, Gupta R, et al. Urine‐based enzyme‐linked immunosorbent assay for the detection of Helicobacter pylori antibodies in children. Journal of Paediatrics & Child Health 2003;39(8):606‐10.

Shimizu 2003b

Shimizu T, Fujii T, Haruna H, Shoji H, Kudo T, Yamashiro Y. Effects of stool dilution on the faecal Helicobacter pylori antigen test. Journal of Paediatrics and Child Health 2003;39(4):286‐8.

Shimoyama 1996

Shimoyama T, Fukuda Y, Fukuda S, Munakata A, Yoshida Y, Shimoyama T. Validity of various diagnostic tests to evaluate cure of Helicobacter pylori infection. Journal of Gastroenterology 1996;31(2):171‐4.

Shimoyama 2009a

Shimoyama T, Oyama T, Matsuzaka M, Danjo K, Nakaji S, Fukuda S. Comparison of a stool antigen test and serology for the diagnosis of Helicobacter pylori infection in mass survey. Helicobacter 2009;14(2):87‐90.

Shimoyama 2009b

Shimoyama T, Kato C, Kodama M, Kobayashi I, Fukuda Y. Applicability of a monoclonal antibody‐based stool antigen test to evaluate the results of Helicobacter pylori eradication therapy. Japanese Journal of Infectious Diseases 2009;62(3):225‐7.

Shimoyama 2010

Shimoyama T, Kobayashi I, Kato C, Kodama M, Fukuda Y. Comparison of monoclonal antibody‐based stool antigen tests to determine the results of Helicobacter pylori eradication therapy. Scandinavian Journal of Gastroenterology 2010;45(12):1431‐4.

Shimoyama 2011

Shimoyama T, Sawaya M, Ishiguro A, Hanabata N, Yoshimura T, Fukuda S. Applicability of a rapid stool antigen test, using monoclonal antibody to catalase, for the management of Helicobacter pylori infection. Journal of Gastroenterology 2011;46(4):487‐91.

Shimoyama 2014

Shimoyama T, Chinda D, Ebina T, Iwamura H, Fukuda S. Screening of Helicobacter pylori infection using stool antigen test for young adults in a Japanese population with high incidence of gastric cancer. Helicobacter 2014;19:121.

Shimoyama 2015

Shimoyama T, Sawada Y, Fukuda S. Accuracy of a stick‐type kit and enzyme‐linked immunosorbent assay for the detection of Helicobacter pylori antibodies in urine. American Journal of Gastroenterology 2015;110:S1020.

Shirin 2001

Shirin H, Kenet G, Shevah O, Wardi Y, Birkenfeld S, Shahmurov M, et al. Evaluation of a novel continuous real time c‐13 urea breath analyser for Helicobacter pylori. Alimentary Pharmacology & Therapeutics 2001;15(3):389‐94.

Shirin 2003

Shirin H, Frenkel D, Shevah O, Levine A, Bruck R, Moss SF, et al. Effect of proton pump inhibitors on the continuous real time c‐13‐urea breath test. American Journal of Gastroenterology 2003;98(1):46‐50.

Shirin 2005

Shirin H, Levine A, Shevah O, Shabat‐Sehayek V, Aeed H, Wardi J, et al. Eradication of Helicobacter pylori can be accurately confirmed 14 days after termination of triple therapy using a high‐dose citric acid‐based c‐13 urea breath test. Digestion 2005;71(4):208‐12.

Shmuely 2007

Shmuely H, Yahav J, Samra Z, Chodick G, Ofek I. Elevated c‐13 urea breath test values females infected with Helicobacter pylori. Digestive Diseases and Sciences 2007;52(2):402‐4.

Shuber 2002

Shuber AP, Ascaño JJ, Boynton KA, Mitchell A, Frierson HF, El‐Rifai W, et al. Accurate, noninvasive detection of Helicobacter pylori DNA from stool samples: Potential usefulness for monitoring treatment. Journal of Clinical Microbiology 2002;40(1):262‐4.

Shukla 2012

Shukla S, Pujani M, Agarwal A, Pujani M, Rohtagi A. Correlation of serology with morphological changes in gastric biopsy in Helicobacter pylori infection and evaluation of immunohistochemistry for h. Pylori identification. Saudi Journal of Gastroenterology 2012;18(6):369‐74.

Sicinschi 2003a

Sicinschi LA, Correa P, Schneider BG. Comparison of genotyping of Helicobacter pylori caga and vaca virulence genes from gastric biopsies and stool specimens. Helicobacter 2003;8(6):601‐7.

Sicinschi 2003b

Sicinschi LA, Correa P, Bravo LE, Schneider BG. Detection and typing of Helicobacter pylori caga/vaca genes by radioactive, one‐step polymerase chain reaction in stool samples from children. Journal of Microbiological Methods 2003;52(2):197‐207.

Siddiqui 2010

Siddiqui AA, Ansari MA, Rahman RU, Jabeen R, Qureshi NR, Kashoob MB. Comparison between Helicobacter pylori fecal antigen detection and endoscopic gastric biopsy in diagnosis of h. Pylori infection in 50 adult cases. Journal of the Liaquat University of Medical and Health Sciences 2010;9(1):23‐6.

Silva 2009

Silva DG, Stevens RH, Macedo JMB, Hirata R, Pinto AC, Alves LM, et al. Higher levels of salivary muc5b and muc7 in individuals with gastric diseases who harbor Helicobacter pylori. Archives of Oral Biology 2009;54(1):86‐90.

Sito 1994

Sito E, Karczewska E, Szczeba J, Kaminski K, Oleksy J, Nowak‐Sadzikowska J, et al. Comparative evaluation of culture techniques and ELISA test in detection of Helicobacter pylori infection. Medycyna Doswiadczalna i Mikrobiologia 1994;46(4):301‐4.

Slade 1999

Slade PE, Davidson AR, Steel A, Cox RA, Blackburn PA. Reducing the endoscopic workload: Does serological testing for Helicobacter pylori help?. European Journal of Gastroenterology & Hepatology 1999;11(8):857‐62.

Slater 2004

Slater C, Preston T, Weaver LT. Is there an advantage in normalising the results of the Helicobacter pylori c‐13 urea breath test for co2 production rate in children?. Isotopes in Environmental and Health Studies 2004;40(1):89‐98.

Slomianski 1994

Slomianski A, Schubert T, Cutler AF. C‐13 urea breath test to confirm eradication of Helicobacter‐pylori. Gastroenterology 1994;106(4 (suppl)):A183.

Slomianski 1995

Slomianski A, Schubert T, Cutler AF. [13C]urea breath test to confirm eradication of Helicobacter pylori. American Journal of Gastroenterology 1995;90(2):224‐6.

Smith 2006

Smith SI, Oyedeji KS, Odeniyi OAM, Arigbabu AO, Coker AO. Diagnosis of Helicobacter pylori infection among patients with dental caries by stool antigen test. British Journal of Biomedical Science 2006;63(3):144‐5.

Smith 2009

Smith SI, Omonigbehin EA, Goodluck HA, Abdulkareem FB, Onyekwere CA, Agomo C, et al. The use of histology as a gold standard for diagnosis of h. Pylori in Nigeria. Helicobacter 2009;14(4):342.

Smith 2010

Smith SI, Fowora MA, Lesi OA, Agbebaku E, Abdulkareem FB, Contreras M, et al. Application of stool‐PCR test for the diagnosis of h. Pylori in Nigeria. Helicobacter 2010;15(4):363.

Smith 2011

Smith SI, Oyedeji KS, Goodluck HA, Fowora MA, Anomneze E, Lesi OA. The use of Helicobacter pylori stool antigen test for the diagnosis of Helicobacter pylori in Lagos, Nigeria. West Indian Medical Journal 2011;60(1):33‐5.

Smith 2012

Smith SI, Fowora MA, Lesi OA, Agbebaku E, Odeigah P, Abdulkareem FB, et al. Application of stool‐PRC for the diagnosis of Helicobacter pylori from stool in Nigeria‐ a pilot study. Springerplus 2012;1(1):78. [DOI: 10.1186/2193‐1801‐1‐78]

Snyder 1999

Snyder JD, Veldhuyzen Van Zanten S. Novel diagnostic tests to detect Helicobacter pylori infection: A pediatric perspective. Canadian Journal of Gastroenterology 1999;13(7):585‐9.

Sobala 1991

Sobala GM, Crabtree JE, Pentith JA, Rathbone BJ, Shallcross TM, Wyatt JI, et al. Screening dyspepsia by serology to Helicobacter pylori. Lancet 1991;338(8759):94‐6.

Sokucu 2002

Sokucu S, Suoglu OD, Turkkan E, Elkabes B, Ozden T, Saner G. Helicobacter pylori infection in turkish children with gastrointestinal symptoms and evaluation of serology. Turkish Journal of Pediatrics 2002;44(2):102‐8.

Song 2000

Song Q, Lange T, Spahr A, Adler G, Bode G. Characteristic distribution pattern of Helicobacter pylori in dental plaque and saliva detected with nested PCR. Journal of Medical Microbiology 2000;49(4):349‐53.

Song 2014

Song Y, Jiang K, Jin H, Wang BM. The application of methane and hydrogen breath test in the diagnosis and treatment of Helicobacter pylori. Journal of Digestive Diseases 2014;15:116.

Sonmezoglu 2005

Sonmezoglu M, Baysal B, Ergen A, Barut SG. Detection and evaluation of salivary antibodies to Helicobacter pylori in dyspeptic patients. International Journal of Clinical Practice 2005;59(4):433‐6.

Sorberg 1997

Sorberg M, Engstrand L, Strom M, Jonsson KA, Jorbeck H, Granstrom M. The diagnostic value of enzyme immunoassay and immunoblot in monitoring eradication of Helicobacter pylori. Scandinavian Journal of Infectious Diseases 1997;29(2):147‐51.

Steen 1995

Steen T, Berstad K, Meling T, Berstad A. Reproducibility of the 14c urea breath test repeated after 1 week. American Journal of Gastroenterology 1995;90(12):2103‐5.

Stege 2010

Stege PW, Raba J, Messina GA. Online immunoaffinity assay‐ce using magnetic nanobeads for the determination of anti‐Helicobacter pylori IgG in human serum. Electrophoresis 2010;31(20):3475‐81.

Stermer 1997

Stermer E, Levy N, Tabak M, Neeman I. Lanzoprazole and ranitidine affect the accuracy of the 14c‐urea breath test by a ph‐dependent mechanism. American Journal of Gastroenterology 1997;92(9):1575‐6.

Sternberg 1997

Sternberg A, Coscas D, Wagner Y, Auslander L, Kaufshtein M, Fireman Z. Comparison of various Helicobacter pylori detection methods: Serology, histology and bacteriology. Israel Journal of Medical Sciences 1997;33(3):160‐3.

Stirling 1995

Stirling N, McCallion W. Helicobacter pylori gastritis: Non‐invasive diagnosis. Paediatric Nursing 1995;7(2):17‐9.

Stojkovic 2011

Stojkovic M, Durutovic DR, Petrovic MN, Stojkovic MV, Petrovic NS, Antic AA, et al. Helicobacter pylori infection in various groups of patients studied, estimated by 14c‐urea breath test. Acta Chirurgica Iugoslavica 2011;58(1):95‐8.

Stone 1997

Stone MA, Mayberry JF, Wicks ACB, Livsey SA, Stevens M, Swann RA, et al. Near patient testing for Helicobacter pylori: A detailed evaluation of the cortecs helisal rapid blood test. European Journal of Gastroenterology & Hepatology 1997;9(3):257‐60.

Storskrubb 2005

Storskrubb T, Aro P, Ronkainen J, Vieth M, Stolte M, Wreiber K, et al. A negative Helicobacter pylori serology test is more reliable for exclusion of premalignant gastric conditions than a negative test for current h. Pylori infection: A report on histology and h. Pylori detection in the general adult population. Scandinavian Journal of Gastroenterology 2005;40(3):302‐11.

Stray‐Pedersen 2007

Stray‐Pedersen A, Gaustad P, Stray‐Pedersen B, Rognum TO. Detection rate of Helicobacter pylori stool antigen in newborn infants and small children. Journal of Perinatal Medicine 2007;35(2):155‐8.

Stuppy 2010

Stuppy W, Everitt M. Correlation of salivary antibody (HPSAigg) and stool antigen (hpstag) in Helicobacter pylori infection. American Journal of Gastroenterology 2010;105:S46.

Stuppy 2011

Stuppy W, El Khoury M. Pre‐ and post‐treatment correlation of salivary antibody with stool antigen in Helicobacter pylori infection. American Journal of Gastroenterology 2011;106:S49.

Sudraba 2010

Sudraba A, Funka K, Tolmanis I, Vanags A, Daugule I, Janciauskas D, et al. Gastric biomarkers in h. Pylori positive and negative patients. Helicobacter 2010;15(4):353.

Sudraba 2011

Sudraba A, Daugule I, Rudzite D, Funka K, Tolmanis I, Engstrand L, et al. Performance of routine Helicobacter pylori tests in patients with atrophic gastritis. Journal of Gastrointestinal & Liver Diseases 2011;20(4):349‐54.

Sue 1996

Sue M, Peura D, Charles C, Doobay R, Reid H, Morris E, et al. Comparison of two treatment strategies for the eradication of h‐pylori utilizing a screening antibody serum blot test and confirmatory c 14 breath test. Gastroenterology 1996;110(4 (suppl)):A266.

Sugiyama 1991

Sugiyama T, Imai K, Yoshida H, Takayama Y, Yabana T, Yokota K, et al. A novel enzyme immunoassay for serodiagnosis of Helicobacter pylori infection. Gastroenterology 1991;101(1):77‐83.

Sujatha 2013

Sujatha R, Arunagiri D, Singh DN, Hariomsharan. Diagnosis of Helicobacter pylori associated acid peptic disease by serology and rapid urease test. Journal of Pure and Applied Microbiology 2013;7(1):691‐5.

Sukhanov 2011

Sukhanov AV, Pikerskii IE, Saifutdinov RG, Makarov AA, Frolov SV. Comparison of various diagnostic methods of Helicobacter infection. Eksperimental'naia i Klinicheskaia Gastroenterologiia [Experimental & Clinical Gastroenterology] 2011;5:8‐15.

Sumona 2009

Sumona AA, Hossain MA, Musa AK, Shamsuzzaman AK, Mahmud MC, Khan MS, et al. Anti h.Pylori igm in symptomatic and asymptomatic population. Mymensingh Medical Journal: MMJ 2009;18(1):18‐20.

Sunnerstam 1999

Sunnerstam B, Kjerstadius T, Jansson L, Giesecke J, Bergstrom M, Ejderhamn J. Detection of Helicobacter pylori antibodies in a pediatric population: Comparison of three commercially available serological tests and one in‐house enzyme immunoassay. Journal of Clinical Microbiology 1999;37(10):3328‐31.

Surveyor 1988

Surveyor I, Goodwin CS, Warren JR, Geelhoed E, Murray RN, Waters TE. Further experience of the c‐14 urea breath test for the detection of c‐pylori infection. Australian and New Zealand Journal of Medicine 1988;18(3):505.

Suto 1997a

Suto H, Azuma T, Ito S, Ito Y, Miyaji H, Yamazaki Y, et al. Evaluation of the endoscopic c‐13‐urea breath test: A new accurate diagnostic test of Helicobacter pylori infection. Gastroenterology 1997;112(4 (suppl)):A301.

Suto 1997b

Suto H, Azuma T, Ito S, Ito Y, Miyaji H, Yamazaki Y, et al. A trial of 13C‐urea breath test combined with endoscopic phenol red test for detection of Helicobacter pylori infection. Digestive Endoscopy 1997;9(4):283‐9.

Suto 1999

Suto H, Azuma T, Ito S, Ito Y, Miyaji H, Yamazaki Y, et al. Evaluation of endoscopic c‐13‐urea breath test for assessment of Helicobacter pylori eradication. Journal of Gastroenterology 1999;34(Suppl 11):67‐71.

Suto 2000a

Suto H, Azuma T, Ito S, Ito Y, Miyaji H, Yamazaki Y, et al. Endoscopic13C‐urea breath test for quantification of Helicobacter pylori infection. Journal of Gastroenterology and Hepatology (Australia) 2000;15(2):161‐7.

Suto 2000b

Suto G, Vincze A, Pakodi F, Hunyady B, Karadi O, Garamszegi M, et al. C‐13‐urea breath test is superior in sensitivity to detect Helicobacter pylori infection than either antral histology or rapid urease test. Journal of Physiology‐Paris 2000;94(2):153‐6.

Suzuki 2010

Suzuki K, Shimoyama T, Kobayashi I, Kato C, Kodama M, Fukuda Y. Comparison of monoclonal antibody‐based stool antigen tests to determine the results of h. Pylori eradication therapy. Helicobacter 2010;15 (4):358.

Syam 2005

Syam AF, Rani AA, Abdullah M, Manan C, Makmun D, Simadibrata M, et al. Accuracy of Helicobacter pylori stool antigen for the detection of Helicobacter pylori infection in dyspeptic patients. World Journal of Gastroenterology 2005;11(3):386‐8.

Sykora 2002

Sykora J, Valeckova K, Hejda V, Varvarovska J, Stozicky F. Accurate noninvasive diagnosis of Helicobacter pylori infection using antigen determination in the feces in the pediatric population. Casopis Lekaru Ceskych 2002;141(13):425‐7.

Sykora 2003

Sykora J, Valeckova K, Stozicky F, Schwarz J, Varvarovska J. Revealing of the Helicobacter pylori infection in children by detection of stool antigen by a novel enzyme immunoassay using monoclonal antibodies (hpstar). Casopis Lekaru Ceskych 2003;142(11):687‐90.

Taha 1992

Taha AS, Boothman P, Nakshabendi I, Reid J, Morran C, Gemmell CG, et al. Diagnostic tests for Helicobacter pylori: Comparison and influence of non‐steroidal anti‐inflammatory drugs. Journal of Clinical Pathology 1992;45(8):709‐12.

Taha 1993

Taha AS, Reid J, Boothmann P, Gemmell CG, Lee FD, Sturrock RD, et al. Serological diagnosis of Helicobacter pylori‐‐evaluation of four tests in the presence or absence of non‐steroidal anti‐inflammatory drugs. Gut 1993;34(4):461‐5.

Takagi 1993

Takagi A, Suyama T, Kida M, Matsuda M, Matsumoto H, Kojima K, et al. Comparison between ELISA and culture method for detection of Helicobacter pylori. Rinsho Byori [Japanese Journal of Clinical Pathology] 1993;41(12):1333‐7.

Takagi 2002

Takagi A, Mine T. Serodiagnosis of Helicobacter pylori infection. Nihon Rinsho [Japanese Journal of Clinical Medicine] 2002;60(Suppl 2):324‐7.

Takagi 2003

Takagi A. Detection of h. Pylori by serum and urine‐based ELISA. Nihon Rinsho [Japanese Journal of Clinical Medicine] 2003;61(1):88‐91.

Takahashi 2010

Takahashi R, Shimoyama T, Abe D, Nakabayashi N, Okuda M, Fukuda Y. Determining cut‐off values for serodiagnosis of Helicobacter hepaticus infection by hrii‐51‐hh‐15 capture enzyme‐linked immunosorbent assay. Helicobacter 2010;15(4):362.

Takwoingi 2013

Takwoingi Y, Leeflang MM, Deeks JJ. Empirical evidence of the importance of comparative studies of diagnostic test accuracy. Annals of internal medicine 2013;158(7):544‐54. [PUBMED: 23546566]

Takwoingi 2017

Takwoingi Y, Guo B, Riley RD, Deeks JJ. Performance of methods for meta‐analysis of diagnostic test accuracy with few studies or sparse data. Statistical Methods in Medical Research2017; Vol. 26, issue 4:1896‐911.

Talebkhan 2009

Talebkhan Y, Ebrahimzadeh F, Esmaeili M, Oghalaie A, Sadeghi M, Mohammadi M. H. Pylori immunoreactive antigens and their screening applications. Helicobacter 2009;14 (4):338.

Talebkhan 2010

Talebkhan Y, Esmaili M, Hassanpour P, Morakabati A, Rakhshani N, Mohagheghi M, et al. Comparison of routinely used invasive and non invasive approaches in diagnosis of h. Pylori infection. Helicobacter 2010;15(4):358‐9.

Talley 1991

Talley NJ, Newell DG, Ormand JE, Carpenter HA, Wilson WR, Zinsmeister AR, et al. Serodiagnosis of Helicobacter pylori: Comparison of enzyme‐linked immunosorbent assays. Journal of Clinical Microbiology 1991;29(8):1635‐9.

Talley 1992

Talley NJ, Kost L, Haddad A, Zinsmeister AR. Comparison of commercial serological tests for detection of Helicobacter pylori antibodies. Journal of Clinical Microbiology 1992;30(12):3146‐50.

Talley 1998

Talley NJ, Lambert JR, Howell S, Xia HH, Lin SK, Agreus L. An evaluation of whole blood testing for Helicobacter pylori in general practice. Alimentary Pharmacology & Therapeutics 1998;12(7):641‐5.

Talley 2008

Talley NJ, Fock KM, Moayyedi P. Gastric Cancer Consensus conference recommends Helicobacter pylori screening and treatment in asymptomatic persons from high‐risk populations to prevent gastric cancer. American Journal of Gastroenterology 2008;103(3):510‐4.

Tamura 2001

Tamura S, Yokoyama Y, Morita T, Tadokoro T, Higashidani Y, Onishi S. Stool test for Helicobacter pylori. American Journal of Gastroenterology 2001;96(6):1936‐8.

Tanahashi 1998

Tanahashi T, Kodama T, Yamaoka Y, Sawai N, Tatsumi Y, Kashima K, et al. Analysis of the c‐13‐urea breath test for detection of Helicobacter pylori infection based on the kinetics of delta‐(co2)‐c‐13 using laser spectroscopy. Journal of Gastroenterology and Hepatology 1998;13(7):732‐7.

Tanaka 2001

Tanaka A, Watanabe K, Tokunaga K, Hoshiya S, Imase K, Sugano H, et al. Evaluation of Helicobacter pylori stool antigen test before and after eradication therapy. Gut 2001;49(suppl):A101.

Tanaka 2003

Tanaka A, Watanabe K, Tokunaga K, Hoshiya S, Imase K, Sugano H, et al. Evaluation of Helicobacter pylori stool antigen test before and after eradication therapy. Journal of Gastroenterology & Hepatology 2003;18(6):732‐8.

Tanaka 2004

Tanaka A, Takahashi S. Helicobacter pylori stool antigen test. Nihon Rinsho [Japanese Journal of Clinical Medicine] 2004;62(3):464‐9.

Tanaka 2005

Tanaka A, Tokunaga K, Imase K, Sugano H, Ishida H, Takahashi S. Evaluation of rapid h‐pylori stool antigen test before and after eradication therapy. American Journal of Gastroenterology 2005;100(9):S69‐70.

Tanigawa 1996

Tanigawa T, Mizo‐oku Y, Moriguchi K, Suzuki T, Osumi T, Odomi M. Simple and rapid quantitative assay of 13C‐labelled urea in human serum using liquid chromatography‐atmospheric pressure chemical ionization mass spectrometry. Journal of Chromatography B: Biomedical Applications 1996;683(2):135‐42.

Taniguchi 1995

Taniguchi Y, Kimura K, Satoh K, Kawada H, Sohara H, Yamamoto H, et al. Substitute, inexpensive diagnosis of Helicobacter‐pylori infection by infrared (ir) spectrophotometer in c‐13‐urea breath test. Gastroenterology 1995;108(4 (Suppl)):A235.

Taylor 1987

Taylor DE, Chang N. Immunoblot and enzyme‐linked immunosorbent assays of campylobacter major outer‐membrane protein and application to the differentiation of campylobacter species. Molecular & Cellular Probes 1987;1(3):261‐74.

Taylor 2014

Taylor J, Hafner M, Yerushalmi E, Smith R, Bellasio J, Vardavas R, et al. Estimating the economic costs of antimicrobial resistance. Model and Results. www.rand.org/pubs/research_reports/RR911.html 2014 (accessed 15 December 2016).

Teich 1997

Teich M, Bohn I, Niessen KH. Validation of a children's c‐13‐urea breath test for diagnosis of Helicobacter pylori. Monatsschrift Kinderheilkunde 1997;145(3):242‐8.

Temelli 2011

Temelli B, Velipasaoglu Z, Akdemir E, Bozkurt MF. Efficacy of carbon‐14 urea breath test in the diagnosis of Helicobacter pylori infection in children: Comparison among different tests to find out the best. European Journal of Nuclear Medicine and Molecular Imaging 2011;38:S190‐S1.

Teo 1997

Teo EK, Fock KM, Ng TM, Khor CJL, Lee YM, Sim CS. 13 carbon‐urea breath test for detection of h‐pylori infection. Gastroenterology 1997;112(4 suppl):A311.

Tepes 2015

Tepes B, Malfertheiner P, Labenz J, Aygen S. The accuracy of a new c‐13 urea breath test meal (refex (r)) for Helicobacter pylori in patients taking proton pump inhibitors. Helicobacter 2015;20:81.

Tereshchenko 2014

Tereshchenko S, Gorbacheva N, Anisimova E, Babushkin V. The diagnostic accuracy of Helicobacter pylori antigen detection in duodenal juice. Helicobacter 2014;19:125‐6.

Tewari 2001

Tewari V, Nath G, Gupta H, Dixit VK, Jain AK. 14c‐urea breath test for assessment of gastric Helicobacter pylori colonization and eradication. Indian Journal of Gastroenterology 2001;20(4):140‐3.

Tham 1993

Tham TCK, McLaughlin N, Hughes DF, Ferguson M, Crosbie JJ, Madden M, et al. Evaluation of a commercial ELISA for the serodiagnosis of Helicobacter‐pylori infection. Gastroenterology 1993;104(4 suppl):A210.

Tham 1994

Tham TCK, McLaughlin M, Hughes DF, Ferguson M, Crosbie JJ, Madden M, et al. Possible role of Helicobacter pylori serology in reducing endoscopy workload. Postgraduate Medical Journal 1994;70(829):809‐12.

Thijs 1994

Thijs JC, Van Zwet AA, Meyer BC, Berrelkamp RJP. Serology to monitor the efficacy of anti‐Helicobacter pylori treatment. European Journal of Gastroenterology & Hepatology 1994;6(7):579‐83.

Thijs 1995a

Thijs WJ, Thijs JC, Kleibeuker JH, Elzinga H, Stellaard F. Evaluation of clinical and home performance of the 13C‐urea breath test for the detection of Helicobacter pylori. European Journal of Gastroenterology & Hepatology 1995;7(7):603‐7.

Thijs 1995b

Thijs WJ, Thijs JC, Kleibeuker JH, Elzinga H, Stellaard F. The c‐13‐urea breath test for the detection of Helicobacter‐pylori ‐ an analysis of the test performed clinically and at home. Gastroenterology 1995;108(4 (suppl)):A241.

Thijs 1996

Thijs JC, Van Zwei AA, Thijs WJ, Oey HB, Karrenbeld A, Stellaard F, et al. Diagnostic tests for Helicobacter pylori: A prospective evaluation of their accuracy, without selecting a single test as the gold standard. American Journal of Gastroenterology 1996;91(10):2125‐9.

Thillainayagam 1991

Thillainayagam AV, Arvind AS, Cook RS, Harrison IG, Tabaqchali S, Farthing MJG. Diagnostic efficiency of an ultrarapid endoscopy room test for Helicobacter‐pylori. Gut 1991;32(5):467‐9.

Thomas 1990

Thomas JE, Whatmore AM, Barer MR, Eastham EJ, Kehoe MA. Serodiagnosis of Helicobacter pylori infection in childhood. Journal of Clinical Microbiology 1990;28(12):2641‐6.

Thomas 1999

Thomas JE, Dale A, Harding M, Coward WA, Cole TJ, Sullivan PB, et al. Interpreting the c‐13‐urea breath test among a large population of young children from a developing country. Pediatric Research 1999;46(2):147‐51.

Thongbai 2007

Thongbai T, Thong‐Ngam D, Mahachai V, Kullavanijaya P. Effect of antiulcer drugs used on the detection of Helicobacter pylori using urea breath test. Helicobacter 2007;12(4):443.

Tindberg 2001

Tindberg Y, Bengtsson C, Bergstrom M, Granstrom M. Phe accuracy of serologic diagnosis of Helicobacter pylori infection in school‐aged children of mixed ethnicity. Helicobacter 2001;6(1):24‐30.

Tinnert 1998

Tinnert A, Hamlet A, Svennerholm AM. Antibodies against Helicobacter pylori in feces and saliva before and after eradication therapy. Clinical Microbiology and Infection 1998;4(11):634‐43.

Tiryaki 2010

Tiryaki Z, Yilmaz‐Ciftdogan D, Kasirga E. Diagnostic value of stool antigen and antibody tests for Helicobacter pylori infection in Turkish children with upper gastrointestinal complaints before and after eradication. Turkish Journal of Pediatrics 2010;52(5):505‐11.

Togashi 2006

Togashi A, Matsukura N, Kato S, Masuda G, Ohkawa K, Tokunaga A, et al. Simple and accurate c‐13‐urea breath test for detection of Helicobacter pylori in the remnant stomach after surgery. Journal of Gastroenterology 2006;41(2):127‐32.

Tokunaga 1998

Tokunaga Y, Shirahase H, Yamamoto E, Gouda Y, Kanaji K, Ohsumi K. Semiquantitative evaluation for diagnosis of Helicobacter pylori infection in relation to histological changes. American Journal of Gastroenterology 1998;93(1):26‐9.

Tokunaga 2000

Tokunaga Y, Shirahase H, Yamamoto E, Inao R, Hamaguchi S, Kanaji K, et al. Modified rapid urease test for Helicobacter pylori detection in relation to an immunohistochemical stain. Journal of Gastroenterology and Hepatology 2000;15(6):617‐21.

Tokunaga 2005

Tokunaga K, Watanabe K, Tanaka A, Sugano H, Imase K, Ishida H, et al. Evaluation of 13C‐urea breath test to confirm eradication of Helicobacter pylori. Japanese Journal of Gastroenterology 2005;102(2):176‐82.

Toporowska‐Kowalska 2005

Toporowska‐Kowalska E, Wasowska‐Krolikowska K, Kurnatowski M, Gebora‐Kowalska B. Clinical applicability of non‐invasive testing of Helicobacter pylori infection in children ‐ stool antygen (HPSA) and urea breath test. Pediatria Wspolczesna 2005;7(3):177‐9.

Tormo 2013

Tormo R. Urea c‐13 test is not enough to diagnose a Helicobacter pylori infection. Journal of Pediatric Gastroenterology and Nutrition 2013;56(6):e53.

Torres 2001

Torres J, Camorlinga M, Perez‐Perez G, Gonzalez G, Muñoz O. Validation of the string test for the recovery of Helicobacter pylori from gastric secretions and correlation of its results with urea breath test results, serology, and gastric ph levels. Journal of Clinical Microbiology 2001;39(4):1650‐1.

Toyama 1999

Toyama J, Kato C, Sato K, Sato S. The 13C‐urea breath test efficacy in determining Helicobacter pylori eradication. Nihon Rinsho [Japanese Journal of Clinical Medicine] 1999;57(1):93‐6.

Trautmann 1994

Trautmann M, Moldrzyk M, Vogt K, Korber J, Held T, Marre R. Use of a receiver operating characteristic in the evaluation of two commercial enzyme immunoassays for detection of Helicobacter pylori infection. European Journal of Clinical Microbiology & Infectious Diseases 1994;13(10):812‐9.

Treiber 2000

Treiber G, Malfertheiner P. Usefulness of serology for diagnosis and follow‐up of h.pylori infection ‐ comparison of third vs. second generation ELISA. Gastroenterology 2000;118(4 Part 2):A1316.

Trevisani 1998

Trevisani L, Sartori S, Galvani F, Rossi MR, Ruina M, Caselli M. Detection of Helicobacter pylori in faeces with a new enzyme immunoassay method: Preliminary results. Scandinavian Journal of Gastroenterology 1998;33(8):893‐4.

Trevisani 1999a

Trevisani L, Sartori S, Ruina M, Caselli M, Rossi MR, Costa F, et al. Helicobacter pylori stool antigen test ‐ clinical evaluation and cost analysis of a new enzyme immunoassay. Digestive Diseases and Sciences 1999;44(11):2303‐6.

Trevisani 1999b

Trevisani L, Sartori S, Galvani F, Rossi MR, Ruina M, Chiamenti C, et al. Evaluation of a new enzyme immunoassay for detecting Helicobacter pylori in feces: A prospective pilot study. American Journal of Gastroenterology 1999;94(7):1830‐3.

Trevisani 2002

Trevisani L, Sartori S. The accuracy of the Helicobacter pylori stool antigen test in diagnosing h‐pylori in treated patients. European Journal of Gastroenterology & Hepatology 2002;14(1):89.

Tseng 2005

Tseng CA, Wang WM, Wu DC. Comparison of the clinical feasibility of three rapid urease tests in the diagnosis of Helicobacter pylori infection. Digestive Diseases and Sciences 2005;50(3):449‐52.

Tu 1999

Tu TC, Lee CL, Wu CH, Chen TK, Chan CC, Huang SH, et al. Comparison of invasive and noninvasive tests for detecting Helicobacter pylori infection in bleeding peptic ulcers. Gastrointestinal Endoscopy 1999;49(3 I):302‐6.

Tucci 1996

Tucci A, Poli L, Donati M, Mazzoni C, Cevenini R, Sambri V, et al. Value of serology (ELISA) for the diagnosis of Helicobacter pylori infection: evaluation in patients attending endoscopy and in those with fundic atrophic gastritis. Italian Journal of Gastroenterology 1996;28(7):371‐6.

Tummala 2007

Tummala S, Sheth SG, Goldsmith JD, Goldar‐Najafi A, Murphy CK, Osburne MS, et al. Quantifying gastric Helicobacter pylori infection: A comparison of quantitative culture, urease breath testing, and histology. Digestive Diseases & Sciences 2007;52(2):396‐401.

Uchida 2011

Uchida T, Vilaichone R, Ratanachu‐Ek T, Mahachai V, Tshering L, Fujioka T, et al. Evaluation of diagnostic tests for h. Pylori infection in the Bhutanese population. Helicobacter 2011;16:114.

Ueda 2014

Ueda J, Okuda M, Nishiyama T, Lin YS, Fukuda Y, Kikuchi S. Diagnostic accuracy of the e‐plate serum antibody test kit in detecting Helicobacter pylori infection among Japanese children. Journal of Epidemiology 2014;24(1):47‐51.

Uematsu 2002

Uematsu T, Matsuno H, Tanba M, Kozawa O, Ikei N, Kawasaki J, et al. Clinical pharmacology study of c‐13 ubt tablet for the in vivo diagnosis of Helicobacter pylori infection. Japanese Journal of Clinical Pharmacology and Therapeutics 2002;33(3):81‐4.

Urita 2000

Urita Y, Miki K. Endoscopic 13C‐urea breath test. Digestive Endoscopy 2000;12(1):29‐32.

Urita 2002

Urita Y, Torii N, Hike K, Kikuchi Y, Kanda E, Sasajima M, et al. Proteinuria reduces the diagnostic accuracy of urine‐based enzyme‐linked immunosorbent assay for detection of antibody to Helicobacter pylori. American Journal of Gastroenterology 2002;97(9):S49.

Urita 2004a

Urita Y, Hike K, Torii N, Kikuchi Y, Kurakata H, Kanda E, et al. Comparison of serum iga and igg antibodies for detecting Helicobacter pylori infection. Internal Medicine 2004;43(7):548‐52.

Urita 2004b

Urita Y, Kikuchi Y, Hike K, Torii N, Kanda E, Kurakata H, et al. Endoscopic 13C‐urea breath test for detection of Helicobacter pylori infection after partial gastrectomy. Gastrointestinal Endoscopy 2004;59(5):AB153.

Urita 2004c

Urita Y, Hike K, Torii N, Kikuchi Y, Kanda E, Kurakata H, et al. Breath sample collection through the nostril reduces false‐positive results of c‐13‐urea breath test for the diagnosis of Helicobacter pylori infection. Digestive and Liver Disease 2004;36(10):661‐5.

Urita 2006

Urita Y, Hike K, Torii N, Kikuchi Y, Kanda E, Kurakata H, et al. Influence of urease activity in the intestinal tract on the results of c‐13‐urea breath test. Journal of Gastroenterology and Hepatology 2006;21(4):744‐7.

Urita 2007a

Urita Y, Maeda T, Ishihara S, Sugimoto M, Watanabe T, Domon K, et al. Endoscopic c‐13‐urea breath test for detection of Helicobacter pylori infection after partial gastrectomy. Hepato‐Gastroenterology 2007;54(78):1891‐4.

Urita 2007b

Urita Y, Hike K, Torii N, Kikuchi Y, Watanabe T, Kurakata H, et al. Ten‐second endoscopic breath test using a 20‐mg dose of c‐13‐urea to detect Helicobacter pylori infection. Hepato‐Gastroenterology 2007;54(75):951‐4.

Us 2002

Us D, Engin D, Hascelik G. Evaluation of western blot methods for serologic diagnosis of Helicobacter pylori infections. Mikrobiyoloji Bulteni 2002;36(2):153‐60.

Uyub 1994

Uyub AM, Anuar AK, Aiyar S. Reliability of two commercial serological kits for serodiagnosing Helicobacter pylori infection. Southeast Asian Journal of Tropical Medicine & Public Health 1994;25(2):316‐20.

Vafaeimanesh 2014

Vafaeimanesh J, Bagherzadeh M. Noninvasive stool antigen assay for screening of Helicobacter pylori infection and assessing success of eradication therapy in patients on hemodialysis. Journal of Gastroenterology and Hepatology (Australia) 2014;29:236.

Vaira 1989

Vaira D, Holton J. Serum immunoglobulin g antibody levels for campylobacter pylori diagnosis. Gastroenterology 1989;97(4):1069‐70.

Vaira 1996

Vaira D, Stanghellini V, Miglioli M, Corinaldesi R. IgG ELISA antibodies and detection of Helicobacter pylori in elderly patients. Italian Helicobacter pylori Study Group. Lancet 1996;347(8996):269‐70.

Vaira 1999a

Vaira D, Malfertheiner P, Megraud F, Axon AT. Diagnosis of Helicobacter pylori infection by HPSA test. European Helicobacter pylori HPSA study group. Lancet 1999;354(9191):1732.

Vaira 1999b

Vaira D, Malfertheiner P, Megraud F, Axon AT, Deltenre M, Hirschl AM, et al. Diagnosis of Helicobacter pylori infection with a new non‐invasive antigen‐based assay. Hpsa European Study Group. Lancet 1999;354(9172):30‐3.

Vaira 1999c

Vaira D, Malferteiner P, Megraud F, Moayyedi P, Axon ATR, Deltenre M, et al. Accuracy of a new antigen based stool test for Helicobacter pylori (hp) in 117 endoscoped patients before and after treatment. European Multicentre Study. Gut 1999;44(Suppl 3):A96.

Vaira 2000a

Vaira D, Menegatti M, Ricci C, Gatta L, Berardi S, Miglioli M. Accurate diagnosis of Helicobacter pylori stool tests. Gastroenterology Clinics of North America 2000;29(4):917‐23.

Vaira 2000b

Vaira D, Ricci C, Menegatti M, Gatta L, Geminiani A, Miglioli M. Clinical role of fecal antigen determination in the diagnosis of Helicobacter pylori infection. Clinical Laboratory 2000;46(9‐10):487‐91.

Vaira 2000c

Vaira D, Malfertheiner P, Megraud F, Axon AT, Deltenre M, Gasbarrini G, et al. Noninvasive antigen‐based assay for assessing Helicobacter pylori eradication: A European multicenter study. The European Helicobacter pylori HPSA Study Group. American Journal of Gastroenterology 2000;95(4):925‐9.

Vaira 2002

Vaira D, Vakil N, Menegatti M, Van't Hoff B, Ricci C, Gatta L, et al. The stool antigen test for detection of Helicobacter pylori after eradication therapy [summary for patients in Annals of Internal Medicine. feb 19 2002;136(4):I36; pmid: 11848739]. Annals of Internal Medicine 2002;136(4):280‐7.

Vaira 2009

Vaira D, Gatta L, Ricci C, Di Mario F, Lanzini A. Accuracy of urea breath tests tablets after 10 minutes compared with standard 30 minutes to diagnose and monitoring Helicobacter pylori infection: A randomized controlled trial. Journal of Clinical Gastroenterology 2009;43(7):693‐4.

Vaira 2010a

Vaira D, Vakil N, Gatta L, Ricci C, Perna F, Saracino I, et al. Accuracy of a new ultrafast rapid urease test to diagnose Helicobacter pylori infection in 1000 consecutive dyspeptic patients. Alimentary Pharmacology & Therapeutics 2010;31(2):331‐8.

Vaira 2010b

Vaira D, Gatta L, Ricci C, Perna F, Saracino I, Fiorini G, et al. A comparison amongst three rapid urease tests to diagnose Helicobacter pylori infection in 375 consecutive dyspeptic. Internal & Emergency Medicine 2010;5(1):41‐7.

Vakil 1999

Vakil N, Affi A, Sundaram M, Robinson J, Dunn B, Phadnis S. Prospective, blinded evaluation of the accuracy of a stool test for the detection of h‐pylori. Gastroenterology 1999;116(4 (suppl)):A342.

Vakil 2000a

Vakil N, Affi A, Robinson J, Sundaram M, Phadnis S. Prospective blinded trial of a fecal antigen test for the detection of Helicobacter pylori infection. American Journal of Gastroenterology 2000;95(7):1699‐701.

Vakil 2000b

Vakil N. Is the stool test out of breath?. Digestive & Liver Disease 2000;32(4):291‐3.

Valdeperez 2003

Valdeperez J, Vicente R, Novella MP, Valle L, Sicilia B, Yus C, et al. Is the breath test reliable in primary care diagnosis of Helicobacter pylori infection?. Atencion Primaria 2003;31(2):93‐7.

Valentine 1991

Valentine JL, Arthur RR, Mobley HLT, Dick JD. Detection of Helicobacter‐pylori by using the polymerase chain‐reaction. Journal of Clinical Microbiology 1991;29(4):689‐95.

Valle 1997

Valle J, Vazquez MA, Zomeno M, FernandezSalazar L, JimenezAlonso I, Lara S, et al. Direct correlation between the c‐13‐urea breath test values and the density of Helicobacter pylori in antrum biopsies. Gut 1997;41:A87.

Valle 2013

Valle PC, Breckan RK, Mortensen L, Amin A, Kildahl‐Andersen O, Paulssen EJ. Managing dyspepsia in the young adult patient: Effects of different tests for Helicobacter pylori in a "test‐and‐scope" approach. Scandinavian Journal of Gastroenterology 2013;48(8):913‐20.

Van Bohemen 1988

Van Bohemen CG, Langenberg ML, Rauws EAJ, Weterings E, Zanen HC. Assay‐igg to campylobacter pylori in histological chronic and biopsy campylobacter positive gastritis. FEMS Microbiology Letters 1988;55(3):321‐6.

Van Bohemen 1989

Van Bohemen CG, Langenberg ML, Rauws EAJ, Oudbier J, Weterings E, Zanen HC. Rapidly decreased serum igg to campylobacter pylori following elimination of campylobacter in histological chronic biopsy campylobacter‐positive gastritis. Immunology Letters 1989;20(1):59‐61.

Van de Wouw 1995

Van de Wouw BA, De Boer WA, Jansz AR, Staals AP, Roymans RT. Serodiagnosis of Helicobacter pylori infection: an evaluation of a commercially available ELISA‐IgG. Netherlands Journal of Medicine 1995;47(6):272‐7.

Van de Wouw 1996

Van de Wouw BA, De Boer WA, Jansz AR, Roymans RT, Staals AP. Comparison of three commercially available enzyme‐linked immunosorbent assays and biopsy‐dependent diagnosis for detecting Helicobacter pylori infection. Journal of Clinical Microbiology 1996;34(1):94‐7.

Van de Wouw 1997

Van de Wouw BA, De Boer WA, Hermsen HW, Valkenburg JG, Geuskens LM, Tytgat GN. Usefulness of the 14c urea breath test as a semi‐quantitative monitoring instrument after therapy for Helicobacter pylori infection. Scandinavian Journal of Gastroenterology 1997;32(2):112‐7.

Van Den 1991

Van Den Oever HLA, Loffeld RJLF, Stobberingh EE. Usefulness of a new serological test (bio‐rad) to diagnose Helicobacter pylori‐associated gastritis. Journal of Clinical Microbiology 1991;29(2):283‐6.

Van Der Ende 1999

Van Der Ende A, Van Der Hulst RWM, Roorda P, Tytgat GNJ, Dankert J. Evaluation of three commercial serological tests with different methodologies to assess Helicobacter pylori infection. Journal of Clinical Microbiology 1999;37(12):4150‐2.

Van der Est 1990

Van der Est MMC, Veenendaal RA, Pena AS, Van Duijn W, Kuiper I, Lamers CBHW. ELISA analysis of IgA subclass antibodies to Helicobacter pylori. Elevated serum IgA1 antibodies in Helicobacter pylori infected patients. Journal of Clinical Nutrition and Gastroenterology 1990;5(1):185‐90.

Van Der Hulst 1999

Van Der Hulst RWM, Lamouliatte H, Megraud F, Pounder RE, Stolte M, Vaira D, et al. Laser assisted ratio analyser 13C‐urea breath testing, for the detection of H. pylori: A prospective diagnostic European multicentre study. Alimentary Pharmacology & Therapeutics 1999;13(9):1171‐7.

Van der Hulst 1999

Van der Hulst RW, Hensen EF, Van der Ende A, Kruizinga SP, Homan A, Tytgat GN. Laser‐assisted 13C‐urea breath test; a new noninvasive detection method for Helicobacter pylori infection. Nederlands Tijdschrift voor Geneeskunde 1999;143(8):400‐4.

Van der Voort 1998

Van der Voort PHJ, Van der Hulst RWM, Zandstra DF, Geraedts AAM, Tytgat GNJ. Detection of h‐pylori in mechanically ventilated intensive care patients using the lara‐c‐13‐urea breath test. Gastroenterology 1998;114(4 (suppl)):A319.

Van der Voort 1999

Van der Voort PHJ, Van der Hulst RWM, Zandstra DF, Van der Ende A, Geraedts AAM, Tytgat GNJ. Detection of Helicobacter pylori in mechanically ventilated patients: The lara‐13C‐urea breath test and serology. Clinical Intensive Care 1999;10(3):91‐5.

Van der Wouden 1999

Van der Wouden ET, Thijs JC, Van Zwet AA, Oey HB, Kleibeuker JH. Reliability of biopsy‐based diagnostic tests for Helicobacter pylori after treatment aimed at its eradication. European Journal of Gastroenterology & Hepatology 1999;11(11):1255‐8.

Van Doorn 2000

Van Doorn LJ, Henskens Y, Nouhan N, Verschuuren A, Vreede R, Herbink P, et al. The efficacy of laboratory diagnosis of Helicobacter pylori infections in gastric biopsy specimens is related to bacterial density and vacA, cagA, and iceA genotypes. Journal of Clinical Microbiology 2000;38(1):13‐7.

Van Doorn 2001

Van Doorn OJ, Bosman DK, Van THBW, Taminiau JA, Ten Kate FJ, Van der Ende A. Helicobacter pylori stool antigen test: A reliable non‐invasive test for the diagnosis of Helicobacter pylori infection in children. European Journal of Gastroenterology & Hepatology 2001;13(9):1061‐5.

Van Leerdam 2002

Van Leerdam ME, Van der Ende A, Ten Kate F, Rauws EAJ, Tytgat GNJ. Lack of accuracy of the non‐invasive Helicobacter pylori stool antigen test in patients with gastroduodenal ulcer bleeding. Gastroenterology 2002;122(4 (suppl)):A46.

Van Leerdam 2003

Van Leerdam ME, Van der Ende A, Ten Kate FJW, Rauws EAJ, Tytgat GNJ. Lack of accuracy of the noninvasive Helicobacter pylori stool antigen test in patients with gastroduodenal ulcer bleeding. American Journal of Gastroenterology 2003;98(4):798‐801.

Van Zanten 1998

Van Zanten SV, Bleau BL, Best L, Hutchison D, Blevins J, Thee D. Use of the Helicobacter pylori stool antigen test (HPSAt) for detection of h‐pylori (hp) infection. Gut 1998;43(Suppl 2):A49.

Van Zanten 1999

Van Zanten S, Bleau BL, Best LM, Hutchison DM, Blevins J, Thee D. Helicobacter pylori stool antigen test (HPSA): Use for detection of infection and eradication. Gastroenterology 1999;116(4 (suppl)):A837.

Van Zwet 1992

Van Zwet AA, Meyer BC, Berrelkamp RJ, Thijs JC. Serological tests to monitor treatment of Helicobacter pylori. Lancet 1992;340(8810):51.

Van Zwet 1994

Van Zwet AA, Thijs JC, Kooistra‐Smid AMD, Schirm J, Snijder JAM. Use of PCR with feces for detection of Helicobacter pylori infections in patients. Journal of Clinical Microbiology 1994;32(5):1346‐8.

Van't Hoff 2000

Van't Hoff BW, Vaira D, Vakil NB, Gasbarrini G, Quina M, Garcia JMP, et al. Early diagnosis of failed Helicobacter pylori (hp) eradication using a stool antigen test. Gastroenterology 2000;118(4):A697.

Vannella 2009

Vannella L, Gianni D, Lahner E, Amato A, Grossi E, Delle Fave G, et al. Pre‐endoscopic screening for Helicobacter pylori and celiac disease in young anemic women. World Journal of Gastroenterology 2009;15(22):2748‐53.

Vargas 2013

Vargas J, Lopez‐Sanchez M, Pabon M, Lamas E, Parra M, CastroFernandez M. Evaluation of a novel chemiluminiscent inmunoassay for the detection of Helicobacter pylori antigen and their correlation with immunochromatographic rapid test in stools samples from adults patients. Helicobacter 2013;18:121.

Vaz Coelho 2005

Vaz Coelho LG, De Castro Boechat L, Rocha Z, Almeida Aguiar RO, Andrade Aragao AL, Silva Dias EE, et al. 13C‐urea breath test for the detection of h. pylori infection in children: determination of the cut‐off point by a graphic method not depending on the gold standard. Gastroenterologia Endoscopia Digestiva 2005;24(1):15‐20.

Vecsei 2010

Vecsei A, Innerhofer A, Binder C, Gizci H, Hammer K, Bruckdorfer A, et al. Stool polymerase chain reaction for Helicobacter pylori detection and clarithromycin susceptibility testing in children. Clinical Gastroenterology & Hepatology 2010;8(3):309‐12.

Veenendaal 1995

Veenendaal RA, Gotz JM, Schroijen V, Kurban F, Bernards AT, Veselic M, et al. Diagnosis of Helicobacter pylori infection by specific gastric mucosal iga and igg pylori antibodies. Journal of Clinical Pathology 1995;48(11):990‐3.

Veijola 2005a

Veijola L, Myllyluoma E, Korpela R, Rautelin H. Stool antigen tests in the diagnosis of Helicobacter pylori infection before and after eradication therapy. World Journal of Gastroenterology 2005;11(46):7340‐4.

Veijola 2005b

Veijola L, Oksanen A, Lofgren T, Sipponen P, Karvonen AL, Rautelin H. Comparison of three stool antigen tests in confirming Helicobacter pylori eradication in adults. Scandinavian Journal of Gastroenterology 2005;40(4):395‐401.

Veijola 2008

Veijola L, Oksanen A, Sipponen P, Rautelin H. Evaluation of a commercial immunoblot, helicoblot 2.1, for diagnosis of Helicobacter pylori infection. Clinical & Vaccine Immunology: CVI 2008;15(11):1705‐10.

Velayos 2012

Velayos B, Fernandez‐Salazar L, Pons‐Renedo F, Muñoz MF, Almaraz A, Aller R, et al. Accuracy of urea breath test performed immediately after emergency endoscopy in peptic ulcer bleeding. Digestive Diseases & Sciences 2012;57(7):1880‐6.

Veldhuyzen 1990

Veldhuyzen van Zanten SJO, Tytgat KMAJ, Hollingsworth J, Jalali S, Rashid FA, Bowen BM, et al. 14C‐urea breath test for the detection of Helicobacter pylori. American Journal of Gastroenterology 1990;85(4):399‐403.

Veldhuyzen 1991

Veldhuyzen van Zanten SJO, Tytgat DeGara KMAJCJ, Goldie J, Rashid FA, Bowen BM, Cook RJ, et al. A prospective comparison of symptoms and five diagnostic tests in patients with Helicobacter pylori positive and negative dyspepsia. European Journal of Gastroenterology & Hepatology 1991;3(6):463‐8.

Vesna 2005

Vesna Vukadinovic M, Prohaska Potocnik C. Specific igg decline after successful treatment of Helicobacter pylori infection according to treatment protocol with azithromycin. Infektoloski Glasnik 2005;25(4):137‐42.

Vincent 1999

Vincent P, Michaud L, Martin de Lasalle E, Benon B, Turck D, Gottrand F. 13C‐urea breath test and gastric mucosal colonization by Helicobacter pylori in children: Quantitative relation and usefulness for diagnosis of infection. Helicobacter 1999;4(4):233‐7.

Vinette 2004

Vinette KMB, Gibney KM, Proujansky R, Fawcett PT. Comparison of PCR and clinical laboratory tests for diagnosing h‐pylori infection in pediatric patients. BMC Microbiology 2004;4:5.

Vivas 1993

Vivas J, Contreras M, Mathew C, Peraza S, Maury de Tami I, Oliver W, et al. The use of urea carbon 14 in breath tests as diagnostic method for Helicobacter pylori infections. GEN 1993;47(3):150‐6.

Von Wulffen 1988a

Von Wulffen H, Grote HJ, Laufs R. Serodiagnosis of campylobacter pylori‐related antrum gastritis by ELISA and immunoblot methods. Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology 1988;268(4):499.

Von Wulffen 1988b

Von Wulffen H, Grote HJ. Enzyme‐linked immunosorbent assay for detection of immunoglobulin a and g antibodies to campylobacter pylori. European Journal of Clinical Microbiology & Infectious Diseases 1988;7(4):559‐65.

Von Wulffen 1989

Von Wulffen H, Grote HJ. Serodiagnosis of campylobacter pylori infection using an enzyme‐linked immunosorbent assay. Gastroduodenal pathology and Campylobacter pylori: European Campylobacter Pylori Study Group ICS847. 1989:231‐6.

Von Wulffen 1993

Von Wulffen H, Gatermann S, Windler E, Gabbe E, Heinrich HC. Performance of Helicobacter pylori acid extract and urease enzyme‐linked immunosorbent assays in relation to 14c‐urea breath test. Zentralblatt fur Bakteriologie 1993;280(1‐2):203‐13.

Vorobjova 1991

Vorobjova T, Maaroos HI, Uibo R, Wadstrom T, Wood WG, Sipponen P. Helicobacter pylori: Histological and serological study on gastric and duodenal ulcer patients in Estonia. Scandinavian Journal of Gastroenterology ‐ Supplement 1991;186:84‐9.

Vyas 1994

Vyas SK, Sharpstone D, Treasure J, Fine D, Hawtin PR. Pre‐endoscopy screening using serodiagnosis of Helicobacter pylori infection. European Journal of Gastroenterology & Hepatology 1994;6(9):783‐5.

Wadstrom 1994

Wadstrom T, Bolin I, Fandriks L, Gad A, Carling L. Diagnosis of Helicobacter pylori infection. Lakartidningen 1994;91(19):1926‐7.

Wallace 2006

Wallace RA, Schluter P, Webb P. Stool antigen testing for the diagnosis and confirmation of eradication of Helicobacter pylori infection. Internal Medicine Journal 2006;36(2):139‐41.

Wang 1998

Wang WM, Lee SC, Ding HJ, Jan CM, Chen LT, Wu DC, et al. Quantification of Helicobacter pylori infection: Simple and rapid c‐13‐urea breath test in Taiwan. Journal of Gastroenterology 1998;33(3):330‐5.

Wang 2000

Wang WM, Lee SC, Wu DC, Chen LT, Liu CS, Peng CF, et al. Simplified 13C‐urea breath test for the diagnosis of Helicobacter pylori infection‐‐the availability of without fasting and without test meal. Kaohsiung Journal of Medical Sciences 2000;16(12):607‐13.

Wang 2001

Wang YL, Sheu BS, Huang JJ, Yang HB. Noninvasive stool antigen assay can effectively screen Helicobacter pylori infection and assess success of eradication therapy in hemodialysis patients. American Journal of Kidney Diseases 2001;38(1):98‐103.

Wang 2002

Wang L, Zhou L, Tian R. Helicobacter pylori antigen and its igg, iga‐type specific immunocomplexes in sera from patients with Helicobacter pylori infection. Chinese Medical Journal 2002;115(3):381‐3.

Wang 2003

Wang SW, Yu FJ, Lo YC, Yang YC, Wu MT, Wu IC, et al. The clinical utility of string‐PCR test in diagnosing Helicobacter pylori infection. Hepato‐Gastroenterology 2003;50(53):1208‐13.

Wang 2015a

Wang H, Zou WJ. Comparison of different methods for detecting Helicobacter pylori.. World Chinese Journal of Digestology 2015;23(3):525‐9.

Wang 2015b

Wang Z, Xie L, Liu C, Zhao H. Reliability of stool antigen test for clinical diagnosis of Helicobacter pylori infection.. Chinese Journal of Gastroenterology 2015;20(2):78‐80.

Watanabe 2001

Watanabe K, Joh T, Seno K, Sasaki M, Todoroki I, Miyashita M, et al. Development and clinical application of an immunoassay using intact Helicobacter pylori attached to a solid phase as an antigen. Clinical Biochemistry 2001;34(4):291‐5.

Watanabe 2013

Watanabe K, Nagata N, Shimbo T, Nakashima R, Furuhata E, Sakurai T, et al. Accuracy of endoscopic diagnosis of Helicobacter pylori infection according to level of endoscopic experience and the effect of training. BMC Gastroenterology 2013;13:128.

Weijnen 2001a

Weijnen CF, De Wit NJ, Numans ME, Kuipers EJ, Hoes AW, Verheij TJM. Helicobacter pylori testing in the primary care setting: Which diagnostic test should be used?. Alimentary Pharmacology and Therapeutics 2001;15(8):1205‐10.

Weijnen 2001b

Weijnen CF, Hendriks HA, Hoes AW, Verweij WM, Verheij TJM, De Wit NJ. New immunoassay for the detection of Helicobacter pylori infection compared with urease test, c‐13 breath test and histology: Validation in the primary care setting. Journal of Microbiological Methods 2001;46(3):235‐40.

Weingart 2003

Weingart V, Ruessmann H, Koletzko S, Weingart J, Hoechter W, Sackmann M. A novel monoclonal stool antigen test for the detection of h. Pylori before and after eradication therapy: A prospective study in outpatients. Gastroenterology 2003;124(4 (suppl)):A177.

Weingart 2004

Weingart V, Russmann H, Koletzko S, Weingart J, Hochter W, Sackmann M. Sensitivity of a novel stool antigen test for detection of Helicobacter pylori in adult outpatients before and after eradication therapy. Journal of Clinical Microbiology 2004;42(3):1319‐21.

Werdmuller 1998

Werdmuller BFM, Van der Putten A, Veenendaal RA, Lamers C, Loffeld R. Can screening for igg antibodies against Helicobacter pylori be used in clinical practice? Omit endoscopy in seropositive or seronegative patients?. Digestive Diseases and Sciences 1998;43(10):2296‐300.

Westblom 1992

Westblom TU, Madan E, Gudipati S, Midkiff BR, Czinn SJ. Diagnosis of Helicobacter pylori infection in adult and pediatric patients by using Pyloriset, a rapid latex agglutination test. Journal of Clinical Microbiology 1992;30(1):96‐8.

Westblom 1999

Westblom TU, Bhatt BD. Diagnosis of Helicobacter pylori infection. Current Topics in Microbiology & Immunology 1999;241:215‐35.

Whiting 2006

Whiting PF, Weswood ME, Rutjes AW, Reitsma JB, Bossuyt PN, Kleijnen J. Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Medical Research Methodology 2006;6:9.

Whiting 2011

Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS‐2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of Internal Medicine 2011;155(8):529‐36.

Wilcox 1996

Wilcox MH, Dent THS, Hunter JO, Gray JJ, Brown DFJ, Wight DGD, et al. Accuracy of serology for the diagnosis of Helicobacter pylori infection ‐ a comparison of eight kits. Journal of Clinical Pathology 1996;49(5):373‐6.

Wildgrube 1995

Wildgrube HJ. C‐12 urea breath test in Helicobacter‐pylori infection of the gastric‐mucosa. Deutsche Medizinische Wochenschrift 1995;120(25‐26):940‐1.

Wildner‐Christensen 2002

Wildner‐Christensen M, Lassen AT, Lindebjerg J, Schaffalitzky De Muckadell OB. Diagnosis of Helicobacter pylori in bleeding peptic ulcer patients, evaluation of urea‐based tests. Digestion 2002;66(1):9‐13.

Wilson 2008

Wilson RB, Lam VWT, Trinh LK. Clo test in Helicobacter gastritis. ANZ Journal of Surgery 2008;78(8):722.

Winiarski 2003a

Winiarski M, Bielanski W, Plonka M, Dobrzanska M, Kaminska A, Bobrzynski A, et al. The usefulness of capsulated 13C‐urea breath test in diagnosis of Helicobacter pylori infection in patients with upper gastrointestinal bleeding.[erratum appears in Journal of Clinical Gastroenterology 2003;37(2):198]. Journal of Clinical Gastroenterology 2003;37(1):34‐8.

Winiarski 2003b

Winiarski M, Bielanski W, Plonka M, Dobrzanska M, Kaminska A, Bobrzynski A, et al. Erratum: The usefulness of capsulated 13C‐urea breath test in diagnosis of Helicobacter pylori infection in patients with upper gastrointestinal bleeding (Journal of Clinical Gastroenterology (2003) 37 (34‐38)). Journal of Clinical Gastroenterology 2003;37(2):198.

Wirtheim 2001

Wirtheim E, Yahav J, Maoz E, Dickman R, Braun M, Fraser GM, et al. Evaluation of novel enzyme immunoassay for detection of Helicobacter pylori antigen in stool. European Journal of Clinical Microbiology and Infectious Diseases 2001;20(4):293‐4.

Wisniewska 2002a

Wisniewska M, Bak‐Romaniszyn L, Planeta‐Malecka I, Rechcinski T, Plonka M, Bielanski W, et al. The detection of Helicobacter pylori antigens in stool with premier platinum HPSA test. Pediatria Wspolczesna 2002;4(3):373‐6.

Wisniewska 2002b

Wisniewska M, Nilsson HO, Bak‐Romaniszyn L, Rechcinski T, Bielanski W, Planeta‐Malecka I, et al. Detection of specific Helicobacter pylori DNA and antigens in stool samples in dyspeptic patients and healthy subjects. Microbiology & Immunology 2002;46(10):657‐65.

Wisniewska 2006

Wisniewska M, Grebowska A, Rechcinski T, Bak‐Romaniszyn L, Czkwianianc E, Planeta‐Malecka I, et al. Usefulness of selected noninvasive tests in detection of Helicobacter pylori infections. Gastroenterologia Polska 2006;13(4):265‐8.

Witt 1990

Witt CS, Anderson J, McShane LA, Montgomery JM, Stiel D, Clancy RL, et al. False positive with campylobacter‐pylori antibody ELISA. Advances in mucosal immunology. Fifth international congress of mucosal immunology; July 1989; London. Dordrecht: Kluwer Academic, 1990:793‐4. [250]

Wong 1999

Wong CY, Wong KW, Lam SK, Lai KC, Hu WHC, Lau GKK, et al. A simplified c13‐urea breath test for detection of Helicobacter pylori (hp) infection. Gastroenterology 1999;116(4 (suppl)):A356‐A7.

Wong 2000a

Wong WM, Wong BC, Wong KW, Fung FM, Lai KC, Hu WH, et al. (13)c‐urea breath test without a test meal is highly accurate for the detection of Helicobacter pylori infection in Chinese. Alimentary Pharmacology & Therapeutics 2000;14(10):1353‐8.

Wong 2000b

Wong BC, Wong W, Tang VS, Lai K, Yuen S, Hu WH, et al. An evaluation of whole blood testing for Helicobacter pylori infection in the Chinese population. Alimentary Pharmacology & Therapeutics 2000;14(3):331‐5.

Wong 2000c

Wong WM, Wong BCY, Wong KW, Fung FMY, Lai KC, Hu WHC, et al. C‐13‐urea breath test without a test meal is highly accurate for the detection of Helicobacter pylori infection in Chinese. Alimentary Pharmacology & Therapeutics 2000;14(10):1353‐8.

Wong 2001a

Wong BC, Wong WM, Wang WH, Tang VS, Young J, Lai KC, et al. An evaluation of invasive and non‐invasive tests for the diagnosis of Helicobacter pylori infection in Chinese. Alimentary Pharmacology & Therapeutics 2001;15(4):505‐11.

Wong 2001b

Wong WM, Wong BCY, Li TM, Wong KW, Cheung KL, Fung FMY, et al. Twenty‐minute 50 mg c‐13‐urea breath test without test meal for the diagnosis of Helicobacter pylori infection in Chinese. Alimentary Pharmacology & Therapeutics 2001;15(9):1499‐504.

Wong 2003a

Wong WM, Lam SK, Lai KC, Chu KM, Xia HHX, Wong KW, et al. A rapid‐release 50‐mg tablet‐based c‐13‐urea breath test for the diagnosis of Helicobacter pylori infection. Alimentary Pharmacology & Therapeutics 2003;17(2):253‐7.

Wong 2003b

Wong BCY, Xia HHX, Cheung HKL, Ng FH, Wong SY, Chow KC, et al. Evaluation of two stool antigen tests for the detection of Helicobacter pylori infection in the Chinese population. Journal of Gastroenterology and Hepatology (Australia) 2003;18(1):26‐31.

Wong 2003c

Wong WM, Lam SK, Tong TSM, Cheung KL, Tang VSY, Xia HHX, et al. Evaluation of a rapid stool antigen test for the diagnosis of Helicobacter pylori infection in Chinese patients. Chinese Journal of Digestive Diseases 2003;4(3):132‐5.

Wu 1992

Wu JC, Liu GL, Zhang ZH, Mou YL, Chen Q, Wu JC, et al. (nh4+)‐n‐15 excretion test ‐ a new method for detection of Helicobacter‐pylori infection. Journal of Clinical Microbiology 1992;30(1):181‐4.

Wu 2001a

Wu DC, Kuo CH, Lu CY, Su YC, Yu FJ, Lee YC, et al. Evaluation of an office‐based urine test for detecting Helicobacter pylori: A prospective pilot study. Hepato‐Gastroenterology 2001;48(39):614‐7.

Wu 2001b

Wu S, Gao Q, Zhang D, Xiao S. 13C‐urea breath test with infrared heterodyne ratiometry in the diagnosis of Helicobacter pylori infection. Chinese Journal of Gastroenterology 2001;6(4):206‐8.

Wu 2003

Wu IC, Ke HL, Lo YC, Yang YC, Chuang CH, Yu FJ, et al. Evaluation of a newly developed office‐based stool test for detecting Helicobacter pylori: An extensive pilot study. Hepato‐Gastroenterology 2003;50(54):1761‐5.

Wu 2004

Wu IC, Wu DC, Lu CY, Kuo CH, Su YC, Yu FJ, et al. Comparison of serum and urine ELISA methods for the diagnosis of Helicobacter pylori ‐ a prospective pilot study. Hepato‐Gastroenterology 2004;51(60):1736‐41.

Wu 2006a

Wu DC, Wu IC, Wang SW, Lu CY, Ke HL, Yuan SSF, et al. Comparison of stool enzyme immunoassay and immunochromatographic method for detecting Helicobacter pylori antigens before and after eradication. Diagnostic Microbiology and Infectious Disease 2006;56(4):373‐8.

Wu 2006b

Wu IC, Wang SW, Yang YC, Yu FJ, Kuo CH, Chuang CH, et al. Comparison of a new office‐based stool immunoassay and c‐13‐ubt in the diagnosis of current Helicobacter pylori infection. Journal of Laboratory and Clinical Medicine 2006;147(3):145‐9.

Wu 2013

Wu Q, Yang ZP, Xu P, Gao LC, Fan DM. Association between Helicobacter pylori infection and the risk of colorectal neoplasia: a systematic review and meta‐analysis. Colorectal Disease 2013;15(7):e352‐64.

Xia 2000a

Xia HH, Kalantar JS, Wyatt JM, Adams S, Cheung K, Eslick GD, et al. High sensitivity and specificity of a laboratory‐based serological test, pylori dtect ELISA, for detection of Helicobacter pylori infection. Diagnostic Microbiology & Infectious Disease 2000;36(2):69‐74.

Xia 2000b

Xia HHX, Kalantar JS, Mitchell HM, Talley NJ. Can Helicobacter pylori serology still be applied as a surrogate marker to identify peptic ulcer disease in dyspepsia?. Alimentary Pharmacology and Therapeutics 2000;14(5):615‐24.

Xia 2002

Xia HHX, Wong BCY, Wong WM, Tang VSY, Cheung HKL, Sham FNF, et al. Optimal serological tests for the detection of Helicobacter pylori infection in the Chinese population. Alimentary Pharmacology and Therapeutics 2002;16(3):521‐6.

Xiao 1991

Xiao SD, Pan ZJ, Zhang ZH, Jiang SJ. Enzyme‐linked immunosorbent assay for detection of immunoglobulin g antibody against Helicobacter pylori. Chinese Medical Journal 1991;104(11):904‐8.

Xiao 2013

Xiao M, Wang Y, Gao Y. Association between Helicobacter pylori infection and pancreatic cancer development: a meta‐analysis. PloS One 2013;8(9):e75559.

Xie 2008a

Xie F, Luo N, Blackhouse G, Goeree R, Lee HP. Cost‐effectiveness analysis of Helicobacter pylori screening in prevention of gastric cancer in Chinese. International Journal of Technology Assessment in Health Care 2008;24(1):87‐95.

Xie 2008b

Xie F, Luo N, Lee HP. Cost effectiveness analysis of population‐based serology screening and 13C‐urea breath test of Helicobacter pylori to prevent gastric cancer: A Markov model. World Journal of Gastroenterology 2008;14(19):3021‐7.

Xue 2001

Xue FB, Xu YY, Wan Y, Pan BR, Ren J, Fan DM. Association of H. pylori infection with gastric carcinoma: a meta analysis. World Journal of Gastroenterology 2001;7(6):801‐4.

Yachi 1991

Yachi A, Yabana T, Imai K, Sugiyama T, Takayama Y, Yoshida H, et al. Novel ELISA for serodiagnosis of Helicobacter‐pylori (campylobacter‐pylori) infection‐associated gastritis. Frontiers of Mucosal Immunology 1991;939:697‐700.

Yakoob 2008

Yakoob J, Jafri W, Abbas Z, Abid S, Islam M, Ahmed Z. The diagnostic yield of various tests for Helicobacter pylori infection in patients on acid‐reducing drugs. Digestive Diseases and Sciences 2008;53(1):95‐100.

Yakoob 2014

Yakoob J, Abbas Z. Agreement between serology and histology for detection of Helicobacter pylori infection. Journal of the College of Physicians & Surgeons ‐ Pakistan 2014;24(10):779‐80.

Yamakawa 1993

Yamakawa O, Takemori Y, Noda Y, Ohta G. Availability of determination of serum anti‐Helicobacter pylori igg antibody in diagnosis of Helicobacter pylori infection. Japanese Journal of Gastroenterology 1993;90(9):2090‐6.

Yamamoto 1995

Yamamoto Y, Kouda M, Abe K, Sakurabayashi S, Sezai S, Hirano M, et al. Detection of Helicobacter pylori by culture and the 13C‐urea breath test using an automated breath 13C analyzer. Japanese Journal of Gastroenterology 1995;92(11):1839‐45.

Yamamoto 1996

Yamamoto Y, Koda M, Abe K, Sakurabayashi M, Sezai H, Hirano M, et al. The detection of Helicobacter pylori by the 13C‐urea breath test (13C‐ubt) using automated breath 13C analyser. Nippon Shokakibyo Gakkai Zasshi [Japanese Journal of Gastroenterology] 1996;93(1):68.

Yamamoto 2000

Yamamoto S, Uemura N, Okamoto S, Yamaguchi S, Mashiba H, Tachikawa T. A new rapid test for detecting anti‐Helicobacter pylori antibody excreted into urine. Helicobacter 2000;5(3):160‐4.

Yamamoto 2003

Yamamoto T, Tamura M, Ishii T, Anjiki H, Hattori K, Saitoh M, et al. Urinary antibody titers to Helicobacter pylori and an impact of clinical characteristics. Journal of Clinical Gastroenterology 2003;36(4):329‐31.

Yamamoto 2005

Yamamoto T, Ishii T, Kawakami T, Sase Y, Horikawa C, Aoki N, et al. Reliability of urinary tests for antibody to Helicobacter pylori in patients with pulmonary tuberculosis. World Journal of Gastroenterology 2005;11(3):412‐4.

Yamamoto 2008

Yamamoto T, Ishii T, Sanaka M, Kuyama Y. Diagnosis of Helicobacter pylori infection using rapirun h. Pylori antibody detection kit. Expert Review of Molecular Diagnostics 2008;8(5):565‐9.

Yamaoka 1998

Yamaoka Y, Kodama T, Graham DY, Kashima K. Comparison of four serological tests to determine the caga or vaca status of Helicobacter pylori strains. Journal of Clinical Microbiology 1998;36(11):3433‐4.

Yamasaki 2004

Yamasaki T, Kume K, Yamasaki M, Yoshikawa I, Otsuki M. Light meal decreased false‐positive in the 13C‐urea breath test for the diagnosis of Helicobacter pylori infection. Gastroenterology 2004;126(4 (suppl)):A187.

Yamashiro 1995

Yamashiro Y, Oguchi S, Otsuka Y, Nagata S, Shioya T, Shimizu T. Helicobacter pylori colonization in children with peptic ulcer disease iii. Diagnostic value of the 13C‐urea breath test to detect gastric h. Pylori colonization. Acta Paediatrica Japonica (Overseas Edition) 1995;37(1):12‐6.

Yan 2010

Yan J, Yamaguchi T, Odaka T, Suzuki T, Ohyama N, Hara T, et al. Stool antigen test is a reliable method to detect Helicobacter pylori in the gastric remnant after distal gastrectomy for gastric cancer. Journal of Clinical Gastroenterology 2010;44(1):73‐4.

Yanez 2000

Yanez P, Madrazo‐de la Graz A, Perez‐Perez G, Cabrera L, Muñoz O, Torres J. Comparison of invasive and noninvasive methods for the diagnosis and evaluation of eradication of Helicobacter pylori infection in children. Archives of Medical Research 2000;31(4):415‐21.

Yang 2005

Yang HR, Seo JK. Diagnostic accuracy of the c‐13‐urea breath test in children: Adjustment of the cut‐off value according to age. Journal of Gastroenterology and Hepatology 2005;20(2):264‐9.

Yang 2007

Yang YJ, Sheu BS, Lee SC, Wu JJ. More economic 25 mg c‐13‐urea breath test can be effective in detecting primary Helicobacter pylori infection in children. Journal of Gastroenterology and Hepatology 2007;22(3):335‐9.

Yang 2008a

Yang HR, Seo JK. Helicobacter pylori stool antigen (HpSA) tests in children before and after eradication therapy: comparison of rapid immunochromatographic assay and HpSA ELISA. Digestive Diseases & Sciences 2008;53(8):2053‐8.

Yang 2008b

Yang HR, Ko JS, Seo JK. Does the diagnostic accuracy of the 13C‐urea breath test vary with age even after the application of urea hydrolysis rate?. Helicobacter 2008;13(4):239‐44.

Yang 2015

Yang BL, Yeh C, Kwong WG, Lee SD. A novel one‐step Helicobacter pylori saliva antigen test. Journal of the Chinese Medical Association 2015;78(2):96‐100.

Yasuda 2009

Yasuda A, Uchida T, Nguyen LT, Kawazato H, Tanigawa M, Murakami K, et al. A novel diagnostic monoclonal antibody specific for Helicobacter pylori caga of east Asian type. APMIS; Acta Pathologica, Microbiologica, et Immunologica Scandinavica 2009;117(12):893‐9.

Ye 2005

Ye WM, Held M, Enroth H, Kraaz W, Engstrand L, Nyren O. Histology and culture results among subjects with antibodies to caga but no evidence of Helicobacter pylori infection with IgG ELISA. Scandinavian Journal of Gastroenterology 2005;40(3):312‐8.

Ye 2014

Ye CL, Liao GP, He S, Pan YN, Kang YB, Zhang ZY. Levofloxacin and proton pump inhibitor‐based triple therapy versus standard triple first‐line therapy for Helicobacter pylori eradication. Pharmacoepidemiology and Drug Safety 2014;23(5):443‐55.

Yee 2002

Yee YK, Yip KT, Que TL, Chang KK, Li KF, Lee CK, et al. Efficacy of enzyme immunoassay for the detection of Helicobacter pylori antigens in frozen stool specimens: Local validation. Alimentary Pharmacology and Therapeutics 2002;16(10):1739‐42.

Yilmaz 2006

Yilmaz O, Sen N, Kupelioglu AA, Simsel I. Detection of h pylori infection by ELISA and western blot techniques and evaluation of anti caga seropositivity in adult Turkish dyspeptic patients. World Journal of Gastroenterology 2006;12(33):5375‐8.

Yin 2015

Yin SM, Zhang F, Shi DM, Xiang P, Xiao L, Huang YQ, et al. Effect of posture on c‐13‐urea breath test in partial gastrectomy patients. World Journal of Gastroenterology 2015;21(45):12888‐95.

Yokota 1990

Yokota K, Oguma K, Yoshida H, Takayama Y, Sugiyama T, Yabana T, et al. Comparison of three methods for detecting campylobacter pylori and measurement of human antibody titers against the whole organisms. Kansenshogaku Zasshi [Journal of the Japanese Association for Infectious Diseases] 1990;64(5):597‐603.

Yong 2006

Yong CS, Kim YI, Park SM, Kwon R, Han HH, Park JG, et al. Trials of novel c‐13‐urea‐containing capsule for more economic and sensitive diagnosis of Helicobacter pylori infection in human subjects. Archives of Pharmacal Research 2006;29(10):879‐83.

Yoo 2007

Yoo JY, Kim N, Park YS, Hwang JH, Kim JW, Jeong SH, et al. Detection rate of Helicobacter pylori against a background of atrophic gastritis and/or intestinal metaplasia. Journal of Clinical Gastroenterology 2007;41(8):751‐5.

Yoshida 1993

Yoshida J, Asaka M. 13C‐urea breath test. Nippon Rinsho [Japanese Journal of Clinical Medicine] 1993;51(12):3196‐200.

Yoshida 2000

Yoshida H, Hirota K, Ogura K, Maeda S, Shiratori Y, Sasaki Y, et al. Determination of the optimal cut‐off value for the c‐13 ‐urea breath test based on a Helicobacter pylori‐specific polymerase chain reaction assay. Journal of Gastroenterology and Hepatology 2000;15(2):155‐60.

Young 1995

Young EL, Cutler AF. Use of the c‐13 urea breath test to evaluate a new rapid urease test for Helicobacter‐pylori. Gastroenterology 1995;108(4 (suppl)):A265.

Young 1996

Young EL, Sharma TK, Cutler AF. Prospective evaluation of a new urea‐membrane test for the detection of Helicobacter pylori in gastric antral tissue. Gastrointestinal Endoscopy 1996;44(5):527‐31.

Zagari 1998

Zagari RM, Pozzato P, Bazzoli F, Fossi S, Ricciardiello L, Nicolini G, et al. A comparative trial to optimize the protocol of the c‐13 urea breath test for the diagnosis of Helicobacter pylori infection. Gastroenterology 1998;114(4):A344.

Zagari 2003

Zagari RM, Bazzoli F. Helicobacter pylori testing in patients with peptic ulcer bleeding. Digestive & Liver Disease 2003;35(4):215‐6.

Zagari 2005

Zagari RM, Pozzato P, Martuzzi C, Fuccio L, Martinelli G, Roda E, et al. C‐13‐urea breath test to assess Helicobacter pylori bacterial load. Helicobacter 2005;10(6):615‐9.

Zagari 2012

Zagari RM, Eusebi LH, Rabitti S, Bazzoli F. 13C‐urea breath‐id system for the real‐time diagnosis of Helicobacter pylori infection. Digestive and Liver Disease 2012;44:S208.

Zalabska 2010

Zalabska E. The evidence of Helicobacter pylori in gastric biopsy and stool samples. Klinicka Mikrobiologie a Infekcni Lekarstvi 2010;16(6):203‐5.

Zambon 2004

Zambon CF, Basso D, Navaglia F, Mazza S, Razetti M, Fogar P, et al. Non‐invasive diagnosis of Helicobacter pylori infection: Simplified c‐13‐urea breath test, stool antigen testing, or DNA PCR in human feces in a clinical laboratory setting?. Clinical Biochemistry 2004;37(4):261‐7.

Zanetti 2002

Zanetti M, Vendramin R, Pieramico O. Stool antigen test for non‐invasive post‐treatment assessment of Helicobacter pylori infection: A comparative study between immunoenzymatic and immunochromatographic tests. Gut 2002;51(Suppl):A111.

Zaremba 1995

Zaremba M, Rozkiewicz M, Pydzinska J, Stasiewicz J, Szalaj W, Musiatowicz B, et al. Diagnostic value of the latex test (Pyloriset) for detection of Helicobacter pylori antibodies in adult patients with upper digestive tract diseases. Medycyna Doswiadczalna i Mikrobiologia 1995;47(1‐2):11‐6.

Zawadzka‐Gralec 2009

Zawadzka‐Gralec A, Wroblewska M, Szaflarska PA, Mierzwa G, Parzecka M, Bala G, et al. The analysis of usefulness different diagnostic methods in children and adolescents with Helicobacter pylori infection. Polski Merkuriusz Lekarski 2009;26(151):24‐8.

Zhang 1990

Zhang QB, Zhang SJ, Jia BQ. Enzyme‐linked immunosorbent assay for the serodiagnosis of campylobacter pylori infection. Zhonghua Nei Ke Za Zhi [Chinese Journal of Internal Medicine] 1990;29(8):457‐60, 509.

Zhang 2002

Zhang WD, Xu ZM. Immunophenotyping of Helicobacter pylori. World Chinese Journal of Digestology 2002;10(5):509‐12.

Zhang 2006

Zhang C, Guan Y, Yuan Z, Wu Y, Yamada N, Wen M, et al. Analysis of histological detection of Helicobacter pylori before and after eradication therapy: Compared with the results of 13C‐urea breath test. Chinese Journal of Gastroenterology 2006;11(4):215‐8.

Zhang 2007

Zhang L, Zhang JZ. Analysis of different diagnostic methods of Helicobacter pylori infection in China. World Chinese Journal of Digestology 2007;15(6):649‐54.

Zhelezova 2006

Zhelezova GZ, Boyanova L. Stool antigen test for diagnosis of Helicobacter pylori infection. Problems of Infectious and Parasitic Diseases 2006;34(2):16‐8.

Zheng 2004

Zheng Q, Chen X, Pan Y, Shi Y. Comparison of reliability of 13C‐urea breath tests using two different reagents for clinical diagnosis of Helicobacter pylori infection. Chinese Journal of Gastroenterology 2004;9(4):210‐2.

Zhou 1996

Zhou DY, Xu KQ, Yang HT, Hoffman S, Marshall B. Microdose c‐14‐urea breath test for the detection of h‐pylori in Chinese patients. Gastroenterology 1996;110(4 (suppl)):A307.

Zhou 2000

Zhou H, Chan KL, Chu KM, Tam PKH. Intrafamilial spread of Helicobacter pylori: A prospective study using urea breath test. Journal of Pediatric Surgery 2000;35(11):1672‐5.

Zhou 2014

Zhou XY, Su J, Xu GX, Zhang GX. Accuracy of stool antigen test for the diagnosis of Helicobacter pylori infection in children: A meta‐analysis. Clinics and Research in Hepatology and Gastroenterology 2014;38(5):629‐38.

Zhou 2017

Zhou Q, Li L, Ai Y, Pan Z, Guo M, Han J. Diagnostic accuracy of the 14c‐urea breath test in Helicobacter pylori infections: A meta‐analysis. Wiener Klinische Wochenschrift2017; Vol. 129, issue 1‐2:38‐45. [DOI: 10.1007/s00508‐016‐1117‐3]

Zhu 2002a

Zhu Y, Lin J, Li D, Du Q, Qian K, Wu Q, et al. Helicobacter pylori antigen and its igg, iga ‐type specific immunocomplexes in sera from patients with Helicobacter pylori infection. Chinese Medical Journal 2002;115(3):381‐3.

Zhu 2002b

Zhu YY, Wu JC, Zhang ZH. Emissive spectral analysis applied in n‐15 excretion test of Helicobacter pylori. Society of Photo‐optical Instrumentation Engineers (SPIE): Optics in health care and biomedical optics: Diagnostics and treatment 2002;4916:194‐6.

Zhukhovitskii 2005

Zhukhovitskii VG, Gorbacheva AP, Golovkin BA, Gidaiatova LA. Serological diagnosis of Helicobacter infection: Comparison of the analytical capacities of three test systems for enzyme immunoassay. Klinicheskaia Laboratornaia Diagnostika 2005;11:12‐4.

Zhuo 2008

Zhuo XL, Wang Y, Zhuo WL, Zhang XY. Possible association of Helicobacter pylori infection with laryngeal cancer risk: an evidence‐based meta‐analysis. Archives of Medical Research 2008;39(6):625‐8.

Zipser 2000

Zipser RD, Parikh MV. Is repeat testing needed for Helicobacter pylori?. Journal of the American Board of Family Practice 2000;13(6):449‐50.

Zubillaga 1997

Zubillaga M, Oliveri P, Calcagno ML, Goldman C, Caro R, Mitta A, et al. Min 14c ubt: A combination of gastric basal transit and 14c‐urea breath test for the detection of Helicobacter pylori infection in human beings. Nuclear Medicine & Biology 1997;24(6):565‐9.

Zubillaga 1999

Zubillaga M, Oliveri P, Panarello H, Buzurro M, Adami J, Goldman C, et al. Stable isotope techniques for the detection of Helicobacter pylori infection in clinical practice. 13C‐urea breath test in different experimental conditions. Acta Physiologica, Pharmacologica et Therapeutica Latinoamericana 1999;49(2):101‐7.

References to other published versions of this review

Gurusamy 2016

Gurusamy KS, Yaghoobi M, Davidson BR. Non‐invasive diagnostic tests for Helicobacter pylori infection. Cochrane Database of Systematic Reviews 2016, Issue 2. [DOI: 10.1002/14651858.CD012080]

Characteristics of studies

Characteristics of included studies [ordered by study ID]

Adamopoulos 2009a

Study characteristics

Patient sampling

Type of study: prospective study
Consecutive or random sample: consecutive patients

Patient characteristics and setting

Sample size: 73
Female: 24 (33%)
Age: 63 years
Presentation:
1. People who had undergone endoscopy (for various indications)
Setting: secondary care, Greece

Index tests

Index test: urea breath test ‐13C
Further details:
Technical specifications: manufacturer ‐ Infai Institut für Biomedizinische; Analytik & NMR‐Imaging GmbH, Bochum
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 4.0% (30 minutes)

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and histopathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Yes

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Yes

Low

Low

DOMAIN 2: Index Test Urea breath test‐13C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Unclear

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

Yes

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

Unclear

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Yes

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Yes

Low

Adamopoulos 2009b

Study characteristics

Patient sampling

Type of study: prospective study
Consecutive or random sample: consecutive patients

Patient characteristics and setting

Sample size: 31
Female: 8 (25.8%)
Age: 71 years
Presentation:
1. People who had undergone Billroth II gastrectomy and endoscopy (for various indications)
Setting: secondary, Greece

Index tests

Index test: urea breath test‐13C
Further details:
Technical specifications: manufacturer ‐ Infai Institut für Biomedizinische; Analytik & NMR‐Imaging GmbH, Bochum
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 4.0% (30 minutes)

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and histopathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Yes

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Yes

Low

High

DOMAIN 2: Index Test Urea breath test‐13C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Unclear

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

Yes

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

Unclear

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Yes

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Yes

Low

Aguilar 2007

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 31
Female: 5 (16.1%)
Age: not stated
Presentation:
1. Dyspepsia
Setting: secondary care, Peru

Index tests

Index test: urea breath test‐14C
Further details:
Technical specifications: Not stated
Performed by: Not stated
Criteria for positive diagnosis: disintegrations per minute > 200 (10 minutes)

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: Not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Low

DOMAIN 2: Index Test Urea breath test‐14C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Al‐Fadda 2000

Study characteristics

Patient sampling

Type of study: prospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 64
Female: not stated
Age: not stated
Presentation:
1. Patients with upper gastroinstestinal symptoms
Setting: secondary care, Peru

Index tests

Index test: urea breath test‐14C
Further details:
Technical specifications: Not stated
Performed by: Not stated
Criteria for positive diagnosis: CO2 recovery > 0.55 (20 minutes)

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: Not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Low

DOMAIN 2: Index Test Urea breath test‐14C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Yes

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Allardyce 1997

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 63
Female: 26 (41.3%)
Age: not stated
Presentation:
1. Dyspepsia
Setting: secondary care, New Zealand

Index tests

Index test: urea breath test‐14C
Further details:
Technical specifications: Not stated
Performed by: Not stated
Criteria for positive diagnosis: disintegrations per minute > 49 (time not stated)

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: Not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Low

DOMAIN 2: Index Test Urea breath test‐14C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

No

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Argentieri 2007

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 215
Female: not stated
Age: not stated
Presentation:
1. Children undergoing upper gastrointestinal endoscopy
Exclusion:
1. Recent H pylori treatment
Setting: secondary care, Italy

Index tests

Index test: stool antigen test
Further details:
Technical specifications: Premier Platinum HpSA
Performed by: Not stated
Criteria for positive diagnosis: Not stated

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: Not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Stool Antigen Test

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

High

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

Yes

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

Unclear

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Arikan 2004

Study characteristics

Patient sampling

Type of study: prospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 100
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing endoscopy
Exclusion:
1. Malignancy
2. Taken antibiotics or proton pump inhibitors in last 2 weeks
Setting: secondary care, Turkey

Index tests

Index test: stool antigen test
Further details:
Technical specifications: Premier Platinum HpSA
Performed by: Not stated
Criteria for positive diagnosis: Not stated

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: Not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Stool Antigen Test

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

High

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Atli 2012

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 100
Female: 57 (57%)
Age: 71 years
Presentation:
1. Patients with dyspepsia and symptoms or signs related to peptic ulcer > 65 years of age
Exclusion:
1. Patients who had taken antibiotics or anti‐ulcer treatment in the past 2 weeks
2. Advanced dementia
3. Cerbrovascular disease
4. Advanced respiratory problems
5. Alarm symptoms for malignancy
Setting: secondary setting, Turkey

Index tests

Index test: urea breath test‐14C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: counts per minute > 50 (10 minutes)

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Urea breath test‐14C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Behrens 1999

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 252
Female: not stated
Age: not stated
Presentation:
1. Children (3 years to 18 years) with abdominal pain, nausea, or vomiting
Exclusion criteria:
1. Previous treatment with antibiotics or proton pump inhibitors
2. WBC < 3500/microlitre or platelets < 100,000/microlitre
Setting: secondary setting, Germany

Index tests

Index test: urea breath test ‐13C
Further details:
Technical specifications: Promochem, Wesel
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 5.0% (30 minutes and 60 minutes)

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Urea breath test‐13C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Bosso 2000

Study characteristics

Patient sampling

Type of study: retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 95
Female: not stated
Age: not stated
Presentation:
1. Patients with upper abdominal symptoms
Exclusion:
1. Patients with previous gastric surgery
Setting: secondary care, France

Index tests

Index test: urea breath test ‐13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 4.0% (30 minutes)

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with Warthin‐Starry stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Urea breath test‐13C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

No

High

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

Yes

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

Unclear

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Yes

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Ceken 2011

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 100
Female: 67 (67%)
Age: 48 years
Presentation:
1. Patients with dyspepsia
Exclusion:
1. Antibiotics or anti‐ulcer treatment within last 4 weeks
2. Gastric surgery
Setting: secondary care, France

Index tests

Index test: stool antigen test
Further details:
Technical specifications: Helicobacter Antigen Quick Castte
Performed by: not stated
Criteria for positive diagnosis: not stated

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Stool Antigen Test

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

High

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Chen 1991

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients

Patient characteristics and setting

Sample size: 96
Female: not stated
Age: not stated
Presentation:
1. Adult patients with dyspepsia
Setting: secondary care, China

Index tests

Index test: serology
Further details:
Technical specifications: Pyloriset
Performed by: not stated
Criteria for positive diagnosis: presence of agglutination (within 3 minutes)

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Yes

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Yes

Low

Low

DOMAIN 2: Index Test Serology

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Yes

Unclear

Chey 1998

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 287
Female: 140 (48.8%)
Age: 53 years
Presentation:
1. People undergoing endoscopy
Exclusion:
1. Recent treatment for H pylori or anti‐ulcer treatment
Setting: Variable settings, USA

Index tests

Index test 1a: serology
Further details:
Technical specifications: HM‐CAP (Enteric Products Inc.)
Performed by: not stated
Criteria for positive diagnosis: not stated

Index test 1b: serology (serum)
Further details:
Technical specifications: Hp Chek (Chem Trak)
Performed by: not stated
Criteria for positive diagnosis: 2 red lines

Index test 1c: serology (whole blood)
Further details: same as for index test 2

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Serology

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Yes

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Yes

Unclear

Czerwionka‐Szaflarska 2007

Study characteristics

Patient sampling

Type of study: retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 100
Female: 66 (66%)
Age: 13 years
Presentation:
1. Children with gastrointestinal disorders
Setting: secondary care, Poland

Index tests

Index test: urea breath test‐13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 4.0 % (time not stated)

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Urea breath test‐13C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

D'Elios 2000

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients

Patient characteristics and setting

Sample size: 256
Female: not stated
Age: not stated
Presentation:
1. Patients with dyspepsia
Exlusion:
1. Gastric surgery
2. Recent treatment for ulcer or H pylori
3. Pulmonary failure
Setting: secondary care, Italy

Index tests

Index test: urea breath test‐13C
Further details:
Technical specifications: AB Analitica
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 4.0% (30 minutes)

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Yes

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Yes

Low

Low

DOMAIN 2: Index Test Urea breath test‐13C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Yes

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Yes

Unclear

Debongnie 1991

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither ‐ patients with previous gastric surgery excluded

Patient characteristics and setting

Sample size: 230
Female: not stated
Age: not stated
Presentation:
1. Patients referred for upper gastrointestinal surgery
Excluded:
1. Gastric surgery
2. Haematologic disease
3. Immunodeficiency
4. Gastric cancer
5. Recent treatment for ulcer or H pylori
6. Atrophic gastritis
Setting: secondary care, Belgium

Index tests

Index test: urea breath test‐14C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: specific activity > 0.3% (10 minutes)

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Cresyl Violet stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 27 (11.7%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

No

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

High

Unclear

DOMAIN 2: Index Test Urea breath test‐14C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

No

High

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Yes

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

No

High

Dede 2015

Study characteristics

Patient sampling

Type of study: prospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 30
Female: 8 (26.7%)
Age: 55 years
Presentation:
1. Patients who had undergone partial gastrectomy
Setting: secondary care, Turkey

Index tests

Index test 1: stool antigen test
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated

Index test 2: urea breath test‐14C
Further details:
Technical specifications: Heliprobe System, Kibion AB
Performed by: not stated

Different criteria for positive diagnosis:

  • Counts per minute > 23 (10 minutes)

  • Counts per minute > 29 (30 minutes)

  • Counts per minute > 35 (20 minutes)

  • Counts per minute > 50 (10 minutes)

  • Counts per minute > 50 (20 minutes)

  • Counts per minute > 50 (30 minutes)

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and modified Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Urea breath test‐14C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

No

High

Low

DOMAIN 2: Index Test Stool Antigen Test

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Yes

Unclear

High

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

No

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

High

Delvin 1999

Study characteristics

Patient sampling

Type of study: prospective study
Consecutive or random sample: consecutive patients

Patient characteristics and setting

Sample size: 79
Female: not stated
Age: not stated
Presentation:
1. Children with gastrointestinal symptoms
Exclusion:
1. Chilren with functional abdominal pain
2. Anti‐ulcer or H pylori treatment in last 6 weeks
Setting: secondary care, Canada

Index tests

Index test 1: urea breath test‐13C
Further details:
Technical specifications: Dia 13‐Helico; Dianatec iso
Performed by: not stated

Different criteria for positive diagnosis:

  • Delta over baseline > 2.0% (30 minutes)

  • Delta over baseline > 2.5% (30 minutes)

  • Delta over baseline > 3.0% (30 minutes)

  • Delta over baseline > 3.5% (30 minutes)

  • Delta over baseline > 4.0% (30 minutes)

  • Delta over baseline > 4.5% (30 minutes)

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Warthin‐Starry stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Yes

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Yes

Low

Low

DOMAIN 2: Index Test Urea breath test‐13C

Were the index test results interpreted without knowledge of the results of the reference standard?

Yes

If a threshold was used, was it pre‐specified?

No

High

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Yes

Unclear

Dinler 1999

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 77
Female: 48 (62.3%)
Age: 13 years
Presentation:
1. Children with recurrent abdominal pain
Setting: secondary care, Turkey

Index tests

Index test: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Serology

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

High

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Duan 1999

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 149
Female: 35 (23.5%)
Age: 44 years
Presentation:
1. Patients with gastritis or gastric ulcer
Exclusion:
1. Treatment with antibiotics or bismuth in the previous 2 months
2. Previous gastric surgery or gastric cancer
Setting: secondary care, China

Index tests

Index test: urea breath test‐13C
Further details:
Technical specifications: Finniga, MAT‐252, USA
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 5 per thousand (30 minutes)

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Warthin‐Starry stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Urea breath test‐13C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Yes

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Eggers 1990

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 100
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing endoscopy
Setting: secondary care, Germany

Index tests

Index test: urea breath test‐13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 8 (7.4%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Urea breath test‐13C

Were the index test results interpreted without knowledge of the results of the reference standard?

Yes

If a threshold was used, was it pre‐specified?

Unclear

Unclear

High

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Yes

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

No

High

Ekesbo 2006

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither ‐ patients with previous gastric surgery excluded

Patient characteristics and setting

Sample size: 126
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing gastroscopy for dyspepsia or gastrointestinal bleeding
Setting: primary care, Sweden

Index tests

Index test: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: staining of a 120 kilodalton protein gel band and/or at least 2 of 5 proteins between 28 – 33 kilodaltons

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with immunostaining
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 40 (24.1%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

No

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

High

Unclear

DOMAIN 2: Index Test Serology

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

Yes

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

Unclear

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

No

High

El‐Din 2013

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither ‐ patients without pathologic data excluded

Patient characteristics and setting

Sample size: 19
Female: 6 (31.6%)
Age: 47 years
Presentation:
1. Patients with upper gastrointestinal disorders
Setting: secondary care, Egypt

Index tests

Index test 1: serology
Further details:
Technical specifications: Ridascreen
Performed by: not stated
Criteria for positive diagnosis: not stated

Index test 2: stool antigen test
Further details:
Technical specifications: Immunodiagnostik AG
Performed by: not stated
Criteria for positive diagnosis: not stated

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 33 (63.5%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

No

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

High

Unclear

DOMAIN 2: Index Test Stool Antigen Test

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

High

DOMAIN 2: Index Test Serology

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

High

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

Yes

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

Unclear

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

No

High

El‐Mekki 2011

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients

Patient characteristics and setting

Sample size: 55
Female: 35 (63.6%)
Age: 37 years
Presentation:
1. Patients with dyspepsia
Setting: secondary care, Saudi Arabia

Index tests

Index test: serology
Further details:
Technical specifications: HeliSAL TM serum
Performed by: not stated
Criteria for positive diagnosis: > 1 units/ml

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Yes

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Yes

Low

Low

DOMAIN 2: Index Test Serology

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Yes

Unclear

El‐Nasr 2003

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 50
Female: 16 (32%)
Age: 36 years
Presentation:
1. Patients with dyspepsia
Setting: secondary care, Egypt

Index tests

Index test: stool antigen test
Further details:
Technical specifications: Premier Platinum HpSA, Meridien Diagnostics
Performed by: not stated
Criteria for positive diagnosis: not stated

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Stool Antigen Test

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

High

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Eltumi 1999

Study characteristics

Patient sampling

Type of study: prospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 50
Female: 17 (34%)
Age: 11 years
Presentation:
1. Children referred for endoscopy
Exclusion:
1. Recent treatment for H pylori
Setting: Tertiary care, UK

Index tests

Index test 1: urea breath test‐13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 5 units/ml (40 minutes)

Index test 2: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Warthin‐Starry stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Urea breath test‐13C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 2: Index Test Serology

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

High

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Epple 1997

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients

Patient characteristics and setting

Sample size: 126
Female: 70 (55.6%)
Age: 48 years
Presentation:
1. Patients undergoing routine endoscopy
Exclusion:
1. Gastric cancer
2. Previous gastric surgery
Setting: secondary care, Germany

Index tests

Index test: urea breath test‐13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: > Mean + 2 standard deviations above normal level (30 minutes)

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Warthin‐Starry stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Yes

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Yes

Low

Low

DOMAIN 2: Index Test Urea breath test‐13C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

No

High

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Yes

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Yes

Low

Fallone 1995

Study characteristics

Patient sampling

Type of study: prospective study
Consecutive or random sample: consecutive patients

Patient characteristics and setting

Sample size: 50
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing endoscopy
Exclusion
1. Conditions that would make gastric biopsy dangerous
2. Lactating
3. Pregnant or women of child‐bearing potential who were not using adequate control
Setting: secondary care, Canada

Index tests

Index test: urea breath test‐13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: > 1.5% excretion (15 minutes)

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with Silver stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 4 (7.4%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Yes

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Urea breath test‐13C

Were the index test results interpreted without knowledge of the results of the reference standard?

Yes

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

Yes

Were the reference standard results interpreted without knowledge of the results of the index tests?

Yes

Low

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Yes

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

No

High

Fallone 1996

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients

Patient characteristics and setting

Sample size: 106
Female: 51 (48.1%)
Age: 54 years
Presentation:
1. Patients undergoing endoscopy
Exclusion:
1. Recent treatment for H pylori
Setting: secondary care, Canada

Index tests

Index test: serology
Further details:
Technical specifications: HeliSAL TM serum
Performed by: not stated
Criteria for positive diagnosis: not stated

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Yes

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Yes

Low

Low

DOMAIN 2: Index Test Serology

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

High

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Yes

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Yes

Low

Fanti 1999

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 84
Female: 45 (53.6%)
Age: 50 years
Presentation:
1. Patients with dyspepsia
2. Not on current treatment for H pylori or ulcers
Setting: secondary care, Italy

Index tests

Index test: stool antigen test
Further details:
Technical specifications: Premier Platinum HpSA (Meridian Diagnostics)
Performed by: not stated
Criteria for positive diagnosis: Absorbance 450/630 nm > 0.150

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Stool Antigen Test

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Faruqui 2007

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 50
Female: 26 (52%)
Age: 36 years
Presentation:
1. Patients with dyspepsia despite anti‐ulcer treatment
Exclusion:
1. Myocardial infarction in the last 6 months
2. Cardiac failure
3. Bleeding diathesis
Setting: secondary care, Pakistan

Index tests

Index test: stool antigen test
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Stool Antigen Test

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

High

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Ferrara 1998

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 100
Female: 56 (56%)
Age: not stated
Presentation:
1. Patients with dyspepsia
2. Not on current treatment for H pylori
Setting: secondary care, Italy

Index tests

Index test: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Serology

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

High

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Formichella 2013

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 500
Female: 263 (52.6%)
Age: 50 years
Presentation:
1. Patients undergoing routine endoscopy
Exclusion:
1. Undergone H pylori eradication therapy
2. Active immunosuppressive therapy
3. Suffering from malignant diseases
Setting: secondary care, Germany

Index tests

Index test 1a: serology
Further details:
Technical specifications: recomWell ELISA (Mikrogen)
Performed by: not stated
Criteria for positive diagnosis: not stated

Index test 1b: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: 2 or more antigens

Index test 1c: serology
Further details:
Technical specifications: Immunoblot Helicobacter (Mikrogen)
Performed by: not stated
Criteria for positive diagnosis: not stated

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain, Warthin‐Starry stain, and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Serology

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

High

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Yes

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Germana 2001

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 100
Female: 52 (52%)
Age: 51 years
Presentation:
1. Patients with dyspepsia
2. Not on current treatment for H pylori
Setting: secondary care, Italy

Index tests

Index test: urea breath test‐13C
Further details:
Technical specifications: Wagner Analysen ‐ Tecturik
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 4.0% (30 minutes)

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and immunohistochemical stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Urea breath test‐13C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Graham 1996a

Study characteristics

Patient sampling

Type of study: retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 75
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing screening for H pylori and who underwent endoscopy
Setting: secondary care, USA

Index tests

Index test: serology
Further details:
Technical specifications: FlexSure HP
Performed by: not stated
Criteria for positive diagnosis: pink line

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 476 (86.4%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Serology

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Yes

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

No

High

Gramley 1999

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients

Patient characteristics and setting

Sample size: 22
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing endoscopy
Setting: secondary care, USA

Index tests

Index test: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Yes

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Yes

Low

Low

DOMAIN 2: Index Test Serology

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

High

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Yes

Unclear

Guo 2011

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 328
Female: 90 (27.4%)
Age: 47 years
Presentation:
1. Patients with gastrointestinal symptoms
2. No previous treatment or stopped treatment for H pylori
Setting: secondary care, China

Index tests

Index test: stool antigen test
Further details:
Technical specifications: Kyowa pharmaceutical
Performed by: not stated
Criteria for positive diagnosis: not stated

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with silver stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Stool Antigen Test

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

High

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

Yes

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

Unclear

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Gurbuz 2005

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither ‐ patients with previous gastric surgery excluded

Patient characteristics and setting

Sample size: 65
Female: 45 (69.2%)
Age: not stated
Presentation:
1. Patients undergoing routine endoscopy
Exclusion:
1. Undergone H pylori eradication therapy
2. Pregnancy or lactation
3. Prior gastric surgery
Setting: secondary care, Turkey

Index tests

Index test: urea breath test‐14C
Further details:
Technical specifications: Heliprobe system
Performed by: not stated
Criteria for positive diagnosis: Counts per minute > 50 (10 minutes)

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 3 (4.4%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

No

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

High

Unclear

DOMAIN 2: Index Test Urea breath test‐14C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Yes

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

No

High

Hafeez 2007

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither ‐ patients with inadequate breath samples excluded

Patient characteristics and setting

Sample size: 60
Female: not stated
Age: not stated
Presentation:
1. Children with gastrointestinal symptoms
Setting: secondary care, Pakistan

Index tests

Index test 1: urea breath test‐13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 4.0% (10 minutes, 20 minutes, and 30 minutes)

Index test 2: stool antigen test
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 6 (10%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

No

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

High

Unclear

DOMAIN 2: Index Test Urea breath test‐13C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 2: Index Test Stool Antigen Test

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

High

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

Yes

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

Unclear

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Yes

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

No

High

Han 2012

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 99
Female: not stated
Age: not stated
Presentation:
1. Patients who had undergone urea breath tests and endoscopy
Setting: secondary care, South Korea

Index tests

Index test: urea breath test ‐ unknown isotope
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Urea breath test ‐ unknown isotope

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

High

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

Yes

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

Unclear

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Inelmen 2004

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients

Patient characteristics and setting

Sample size: 122
Female: 81 (66.4%)
Age: 80 years
Presentation:
1. Patients undergoing upper gastrointestinal endoscopy
Setting: secondary care, Italy

Index tests

Index test 1: urea breath test‐13C
Further details:
Technical specifications: BreathQuality‐UBT 13C‐Urea Kit, Zeta Farmaceutici SpA
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 5.0% (30 minutes)

Index test 2: stool antigen test
Further details:
Technical specifications: Premier Platinum HpSA (Meridian Diagnostics)
Performed by: not stated
Criteria for positive diagnosis: definite yellow colour

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Yes

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Yes

Low

Low

DOMAIN 2: Index Test Urea breath test‐13C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 2: Index Test Stool Antigen Test

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Yes

Unclear

Iqbal 2013

Study characteristics

Patient sampling

Type of study: retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 50
Female: 19 (38%)
Age: 41 years
Presentation:
1. Patients who underwent upper gastrointestinal endoscopy
Setting: secondary care, Pakistan

Index tests

Index test: serology
Further details:
Technical specifications: HpG screen ELISA kit
Performed by: not stated
Criteria for positive diagnosis: > 7 units/ml

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Serology

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Yes

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Islam 2005

Study characteristics

Patient sampling

Type of study: prospective study
Consecutive or random sample: neither ‐ patients without stool samples excluded

Patient characteristics and setting

Sample size: 112
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing upper gastrointestinal endoscopy
Setting: secondary care, New Zealand

Index tests

Index test: stool antigen test
Further details:
Technical specifications: Premier Platinum HpSA (Meridian Diagnostics)
Performed by: pathologists
Criteria for positive diagnosis: Absorbance 450/630 nm > 0.120

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Immunoperoxidase stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 15 (11.8%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

No

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

High

Unclear

DOMAIN 2: Index Test Stool Antigen Test

Were the index test results interpreted without knowledge of the results of the reference standard?

Yes

If a threshold was used, was it pre‐specified?

Yes

Low

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Yes

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

No

High

Ivanova 2010

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 33
Female: 16 (48.5%)
Age: 42 years
Presentation:
1. Patients undergoing upper gastrointestinal endoscopy
Setting: secondary care, Bulgaria

Index tests

Index test: serology
Further details:
Technical specifications: Rapid HP, US Meds
Performed by: not stated
Criteria for positive diagnosis: not stated

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Serology

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

High

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

Yes

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

Unclear

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Jekarl 2013

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither ‐ patients with a recent antibiotic treatment were excluded

Patient characteristics and setting

Sample size: 209
Female: 85 (40.7%)
Age: not stated
Presentation:
1. Patients undergoing routine health check‐up and upper gastrointestinal endoscopy
Exclusion:
1. Recent ulcer or H pylori treatment
2. Previous gastric surgery
3. Previous gastric cancer
Setting: secondary care, Korea

Index tests

Index test: stool antigen test
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: Absence of yellow

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Warthin‐Starry stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 57 (21.4%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

No

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

High

Unclear

DOMAIN 2: Index Test Stool Antigen Test

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Yes

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

No

High

Jensen 1998

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear

Patient characteristics and setting

Sample size: 35
Female: not stated
Age: not stated
Presentation:
1. Patients referred for endoscopy
Exclusion:
Recent H pylori treatment
Setting: secondary care, USA

Index tests

Index test: urea breath test‐14C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: disintegrations per minute > 200 (10 minutes)

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 7 (16.7%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Urea breath test‐14C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Yes

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

No

High

Jordaan 2008

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither ‐ patients with previous gastrointestinal surgery excluded

Patient characteristics and setting

Sample size: 103
Female: not stated
Age: not stated
Presentation:
1. Patients with dyspepsia
Exclusion criteria:
1. Recent H pylori therapy
2. Major gastrointestinal surgery
Setting: secondary care, South Africa

Index tests

Index test: urea breath test‐13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 4.5% (time not stated)

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 8 (7.2%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

No

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

High

Unclear

DOMAIN 2: Index Test Urea breath test‐13C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

No

High

Kalach 1998a

Study characteristics

Patient sampling

Type of study: prospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 100
Female: 35 (35%)
Age: 11 years
Presentation:
1. Children undergoing upper gastrointestinal endoscopy for recurrent epigastric pain or upper GI tract disorders
Exclusion:
1. Recent H pylori treatment
Setting: secondary care, France

Index tests

Index test: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: > 6 IU /ml

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Serology

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Yes

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Kamel 2011

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 55
Female: not stated
Age: 67 years
Presentation:
1. Older adults with dyspepsia and no gastrointestinal bleeding
Setting: secondary care, Egypt

Index tests

Index test: stool antigen test
Further details:
Technical specifications: CerTest H pylori Card
Performed by: not stated
Criteria for positive diagnosis: not stated

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Stool Antigen Test

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Yes

Unclear

High

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Kim 2016

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 107
Female: 56 (52.3%)
Age: 41 years
Presentation:
1. Patients undergoing upper gastrointestinal endoscopy
Exclusion:
1. Recent H pylori treatment
Setting: secondary care, South Korea

Index tests

Index test: urea breath test‐13C
Further details:
Technical specifications: UbiT‐IR300 apparatus
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 2.5% (20 minutes)

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Urea breath test‐13C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

Yes

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

Unclear

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Korstanje 2006

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 20
Female: 9 (45%)
Age: 68 years
Presentation:
1. Patients with atrophic gastritis
Setting: primary care, Netherlands

Index tests

Index test 1: urea breath test‐13C
Further details:
Technical specifications: INFAI, Bochum, Germany
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 4.0% (30 minutes)

Index test 2: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: Absorbance (wavelength not stated) > 0.320

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

High

DOMAIN 2: Index Test Urea breath test‐13C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 2: Index Test Serology

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Kuloglu 2008

Study characteristics

Patient sampling

Type of study: prospective study
Consecutive or random sample: neither ‐ patients without a either a stool sample or a breath sample excluded

Patient characteristics and setting

Sample size: 109
Female: 58 (53.2%)
Age: 12 years
Presentation:
1. Children with symptoms suggestive of H pylori infection
Exclusion criteria:
1. Recent H pylori treatment
Setting: secondary care, Turkey

Index tests

Index test 1: urea breath test‐14C
Further details:
Technical specifications: Heliprobe BreathCard
Performed by: not stated
Criteria for positive diagnosis: Counts per minute > 50 (10 minutes)

Index test 2: stool antigen test
Further details:
Technical specifications: Rapid HpSA test (LİNEAR Chemical)
Performed by: not stated
Criteria for positive diagnosis: pinkish red band (within 10 minutes)

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 16 (12.8%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

No

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

High

Unclear

DOMAIN 2: Index Test Urea breath test‐14C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 2: Index Test Stool Antigen Test

Were the index test results interpreted without knowledge of the results of the reference standard?

Yes

If a threshold was used, was it pre‐specified?

Yes

Low

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Yes

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

No

High

Ladas 2002a

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients

Patient characteristics and setting

Sample size: 130
Female: 48 (36.9%)
Age: 50 years
Presentation:
1. Patients with dyspepsia
Exclusion:
1. Recent H pylori therapy
2. Malignancy
3. Pregnancy
4. Gastric surgery
Setting: secondary care, Greece

Index tests

Index test 1a: serology
Further details:
Technical specifications: Pyloriset EIA‐G
Performed by: not stated
Criteria for positive diagnosis: ≥ 300

Index test 1b: serology
Further details:
Technical specifications: Milenia H Pylori IgG
Performed by: not stated
Criteria for positive diagnosis: ≥ 44

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa and Warthin‐Starry stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Yes

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Yes

Low

Low

DOMAIN 2: Index Test Serology

Were the index test results interpreted without knowledge of the results of the reference standard?

Yes

If a threshold was used, was it pre‐specified?

Yes

Low

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

Yes

Were the reference standard results interpreted without knowledge of the results of the index tests?

Yes

Low

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Yes

Unclear

Lahner 2004

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients

Patient characteristics and setting

Sample size: 27
Female: 19 (70.4%)
Age: 52 years
Presentation:
1. Patients with atrophic gastritis
Exclusion criteria:
1. Gastric surgery
2. Gastric malignancy
3. Recent H pylori treatment
4. Diarrhoea
5. Constipation
Setting: not stated

Index tests

Index test 1: urea breath test‐13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 4.5% (15 minutes and 30 minutes)

Index test 2: stool antigen test
Further details:
Technical specifications: HpSA, Meridian
Performed by: not stated
Criteria for positive diagnosis: Absorbance 450 nm ≥ 0.160

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Yes

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Yes

Low

Low

DOMAIN 2: Index Test Urea breath test‐13C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 2: Index Test Stool Antigen Test

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

Yes

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

Unclear

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Yes

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Yes

Low

Lee 1998

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients

Patient characteristics and setting

Sample size: 71
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing endoscopy for duodenitis, gastritis, duodenal ulcer, gastric ulcer
Exclusion criteria:
1. Recent H pylori treatment
Setting: secondary care, Singapore

Index tests

Index test: urea breath test‐13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 6% (30 minutes)

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Yes

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Yes

Low

Low

DOMAIN 2: Index Test Urea breath test‐13C

Were the index test results interpreted without knowledge of the results of the reference standard?

Yes

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Yes

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Yes

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Yes

Low

Logan 1991a

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 50
Female: 24 (48%)
Age: 51 years
Presentation:
1. Patients undergoing upper gastrointestinal endoscopy
Exclusion criteria:
1. Recent H pylori infection
2. Previous gastric surgery
Setting: secondary care, UK

Index tests

Index test: urea breath test‐13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: > Mean + 3 standard deviations above normal level (60 minutes)

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Urea breath test‐13C

Were the index test results interpreted without knowledge of the results of the reference standard?

No

If a threshold was used, was it pre‐specified?

No

High

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Yes

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Lombardo 2003

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither ‐ histology performed in a subset of patients

Patient characteristics and setting

Sample size: 28
Female: not stated
Age: not stated
Presentation:
1. Patients who had undergone gastrectomy
Setting: secondary care, Italy

Index tests

Index test: urea breath test ‐ unknown isotope
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 4 per ml (at 5‐minute intervals up to 30 minutes)

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 72 (72%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

No

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

High

High

DOMAIN 2: Index Test Urea breath test ‐ unknown isotope

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

No

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

No

High

Lottspeich 2007

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither ‐ patients with recent antibiotic treatment were excluded

Patient characteristics and setting

Sample size: 56 for urea breath test, 100 for stool antigen test
Female: not stated
Age: 10 years
Presentation:
1. Children with abdominal symptoms undergoing endoscopy
Exclusion criteria:
1. Recent H pylori treatment
Setting: secondary care, Germany

Index tests

Index test 1: urea breath test‐13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 5.0% (30 minutes)

Index test 2: stool antigen test
Further details:
Technical specifications: IDEIA HpStAR assay (DakoCytomation)
Performed by: not stated
Criteria for positive diagnosis: Absorbance 450/620 nm to 650 nm ≥ 0.150

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain or Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 44 (44%) for urea breath test; 0 (0%) for stool antigen test

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

No

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

High

Unclear

DOMAIN 2: Index Test Urea breath test‐13C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 2: Index Test Stool Antigen Test

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Yes

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Yes

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Luthra 1998

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 240
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing upper gastrointestinal endoscopy
Excluded:
1. People with upper GI bleeding
2. People with coagulation abnormalities
Setting: not stated

Index tests

Index test: serology
Further details:
Technical specifications: Pyloristat (BioWhittaker)
Performed by: not stated
Criteria for positive diagnosis: not stated

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain, immunostain, or Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Serology

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

High

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Mana 2001a

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients

Patient characteristics and setting

Sample size: 182
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing upper gastrointestinal endoscopy
2. People not taking H pylori medication
Setting: secondary care, Belgium

Index tests

Index test 1: urea breath test‐13C
Further details:
Technical specifications: not stated
Performed by: not stated
Multiple criteria for positive diagnosis:

  • Delta over baseline > 3.0% (10 minutes)

  • Delta over baseline > 3.0% (20 minutes)

  • Delta over baseline > 3.0% (30 minutes)

  • Delta over baseline > 3.5% (10 minutes)

  • Delta over baseline > 3.5% (20 minutes)

  • Delta over baseline > 3.5% (30 minutes)

  • Delta over baseline > 4.0% (10 minutes)

  • Delta over baseline > 4.0% (20 minutes)

  • Delta over baseline > 4.0% (30 minutes)

  • Delta over baseline > 4.5% (10 minutes)

  • Delta over baseline > 4.5% (20 minutes)

  • Delta over baseline > 4.5% (30 minutes)

  • Delta over baseline > 5.0% (10 minutes)

  • Delta over baseline > 5.0% (20 minutes)

  • Delta over baseline > 5.0% (30 minutes)

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with immunohistochemistry and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Yes

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Yes

Low

Low

DOMAIN 2: Index Test Urea breath test‐13C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

No

High

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

Yes

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

Unclear

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Yes

Unclear

Mansour‐Ghanaei 2011

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients

Patient characteristics and setting

Sample size: 125
Female: 65 (52%)
Age: 36 years
Presentation:
1. Patients with dyspepsia
Exclusion:
1. Recent or past H pylori eradication
2. Pregnancy
3. Severe cardiopulmonary disorders or other life‐threatening illnesses
Setting: secondary care, Iran

Index tests

Index test 1: urea breath test‐14C
Further details:
Technical specifications: Heliprobe BreathCard
Performed by: not stated
Criteria for positive diagnosis: Counts per minute > 50 (15 minutes)

Index test 2: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: > 11 IU

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Yes

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Yes

Low

Low

DOMAIN 2: Index Test Urea breath test‐14C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

No

High

Low

DOMAIN 2: Index Test Serology

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Yes

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Yes

Low

Mion 1994

Study characteristics

Patient sampling

Type of study: retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 95
Female: not stated
Age: not stated
Presentation:
1. Patients with upper abdominal symptoms
Exclusion:
1. Patients with previous gastric surgery
Setting: secondary care, France

Index tests

Index test: urea breath test‐13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: > + 3 delta 0/00 (30 minutes)

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with Warthin‐Starry stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Urea breath test‐13C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

No

High

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

Yes

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

Unclear

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Yes

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Misawa 1998

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 114
Female: 46 (40.4%)
Age: not stated
Presentation:
1. Patients with gastritis, gastric, or duodenal ulcers
Setting: secondary care, Japan

Index tests

Index test 1a: serology (IgA)
Further details:
Technical specifications: GAP‐IgA (BioMerica)
Performed by: not stated
Criteria for positive diagnosis: not stated

Index test 1b: serology (IgG)
Further details:
Technical specifications: GAP‐IgG (BioMerica)
Performed by: not stated
Criteria for positive diagnosis: not stated

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with immunostaining (Carnoy's solution)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Serology

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

High

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

Yes

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

Unclear

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Mohammadian 2007

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 179
Female: 108 (60.3%)
Age: 54 years
Presentation:
1. Patients undergoing endoscopy for gastrointestinal problems
Setting: secondary care, Iran

Index tests

Index test: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Serology

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

High

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

Yes

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

Unclear

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Monteiro 2001a

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients

Patient characteristics and setting

Sample size: 104
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing endoscopy
Exclusion criteria:
1. Recent H pylori therapy
2. Bleeding disorders or other conditions with contraindication for endoscopy or biopsy
Setting: secondary care, France

Index tests

Index test 1: urea breath test‐13C
Further details:
Technical specifications: ABCA, Europa Scientific
Performed by: not stated
Criteria for positive diagnosis: not stated

Index test 2a: serology
Further details:
Technical specifications: Pyloriset EIA Kit (Orion Diagnostica)
Performed by: not stated
Criteria for positive diagnosis: > = 300

Index test 2b: serology
Further details:
Technical specifications: Helicoblot Immunoblot kit
Performed by: not stated
Criteria for positive diagnosis: not stated

Index test 3: stool antigen test
Further details:
Technical specifications: Premier Platinum HpSA, Meridian
Performed by: not stated
Criteria for positive diagnosis: Absorbance (wavelength not reported) > = 0.160

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Yes

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Yes

Low

Low

DOMAIN 2: Index Test Urea breath test‐13C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

High

DOMAIN 2: Index Test Stool Antigen Test

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 2: Index Test Serology

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Yes

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Morales 1995

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 104
Female: 52 (50%)
Age: 50 years
Presentation:
1. Patients with upper abdominal symptoms
Setting: Outpatients, Mexico

Index tests

Index test 1: urea breath test‐14C
Further details:
Technical specifications: not stated
Performed by: not stated
Multiple criteria for positive diagnosis:

First criterion: ≥ 1.6% excretion (time not stated)

Second criterion: not stated

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with Warthin‐Starry stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Urea breath test‐14C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

No

High

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

Yes

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

Unclear

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Noguera 1998

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear

Patient characteristics and setting

Sample size: 38
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing urea breath tests and endoscopic biopsy
Setting: secondary care, Argentina

Index tests

Index test 1: urea breath test‐13C
Further details:
Technical specifications: not stated
Performed by: not stated
Multiple criteria for positive diagnosis:

  • > 1% excretion (10 minutes)

  • > 1% excretion (20 minutes)

  • > 1% excretion (30 minutes)

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 87 (69.6%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Urea breath test‐14C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

No

High

Novis 1991

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 76
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing endoscopy for gastrointestinal symptoms
Setting: secondary care, Israel

Index tests

Index test 1: urea breath test‐14C
Further details:
Technical specifications: not stated
Performed by: not stated
Multiple criteria for positive diagnosis:

  • > 4.7% excretion (5 minutes)

  • > 4.7% excretion (10 minutes)

  • > 4.7% excretion (15 minutes)

  • > 4.7% excretion (20 minutes)

  • > 4.7% excretion (25 minutes)

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Urea breath test‐14C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

No

High

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

Yes

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

Unclear

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Yes

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Ogata 2001

Study characteristics

Patient sampling

Type of study: prospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 47
Female: 27 (57.4%)
Age: 12 years
Presentation:
1. Children with dyspepsia undergoing endoscopy
Exclusion:
1. Recent H pylori treatment
2. Immunosuppressive treatment or chemotherapy
3. Extradigestive disease
Setting: secondary care, Brazil

Index tests

Index test 1: urea breath test‐13C
Further details:
Technical specifications: Isomed
Performed by: not stated
Criteria for positive diagnosis: > 3% excretion (time not stated)

Index test 2: serology
Further details:
Technical specifications: Cobas Core II (Roche)
Performed by: not stated
Criteria for positive diagnosis: > 7 U/ml

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

High

DOMAIN 2: Index Test Urea breath test‐13C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 2: Index Test Serology

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Yes

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Ozturk 2003

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 73
Female: 56 (74.6%)
Age: 41 years
Presentation:
1. Patients with dyspepsia
Setting: secondary care, Turkey

Index tests

Index test 1a: urea breath test‐14C
Further details:
Technical specifications: Heliprobe BreathCard
Performed by: not stated
Criteria for positive diagnosis: Counts per minute > 50 (10 minutes)

Index test 1b: urea breath test‐14C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: disintegrations per minute > 100 (10 minutes)

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Urea breath test‐14C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

Yes

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

Unclear

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Yes

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Peitz 2001

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients

Patient characteristics and setting

Sample size: 145
Female: 87 (60%)
Age: 59 years
Presentation:
1. Patients with dyspepsia
Exclusion criteria:
1. Recent H pylori treatment
2. Recent NSAID treatment
3. Previous gastric surgery
4. Clotting disorders
Setting: secondary care, Germany

Index tests

Index test: serology
Further details:
Technical specifications: Helisa Rapid Whole Blood Test (Cortecs Diagnostics Ltd)
Performed by: not stated
Criteria for positive diagnosis: not stated

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Yes

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Yes

Low

Low

DOMAIN 2: Index Test Serology

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Yes

Unclear

High

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Yes

Unclear

Peura 1996

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 200
Female: 118 (59%)
Age: not stated
Presentation:
1. Patients undergoing endoscopy
Exclusion criteria:
1. Recent H pylori treatment
2. Gastric surgery
Setting: secondary care, USA

Index tests

Index test: urea breath test‐14C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: disintegrations per minute > 200 (10 minutes)

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Urea breath test‐14C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

Yes

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

Unclear

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Yes

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Puspok 1999

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients

Patient characteristics and setting

Sample size: 72
Female: 42 (58.3%)
Age: 55 years
Presentation:
1. Patients undergoing endoscopy
Exclusion criteria:
1. Recent H pylori treatment
Setting: secondary care, Austria

Index tests

Index test: stool antigen test
Further details:
Technical specifications: Premier Platinum HpSA (Meridian Diagnostics)
Performed by: not stated
Criteria for positive diagnosis: Absorbance 450/620 nm ≥ 0.100

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Yes

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Yes

Low

Low

DOMAIN 2: Index Test Stool Antigen Test

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Yes

Unclear

Qadeer 2009

Study characteristics

Patient sampling

Type of study: prospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 100
Female: 50 (50%)
Age: 39 years
Presentation:
1. Patients with dyspepsia
Exlusion criteria:
1. Recent H pylori therapy
2. Not on anti‐coagulant therapy
3. Oral anticoagulants or NSAID treatment
Setting: secondary care, Pakistan

Index tests

Index test: stool antigen test
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: pink‐red band

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Stool Antigen Test

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

Yes

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

Unclear

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Rafeey 2007

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 96
Female: 31 (32.3%)
Age: 8 years
Presentation:
1. Children with dyspepsia or abdominal pain
Exclusion criteria:
1. Recent H pylori treatment
2. Diarrhoea
Setting: secondary care, Iran

Index tests

Index test: stool antigen test
Further details:
Technical specifications: Equipar HPSA test
Performed by: not stated
Criteria for positive diagnosis: not stated

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Stool Antigen Test

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

High

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Rasool 2007

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients

Patient characteristics and setting

Sample size: 94
Female: 34 (36.2%)
Age: 41 years
Presentation:
1. Patients with dyspepsia
Exclusion criteria:
1. Recent H pylori treatment
2. Pregnancy
3. Gastric surgery
Setting: secondary care, Pakistan

Index tests

Index test: urea breath test
Further details:
Technical specifications: Heliprobe BreathCard
Performed by: not stated
Criteria for positive diagnosis: Counts per minute > 50 (10 minutes)

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Yes

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Yes

Low

Low

DOMAIN 2: Index Test Urea breath test‐14C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Yes

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Rathbone 1986

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 73
Female: not stated
Age: not stated
Presentation:
1. Patients with dyspepsia
Setting: secondary care, UK

Index tests

Index test: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: > Mean + 2 standard deviations above normal level

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Serology

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

No

High

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Safe 1993

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 100
Female: 59 (59%)
Age: 72 years
Presentation:
1. Elderly dyspeptic patients
Setting: secondary care, UK

Index tests

Index test: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: > 10 units/ml

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Serology

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Yes

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Yes

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Salles‐Montaudon 2002

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 107
Female: 71 (66.4%)
Age: 85 years
Presentation:
1. Adults > 75 years
Exclusion criteria:
1. Contraindication to biopsy
Setting: secondary care, Switzerland

Index tests

Index test 1: urea breath test‐13C
Further details:
Technical specifications: ABCA, Europa Scientific
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 3.5% (30 minutes)

Index test 2: serology
Further details:
Technical specifications: Pyloriset EIA Kit (Orion Diagnostica)
Performed by: not stated
Criteria for positive diagnosis: > 300 Units

Index test 3: stool antigen test
Further details:
Technical specifications: Premier Platinum HpSA, Meridian
Performed by: not stated
Criteria for positive diagnosis: Absorbance (wavelength not reported) > 0.160

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Urea breath test‐13C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 2: Index Test Stool Antigen Test

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 2: Index Test Serology

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Yes

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Schilling 2001

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 68
Female: 20 (29.4%)
Age: 62 years
Presentation:
1. Patients with partial gastric resection
Exclusion criteria:
Recent H pylori treatment
Setting: secondary care, Germany

Index tests

Index test: urea breath test‐13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 4.0% (30 minutes)

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with Warthin‐Starry stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

High

DOMAIN 2: Index Test Urea breath test‐13C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

Yes

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

Unclear

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Scuderi 2000

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 250
Female: 127 (50.8%)
Age: 58 years
Presentation:
1. Patients with dyspeptic symptoms
Setting: secondary care, Italy

Index tests

Index test: stool antigen test
Further details:
Technical specifications: Premier Platinum HpSA (Meridian Diagnostics)
Performed by: not stated
Criteria for positive diagnosis: not stated

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Stool Antigen Test

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

High

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

Yes

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

Unclear

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Segamwenge 2014

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither ‐ patients with recent antibiotic treatment were excluded

Patient characteristics and setting

Sample size: 160
Female: not stated
Age: not stated
Presentation:
1. Patients with dyspepsia
Exclusion criteria
1. Could not tolerate endoscopy
2. Recent H pylori treatment
3. Pain attributable to pancreas or liver
4. NSAID‐related dyspepsia
Setting: secondary care, Italy

Index tests

Index test: stool antigen test
Further details:
Technical specifications: Rapid strip HPSA (Meridian Bioscience)
Performed by: not stated
Criteria for positive diagnosis: not stated

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

No

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

High

Unclear

DOMAIN 2: Index Test Stool Antigen Test

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

High

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

No

High

Selcukcan 2011

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 100
Female: 47 (47%)
Age: not stated
Presentation:
1. Infants undergoing endoscopy
Exclusion criteria:
1. No recent H pylori treatment
Setting: secondary care, Turkey

Index tests

Index test: urea breath test‐14C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Urea breath test‐14C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

High

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Sharbatdaran 2013

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients

Patient characteristics and setting

Sample size: 61
Female: 36 (59%)
Age: 31 years
Presentation:
1. Patients with dyspepsia
Exclusion criteria:
1. Recent H pylori infection
2. Gastric cancer
3. Bleeding during endoscopy
Setting: secondary care, Iran

Index tests

Index test: stool antigen test
Further details:
Technical specifications: GA Generic Assay
Performed by: not stated
Criteria for positive diagnosis: Absorbance 450 nm > + 0.1 of negative control

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Yes

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Yes

Low

Low

DOMAIN 2: Index Test Stool Antigen Test

Were the index test results interpreted without knowledge of the results of the reference standard?

Yes

If a threshold was used, was it pre‐specified?

Yes

Low

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Yes

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Yes

Unclear

Sheu 1998a

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 135
Female: not stated
Age: not stated
Presentation:
1. Patients with dyspepsia
Setting: secondary care, Mexico

Index tests

Index test: urea breath test‐13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not clearly stated

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Urea breath test‐13C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

High

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Sheu 1998b

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 66
Female: not stated
Age: not stated
Presentation:
1. Patients with gastrectomy
Setting: secondary care, Mexico

Index tests

Index test: urea breath test‐13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not clearly stated

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

High

DOMAIN 2: Index Test Urea breath test‐13C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

High

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Shin 2009

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 651
Female: 254 (39%)
Age: 58 years
Presentation:
1. Patients undergoing endoscopy
Exclusion criteria:
1. Recent H pylori treatment
2. Chronic medication
3. Gastric surgery
Setting: secondary care, South Korea

Index tests

Index test: serology
Further details:
Technical specifications: Genedia H pylori
Performed by: not stated
Criteria for positive diagnosis: Absorbance 450 nm > 0.406

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Serology

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Yes

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

Yes

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

Unclear

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Soomro 2012

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 100
Female: 44 (44%)
Age: not stated
Presentation:
1. Patients undergoing endoscopic biopsy for dyspepsia or gastritis
Setting: secondary care, Pakistan

Index tests

Index test: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated

Index test: stool antigen test
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Stool Antigen Test

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

High

DOMAIN 2: Index Test Serology

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

High

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

Yes

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

Unclear

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Surveyor 1989

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients

Patient characteristics and setting

Sample size: 63
Female: 30 (47.8%)
Age: 59 years
Presentation:
1. Patients with symptoms related to upper gastrointestinal tract undergoing endoscopy
Setting: secondary care, Australia

Index tests

Index test: urea breath test‐14C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain, Warthin‐Starry stain, and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Yes

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Yes

Low

Low

DOMAIN 2: Index Test Urea breath test‐14C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

High

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Yes

Unclear

Thobani 1995

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 26
Female: not stated
Age: not stated
Presentation:
1. Patients with upper gastrointestinal symptoms
Setting: secondary care, Pakistan

Index tests

Index test: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: > 2

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Serology

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Tiwari 2014

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 30
Female: 25 (83.3%)
Age: not stated
Presentation:
1. Patients undergoing endoscopy
Exclusion criteria:
1. Recent H pylori treatment
Setting: secondary care, India

Index tests

Index test: urea breath test‐14C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: disintegrations per minute > 200 (10 minutes)

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Urea breath test‐14C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Trevisani 2005

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 105
Female: 50 (47.6%)
Age: 58 years
Presentation:
1. Patients referred to endoscopy centre
Exclusion criteria:
1. Recent H pylori treatment
2. Pregnancy or lactation
3. Steroids or NSAID treatment
4. Prior gastric surgery
5. Bleeding peptic ulcer
6. Severe concomitant diseases
Setting: secondary care, Italy

Index tests

Index test 1a: stool antigen test
Further details:
Technical specifications: Amplified IDEA Hp StAR
Performed by: doctor
Criteria for positive diagnosis: Absorbance 450 nm ≥ 0.190

Index test 1b: stool antigen test
Further details:
Technical specifications: Immunocard Stat
Performed by: doctor
Criteria for positive diagnosis: pink red band (5 minutes)

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Stool Antigen Test

Were the index test results interpreted without knowledge of the results of the reference standard?

Yes

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Vandenplas 1992

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients

Patient characteristics and setting

Sample size: 95
Female: 50 (52.6%)
Age: 9 years
Presentation:
1. Children with chronic abdominal pain
Exclusion criteria:
1. Recent H pylori treatment
Setting: secondary care, Belgium

Index tests

Index test 1: urea breath test‐13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not clearly stated

Index test 2: serology
Further details:
Technical specifications: Malakit Helicobacter pylori (Biolab)
Performed by: not stated
Criteria for positive diagnosis: > Mean + 3 standard deviations above normal level

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Yes

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Yes

Low

Low

DOMAIN 2: Index Test Urea breath test‐13C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

High

DOMAIN 2: Index Test Serology

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Yes

Unclear

Villalobos 1992

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 105
Female: 69 (65.7%)
Age: not stated
Presentation:
1. Patients with dyspepsia
Excluded:
1. Recent H pylori treatment
2. Patients taking steroids
3. Patients with coagulopathy
4. Patients allergic to penicillin
5. Pregnancy or lactation
Setting: secondary care, Mexico

Index tests

Index test: urea breath test‐14C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: disintegrations per minute > 1.6% (60 minutes)

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Urea breath test‐14C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

Yes

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

Unclear

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Wang 2008

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither ‐ patients with recent antibiotic treatment were excluded

Patient characteristics and setting

Sample size: 123
Female: 69 (56.1%)
Age: 48 years
Presentation:
1. Asymptomatic individuals
Exclusion criteria:
1. Recent H pylori therapy
2. Gastric surgery
Setting: secondary care, Italy

Index tests

Index test: serology
Further details:
Technical specifications: Assure H pylori Rapid Test (CIM‐test, Genelabs Diagnostics Ltd)
Performed by: not stated
Criteria for positive diagnosis: not stated

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain, Warthin‐Starry stain, and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 214 (63.5%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

No

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

High

Unclear

DOMAIN 2: Index Test Serology

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Yes

Unclear

High

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

No

High

Wardi 2012

Study characteristics

Patient sampling

Type of study: retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 76
Female: 15 (19.7%)
Age: 70 years
Presentation:
1. Patients with partial gastrectomy
Setting: secondary care, Israel

Index tests

Index test: urea breath test ‐ C13
Further details:
Technical specifications: BreathID
Performed by: not stated
Criteria for positive diagnosis: not clearly stated

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

High

DOMAIN 2: Index Test Urea breath test‐13C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

No

High

High

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Weiss 1994

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 95
Female: not stated
Age: not stated
Presentation:
1. Patients with abdominal pain
Exclusion criteria:
1. Recent H pylori treatment
Setting: secondary care, USA

Index tests

Index test 1a: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated

Index test 1b: serology
Further details:
Technical specifications: Cobas Core anti‐H pylori (Roche)
Performed by: not stated
Criteria for positive diagnosis: not stated

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Serology

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

High

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Yan 2003

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither ‐ patients with recent antibiotic treatment were excluded

Patient characteristics and setting

Sample size: 31
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing endoscopy
Exclusion criteria:
1. Recent H pylori treatment
Setting: secondary care, China

Index tests

Index test: stool antigen test
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: Absorbance 450/630 nm ≥ 0.120

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with Warthin‐Starry stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 32 (50.8%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

No

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

High

Unclear

DOMAIN 2: Index Test Stool Antigen Test

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

Yes

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

Unclear

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

No

High

Yoshimura 2001

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process

Patient characteristics and setting

Sample size: 72
Female: 34 (47.2%)
Age: 13 years
Presentation:
1. Children undergoing endoscopy for symptoms such as anaemia and abdominal pain
Exclusion criteria:
1. Recent H pylori treatment
Setting: secondary care, Japan

Index tests

Index test 1: urea breath test‐13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 3.0% (20 minutes and 30 minutes)

Index test 2: serology
Further details:
Technical specifications: HM‐CAP Anti‐H pylori‐EIA; Kyowa Medics
Performed by: not stated
Criteria for positive diagnosis: ≥ 1.8

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Unclear

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

Unclear

Unclear

DOMAIN 2: Index Test Urea breath test‐13C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Yes

Unclear

Low

DOMAIN 2: Index Test Serology

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Unclear

Unclear

Yu 1999

Study characteristics

Patient sampling

Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither ‐ patients with recent antibiotic treatment were excluded

Patient characteristics and setting

Sample size: 88
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing endoscopy
Exclusion criteria:
1. Recent H pylori treatment
Setting: secondary care, Singapore

Index tests

Index test: urea breath test‐14C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Warthin‐Starry stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 16 (16.5%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

No

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Unclear

High

Unclear

DOMAIN 2: Index Test Urea breath test‐14C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Yes

Unclear

High

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

No

High

Yu 2001

Study characteristics

Patient sampling

Type of study: retrospective study
Consecutive or random sample: consecutive patients

Patient characteristics and setting

Sample size: 32
Female: 14 (43.8%)
Age: 51 years
Presentation:
1. Patients undergoing endoscopy
Exclusion criteria:
1. Recent H pylori treatment
2. Gastric surgery
Setting: secondary care, Taiwan, China

Index tests

Index test 1: urea breath test‐13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 2.8% (15 minutes)

Index test 2: stool antigen test
Further details:
Technical specifications: Premier Platinum HpSA, Meridian
Performed by: not stated
Multiple criteria for positive diagnosis:

  • Absorbance 450 nm > 0.140

  • Visual assessment by gastroenterologists

Target condition and reference standard(s)

Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy

Flow and timing

Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)

Comparative

Notes

Methodological quality

Item

Authors' judgement

Risk of bias

Applicability concerns

DOMAIN 1: Patient Selection

Was a consecutive or random sample of patients enrolled?

Yes

Was a case‐control design avoided?

Yes

Did the study avoid inappropriate exclusions?

Yes

Low

Low

DOMAIN 2: Index Test Urea breath test‐13C

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Yes

Unclear

Low

DOMAIN 2: Index Test Stool Antigen Test

Were the index test results interpreted without knowledge of the results of the reference standard?

Unclear

If a threshold was used, was it pre‐specified?

Unclear

Unclear

Low

DOMAIN 3: Reference Standard

Is the reference standards likely to correctly classify the target condition?

No

Were the reference standard results interpreted without knowledge of the results of the index tests?

Unclear

High

Low

DOMAIN 4: Flow and Timing

Was there an appropriate interval between index test and reference standard?

Unclear

Did all patients receive the same reference standard?

Yes

Were all patients included in the analysis?

Yes

Unclear

CO2 ‐ carbon dioxide;
H & E stain ‐ haematoxylin and eosin stain;
HpSA ‐ H pylori stool antigen;
IgA ‐ immunoglobulin A;
IgG ‐ immunoglobulin G;
NMR ‐ nuclear magnetic resonance;
NSAID ‐ non‐steroidal anti‐inflammatory
WBC ‐ white blood cell

All other acronyms and abbreviations are the full title of either products or companies producing products included in the study.

Characteristics of studies awaiting classification [ordered by study ID]

Buhigas‐Garcia 2008

Study characteristics

Patient sampling

Patient characteristics and setting

Index tests

urea breath test‐13C

Target condition and reference standard(s)

Flow and timing

Comparative

Notes

Fazeli 2004

Study characteristics

Patient sampling

Patient characteristics and setting

Index tests

salivary test, potential index tests of interest

Target condition and reference standard(s)

Flow and timing

Comparative

Notes

Fuke 2009

Study characteristics

Patient sampling

Patient characteristics and setting

Index tests

serology

Target condition and reference standard(s)

Flow and timing

Comparative

Notes

Glupczynski 1991

Study characteristics

Patient sampling

Patient characteristics and setting

Index tests

urea breath test‐13C

Target condition and reference standard(s)

Flow and timing

Comparative

Notes

Karczewska 1997

Study characteristics

Patient sampling

Patient characteristics and setting

Index tests

serology

Target condition and reference standard(s)

Flow and timing

Comparative

Notes

Kushch 2014

Study characteristics

Patient sampling

Patient characteristics and setting

Index tests

unclear

Target condition and reference standard(s)

Flow and timing

Comparative

Notes

Lappas 1997

Study characteristics

Patient sampling

Patient characteristics and setting

Index tests

salivary test, potential index tests of interest

Target condition and reference standard(s)

Flow and timing

Comparative

Notes

Lee 1999a

Study characteristics

Patient sampling

Patient characteristics and setting

Index tests

urea breath test‐13C

Target condition and reference standard(s)

Flow and timing

Comparative

Notes

Martin‐de‐Argila 1997

Study characteristics

Patient sampling

Patient characteristics and setting

Index tests

serology

Target condition and reference standard(s)

Flow and timing

Comparative

Notes

Mason 1997

Study characteristics

Patient sampling

Patient characteristics and setting

Index tests

urea breath test

Target condition and reference standard(s)

Flow and timing

Comparative

Notes

Thong‐Ngam 2011

Study characteristics

Patient sampling

Patient characteristics and setting

Index tests

serology

Target condition and reference standard(s)

Flow and timing

Comparative

Notes

Tokunaga 2005a

Study characteristics

Patient sampling

Patient characteristics and setting

Index tests

urea breath test

Target condition and reference standard(s)

Flow and timing

Comparative

Notes

Xu 1995

Study characteristics

Patient sampling

Patient characteristics and setting

Index tests

urea breath test‐13C

Target condition and reference standard(s)

Flow and timing

Comparative

Notes

Data

Presented below are all the data for all of the tests entered into the review.

Open in table viewer
Tests. Data tables by test

Test

No. of studies

No. of participants

1 Urea breath test‐13C Show forest plot

34

3139


Urea breath test‐13C.

Urea breath test‐13C.

2 Urea breath test‐14C Show forest plot

21

1810


Urea breath test‐14C.

Urea breath test‐14C.

3 Urea breath test ‐ Unknown isotope Show forest plot

2

127


Urea breath test ‐ Unknown isotope.

Urea breath test ‐ Unknown isotope.

4 Serology Show forest plot

34

4242


Serology.

Serology.

5 Stool antigen test Show forest plot

29

2988


Stool antigen test.

Stool antigen test.

6 Urea breath test‐13C (delta over baseline > 3% (20 minutes)) Show forest plot

2

254


Urea breath test‐13C (delta over baseline > 3% (20 minutes)).

Urea breath test‐13C (delta over baseline > 3% (20 minutes)).

7 Urea breath test‐13C (delta over baseline > 3% (30 minutes)) Show forest plot

3

333


Urea breath test‐13C (delta over baseline > 3% (30 minutes)).

Urea breath test‐13C (delta over baseline > 3% (30 minutes)).

8 Urea breath test‐13C (delta over baseline > 3.5% (30 minutes)) Show forest plot

3

368


Urea breath test‐13C (delta over baseline > 3.5% (30 minutes)).

Urea breath test‐13C (delta over baseline > 3.5% (30 minutes)).

9 Urea breath test‐13C (delta over baseline > 4% (10 minutes)) Show forest plot

2

236


Urea breath test‐13C (delta over baseline > 4% (10 minutes)).

Urea breath test‐13C (delta over baseline > 4% (10 minutes)).

10 Urea breath test‐13C (delta over baseline > 4% (20 minutes)) Show forest plot

2

236


Urea breath test‐13C (delta over baseline > 4% (20 minutes)).

Urea breath test‐13C (delta over baseline > 4% (20 minutes)).

11 Urea breath test‐13C (delta over baseline > 4% (30 minutes)) Show forest plot

10

958


Urea breath test‐13C (delta over baseline > 4% (30 minutes)).

Urea breath test‐13C (delta over baseline > 4% (30 minutes)).

12 Urea breath test‐13C (delta over baseline > 4.5% (30 minutes)) Show forest plot

3

288


Urea breath test‐13C (delta over baseline > 4.5% (30 minutes)).

Urea breath test‐13C (delta over baseline > 4.5% (30 minutes)).

13 Urea breath test‐13C (delta over baseline > 5% (30 minutes)) Show forest plot

4

601


Urea breath test‐13C (delta over baseline > 5% (30 minutes)).

Urea breath test‐13C (delta over baseline > 5% (30 minutes)).

14 Urea breath test‐14C (counts per minute > 50) Show forest plot

6

471


Urea breath test‐14C (counts per minute > 50).

Urea breath test‐14C (counts per minute > 50).

15 Urea breath test‐14C (disintegrations per minute > 200) Show forest plot

4

296


Urea breath test‐14C (disintegrations per minute > 200).

Urea breath test‐14C (disintegrations per minute > 200).

16 Serology > 7 units/ml Show forest plot

2

97


Serology > 7 units/ml.

Serology > 7 units/ml.

17 Serology ≥300 units Show forest plot

2

234


Serology ≥300 units.

Serology ≥300 units.

Clinical pathway
Figuras y tablas -
Figure 1

Clinical pathway

Study flow diagram.
Figuras y tablas -
Figure 2

Study flow diagram.

Risk of bias and applicability concerns graph: review authors' judgements about each domain presented as percentages across included studies. For each domain, the numbers shown on the bar represent the number of studies that were scored as high, unclear or low in terms of risk of bias or applicability concern.
Figuras y tablas -
Figure 3

Risk of bias and applicability concerns graph: review authors' judgements about each domain presented as percentages across included studies. For each domain, the numbers shown on the bar represent the number of studies that were scored as high, unclear or low in terms of risk of bias or applicability concern.

Forest plot of urea breath test‐13C.FN = false negative; FP = false positive; TN = true negative; TP = true positive. The forest plot shows an estimate of sensitivity and specificity from each study and the threshold used. Studies are sorted by threshold, sensitivity and specificity. For threshold, the number of minutes in brackets is the time after administration of urea.
Figuras y tablas -
Figure 4

Forest plot of urea breath test‐13C.FN = false negative; FP = false positive; TN = true negative; TP = true positive. The forest plot shows an estimate of sensitivity and specificity from each study and the threshold used. Studies are sorted by threshold, sensitivity and specificity. For threshold, the number of minutes in brackets is the time after administration of urea.

Forest plot of urea breath test‐13C at commonly reported thresholds. FN = false negative; FP = false positive; TN = true negative; TP = true positive. Thresholds are shown in brackets and the number of minutes in brackets is the time after administration of urea.
Figuras y tablas -
Figure 5

Forest plot of urea breath test‐13C at commonly reported thresholds. FN = false negative; FP = false positive; TN = true negative; TP = true positive. Thresholds are shown in brackets and the number of minutes in brackets is the time after administration of urea.

Forest plot of urea breath test‐14C. FN = false negative; FP = false positive; TN = true negative; TP = true positive. The forest plot shows an estimate of sensitivity and specificity from each study and the threshold used. Studies are sorted by threshold, sensitivity and specificity. For threshold, the number of minutes in brackets is the time after administration of urea.
Figuras y tablas -
Figure 6

Forest plot of urea breath test‐14C. FN = false negative; FP = false positive; TN = true negative; TP = true positive. The forest plot shows an estimate of sensitivity and specificity from each study and the threshold used. Studies are sorted by threshold, sensitivity and specificity. For threshold, the number of minutes in brackets is the time after administration of urea.

Forest plot of serology. FN = false negative; FP = false positive; SD = standard deviation; TN = true negative; TP = true positive. The forest plot shows an estimate of sensitivity and specificity from each study and the threshold used. Studies are sorted by threshold, sensitivity and specificity. Other threshold is staining of a 120kDa protein (CagA) gel band and/or at least two of five proteins between 28–33 kDa.
Figuras y tablas -
Figure 7

Forest plot of serology. FN = false negative; FP = false positive; SD = standard deviation; TN = true negative; TP = true positive. The forest plot shows an estimate of sensitivity and specificity from each study and the threshold used. Studies are sorted by threshold, sensitivity and specificity. Other threshold is staining of a 120kDa protein (CagA) gel band and/or at least two of five proteins between 28–33 kDa.

Forest plot of stool antigen test. FN = false negative; FP = false positive; TN = true negative; TP = true positive; WL = wavelength. The forest plot shows an estimate of sensitivity and specificity from each study and the threshold used. Studies are sorted by threshold, sensitivity and specificity.
Figuras y tablas -
Figure 8

Forest plot of stool antigen test. FN = false negative; FP = false positive; TN = true negative; TP = true positive; WL = wavelength. The forest plot shows an estimate of sensitivity and specificity from each study and the threshold used. Studies are sorted by threshold, sensitivity and specificity.

Summary ROC plot of non‐invasive tests for H pylori infection. The SROC curves for the four tests are parallel. The curve for each test is drawn within the range of estimates of specificity from the studies included for the test.
Figuras y tablas -
Figure 9

Summary ROC plot of non‐invasive tests for H pylori infection. The SROC curves for the four tests are parallel. The curve for each test is drawn within the range of estimates of specificity from the studies included for the test.

Summary ROC plot of direct comparisons of urea breath test‐13C and serology. Each summary curve was drawn restricted to the range of specificities for each test. The size of each symbol was scaled according to the precision of sensitivity and specificity in the study. A dotted line joins the pair of points for the two tests from each study.
Figuras y tablas -
Figure 10

Summary ROC plot of direct comparisons of urea breath test‐13C and serology. Each summary curve was drawn restricted to the range of specificities for each test. The size of each symbol was scaled according to the precision of sensitivity and specificity in the study. A dotted line joins the pair of points for the two tests from each study.

Summary ROC plot of direct comparisons of urea breath test‐13C and stool antigen test. Each summary curve was drawn restricted to the range of specificities for each test. The size of each symbol was scaled according to the precision of sensitivity and specificity in the study. A dotted line joins the pair of points for the two tests from each study.
Figuras y tablas -
Figure 11

Summary ROC plot of direct comparisons of urea breath test‐13C and stool antigen test. Each summary curve was drawn restricted to the range of specificities for each test. The size of each symbol was scaled according to the precision of sensitivity and specificity in the study. A dotted line joins the pair of points for the two tests from each study.

Risk of bias and applicability concerns summary: review authors' judgements about each domain for each study included for urea breath test‐13C
Figuras y tablas -
Figure 12

Risk of bias and applicability concerns summary: review authors' judgements about each domain for each study included for urea breath test‐13C

Risk of bias and applicability concerns summary: review authors' judgements about each domain for each study included for urea breath test‐14C.
Figuras y tablas -
Figure 13

Risk of bias and applicability concerns summary: review authors' judgements about each domain for each study included for urea breath test‐14C.

Risk of bias and applicability concerns summary: review authors' judgements about each domain for each study included for serology
Figuras y tablas -
Figure 14

Risk of bias and applicability concerns summary: review authors' judgements about each domain for each study included for serology

Risk of bias and applicability concerns summary: review authors' judgements about each domain for each study included for the stool antigen test
Figuras y tablas -
Figure 15

Risk of bias and applicability concerns summary: review authors' judgements about each domain for each study included for the stool antigen test

Urea breath test‐13C.
Figuras y tablas -
Test 1

Urea breath test‐13C.

Urea breath test‐14C.
Figuras y tablas -
Test 2

Urea breath test‐14C.

Urea breath test ‐ Unknown isotope.
Figuras y tablas -
Test 3

Urea breath test ‐ Unknown isotope.

Serology.
Figuras y tablas -
Test 4

Serology.

Stool antigen test.
Figuras y tablas -
Test 5

Stool antigen test.

Urea breath test‐13C (delta over baseline > 3% (20 minutes)).
Figuras y tablas -
Test 6

Urea breath test‐13C (delta over baseline > 3% (20 minutes)).

Urea breath test‐13C (delta over baseline > 3% (30 minutes)).
Figuras y tablas -
Test 7

Urea breath test‐13C (delta over baseline > 3% (30 minutes)).

Urea breath test‐13C (delta over baseline > 3.5% (30 minutes)).
Figuras y tablas -
Test 8

Urea breath test‐13C (delta over baseline > 3.5% (30 minutes)).

Urea breath test‐13C (delta over baseline > 4% (10 minutes)).
Figuras y tablas -
Test 9

Urea breath test‐13C (delta over baseline > 4% (10 minutes)).

Urea breath test‐13C (delta over baseline > 4% (20 minutes)).
Figuras y tablas -
Test 10

Urea breath test‐13C (delta over baseline > 4% (20 minutes)).

Urea breath test‐13C (delta over baseline > 4% (30 minutes)).
Figuras y tablas -
Test 11

Urea breath test‐13C (delta over baseline > 4% (30 minutes)).

Urea breath test‐13C (delta over baseline > 4.5% (30 minutes)).
Figuras y tablas -
Test 12

Urea breath test‐13C (delta over baseline > 4.5% (30 minutes)).

Urea breath test‐13C (delta over baseline > 5% (30 minutes)).
Figuras y tablas -
Test 13

Urea breath test‐13C (delta over baseline > 5% (30 minutes)).

Urea breath test‐14C (counts per minute > 50).
Figuras y tablas -
Test 14

Urea breath test‐14C (counts per minute > 50).

Urea breath test‐14C (disintegrations per minute > 200).
Figuras y tablas -
Test 15

Urea breath test‐14C (disintegrations per minute > 200).

Serology > 7 units/ml.
Figuras y tablas -
Test 16

Serology > 7 units/ml.

Serology ≥300 units.
Figuras y tablas -
Test 17

Serology ≥300 units.

Summary of findings Performance of non‐invasive tests for diagnosis of H pylori infection

What is the best non‐invasive test for diagnosis of H pylori infection?

Population

Children and adults with gastrointestinal symptoms

Setting

Primary care setting

Index tests

Urea breath test‐13C, Urea breath test‐14C, serology, and stool antigen test

Threshold

Various thresholds were used for each test

Role and purpose of test

Screening and diagnosis of H pylori

Reference standard

Endoscopic biopsy with Haemotoxylin & Eosin stain, special stains, or combination of Haemotoxylin & Eosin and special stains

Quality of evidence

Risk of bias was generally high or unclear with respect to the selection of participants, and the conduct and interpretation of the index tests and reference standard. Applicability concerns were also generally high or unclear with respect to selection of participants

Limitations

There was heterogeneity in thresholds and reference standards. Studies did not often prespecify or clearly report thresholds used

Pre‐test probability (prevalence of Helicobacter pylori)

Median (interquartile range) = 53.7% (42.0% to 66.5%)

Index test

Number of participants (studies)

Diagnostic odds ratio (95% CI)

Sensitivity (95% CI) at fixed specificity of 0.901

Missed H pylori cases per 1000 people tested (95% CI)2

Urea breath test‐13C

3139 participants

(34 studies)

153 (95% CI 73.7 to 316)

0.94 (0.89 to 0.97)

30 (15 to 58)

Urea breath test‐14C

1810 participants

(21 studies)

105 (95% CI 74.0 to 150)

0.92 (0.89 to 0.94)

42 (30 to 58)

Serology

4242 participants

(34 studies)

47.4 (95% CI 25.5 to 88.1)

0.84 (0.74 to 0.91)

86 (50 to 140)

Stool antigen test

2988 participants

(29 studies)

45.1 (95% CI 24.2 to 84.1)

0.83 (0.73 to 0.90)

89 (52 to 146)

Comparison of non‐invasive tests for H pylori infection

Based on an indirect comparison of the four tests using all the studies, there was statistical evidence of a difference in diagnostic accuracy (P = 0.024). Direct comparisons were based on few head‐to‐head studies. The ratios of diagnostic odds ratios (95% CI; P value) were 0.68 (95% CI 0.12 to 3.70; P = 0.56) for urea breath test‐13C versus serology (seven studies), and 0.88 (95% CI 0.14 to 5.56; P = 0.84) for urea breath test‐13C versus stool antigen test (seven studies). The 95% confidence intervals of these estimates overlap with those of the ratios of diagnostic odds ratios from the indirect comparison. Data were limited or unavailable for meta‐analysis of other direct comparisons.

Conclusions

In people with no history of gastrectomy and those who have not recently had antibiotics or proton pump inhibitors, urea breath tests had high diagnostic accuracy while serology and stool antigen tests had lower accuracy to detect H pylori infection. Although susceptible to bias due to confounding, this conclusion is based on evidence from indirect test comparisons as evidence from direct comparisons was based on few studies or was unavailable. It should be noted that studies were generally of poor methodological quality. The thresholds used for the tests were highly variable and there is currently insufficient evidence to recommend specific thresholds for use in clinical practice.

1The sensitivities were estimated along the SROC curves at the median specificity across the studies included for the four tests.

2Based on the sensitivity estimated at the median specificity of 0.90, and the median prevalence of 53.7% from the included studies, the numbers of missed H pylori cases were calculated using a hypothetical cohort of 1000 people suspected of having H pylori infection. The 95% CI for the number of missed cases is from the 95% CI for sensitivity. For a specificity of 0.90 and prevalence of 53.7%, there will be 46 false positives. See Table 3 for results for other values of specificity and prevalence.

Figuras y tablas -
Summary of findings Performance of non‐invasive tests for diagnosis of H pylori infection
Table 1. Summary of results at thresholds commonly reported for urea breath test‐13C, urea breath test‐14C and serology

Threshold

Studies

Number of participants (cases)

Sensitivity (95% CI)

Specificity (95% CI)

Urea breath test‐13C

Delta over baseline > 3% (20 minutes)

2

254 (128)

0.98 (0.90 to 1.00)

0.92 (0.82 to 0.97)

Delta over baseline > 3% (30 minutes)

3

333 (140)

0.99 (0.92 to 1.00)

0.95 (0.90 to 0.98)

Delta over baseline > 3.5% (30 minutes)

3

368 (120)

0.75 to 1.00

0.77 to 1.00

Delta over baseline > 4% (10 minutes)

2

236 (118)

0.91 to 1.00

0.60 to 0.95

Delta over baseline > 4% (20 minutes)

2

236 (118)

0.91 to 1.00

0.60 to 0.96

Delta over baseline > 4% (30 minutes)

10

958 (423)

0.95 (0.79 to 0.99)

0.95 (0.87 to 0.98)

Delta over baseline > 4.5% (30 minutes)

3

288 (106)

0.50 to 0.96

0.82 to 0.96

Delta over baseline > 5% (30 minutes)

4

601 (315)

0.95 (0.49 to 1.00)

0.94 (0.84 to 0.98)

Urea breath test‐14C

Counts per minute > 50 (10 minutes)

6

471 (231)

0.89 (0.55 to 0.98)

0.91 (0.79 to 0.96)

Disintegrations per minute > 200 (10 minutes)

4

296 (132)

0.95 (0.33 to 1.00)

0.95 (0.80 to 0.99)

Serology

> 7 units/ml

2

97 (48)

0.98 (0.74 to 1.00)

0.71 (0.51 to 0.86)

≥ 300 unit

2

234 (143)

0.91 (0.82 to 0.96)

0.86 (0.72 to 0.93)

Tests evaluated at the same threshold by more than one study are presented in the table. When there were two or three studies at the same threshold, and little or no heterogeneity was observed in ROC space, estimates of summary sensitivity and summary specificity were obtained by using univariate fixed‐effect logistic regression models to pool sensitivities and specificities separately. When there were two or three studies and we observed heterogeneity, we did not perform meta‐analysis but report the range of the sensitivities and specificities.

Figuras y tablas -
Table 1. Summary of results at thresholds commonly reported for urea breath test‐13C, urea breath test‐14C and serology
Table 2. Indirect comparison of the accuracy of non‐invasive tests for H pylori infection

Index tests

Studies;

participants (H pyloripresent)

DOR (95% CI)

Ratio of diagnostic odds ratios (95% CI), P value

Urea breath test‐13C

Urea breath test‐14C

Serology

Urea breath test‐13C

34; 3139 (1526)

153 (73.7 to 316)

Urea breath test‐14C

21; 1810 (1018)

105 (74.0 to 150)

1.45 (0.65 to 3.26),

P = 0.36

Serology

34; 4242 (2477)

47.4 (25.5 to 88.1)

3.22 (1.24 to 8.37),

P = 0.017

2.22 (1.09 to 4.51),

P = 0.028

Stool antigen test

29; 2988 (1311)

45.1 (24.2 to 84.1)

3.39 (1.30 to 8.83),

P = 0.013

2.33 (1.14 to 4.76),

P = 0.020

1.05 (0.44 to 2.53),

P = 0.91

The indirect comparison included all studies that evaluated at least one of the four tests, i.e. all available data. The ratio of diagnostic odds ratios is the diagnostic odds ratio (DOR) of the test in the column divided by the DOR of the test in the row. If the ratio is greater than one, then the test in the column is more accurate than the test in the row; if the ratio is less than one, the test in the row is more accurate than the test in the column.

Figuras y tablas -
Table 2. Indirect comparison of the accuracy of non‐invasive tests for H pylori infection
Table 3. Accuracy of non‐invasive tests for H pylori infection at different levels of prevalence

Prevalence (%)

Specificity

False positives1

Test

Sensitivity (95% CI)

Missed cases (95% CI)

42.0

0.79

122

Urea breath test‐13C

0.98 (0.95 to 0.99)

10 (5 to 20)

Urea breath test‐14C

0.97 (0.95 to 0.98)

15 (10 to 20)

Serology

0.93 (0.87 to 0.96)

31 (17 to 54)

Stool antigen test

0.92 (0.87 to 0.96)

32 (18 to 57)

53.7

0.79

97

Urea breath test‐13C

0.98 (0.95 to 0.99)

13 (6 to 26)

Urea breath test‐14C

0.97 (0.95 to 0.98)

19 (13 to 26)

Serology

0.93 (0.87 to 0.96)

39 (22 to 69)

Stool antigen test

0.92 (0.87 to 0.96)

41 (23 to 72)

66.5

0.79

70

Urea breath test‐13C

0.98 (0.95 to 0.99)

16 (8 to 32)

Urea breath test‐14C

0.97 (0.95 to 0.98)

23 (16 to 32)

Serology

0.93 (0.87 to 0.96)

49 (27 to 85)

Stool antigen test

0.92 (0.87 to 0.96)

51 (28 to 89)

42.0

0.90

58

Urea breath test‐13C

0.94 (0.89 to 0.97)

23 (12 to 46)

Urea breath test‐14C

0.92 (0.89 to 0.94)

33 (24 to 46)

Serology

0.84 (0.74 to 0.91)

67 (39 to 110)

Stool antigen test

0.83 (0.73 to 0.90)

70 (41 to 114)

53.7

0.90

46

Urea breath test‐13C

0.94 (0.89 to 0.97)

30 (15 to 58)

Urea breath test‐14C

0.92 (0.89 to 0.94)

42 (30 to 58)

Serology

0.84 (0.74 to 0.91)

86 (50 to 140)

Stool antigen test

0.83 (0.73 to 0.90)

89 (52 to 146)

66.5

0.90

34

Urea breath test‐13C

0.94 (0.89 to 0.97)

37 (18 to 72)

Urea breath test‐14C

0.92 (0.89 to 0.94)

53 (38 to 72)

Serology

0.84 (0.74 to 0.91)

106 (62 to 173)

Stool antigen test

0.83 (0.73 to 0.90)

111 (64 to 180)

42.0

0.96

23

Urea breath test‐13C

0.86 (0.75 to 0.93)

57 (30 to 103)

Urea breath test‐14C

0.81 (0.76 to 0.86)

78 (58 to 103)

Serology

0.66 (0.52 to 0.79)

141 (90 to 204)

Stool antigen test

0.65 (0.50 to 0.78)

146 (93 to 209)

53.7

0.96

19

Urea breath test‐13C

0.86 (0.75 to 0.93)

73 (38 to 132)

Urea breath test‐14C

0.81 (0.76 to 0.86)

100 (74 to 132)

Serology

0.66 (0.52 to 0.79)

181 (115 to 260)

Stool antigen test

0.65 (0.50 to 0.78)

187 (119 to 267)

66.5

0.96

13

Urea breath test‐13C

0.86 (0.75 to 0.93)

90 (47 to 163)

Urea breath test‐14C

0.81 (0.76 to 0.86)

124 (92 to 163)

Serology

0.66 (0.52 to 0.79)

224 (142 to 322)

Stool antigen test

0.65 (0.50 to 0.78)

231 (148 to 331)

1Average number of participants who are diagnosed with H pylori infection but do not have the infection per 1000 tested.

The sensitivities were estimated from the SROC curves at fixed values (lower quartile, median and upper quartile) of specificity from the included studies across all tests. Based on these sensitivities and specificities, and quartiles of prevalence from the included studies (across all tests), the numbers of missed H pylori cases and false positives (i.e. overdiagnosed people) were calculated using a hypothetical cohort of 1000 people suspected of having H pylori infection.

Figuras y tablas -
Table 3. Accuracy of non‐invasive tests for H pylori infection at different levels of prevalence
Table 4. Direct comparison of the accuracy of non‐invasive tests for H pylori infection

Test

Urea breath test‐13C

Urea breath test‐14C

Serology

Urea breath test‐13C

Urea breath test‐14C

N = 0

Serology

N = 7

DOR (95% CI) of urea breath test‐13C = 74.8 (95% CI 17.8 to 314)

DOR (95% CI) of serology = 111 (95% CI 41.2 to 297)

RDORs (95% CI) of urea breath test‐13C versus serology, P value = 0.68 (95% CI 0.12 to 3.70), P = 0.56

N = 1

Stool antigen test

N = 7
DOR (95% CI) of urea breath test‐13C = 46.6 (95% CI 3.30 to 658)

DOR (95% CI) of stool antigen test = 53.0 (95% CI 5.34 to 527)

RDORs (95% CI) of urea breath test‐13C versus stool antigen test, P value = 0.88 (95% CI 0.14 to 5.56), P = 0.84

N = 2

N = 4

DOR = diagnostic odds ratio; N = number of studies; RDORs = ratio of diagnostic odds ratios.

Due to paucity of data and substantial heterogeneity observed in ROC space which precluded the use of simpler meta‐analytic models, meta‐analyses were not possible for two test comparisons that had more than one study. For the single study of urea breath test‐14C versus serology (Mansour‐Ghanaei 2011), both tests had similar sensitivity, but specificity was higher for urea breath test‐14C than for serology. The ratio of diagnostic odds ratios is the DOR of the test in the column divided by the DOR of the test in the row. If the ratio is greater than one, then the test in the column is more accurate than the test in the row; if the ratio is less than one, the test in the row is more accurate than the test in the column.

Figuras y tablas -
Table 4. Direct comparison of the accuracy of non‐invasive tests for H pylori infection
Table Tests. Data tables by test

Test

No. of studies

No. of participants

1 Urea breath test‐13C Show forest plot

34

3139

2 Urea breath test‐14C Show forest plot

21

1810

3 Urea breath test ‐ Unknown isotope Show forest plot

2

127

4 Serology Show forest plot

34

4242

5 Stool antigen test Show forest plot

29

2988

6 Urea breath test‐13C (delta over baseline > 3% (20 minutes)) Show forest plot

2

254

7 Urea breath test‐13C (delta over baseline > 3% (30 minutes)) Show forest plot

3

333

8 Urea breath test‐13C (delta over baseline > 3.5% (30 minutes)) Show forest plot

3

368

9 Urea breath test‐13C (delta over baseline > 4% (10 minutes)) Show forest plot

2

236

10 Urea breath test‐13C (delta over baseline > 4% (20 minutes)) Show forest plot

2

236

11 Urea breath test‐13C (delta over baseline > 4% (30 minutes)) Show forest plot

10

958

12 Urea breath test‐13C (delta over baseline > 4.5% (30 minutes)) Show forest plot

3

288

13 Urea breath test‐13C (delta over baseline > 5% (30 minutes)) Show forest plot

4

601

14 Urea breath test‐14C (counts per minute > 50) Show forest plot

6

471

15 Urea breath test‐14C (disintegrations per minute > 200) Show forest plot

4

296

16 Serology > 7 units/ml Show forest plot

2

97

17 Serology ≥300 units Show forest plot

2

234

Figuras y tablas -
Table Tests. Data tables by test